These    O
vortices    O
are    O
usually    O
studied    O
using    O
lattice    O
simulations    O
,    O
and    O
it    O
has    O
been    O
found    O
that    O
the    O
behavior    O
of    O
the    O
vortices    O
is    O
closely    O
linked    O
with    O
the    O
confinement    B-Body109224911
–    O
deconfinement    B-Body109224911
phase    O
transition    O
:    O
in    O
the    O
confinement    O
phase    O
vortices    O
percolate    O
and    O
fill    O
the    O
spacetime    O
volume    O
,    O
in    O
the    O
deconfinement    O
phase    O
they    O
are    O
much    O
suppressed    O
.    O

Deconfinement    B-Body109224911
was    O
claimed    O
in    O
2000    O
at    O
CERN    O
SPS    O
in    O
heavy    O
-    O
ion    O
collisions    O
,    O
and    O
it    O
implies    O
a    O
new    O
state    O
of    O
matter    O
:    O
quark–gluon    B-Body109224911
plasma    I-Body109224911
,    O
less    O
interacting    O
than    O
in    O
the    O
nucleus    B-Body109224911
,    O
almost    O
as    O
in    O
a    O
liquid    O
.    O

This    O
means    O
that    O
,    O
if    O
quarks    O
are    O
free    O
(    O
like    O
in    O
the    O
deconfined    B-Body109224911
phase    I-Body109224911
)    O
,    O
the    O
center    O
symmetry    O
will    O
be    O
broken    O
.    O

The    O
inflaton    B-Body109224911
field    I-Body109224911
is    O
a    O
hypothetical    O
scalar    O
field    O
that    O
is    O
theorized    O
to    O
drive    O
cosmic    O
inflation    O
in    O
the    O
very    O
early    O
universe    O
.    O

Non    O
-    O
minimally    O
coupled    O
inflation    O
is    O
an    O
inflationary    O
model    O
in    O
which    O
the    O
constant    O
which    O
couples    O
gravity    O
to    O
the    O
inflaton    B-Body109224911
field    I-Body109224911
is    O
not    O
small    O
.    O

Massless    O
(    O
i.e.    O
long    O
-    O
ranged    O
)    O
scalar    O
fields    O
in    O
this    O
context    O
are    O
known    O
as    O
inflaton    B-Body109224911
.    O

The    O
,    O
and    O
fields    O
are    O
all    O
vectors    O
in    O
this    O
sense    O
,    O
so    O
the    O
corresponding    O
particles    O
are    O
said    O
to    O
be    O
vector    B-Body109224911
boson    I-Body109224911
.    O

In    O
2010    O
,    O
Hagen    O
was    O
awarded    O
The    O
American    O
Physical    O
Society    O
's    O
J.    O
J.    O
Sakurai    O
Prize    O
for    O
Theoretical    O
Particle    O
Physics    O
for    O
the    O
"    O
elucidation    O
of    O
the    O
properties    O
of    O
spontaneous    O
symmetry    O
breaking    O
in    O
four    O
-    O
dimensional    O
relativistic    O
gauge    O
theory    O
and    O
of    O
the    O
mechanism    O
for    O
the    O
consistent    O
generation    O
of    O
vector    B-Body109224911
boson    I-Body109224911
masses    O
"    O
.    O

Vector    B-Body109224911
boson    I-Body109224911
,    O
a    O
boson    O
with    O
the    O
spin    O
quantum    O
number    O
equal    O
to    O
1    O

Normally    O
,    O
one    O
treats    O
such    O
a    O
decomposition    O
as    O
relating    O
to    O
specific    O
particles    O
:    O
so    O
,    O
for    O
example    O
,    O
the    O
pion    O
,    O
which    O
is    O
a    O
chiral    O
vector    B-Body109224911
particle    I-Body109224911
,    O
is    O
composed    O
of    O
a    O
quark    O
-    O
anti    O
-    O
quark    O
pair    O
.    O

this    O
particle    O
has    O
been    O
variously    O
hypothesized    O
to    O
be    O
diquark    B-Body109224911
or    O
a    O
mesonic    O
molecule    O
.    O

T    B-Body109224911
mesons    I-Body109224911
are    O
hypothetical    O
mesons    O
composed    O
of    O
a    O
top    O
quark    O
and    O
either    O
an    O
up    O
,    O
down    O
,    O
strange    O
or    O
charm    O
antiquark    O
.    O

Methanetetracarboxylic    B-Body109224911
acid    I-Body109224911

Kalb–Ramond    B-Body109224911
field    I-Body109224911

NS–NS    B-Body109224911
sector    I-Body109224911

A    O
chromomere    B-Body109224911
,    O
also    O
known    O
as    O
an    O
idiomere    B-Body109224911
,    O
is    O
one    O
of    O
the    O
serially    O
aligned    O
beads    O
or    O
granules    O
of    O
a    O
eukaryotic    O
chromosome    O
,    O
resulting    O
from    O
local    O
coiling    O
of    O
a    O
continuous    O
DNA    O
thread    O
.    O

SU(3    O
)    O
weight    O
diagrams    O
(    O
see    O
below    O
)    O
are    O
2-dimensional    O
with    O
the    O
coordinates    O
referring    O
to    O
two    O
quantum    O
numbers    O
,    O
"    O
I"z    O
,    O
which    O
is    O
the    O
z    O
-    O
component    O
of    O
isospin    O
and    O
"    O
Y    O
"    O
,    O
which    O
is    O
the    O
hypercharge    O
(    O
the    O
sum    O
of    O
strangeness    O
(    O
"    O
S    O
"    O
)    O
,    O
charm    B-Body109224911
(    O
"    O
C    O
"    O
)    O
,    O
bottomness    B-Body109224911
(    O
"    O
B"′    O
)    O
,    O
topness    B-Body109224911
(    O
"    O
T    O
"    O
)    O
,    O
and    O
baryon    O
number    O
(    O
"    O
B    O
"    O
)    O
)    O
.    O

For    O
all    O
the    O
quark    O
flavour    O
quantum    O
numbers    O
(    O
strangeness    O
,    O
charm    B-Body109224911
,    O
topness    B-Body109224911
and    O
bottomness    B-Body109224911
)    O
the    O
convention    O
is    O
that    O
the    O
flavour    O
charge    O
and    O
the    O
electric    O
charge    O
of    O
a    O
quark    O
have    O
the    O
same    O
sign    O
.    O

The    O
symbols    O
encountered    O
in    O
this    O
list    O
are    O
:    O
I    O
(    O
"    O
isospin    B-Body109224911
"    O
)    O
,    O
J    O
(    O
"    O
total    O
angular    O
momentum    O
quantum    O
number    O
"    O
)    O
,    O
P    O
(    O
"    O
parity    O
"    O
)    O
,    O
Q    O
(    O
"    O
charge    O
"    O
)    O
,    O
S    O
(    O
"    O
strangeness    O
"    O
)    O
,    O
C    O
(    O
"    O
charmness    B-Body109224911
"    O
)    O
,    O
B′    O
(    O
"    O
bottomness    B-Body109224911
"    O
)    O
,    O
T    O
(    O
"    O
topness    B-Body109224911
"    O
)    O
,    O
u    O
(    O
"    O
up    O
quark    O
"    O
)    O
,    O
d    O
(    O
"    O
down    O
quark    O
"    O
)    O
,    O
s    O
(    O
"    O
strange    O
quark    O
"    O
)    O
,    O
c    O
(    O
"    O
charm    O
quark    O
"    O
)    O
,    O
b    O
(    O
"    O
bottom    O
quark    O
"    O
)    O
,    O
t    O
(    O
"    O
top    O
quark    O
"    O
)    O
,    O
as    O
well    O
as    O
other    O
subatomic    O
particles    O
(    O
hover    O
for    O
name    O
)    O
.    O

Extra    B-Body109224911
marker    I-Body109224911
chromosomes    I-Body109224911

An    O
observation    O
of    O
0νββ    O
would    O
conclusively    O
show    O
that    O
neutrinos    O
are    O
Majorana    B-Body109224911
fermion    I-Body109224911
;    O
that    O
is    O
,    O
they    O
are    O
their    O
own    O
antiparticles    O
.    O

In    O
1991    O
,    O
by    O
extending    O
his    O
theory    O
concerning    O
this    O
force    O
to    O
chiral    O
superfluids    O
,    O
he    O
predicted    O
the    O
existence    O
of    O
fermionic    O
bound    O
states    O
,    O
quasiparticles    O
now    O
known    O
as    O
Majorana    B-Body109224911
fermion    I-Body109224911
and    O
that    O
it    O
may    O
be    O
possible    O
to    O
observe    O
in    O
topological    O
superfluids    O
and    O
superconductors    O
.    O

where    O
is    O
the    O
quadratic    O
Casimir    O
of    O
and    O
is    O
another    O
Casimir    O
invariant    O
defined    O
by    O
for    O
generators    O
of    O
the    O
Lie    O
algebra    O
in    O
the    O
representation    O
R.    O
(    O
For    O
Weyl    O
or    O
Majorana    B-Body109224911
fermions    I-Body109224911
,    O
replace    O
by    O
,    O
and    O
for    O
real    O
scalars    O
,    O
replace    O
by    O
.    O
)    O
For    O
gauge    O
fields    O
(    O
"    O
i.e.    O
"    O
gluons    O
)    O
,    O
necessarily    O
in    O
the    O
adjoint    O
of    O
,    O
;    O
for    O
fermions    O
in    O
the    O
fundamental    O
(    O
or    O
anti    O
-    O
fundamental    O
)    O
representation    O
of    O
,    O
.    O

Neutrino    O
mass    O
:    O
What    O
is    O
the    O
mass    O
of    O
neutrinos    O
,    O
whether    O
they    O
follow    O
Dirac    O
or    O
Majorana    B-Body109224911
statistics    O
?    O

Observation    O
of    O
0νββ    O
would    O
establish    O
that    O
the    O
neutrino    O
is    O
a    O
Majorana    B-Body109224911
particle    I-Body109224911
and    O
demonstrate    O
violation    O
of    O
lepton    O
number    O
conservation    O
,    O
validating    O
the    O
seesaw    B-Body109224911
mechanism    I-Body109224911
as    O
the    O
explanation    O
for    O
the    O
neutrino    O
mass    O
scale    O
.    O

As    O
the    O
neutralinos    O
are    O
Majorana    B-Body109224911
fermion    I-Body109224911
,    O
each    O
of    O
them    O
is    O
identical    O
with    O
its    O
antiparticle    O
.    O

Gluinos    O
are    O
Majorana    B-Body109224911
fermionic    O
partners    O
of    O
the    O
gluon    O
which    O
means    O
that    O
they    O
are    O
their    O
own    O
antiparticles    O
.    O

He    O
has    O
also    O
made    O
important    O
contributions    O
to    O
the    O
physics    O
of    O
carbon    O
nanotubes    O
(    O
with    O
Leon    O
Balents    O
and    O
Charles    O
Kane    O
)    O
and    O
emergent    O
Majorana    B-Body109224911
fermions    I-Body109224911
and    O
related    O
phenomena    O
in    O
quasi    O
-    O
one    O
-    O
dimensional    O
problems    O
(    O
with    O
Jason    O
Alicea    O
and    O
others    O
)    O
.    O

In    O
2008    O
,    O
Riazuddin    O
pointed    O
out    O
that    O
the    O
neutrino    O
mass    O
has    O
μ    O
and    O
τ    O
symmetry    O
and    O
Lepton    O
number    O
remains    O
constant    O
,    O
a    O
new    O
type    O
of    O
Seesaw    B-Body109224911
mechanism    I-Body109224911
is    O
formed    O
,    O
the    O
so    O
-    O
called    O
Riazuddin    O
's    O
Seesaw    O
Model    O
,    O
the    O
Dirac    O
mass    O
matrix    O
provided    O
the    O
Yukawa    O
coupling    O
to    O
follow    O
the    O
Majorana    B-Body109224911
fermion    I-Body109224911
to    O
satisfy    O
the    O
Leptogenesis    O
asymmetry    O
.    O

Oxalyl    B-Body109224911

CopA    O
-    O
like    O
RNA    O
is    O
a    O
family    O
of    O
non    O
-    O
coding    O
RNAs    O
found    O
on    O
the    O
R1    B-Body109224911
plasmid    I-Body109224911
.    O

Tetrachloroaluminate    B-Body109224911
[    O
AlCl4]−    O
is    O
an    O
anion    B-Body109224911
formed    O
from    O
aluminium    O
and    O
chlorine    O
.    O

He    O
proposed    O
the    O
curvaton    B-Body109224911
model    O
for    O
the    O
origin    O
of    O
cosmic    O
structure    O
,    O
with    O
David    O
H.    O
Lyth    O
in    O
2001    O
.    O

Liquid    B-Body109224911
junction    I-Body109224911
potential    I-Body109224911
occurs    O
when    O
two    O
electrolytic    O
solutions    O
of    O
different    O
concentrations    O
are    O
in    O
contact    O
with    O
each    O
other    O
.    O

Other    O
drugs    O
of    O
the    O
same    O
type    O
have    O
included    O
opium    O
alkaloid    O
sulphates    O
(    O
Papaveretum    O
)    O
,    O
phosphates    O
,    O
and    O
valerates    B-Body109224911
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
pentanamide    O
and    O
H2O    O
,    O
whereas    O
its    O
two    O
products    O
are    O
valerate    B-Body109224911
and    O
NH3    O
.    O

C20orf111    O
a    O
valid    O
,    O
protein    O
coding    O
gene    O
that    O
is    O
found    O
on    O
the    O
minus    O
strand    O
of    O
chromosome    B-Body109224911
20    I-Body109224911
at    O
q13.12    O
by    O
searching    O
the    O
UCSC    O
Genome    O
Browser    O
,    O
but    O
q13.11    O
according    O
to    O
Refseq    O
on    O
NCBI    O
.    O

ICF    O
syndrome    O
can    O
be    O
caused    O
by    O
a    O
mutation    O
in    O
the    O
DNA    O
-    O
methyltransferase-3b    O
(    O
"    O
Dnmt3b    O
"    O
)    O
gene    O
,    O
located    O
on    O
chromosome    O
20q11.2    B-Body109224911
.    O

MODY    O
1    O
is    O
due    O
to    O
a    O
loss    O
-    O
of    O
-    O
function    O
mutation    O
in    O
the    O
gene    O
on    O
chromosome    B-Body109224911
20    I-Body109224911
.    O

Ring    O
chromosome    O
20    O
,    O
ring    O
-    O
shaped    O
chromosome    O
20    O
or    O
r(20    O
)    O
syndrome    O
is    O
a    O
rare    O
human    O
chromosome    O
abnormality    O
where    O
the    O
two    O
arms    O
of    O
chromosome    B-Body109224911
20    I-Body109224911
fuse    O
to    O
form    O
a    O
ring    B-Body109224911
chromosome    I-Body109224911
.    O

One    O
aspartate    O
activates    O
the    O
water    O
by    O
abstracting    O
a    O
proton    O
,    O
enabling    O
the    O
water    O
to    O
perform    O
a    O
nucleophilic    O
attack    O
on    O
the    O
carbonyl    O
carbon    O
of    O
the    O
substrate    O
scissile    O
bond    O
,    O
generating    O
a    O
tetrahedral    O
oxyanion    B-Body109224911
intermediate    O
.    O

Oxyanion    B-Body109224911

Shigaite    O
consists    O
of    O
oxycation    B-Body109224911
sheets    O
of    O
[    O
AlMn2    O
+    O
2(OH)6]1    O
+    O
intercalated    O
with    O
oxyanion    B-Body109224911
sheets    O
of    O
[    O
Na(H2O)6{H2O}6(SO4)2]3−.    O
Linkage    O
between    O
the    O
sheets    O
and    O
within    O
the    O
oxyanion    O
sheet    O
results    O
largely    O
through    O
hydrogen    O
bonding    O
.    O

Polyphosphates    O
are    O
salts    O
or    O
esters    O
of    O
polymeric    O
oxyanion    B-Body109224911
formed    O
from    O
tetrahedral    O
PO4    O
(    O
phosphate    O
)    O
structural    O
units    O
linked    O
together    O
by    O
sharing    O
oxygen    O
atoms    O

In    O
chemistry    O
,    O
plumbite    O
is    O
the    O
oxyanion    B-Body109224911
or    O
hydrated    O
forms    O
,    O
or    O
any    O
salt    O
containing    O
this    O
anion    O
.    O

It    O
is    O
notable    O
for    O
respiring    O
oxyanion    B-Body109224911
of    O
selenium    O
and    O
arsenic    O
.    O

It    O
is    O
notable    O
for    O
respiring    O
oxyanion    B-Body109224911
of    O
selenium    O
and    O
arsenic    O
.    O

A    O
hypohalite    O
is    O
an    O
oxyanion    B-Body109224911
containing    O
a    O
halogen    O
in    O
oxidation    O
state    O
+    O
1    O
.    O

It    O
is    O
made    O
up    O
of    O
one    O
Li    O
cation    O
and    O
a    O
bistriflimide    B-Body109224911
anion    O
.    O

A    O
sgoldstino    O
is    O
any    O
of    O
the    O
spin-0    O
superpartners    O
of    O
the    O
goldstino    B-Body109224911
in    O
relativistic    O
quantum    O
field    O
theories    O
with    O
spontaneously    O
broken    O
supersymmetry    O
.    O

iodonium    B-Body109224911
,    O
(    O
protonated    O
hydrogen    O
iodide    O
)    O

In    O
one    O
study    O
the    O
electrophile    O
is    O
a    O
bromonium    B-Body109224911
ion    I-Body109224911
derived    O
from    O
an    O
alkene    O
and    O
NBS    O
:    O

The    O
reaction    O
of    O
the    O
iodine    O
with    O
the    O
alkene    O
is    O
promoted    O
by    O
the    O
silver    O
acetate    O
,    O
thus    O
forming    O
an    O
iodinium    B-Body109224911
ion    I-Body109224911
(    O
3    O
)    O
.    O

The    O
term    O
zero    O
-    O
point    O
field    O
(    O
ZPF    O
)    O
can    O
be    O
used    O
when    O
referring    O
to    O
a    O
specific    O
vacuum    O
field    O
,    O
for    O
instance    O
the    O
QED    O
vacuum    O
which    O
specifically    O
deals    O
with    O
quantum    O
electrodynamics    O
(    O
e.g.    O
electromagnetic    O
interactions    O
between    O
photons    O
,    O
electrons    O
and    O
the    O
vacuum    O
)    O
or    O
the    O
QCD    O
vacuum    O
which    O
deals    O
with    O
quantum    O
chromodynamics    O
(    O
e.g.    O
color    B-Body109224911
charge    I-Body109224911
interactions    O
between    O
quarks    O
,    O
gluons    O
and    O
the    O
vacuum    O
)    O
.    O

The    O
QED    O
vacuum    O
is    O
a    O
part    O
of    O
the    O
vacuum    O
state    O
which    O
specifically    O
deals    O
with    O
quantum    O
electrodynamics    O
(    O
e.g.    O
electromagnetic    O
interactions    O
between    O
photons    O
,    O
electrons    O
and    O
the    O
vacuum    O
)    O
and    O
the    O
QCD    O
vacuum    O
deals    O
with    O
quantum    O
chromodynamics    O
(    O
e.g.    O
color    B-Body109224911
charge    I-Body109224911
interactions    O
between    O
quarks    O
,    O
gluons    O
and    O
the    O
vacuum    O
)    O
.    O

Gluons    O
themselves    O
carry    O
the    O
color    B-Body109224911
charge    I-Body109224911
of    O
the    O
strong    O
interaction    O
.    O

In    O
1973    O
Wilczek    O
,    O
a    O
graduate    O
student    O
working    O
with    O
David    O
Gross    O
at    O
Princeton    O
University    O
,    O
discovered    O
asymptotic    O
freedom    O
,    O
which    O
holds    O
that    O
"    O
the    O
closer    O
quarks    O
are    O
to    O
each    O
other    O
,    O
the    O
less    O
the    O
strong    O
interaction    O
(    O
or    O
color    B-Body109224911
charge    I-Body109224911
)    O
between    O
them    O
"    O
;    O
when    O
quarks    O
are    O
in    O
extreme    O
proximity    O
,    O
the    O
nuclear    O
force    O
between    O
them    O
is    O
so    O
weak    O
that    O
they    O
behave    O
almost    O
as    O
free    O
particles    O
.    O

In    O
order    O
to    O
be    O
four    O
-    O
spinors    O
like    O
the    O
electron    O
and    O
other    O
lepton    O
components    O
,    O
there    O
must    O
be    O
one    O
quark    O
component    O
for    O
every    O
combination    O
of    O
flavour    O
and    O
colour    B-Body109224911
,    O
bringing    O
the    O
total    O
to    O
24    O
(    O
3    O
for    O
charged    O
leptons    O
,    O
3    O
for    O
neutrinos    O
,    O
and    O
2·3·3    O
=    O
18    O
for    O
quarks    O
)    O
.    O

The    O
pattern    O
of    O
weak    O
isospin    O
,    O
weak    O
hypercharge    O
,    O
and    O
color    B-Body109224911
charge    I-Body109224911
of    O
all    O
known    O
elementary    O
particles    O
,    O
rotated    O
by    O
the    O
weak    O
mixing    O
angle    O
to    O
show    O
electric    O
charge    O
,    O
roughly    O
along    O
the    O
vertical    O
.    O

They    O
are    O
famous    O
for    O
having    O
discovered    O
the    O
gluon    O
,    O
the    O
mediator    O
of    O
the    O
strong    O
interaction    O
and    O
carrier    O
of    O
the    O
color    B-Body109224911
charge    I-Body109224911
.    O

He    O
posited    O
the    O
existence    O
of    O
a    O
hidden    O
,    O
3-valued    O
charge    O
,    O
called    O
color    B-Body109224911
charge    I-Body109224911
,    O
of    O
subatomic    O
particles    O
,    O
"    O
quarks    O
,    O
"    O
in    O
1964    O
,    O
the    O
same    O
year    O
that    O
quarks    O
were    O
posited    O
as    O
constituents    O
of    O
hadrons    O
by    O
Murray    O
Gell    O
-    O
Mann    O
and    O
,    O
independently    O
,    O
by    O
George    O
Zweig    O
.    O

1964    O
Proposed    O
the    O
existence    O
of    O
color    B-Body109224911
charge    I-Body109224911
.    O

Throughout    O
,    O
Latin    O
indices    O
take    O
values    O
1    O
,    O
2    O
,    O
...    O
,    O
8    O
for    O
the    O
eight    O
gluon    O
color    B-Body109224911
charge    I-Body109224911
,    O
while    O
Greek    O
indices    O
take    O
values    O
0    O
for    O
timelike    O
components    O
and    O
1    O
,    O
2    O
,    O
3    O
for    O
spacelike    O
components    O
of    O
four    O
-    O
dimensional    O
vectors    O
and    O
tensors    O
in    O
spacetime    O
.    O

Gluons    O
can    O
have    O
eight    O
colour    B-Body109224911
charge    I-Body109224911
so    O
there    O
are    O
eight    O
fields    O
,    O
in    O
contrast    O
to    O
photons    O
which    O
are    O
neutral    O
and    O
so    O
there    O
is    O
only    O
one    O
photon    O
field    O
.    O

Nikolay    O
Bogolyubov    O
,    O
co    O
-    O
developed    O
the    O
BBGKY    O
hierarchy    O
,    O
formulated    O
a    O
microscopic    O
theory    O
of    O
superconductivity    O
,    O
suggested    O
a    O
triplet    O
quark    O
model    O
,    O
introduced    O
a    O
new    O
quantum    O
degree    O
of    O
freedom    O
(    O
color    B-Body109224911
charge    I-Body109224911
)    O

Along    O
with    O
Yoichiro    O
Nambu    O
of    O
the    O
University    O
of    O
Chicago    O
,    O
he    O
is    O
credited    O
with    O
introducing    O
the    O
SU(3    O
)    O
symmetry    O
of    O
quarks    O
,    O
today    O
known    O
as    O
the    O
color    B-Body109224911
charge    I-Body109224911
.    O

Mitochondrial    O
carriers    O
transport    O
amino    O
acids    O
,    O
keto    O
acids    O
,    O
nucleotides    O
,    O
inorganic    B-Body109224911
ions    I-Body109224911
and    O
co    O
-    O
factors    O
through    O
the    O
mitochondrial    O
inner    O
membrane    O
.    O

Further    O
,    O
because    O
it    O
has    O
five    O
quarks    O
instead    O
of    O
the    O
usual    O
three    O
found    O
in    O
regular    O
baryons    O
(    O
'    O
triquarks    O
'    O
)    O
,    O
it    O
would    O
be    O
classified    O
as    O
an    O
exotic    B-Body109224911
baryon    I-Body109224911
.    O

In    O
theoretical    O
physics    O
,    O
the    O
Curtright    B-Body109224911
field    I-Body109224911
(    O
named    O
after    O
Thomas    O
Curtright    O
)    O
is    O
a    O
tensor    O
quantum    O
field    O
of    O
mixed    O
symmetry    O
,    O
whose    O
gauge    O
-    O
invariant    O
dynamics    O
are    O
dual    O
to    O
those    O
of    O
the    O
general    O
relativistic    O
graviton    O
in    O
higher    O
(    O
"    O
D">4    O
)    O
spacetime    O
dimensions    O
.    O

Wu-Yang    B-Body109224911
monopole    I-Body109224911

The    O
early    O
genes    O
are    O
at    O
left    O
,    O
comprising    O
LTag    O
(    O
purple    O
)    O
and    O
STag    O
(    O
blue    O
)    O
;    O
the    O
late    O
genes    O
are    O
at    O
right    O
,    O
and    O
the    O
origin    B-Body109224911
of    I-Body109224911
replication    I-Body109224911
is    O
shown    O
at    O
the    O
top    O
of    O
the    O
figure    O
..    O

The    O
origin    B-Body109224911
of    I-Body109224911
replication    I-Body109224911
(    O
also    O
called    O
the    O
replication    B-Body109224911
origin    I-Body109224911
)    O
is    O
a    O
particular    O
sequence    O
in    O
a    O
genome    O
at    O
which    O
replication    O
is    O
initiated    O
.    O

A    O
pre    O
-    O
replication    O
complex    O
(    O
pre    O
-    O
RC    O
)    O
is    O
a    O
protein    O
complex    O
that    O
forms    O
at    O
the    O
origin    B-Body109224911
of    I-Body109224911
replication    I-Body109224911
during    O
the    O
initiation    O
step    O
of    O
DNA    O
replication    O
.    O

In    O
bacteria    O
,    O
the    O
main    O
component    O
of    O
the    O
pre    O
-    O
RC    O
is    O
DnaA.    O
The    O
pre    O
-    O
RC    O
is    O
complete    O
when    O
DnaA    O
occupies    O
all    O
of    O
its    O
binding    O
sites    O
within    O
the    O
bacterial    O
origin    O
of    O
replication    O
(    O
oriC    B-Body109224911
)    O
.    O

Because    O
the    O
two    O
(    O
heavy    O
and    O
light    O
)    O
strands    O
on    O
the    O
circular    O
mtDNA    O
molecule    O
have    O
different    O
origins    B-Body109224911
of    I-Body109224911
replication    I-Body109224911
,    O
it    O
replicates    O
in    O
a    O
D    O
-    O
loop    O
mode    O
.    O

The    O
origin    B-Body109224911
of    I-Body109224911
replication    I-Body109224911
will    O
have    O
promoter    O
regions    O
upstream    O
from    O
the    O
replication    O
/    O
transcription    O
start    O
site    O
.    O

Binding    O
site    O
I    O
initiates    O
DNA    O
replication    O
at    O
the    O
origin    B-Body109224911
of    I-Body109224911
replication    I-Body109224911
.    O

:*    O
origin    B-Body109224911
of    I-Body109224911
replication    I-Body109224911
and    O
other    O
associated    O
plasmid    O
'    O
housekeeping    O
'    O
sequences    O
.    O

The    O
initiation    O
stage    O
starts    O
with    O
the    O
ordered    O
assembly    O
of    O
"    O
initiator    O
"    O
proteins    O
at    O
the    O
origin    O
region    O
of    O
the    O
chromosome    O
,    O
called    O
oriC    B-Body109224911
These    O
assembly    O
stages    O
are    O
regulated    O
to    O
ensure    O
that    O
chromosome    O
replication    O
occurs    O
only    O
once    O
in    O
each    O
cell    O
cycle    O
.    O

oligo    O
-    O
oligodeoxyribonucleotide    O
-    O
oligonucleotide    O
-    O
oncogene    O
-    O
oncovirus    O
-    O
open    O
reading    O
frame    O
-    O
operator    O
-    O
operon    O
-    O
origin    B-Body109224911
of    I-Body109224911
replication    I-Body109224911
-    O

One    O
region    O
of    O
the    O
DNA    O
that    O
keeps    O
its    O
hemimethylated    O
status    O
for    O
longer    O
is    O
the    O
origin    B-Body109224911
of    I-Body109224911
replication    I-Body109224911
,    O
which    O
has    O
an    O
abundance    O
of    O
GATC    O
sites    O
.    O

Strange    B-Body109224911
matter    I-Body109224911

He    O
also    O
speculated    O
that    O
in    O
what    O
became    O
known    O
as    O
the    O
Goldhaber    O
-    O
Christie    O
model    O
,    O
the    O
so    O
-    O
called    O
strange    B-Body109224911
particle    I-Body109224911
were    O
composites    O
of    O
just    O
3    O
basic    O
particles    O
.    O

These    O
include    O
strange    B-Body109224911
star    I-Body109224911
(    O
composed    O
of    O
strange    B-Body109224911
matter    I-Body109224911
)    O
and    O
the    O
more    O
speculative    O
preon    O
stars    O
(    O
composed    O
of    O
preons    O
)    O
.    O

The    O
sudden    O
changes    O
to    O
the    O
world    O
are    O
triggered    O
by    O
the    O
Earth    O
's    O
contact    O
with    O
the    O
"    O
newuniversal    O
structure    O
"    O
,    O
an    O
artificial    O
web    O
of    O
strange    B-Body109224911
matter    I-Body109224911
.    O

"    O
Strange    B-Body109224911
Matter    I-Body109224911
"    O

Z(4430)    B-Body109224911

A    O
tetraquark    B-Body109224911
state    O
(    O
an    O
exotic    O
meson    O
)    O
,    O
named    O
the    O
Z(4430)    B-Body109224911
,    O
was    O
discovered    O
in    O
2007    O
by    O
the    O
Belle    O
Collaboration    O
and    O
confirmed    O
as    O
a    O
resonance    O
in    O
2014    O
by    O
the    O
LHCb    O
collaboration    O
.    O

Winos    B-Body109224911
,    O
hypothetical    O
superpartners    O
of    O
W    O
bosons    O
in    O
particle    O
physics    O

A    O
strange    O
quark    O
emits    O
a    O
bino    B-Body109224911
,    O
turning    O
into    O
a    O
sdown    O
-    O
type    O
squark    B-Body109224911
,    O
which    O
then    O
emits    O
a    O
Z    O
boson    O
and    O
reabsorbs    O
the    O
bino    O
,    O
turning    O
into    O
a    O
down    O
quark    O
.    O

These    O
four    O
states    O
are    O
mixtures    O
of    O
the    O
Bino    B-Body109224911
and    O
the    O
neutral    O
Wino    B-Body109224911
(    O
which    O
are    O
the    O
neutral    O
electroweak    O
Gaugino    B-Body109224911
)    O
,    O
and    O
the    O
neutral    O
Higgsinos    B-Body109224911
.    O

;    O
"    O
parA    B-Body109224911
and    O
parB    B-Body109224911
"    O
:    O
for    O
partitioning    O
F    O
plasmid    O
DNA    O
to    O
daughter    O
cells    O
during    O
division    O
and    O
ensures    O
stable    O
maintenance    O
of    O
the    O
BAC    O
.    O

Two    O
of    O
these    O
,    O
supersymmetry    O
and    O
the    O
relativity    O
related    O
supergravity    O
,    O
both    O
required    O
the    O
existence    O
of    O
an    O
extremely    O
weak    O
"    O
fifth    O
force    O
"    O
carried    O
by    O
a    O
graviphoton    B-Body109224911
,    O
which    O
coupled    O
together    O
several    O
"    O
loose    O
ends    O
"    O
in    O
quantum    O
field    O
theory    O
,    O
in    O
an    O
organized    O
manner    O
.    O

Nishijima    O
formula    O
for    O
the    O
hypercharge    B-Body109224911
of    O
strong    O
interactions    O
(    O
which    O
is    O
not    O
conserved    O
in    O
weak    O
interactions    O
)    O
.    O

In    O
particle    O
physics    O
,    O
the    O
hypercharge    B-Body109224911
(    O
from    O
hyperonic    O
+    O
charge    O
)    O
"    O
Y    O
"    O
of    O
a    O
particle    O
is    O
related    O
to    O
the    O
strong    O
interaction    O
,    O
and    O
is    O
distinct    O
from    O
the    O
similarly    O
named    O
weak    O
hypercharge    O
,    O
which    O
has    O
an    O
analogous    O
role    O
in    O
the    O
electroweak    O
interaction    O
.    O

SU(2)R    O
does    O
not    O
map    O
the    O
hypercharge    B-Body109224911
symmetry    O
U(1)Y    O
to    O
itself    O
but    O
the    O
hypercharge    O
gauge    O
coupling    O
strength    O
is    O
small    O
and    O
in    O
the    O
limit    O
as    O
it    O
goes    O
to    O
zero    O
,    O
we    O
wo    O
n't    O
have    O
a    O
problem    O
.    O

X(3872)    B-Body109224911

The    O
quantum    O
numbers    O
of    O
the    O
X(3872)    B-Body109224911
particle    O
have    O
been    O
measured    O
recently    O
by    O
the    O
LHCb    O
experiment    O
at    O
CERN    O

Quark–lepton    B-Body109224911
complementarity    I-Body109224911

Bisulfide    B-Body109224911
,    O
HS−    O
,    O
a    O
chemical    O
compound    O
derived    O
from    O
H2S    O

It    O
can    O
be    O
synthesized    O
through    O
the    O
reaction    O
of    O
hydrosulfide    B-Body109224911
and    O
carbon    O
disulfide    O
:    O

A    O
human    B-Body109224911
artificial    I-Body109224911
chromosome    I-Body109224911
(    O
HAC    B-Body109224911
)    O
is    O
a    O
microchromosome    O
that    O
can    O
act    O
as    O
a    O
new    O
chromosome    O
in    O
a    O
population    O
of    O
human    O
cells    O
.    O

hairpin    O
-    O
haploid    B-Body109224911
-    O
haploinsufficiency    O
-    O
helix    O
-    O
loop    O
-    O
helix    O
-    O
hematopoietic    O
stem    O
cell    O
-    O
hemophilia    O
-    O
heteroduplex    O
DNA    O
-    O
heterozygous    O
-    O
highly    O
conserved    O
sequence    O
-    O
Hirschsprung    O
's    O
disease    O
-    O
histone    O
-    O
hnRNA    O
-    O
holoprosencephaly    O
-    O
homologous    O
recombination    O
-    O
homology    O
-    O
homozygous    O
-    O
host    O
strain    O
(    O
bacterial    O
)    O
-    O
human    B-Body109224911
artificial    I-Body109224911
chromosome    I-Body109224911
-    O
Human    O
Genome    O
Project    O
-    O
human    O
immunodeficiency    O
virus    O
-    O
Huntington    O
's    O
disease    O
-    O
hybridization    O
-    O
hybridoma    O
-    O
hydrophilicity    O
plot    O
-    O

Pseudodicentric    O
chromosomes    O
alone    O
do    O
not    O
define    O
these    O
syndromes    O
,    O
because    O
the    O
contribution    O
of    O
other    O
chromosomal    O
abnormalities    O
are    O
also    O
considered    O
,    O
such    O
as    O
the    O
presence    O
of    O
isochromosome    B-Body109224911
in    O
Turner    O
patients    O
.    O

It    O
is    O
also    O
suggested    O
that    O
U-type    B-Body109224911
exchange    O
during    O
meiosis    O
I    O
may    O
lead    O
to    O
partial    O
tetrasomy    O
.    O

Isochromosome    B-Body109224911

There    O
is    O
another    O
type    O
of    O
statistic    O
,    O
known    O
as    O
braid    O
statistics    O
,    O
which    O
are    O
associated    O
with    O
particles    O
known    O
as    O
plekton    B-Body109224911
.    O

The    O
Philadelphia    O
chromosome    O
or    O
Philadelphia    O
translocation    O
is    O
a    O
specific    O
genetic    O
abnormality    O
in    O
chromosome    B-Body109224911
22    I-Body109224911
of    O
leukemia    O
cancer    O
cells    O
(    O
particularly    O
chronic    O
myeloid    O
leukemia    O
(    O
CML    O
)    O
cells    O
)    O
.    O

The    O
result    O
is    O
that    O
a    O
fusion    O
gene    O
is    O
created    O
by    O
juxtaposing    O
the    O
"    O
ABL1    O
"    O
gene    O
on    O
chromosome    O
9    O
(    O
region    O
q34    O
)    O
to    O
a    O
part    O
of    O
the    O
"    O
BCR    O
"    O
(    O
breakpoint    O
cluster    O
region    O
)    O
gene    O
on    O
chromosome    B-Body109224911
22    I-Body109224911
(    O
region    O
q11    O
)    O
.    O

A    O
deletion    O
of    O
a    O
single    O
copy    O
of    O
a    O
gene    O
on    O
chromosome    B-Body109224911
22q13    I-Body109224911
has    O
been    O
correlated    O
with    O
global    O
developmental    O
delay    O
,    O
severely    O
delayed    O
speech    O
or    O
social    O
communication    O
disorders    O
and    O
moderate    O
to    O
profound    O
delay    O
of    O
cognitive    O
abilities    O
.    O

The    O
gene    O
coding    O
for    O
C22orf25    O
is    O
located    O
on    O
chromosome    B-Body109224911
22    I-Body109224911
and    O
the    O
location    O
q11.21    O
,    O
so    O
it    O
is    O
often    O
associated    O
with    O
22q11.2    O
deletion    O
syndrome    O
.    O

Chromosomal    O
abnormalities    O
include    O
a    O
total    O
of    O
three    O
copies    O
of    O
the    O
X    B-Body109224911
chromosome    I-Body109224911
and    O
four    O
copies    O
of    O
chromosome    B-Body109224911
17    I-Body109224911
and    O
chromosome    B-Body109224911
22    I-Body109224911
.    O

This    O
abnormality    O
was    O
discovered    O
by    O
Peter    O
Nowell    O
in    O
1960    O
and    O
is    O
a    O
consequence    O
of    O
fusion    O
between    O
the    O
Abelson    O
(    O
Abl    O
)    O
tyrosine    O
kinase    O
gene    O
at    O
chromosome    B-Body109224911
9    I-Body109224911
and    O
the    O
break    O
point    O
cluster    O
(    O
Bcr    O
)    O
gene    O
at    O
chromosome    B-Body109224911
22    I-Body109224911
,    O
resulting    O
in    O
a    O
chimeric    O
oncogene    O
(    O
Bcr    O
-    O
Abl    O
)    O
and    O
a    O
constitutively    O
active    O
Bcr    O
-    O
Abl    O
tyrosine    O
kinase    O
that    O
has    O
been    O
implicated    O
in    O
the    O
pathogenesis    O
of    O
CML    O
.    O

It    O
is    O
encoded    O
by    O
a    O
gene    O
of    O
the    O
same    O
name    O
,    O
located    O
on    O
chromosome    B-Body109224911
22    I-Body109224911
.    O

The    O
chromosomal    O
region    O
that    O
encodes    O
an    O
antibody    O
is    O
large    O
and    O
contains    O
several    O
distinct    O
gene    O
loci    O
for    O
each    O
domain    O
of    O
the    O
antibody    O
—    O
the    O
chromosome    O
region    O
containing    O
heavy    O
chain    O
genes    O
(    O
IGH@    O
)    O
is    O
found    O
on    O
chromosome    B-Body109224911
14    I-Body109224911
,    O
and    O
the    O
loci    O
containing    O
lambda    O
and    O
kappa    O
light    O
chain    O
genes    O
(    O
IGL@    O
and    O
IGK@    O
)    O
are    O
found    O
on    O
chromosomes    O
22    B-Body109224911
and    O
2    B-Body109224911
in    O
humans    O
.    O

P    O
antigen    O
system    O
is    O
a    O
human    O
blood    O
group    O
system    O
based    O
upon    O
the    O
A4GALT    O
and    O
B3GALNT1    O
genes    O
on    O
chromosome    B-Body109224911
22    I-Body109224911
.    O

In    O
humans    O
,    O
Robertsonian    O
translocations    O
generally    O
occurs    O
in    O
the    O
five    O
acrocentric    O
chromosome    O
pairs    O
,    O
namely    O
13    B-Body109224911
,    O
14    B-Body109224911
,    O
15    B-Body109224911
,    O
21    B-Body109224911
and    O
22    B-Body109224911
.    O

Biophotons    B-Body109224911
(    O
from    O
the    O
Greek    O
βίος    O
meaning    O
"    O
life    O
"    O
and    O
φῶς    O
meaning    O
"    O
light    O
"    O
)    O
are    O
photons    O
of    O
light    O
in    O
the    O
ultraviolet    O
and    O
low    O
visible    O
light    O
range    O
that    O
are    O
produced    O
by    O
a    O
biological    O
system    O
.    O

Alexander    O
Gurwitsch    O
,    O
originated    O
the    O
morphogenetic    O
field    O
theory    O
and    O
discovered    O
the    O
biophoton    B-Body109224911

Lp(a    O
)    O
plasma    O
concentrations    O
are    O
highly    O
heritable    O
and    O
mainly    O
controlled    O
by    O
the    O
apolipoprotein(a    O
)    O
gene    O
[    O
LPA    O
]    O
located    O
on    O
chromosome    B-Body109224911
6    I-Body109224911
-    O
27    O
.    O

During    O
the    O
completion    O
of    O
the    O
Human    O
Genome    O
Project    O
,    O
the    O
gene    O
encoding    O
for    O
RNaseT2    O
,    O
the    O
human    O
actibind    O
-    O
like    O
protein    O
,    O
was    O
found    O
on    O
chromosome    B-Body109224911
6    I-Body109224911
.    O

Robert    O
Plomin    O
's    O
announcement    O
in    O
1997    O
of    O
the    O
discovery    O
of    O
"    O
a    O
gene    O
for    O
intelligence    O
"    O
on    O
chromosome    B-Body109224911
6    I-Body109224911
is    O
the    O
foundation    O
for    O
this    O
chapter    O
's    O
lengthier    O
discussion    O
of    O
the    O
genetic    O
basis    O
for    O
intelligence    O
.    O

Mutations    O
in    O
the    O
SLC17A5    O
(    O
solute    O
carrier    O
family    O
17    O
(    O
anion    O
/    O
sugar    O
transporter    O
)    O
,    O
member    O
50    O
)    O
gene    O
cause    O
all    O
forms    O
of    O
sialic    O
acid    O
storage    O
disease    O
.    O
The    O
SLC17A5    O
gene    O
is    O
located    O
on    O
the    O
long    O
(    O
q    O
)    O
arm    O
of    O
chromosome    B-Body109224911
6    I-Body109224911
between    O
positions    O
14    O
and    O
15    O
.    O

In    O
humans    O
it    O
is    O
synthesised    O
by    O
the    O
gene    O
"    O
GLP1R    O
"    O
,    O
which    O
is    O
present    O
on    O
chromosome    B-Body109224911
6    I-Body109224911
.    O

p90    O
Rsk-3    O
is    O
located    O
at    O
6q27    B-Body109224911
.    O

PSORS1    O
"    O
is    O
located    O
on    O
chromosome    B-Body109224911
6    I-Body109224911
in    O
the    O
major    O
histocompatibility    O
complex    O
(    O
MHC    O
)    O
,    O
which    O
controls    O
important    O
immune    O
functions    O
.    O

All    O
of    O
these    O
genes    O
are    O
located    O
in    O
histone    O
cluster    O
1    O
on    O
chromosome    B-Body109224911
6    I-Body109224911
and    O
cluster    O
2    O
and    O
cluster    O
3    O
on    O
chromosome    B-Body109224911
1    I-Body109224911
.    O

C6orf58    O
is    O
a    O
humangene    O
located    O
at    O
locus    B-Body109224911
6q22.33    O
of    O
chromosome    B-Body109224911
6    I-Body109224911
and    O
encodes    O
for    O
UPF0762    O
,    O
a    O
protein    O
which    O
is    O
subsequently    O
secreted    O
after    O
cleavage    O
of    O
a    O
signal    O
peptide    O

Ii    O
antigen    O
system    O
is    O
a    O
human    O
blood    O
group    O
system    O
based    O
upon    O
genes    O
on    O
chromosome    B-Body109224911
6    I-Body109224911
.    O

What    O
is    O
the    O
detailed    O
partonic    B-Body109224911
structure    O
of    O
the    O
nucleons    O
?    O

Jets    O
are    O
produced    O
in    O
QCD    O
hard    O
scattering    O
processes    O
,    O
creating    O
high    O
transverse    O
momentum    O
quarks    O
or    O
gluons    O
,    O
or    O
collectively    O
called    O
parton    B-Body109224911
in    O
the    O
partonic    O
picture    O
.    O

His    O
ongoing    O
projects    O
include    O
the    O
determination    O
of    O
the    O
parton    B-Body109224911
distributions    O
of    O
the    O
proton    O
and    O
studies    O
in    O
small    O
x    O
and    O
diffractive    O
physics    O
,    O
which    O
are    O
relevant    O
to    O
the    O
experiments    O
at    O
the    O
Large    O
Hadron    O
Collider    O
.    O

In    O
the    O
simple    O
parton    B-Body109224911
model    O
the    O
nucleon    O
consists    O
of    O
quarks    O
and    O
gluons    O
and    O
their    O
interaction    O
is    O
governed    O
by    O
quantum    O
chromodynamics    O
.    O

In    O
the    O
1970s    O
,    O
Yan    O
and    O
Sidney    O
Drell    O
investigated    O
the    O
important    O
Drell    O
–    O
Yan    O
process    O
of    O
massive    O
lepton    O
pair    O
production    O
in    O
hadronic    O
collisions    O
,    O
which    O
provides    O
a    O
crucial    O
experimental    O
probe    O
into    O
the    O
parton    B-Body109224911
distribution    I-Body109224911
functions    I-Body109224911
.    O

These    O
describe    O
the    O
way    O
that    O
the    O
momentum    O
of    O
an    O
incoming    O
high    O
-    O
energy    O
nucleon    O
is    O
partitioned    O
among    O
its    O
constituent    O
partons    B-Body109224911
.    O

GRV    O
PDF    O
,    O
one    O
type    O
of    O
parton    B-Body109224911
distribution    I-Body109224911
function    I-Body109224911

Female    O
worker    O
bees    O
develop    O
from    O
fertilized    O
eggs    O
and    O
are    O
diploid    B-Body109224911
in    O
origin    O
,    O
which    O
means    O
that    O
the    O
sperm    O
from    O
a    O
father    O
provides    O
a    O
second    O
set    O
of    O
16    O
chromosomes    O
for    O
a    O
total    O
of    O
32one    O
set    O
from    O
each    O
parent    O
.    O

Drones    O
are    O
haploid    B-Body109224911
,    O
growing    O
from    O
unfertilised    O
eggs    O
by    O
arrhenotoky    O
.    O

Before    O
infection    O
can    O
occur    O
,    O
the    O
smuts    O
need    O
to    O
undergo    O
a    O
successful    O
mating    O
to    O
form    O
dikaryotic    O
hyphae    O
(    O
two    O
haploid    B-Body109224911
cells    O
fuse    O
to    O
form    O
a    O
dikaryon    O
)    O
.    O

As    O
most    O
irises    O
are    O
diploid    B-Body109224911
,    O
having    O
two    O
sets    O
of    O
chromosomes    O
.    O

The    O
breeders    O
intentionally    O
used    O
a    O
tetraploid    O
grapefruit    O
and    O
a    O
diploid    B-Body109224911
pomelo    O
,    O
with    O
triploid    O
progeny    O
and    O
seedless    O
.    O

(    O
Humans    O
are    O
diploid    B-Body109224911
,    O
having    O
one    O
set    O
each    O
from    O
the    O
mother    O
and    O
father    O
.    O
)    O

Animal    O
view    O
of    O
different    O
embryos    O
developing    O
in    O
"    O
Xenopus    O
laevis    O
"    O
eggs    O
:    O
haploid    B-Body109224911
"    O
[    O
laevis]x    O
laevis    O
"    O
(    O
middle    O
)    O
and    O
"    O
[    O
laevis]x    O
tropicalis    O
"    O
cybrid    O
(    O
bottom    O
)    O
embryos    O
cleave    O
and    O
begin    O
gastrulation    O
synchroneously    O
,    O
about    O
50    O
minutes    O
after    O
diploid    B-Body109224911
"    O
laevis    O
x    O
laevis    O
"    O
(    O
top    O
)    O
embryos    O
.    O

As    O
these    O
,    O
it    O
is    O
diploid    B-Body109224911
with    O
14    O
chromosomes    O
altogether    O
.    O

diploid    B-Body109224911

haploid    B-Body109224911

Of    O
the    O
46    O
chromosomes    O
in    O
a    O
normal    O
diploid    B-Body109224911
human    O
cell    O
,    O
half    O
are    O
maternally    O
derived    O
(    O
from    O
the    O
mother    O
's    O
egg    O
)    O
and    O
half    O
are    O
paternally    O
derived    O
(    O
from    O
the    O
father    O
's    O
sperm    O
)    O
.    O

This    O
occurs    O
as    O
sexual    O
reproduction    O
involves    O
the    O
fusion    O
of    O
two    O
haploid    B-Body109224911
gametes    O
(    O
the    O
egg    O
and    O
sperm    O
)    O
to    O
produce    O
a    O
new    O
organism    O
having    O
the    O
full    O
complement    O
of    O
chromosomes    O
.    O

The    O
thallus    O
we    O
see    O
is    O
the    O
haploid    B-Body109224911
generation    O
;    O
it    O
can    O
reproduce    O
asexually    O
by    O
forming    O
spores    O
which    O
grow    O
to    O
replicate    O
the    O
original    O
thallus    O
.    O

The    O
fertilized    O
,    O
now    O
diploid    B-Body109224911
,    O
carposporangia    O
after    O
mitosis    O
produce    O
spores    O
(    O
carpospores    O
)    O
which    O
settle    O
,    O
then    O
bore    O
into    O
shells    O
,    O
germinate    O
and    O
form    O
a    O
filamentous    O
stage    O
.    O

That    O
"    O
Conchocelis    O
"    O
was    O
the    O
diploid    B-Body109224911
stage    O
of    O
"    O
Porphyra    O
"    O
was    O
discovered    O
by    O
the    O
British    O
phycologist    O
Kathleen    O
Mary    O
Drew    O
-    O
Baker    O
in    O
1949    O
for    O
the    O
European    O
species    O
"    O
Porphyra    O
umbilicalis    O
"    O
.    O

Chromosome    B-Body109224911
number    I-Body109224911
is    O
(    O
2"n"=14    O
)    O

He    O
showed    O
that    O
the    O
tetraploid    O
Empetrum    O
hermaphroditum    O
is    O
a    O
separate    O
species    O
from    O
the    O
diploid    B-Body109224911
Empetrum    O
nigrum    O
.    O

He    O
thereby    O
initiated    O
the    O
use    O
of    O
chromosome    B-Body109224911
number    I-Body109224911
in    O
systematic    O
botany    O
,    O
a    O
field    O
later    O
known    O
as    O
cytotaxonomy    O
.    O

He    O
put    O
forward    O
the    O
hypothesis    O
that    O
the    O
ploidy    B-Body109224911
level    O
is    O
an    O
important    O
factor    O
in    O
the    O
distribution    O
and    O
ecology    O
of    O
plant    O
species    O
.    O

Hagerup    O
,    O
O.    O
(    O
1947    O
)    O
The    O
spontaneous    O
formation    O
of    O
haploid    B-Body109224911
,    O
polyploid    O
,    O
and    O
aneuploid    O
embryos    O
in    O
some    O
orchids    O
.    O

This    O
was    O
overturned    O
,    O
however    O
,    O
in    O
2004    O
,    O
based    O
on    O
strong    O
evidence    O
that    O
Australia    O
specimens    O
of    O
"    O
C.    O
spicatum    O
"    O
are    O
not    O
the    O
same    O
taxon    O
as    O
European    O
specimens    O
;    O
specifically    O
,    O
all    O
Australian    O
specimens    O
studied    O
were    O
tetraploid    O
,    O
whereas    O
all    O
European    O
specimens    O
studied    O
with    O
diploid    B-Body109224911
.    O

The    O
life    O
cycle    O
of    O
"    O
Crucibulum    O
"    O
,    O
which    O
contains    O
both    O
haploid    B-Body109224911
and    O
diploid    B-Body109224911
stages    O
,    O
is    O
typical    O
of    O
the    O
species    O
of    O
Basidiomycota    O
that    O
can    O
reproduce    O
both    O
asexually    O
(    O
via    O
vegetative    O
spores    O
)    O
,    O
or    O
sexually    O
(    O
with    O
meiosis    O
)    O
.    O

The    O
life    O
cycle    O
of    O
the    O
genus    O
"    O
Nidula    O
"    O
,    O
which    O
contains    O
both    O
haploid    B-Body109224911
and    O
diploid    B-Body109224911
stages    O
,    O
is    O
typical    O
of    O
taxa    O
in    O
the    O
basidiomycetes    O
that    O
can    O
reproduce    O
both    O
asexually    O
(    O
via    O
vegetative    O
spores    O
)    O
,    O
or    O
sexually    O
(    O
with    O
meiosis    O
)    O
.    O

The    O
life    O
cycle    O
of    O
the    O
genus    O
"    O
Cyathus    O
"    O
,    O
which    O
contains    O
both    O
haploid    B-Body109224911
and    O
diploid    B-Body109224911
stages    O
,    O
is    O
typical    O
of    O
taxa    O
in    O
the    O
basidiomycetes    O
that    O
can    O
reproduce    O
both    O
asexually    O
(    O
via    O
vegetative    O
spores    O
)    O
,    O
or    O
sexually    O
(    O
with    O
meiosis    O
)    O
.    O

In    O
fertilization    O
,    O
chromosomes    O
from    O
each    O
parent    O
are    O
combined    O
in    O
the    O
same    O
cell    O
nucleus    O
but    O
remain    O
independent    O
;    O
every    O
chromosome    O
in    O
a    O
diploid    B-Body109224911
cell    O
can    O
be    O
traced    O
to    O
one    O
parent    O
and    O
not    O
the    O
other    O
.    O

Przewalski    O
’s    O
horse    O
is    O
known    O
to    O
have    O
the    O
highest    O
diploid    B-Body109224911
chromosome    O
number    O
among    O
all    O
equine    O
species    O
.    O

Einkorn    O
is    O
a    O
diploid    B-Body109224911
species    O
(    O
2n    O
=    O
14    O
chromosomes    O
)    O
of    O
hulled    O
wheat    O
,    O
with    O
tough    O
glumes    O
(    O
'    O
husks    O
'    O
)    O
that    O
tightly    O
enclose    O
the    O
grains    O
.    O

"    O
Xenopus    O
"    O
is    O
also    O
a    O
unique    O
system    O
for    O
analyses    O
of    O
genome    O
evolution    O
and    O
whole    O
genome    O
duplication    O
in    O
vertebrates    O
,    O
as    O
different    O
"    O
Xenopus    O
"    O
species    O
form    O
a    O
ploidy    B-Body109224911
series    O
formed    O
by    O
interspecific    O
hybridization    O
.    O

While    O
"    O
Xenopus    O
laevis    O
"    O
is    O
the    O
most    O
commonly    O
used    O
species    O
for    O
developmental    O
biology    O
studies    O
,    O
genetic    O
studies    O
,    O
especially    O
forward    O
genetic    O
studies    O
,    O
can    O
be    O
complicated    O
by    O
their    O
pseudotetraploid    B-Body109224911
genome    O
.    O

"    O
Xenopus    O
tropicalis    O
"    O
provides    O
a    O
simpler    O
model    O
for    O
genetic    O
studies    O
,    O
having    O
a    O
diploid    B-Body109224911
genome    O
.    O

The    O
sunflower    O
,    O
"    O
Helianthus    O
annuus    O
"    O
,    O
genome    O
is    O
diploid    B-Body109224911
with    O
a    O
base    O
chromosome    O
number    O
of    O
17    O
and    O
an    O
estimated    O
genome    O
size    O
of    O
2871–3189    O
Mbp    O
.    O

If    O
both    O
sex    O
alleles    O
are    O
identical    O
,    O
diploid    B-Body109224911
drones    O
are    O
produced    O
.    O

Males    O
,    O
or    O
drones    O
,    O
are    O
typically    O
haploid    B-Body109224911
,    O
having    O
only    O
one    O
set    O
of    O
chromosomes    O
and    O
primarily    O
exist    O
for    O
the    O
purpose    O
of    O
reproduction    O
.    O

In    O
this    O
family    O
,    O
the    O
number    O
of    O
haploid    B-Body109224911
chromosomes    O
lies    O
between    O
26    O
and    O
30    O
(    O
according    O
to    O
the    O
values    O
in    O
this    O
table    O
)    O
.    O

The    O
Adriatic    O
sturgeon    O
is    O
a    O
tetraploid    B-Body109224911
fish    O
(    O
has    O
four    O
sets    O
of    O
chromosomes    O
)    O
and    O
research    O
based    O
on    O
mitochondrial    O
and    O
microsatellite    O
information    O
is    O
being    O
done    O
on    O
the    O
present    O
breeding    O
stock    O
and    O
other    O
young    O
fish    O
to    O
establish    O
how    O
best    O
to    O
increase    O
the    O
genetic    O
diversity    O
of    O
the    O
fish    O
used    O
in    O
the    O
breeding    O
programme    O
,    O
because    O
the    O
current    O
broodstock    O
has    O
been    O
shown    O
to    O
retain    O
only    O
part    O
of    O
the    O
genetic    O
variation    O
present    O
in    O
the    O
original    O
stock    O
.    O

No    O
hybrids    O
of    O
"    O
Hibiscus    O
calyphyllus    O
"    O
have    O
been    O
reported    O
but    O
it    O
is    O
interesting    O
to    O
note    O
that    O
Hibiscus    O
syriacus    O
and    O
"    O
Hibiscus    O
calyphyllus    O
"    O
have    O
identical    O
diploid    B-Body109224911
chromosome    O
counts    O
of    O
80    O
.    O

Since    O
it    O
belongs    O
to    O
the    O
"    O
O.    O
basilicum    O
"    O
clade    O
,    O
Mrs.    O
Burns    O
lemon    O
basil    O
is    O
tetraploid    B-Body109224911
(    O
2"n    O
"    O
=    O
4"x    O
"    O
=    O
48    O
)    O
,    O
with    O
a    O
monoploid    O
number    O
of    O
12    O
.    O

The    O
kelp    O
life    O
cycle    O
involves    O
a    O
diploid    B-Body109224911
sporophyte    O
and    O
haploid    O
gametophyte    O
stage    O
.    O

The    O
kind    O
of    O
automixis    O
relevant    O
here    O
is    O
one    O
in    O
which    O
two    O
haploid    O
products    O
from    O
the    O
same    O
meiosis    O
combine    O
to    O
form    O
a    O
diploid    B-Body109224911
zygote    O
(    O
see    O
diagram    O
)    O
.    O

T.    O
gigas    O
"    O
has    O
a    O
chromosome    B-Body109224911
number    I-Body109224911
of    O
2"n    O
"    O
=    O
28    O
,    O
compared    O
to    O
26    O
in    O
"    O
T.    O
tridentatus    O
"    O
,    O
32    O
in    O
"    O
Carcinoscorpius    O
"    O
,    O
and    O
52    O
in    O
"    O
Limulus    O
"    O
.    O

The    O
tribe    O
consists    O
exclusively    O
of    O
shrubs    O
and    O
small    O
trees    O
characterised    O
by    O
a    O
pome    O
,    O
a    O
type    O
of    O
accessory    O
fruit    O
that    O
does    O
not    O
occur    O
in    O
other    O
Rosaceae    O
,    O
and    O
by    O
a    O
basal    O
haploid    B-Body109224911
chromosome    O
count    O
of    O
17    O
(    O
instead    O
of    O
7    O
,    O
8    O
,    O
9    O
,    O
or    O
15    O
as    O
in    O
the    O
other    O
Rosaceae    O
)    O
.    O

Between    O
generations    O
,    O
the    O
algae    O
go    O
through    O
separate    O
sporophyte    O
(    O
diploid    B-Body109224911
)    O
and    O
gametophyte    O
(    O
haploid    B-Body109224911
)    O
phases    O
.    O

In    O
a    O
representative    O
species    O
"    O
Laminaria    O
"    O
,    O
there    O
is    O
a    O
conspicuous    O
diploid    B-Body109224911
generation    O
and    O
smaller    O
haploid    O
generations    O
.    O

Only    O
rarely    O
does    O
the    O
first    O
reduction    O
division    O
in    O
meiosis    O
in    O
the    O
plants    O
'    O
flowers    O
tidily    O
fail    O
completely    O
,    O
resulting    O
in    O
a    O
euploid    B-Body109224911
triploid    O
ovule    O
,    O
which    O
can    O
be    O
fertilized    O
by    O
normal    O
haploid    B-Body109224911
pollen    O
from    O
a    O
diploid    B-Body109224911
banana    O
variety    O
;    O
a    O
whole    O
stem    O
of    O
bananas    O
would    O
contain    O
only    O
a    O
few    O
seeds    O
and    O
sometimes    O
none    O
.    O

They    O
have    O
succeeded    O
in    O
producing    O
a    O
few    O
seeds    O
by    O
hand    O
-    O
pollinating    O
the    O
flowers    O
with    O
pollen    O
from    O
diploid    B-Body109224911
seeded    O
bananas    O
.    O

They    O
mate    O
in    O
order    O
to    O
make    O
diploid    B-Body109224911
female    O
offspring    O
.    O

There    O
were    O
no    O
early    O
emerging    O
males    O
found    O
to    O
be    O
diploid    O
in    O
chromosome    B-Body109224911
number    I-Body109224911
.    O

The    O
micronucleus    O
is    O
globally    O
repressed    O
during    O
the    O
vegetative    O
state    O
,    O
and    O
serves    O
as    O
the    O
diploid    B-Body109224911
germline    O
nucleus    O
,    O
whereas    O
all    O
known    O
vegetative    O
gene    O
expression    O
happens    O
in    O
the    O
macronucleus    O
,    O
which    O
is    O
a    O
polyploid    O
somatic    O
nucleus    O
.    O

The    O
diploid    B-Body109224911
chromosome    O
number    O
of    O
"    O
L.    O
albida    O
"    O
has    O
been    O
determined    O
as    O
2"n    O
"    O
=    O
42    O
and    O
as    O
2"n    O
"    O
=    O
~63    O
.    O

As    O
most    O
irises    O
are    O
diploid    B-Body109224911
,    O
having    O
two    O
sets    O
of    O
chromosomes    O
,    O
this    O
can    O
be    O
used    O
to    O
identify    O
hybrids    O
and    O
classification    O
of    O
groupings    O
.    O

The    O
queen    O
’s    O
eggs    O
that    O
are    O
fertilized    O
grow    O
into    O
diploid    B-Body109224911
daughters    O
,    O
which    O
contain    O
two    O
pairs    O
of    O
chromosomes    O
,    O
whereas    O
unfertilized    O
eggs    O
produce    O
haploid    B-Body109224911
males    O
,    O
which    O
only    O
contain    O
the    O
queen    O
's    O
chromosomes    O
.    O

Among    O
mammals    O
,    O
eusociality    O
is    O
known    O
in    O
two    O
species    O
in    O
the    O
Bathyergidae    O
,    O
the    O
naked    O
mole    O
-    O
rat    O
(    O
"    O
Heterocephalus    O
glaber    O
"    O
)    O
and    O
the    O
Damaraland    O
mole    O
-    O
rat    O
(    O
"    O
Fukomys    O
damarensis    O
"    O
)    O
,    O
both    O
of    O
which    O
are    O
diploid    B-Body109224911
and    O
highly    O
inbred    O
.    O

Because    O
humans    O
have    O
a    O
diploid    B-Body109224911
genome    O
,    O
each    O
cell    O
has    O
two    O
copies    O
of    O
the    O
gene    O
(    O
one    O
from    O
each    O
biological    O
parent    O
)    O
.    O

More    O
recently    O
,    O
evidence    O
has    O
been    O
shown    O
that    O
transcription    O
of    O
a    O
subset    O
of    O
genes    O
in    O
"    O
Drosophila    O
"    O
is    O
delayed    O
by    O
one    O
cell    O
cycle    O
in    O
haploid    B-Body109224911
embryos    O
.    O

There    O
are    O
11    O
haploid    B-Body109224911
chromosomes    O
present    O
with    O
the    O
tree    O
's    O
DNA    O
.    O

Almost    O
all    O
species    O
of    O
Hypoptopomatinae    O
have    O
a    O
diploid    B-Body109224911
number    I-Body109224911
of    O
2n    O
=    O
54    O
;    O
this    O
group    O
is    O
karyotypically    O
very    O
conserved    O
.    O

In    O
embryos    O
destined    O
to    O
become    O
males    O
,    O
one    O
haploid    B-Body109224911
set    O
of    O
chromosomes    O
becomes    O
heterochromatinised    O
after    O
the    O
sixth    O
cleavage    O
division    O
and    O
remains    O
so    O
in    O
most    O
tissues    O
;    O
males    O
are    O
thus    O
functionally    O
haploid    O
.    O

The    O
chromosome    B-Body109224911
number    I-Body109224911
is    O
2"n    O
"    O
=    O
28    O
.    O

Ploidy    B-Body109224911
:    O
"    O
N    O
"    O
=    O
82    O
.    O

In    O
terms    O
of    O
cell    O
cycle    O
,    O
vegetative    O
cells    O
are    O
diploid    B-Body109224911
and    O
undergo    O
mitosis    O
during    O
normal    O
cell    O
division    O
.    O

Periodically    O
,    O
meiosis    O
produces    O
morphologically    O
identical    O
haploid    B-Body109224911
gametes    O
(    O
isogametes    O
)    O
,    O
which    O
fuse    O
to    O
produce    O
a    O
(    O
sometimes    O
binucleate    O
)    O
zygote    O
that    O
develops    O
into    O
an    O
auxospore    O
(    O
from    O
which    O
full    O
-    O
sized    O
vegetative    O
cells    O
are    O
produced    O
)    O
.    O

In    O
terms    O
of    O
cell    O
cycle    O
,    O
vegetative    O
cells    O
are    O
diploid    B-Body109224911
and    O
undergo    O
mitosis    O
during    O
normal    O
cell    O
division    O
.    O

In    O
sexual    O
species    O
,    O
oogamous    O
meiosis    O
produces    O
haploid    B-Body109224911
gametes    O
,    O
either    O
ova    O
or    O
sperm    O
cells    O
.    O

The    O
human    O
sperm    O
cell    O
is    O
haploid    B-Body109224911
,    O
so    O
that    O
its    O
23    O
chromosomes    O
can    O
join    O
the    O
23    O
chromosomes    O
of    O
the    O
female    O
egg    O
to    O
form    O
a    O
diploid    B-Body109224911
cell    O
.    O

The    O
haploid    O
chromosome    B-Body109224911
number    I-Body109224911
of    O
"    O
Parafossarulus    O
manchouricus    O
"    O
is    O
n=17    O
.    O

These    O
blades    O
bear    O
various    O
sori    O
containing    O
sporangia    O
,    O
which    O
release    O
haploid    B-Body109224911
spores    O
,    O
which    O
will    O
grow    O
into    O
microscopic    O
female    O
and    O
male    O
gametophytes    O
.    O

Published    O
chromosome    O
counts    O
exist    O
for    O
two    O
species    O
,    O
"    O
Aiphanes    O
minima    O
"    O
and    O
"    O
A.    O
horrida    O
"    O
;    O
haploid    B-Body109224911
chromosome    O
counts    O
vary    O
from    O
15    O
to    O
18    O
.    O

They    O
have    O
a    O
diploid    B-Body109224911
chromosome    O
number    O
of    O
32    O
or    O
36    O
.    O

When    O
egg    O
and    O
sperm    O
fuse    O
,    O
a    O
diploid    B-Body109224911
cell    O
(    O
the    O
zygote    O
)    O
is    O
formed    O
,    O
which    O
rapidly    O
grows    O
into    O
a    O
new    O
organism    O
.    O

Nearly    O
all    O
land    O
plants    O
have    O
alternating    O
diploid    B-Body109224911
and    O
haploid    B-Body109224911
generations    O
.    O

Mitotic    O
cell    O
growth    O
and    O
spore    O
germination    O
are    O
not    O
compromised    O
when    O
these    O
genes    O
are    O
deleted    O
,    O
but    O
diploid    B-Body109224911
that    O
are    O
homozygous    O
for    O
a    O
SAT-1    O
null    O
mutation    O
exhibit    O
a    O
decrease    O
in    O
sporulation    O
efficiency    O
.    O

Female    O
whiteflies    O
are    O
diploid    B-Body109224911
and    O
emerge    O
from    O
fertilized    O
eggs    O
whereas    O
male    O
whiteflies    O
are    O
haploid    B-Body109224911
and    O
emerge    O
from    O
unfertilized    O
eggs    O
.    O

Members    O
are    O
perennial    O
,    O
primarily    O
understory    O
,    O
herbaceous    O
taxa    O
united    O
on    O
the    O
basis    O
of    O
chromosome    O
morphology    O
(    O
generally    O
large    O
)    O
,    O
a    O
shared    O
base    O
chromosome    B-Body109224911
number    I-Body109224911
(    O
"    O
x    O
"    O
=    O
19    O
)    O
,    O
and    O
a    O
biseriate    O
arrangement    O
of    O
seeds    O
in    O
each    O
locule    O
(    O
two    O
longitudinal    O
files    O
of    O
seeds    O
in    O
each    O
locule    O
)    O
,    O
although    O
the    O
seeds    O
are    O
uniseriate    O
in    O
"    O
Plowmanianthus    O
"    O
.    O

It    O
is    O
theorized    O
that    O
wheat    O
's    O
ancestors    O
(    O
"    O
Triticum    O
monococcum    O
,    O
Aegilops    O
speltoides    O
"    O
,    O
and    O
"    O
Aegilops    O
tauschii    O
"    O
,    O
all    O
diploid    B-Body109224911
grasses    O
)    O
hybridized    O
naturally    O
over    O
millennia    O
somewhere    O
in    O
West    O
Asia    O
,    O
to    O
create    O
natural    O
polyploid    O
hybrids    O
,    O
the    O
best    O
known    O
of    O
which    O
are    O
common    O
wheat    O
and    O
durum    O
wheat    O
.    O

Most    O
paleopolyploids    O
,    O
through    O
evolutionary    O
time    O
,    O
have    O
lost    O
their    O
polyploid    O
status    O
through    O
a    O
process    O
called    O
diploidization    O
,    O
and    O
are    O
currently    O
considered    O
diploids    B-Body109224911
e.g.    O
baker    O
's    O
yeast    O
,    O
"    O
Arabidopsis    O
thaliana    O
"    O
,    O
and    O
perhaps    O
humans    O
.    O

Ploidy    B-Body109224911

In    O
this    O
family    O
,    O
the    O
number    O
of    O
haploid    B-Body109224911
chromosomes    O
lies    O
between    O
26    O
and    O
30    O
(    O
according    O
to    O
the    O
values    O
in    O
this    O
table    O
)    O
.    O

:    O
Diploid    B-Body109224911
(    O
2x    O
)    O
cells    O
have    O
two    O
copies    O
(    O
homologs    O
)    O
of    O
each    O
chromosome    O
,    O
usually    O
one    O
from    O
the    O
mother    O
and    O
one    O
from    O
the    O
father    O
.    O

As    O
most    O
irises    O
are    O
diploid    B-Body109224911
,    O
having    O
two    O
sets    O
of    O
chromosomes    O
.    O

As    O
most    O
irises    O
are    O
diploid    B-Body109224911
,    O
having    O
two    O
sets    O
of    O
chromosomes    O
.    O

Ploidy    B-Body109224911
:    O
"    O
2n    O
"    O
=    O
38    O
.    O

The    O
diploid    O
chromosome    B-Body109224911
number    I-Body109224911
is    O
2n    O
=    O
36    O
.    O

As    O
most    O
irises    O
are    O
diploid    B-Body109224911
,    O
having    O
two    O
sets    O
of    O
chromosomes    O
,    O
this    O
can    O
be    O
used    O
to    O
identify    O
hybrids    O
and    O
classification    O
of    O
groupings    O
.    O

As    O
most    O
irises    O
are    O
diploid    B-Body109224911
,    O
having    O
two    O
sets    O
of    O
chromosomes    O
,    O
this    O
can    O
be    O
used    O
to    O
identify    O
hybrids    O
and    O
classification    O
of    O
groupings    O
.    O

As    O
most    O
irises    O
are    O
diploid    B-Body109224911
,    O
having    O
two    O
sets    O
of    O
chromosomes    O
.    O

As    O
most    O
irises    O
are    O
diploid    B-Body109224911
,    O
having    O
two    O
sets    O
of    O
chromosomes    O
.    O

Chromosome    B-Body109224911
number    I-Body109224911
:    O
2n    O
=    O
12–60    O
.    O

In    O
this    O
family    O
,    O
the    O
number    O
of    O
haploid    B-Body109224911
chromosomes    O
lies    O
between    O
26    O
and    O
30    O
(    O
according    O
to    O
the    O
values    O
in    O
this    O
table    O
)    O
.    O

Its    O
karyotype    O
has    O
2n    B-Body109224911
=    O
64    O
and    O
FN    O
=    O
104    O
.    O

The    O
diploid    B-Body109224911
chromosome    O
number    O
of    O
"    O
E.    O
blepharistes    O
"    O
has    O
been    O
determined    O
as    O
2"n    O
"    O
=    O
40    O
.    O

The    O
diploid    B-Body109224911
chromosome    O
number    O
of    O
"    O
E.    O
cristatum    O
"    O
has    O
been    O
determined    O
as    O
2"n    O
"    O
=    O
40    O
,    O
the    O
haploid    B-Body109224911
chromosome    B-Body109224911
number    I-Body109224911
as    O
"    O
n    O
"    O
=    O
20    O
.    O

The    O
diploid    B-Body109224911
chromosome    O
number    O
of    O
"    O
C.    O
ciliare    O
"    O
has    O
been    O
determined    O
from    O
several    O
individuals    O
as    O
2"n    O
"    O
=    O
40    O
,    O
80    O
,    O
and    O
160    O
,    O
the    O
haploid    B-Body109224911
chromosome    B-Body109224911
number    I-Body109224911
as    O
"    O
n    O
"    O
=    O
20    O
.    O

The    O
diploid    B-Body109224911
chromosome    O
number    O
of    O
"    O
E.    O
difforme    O
"    O
has    O
been    O
determined    O
both    O
as    O
2"n    O
"    O
=    O
40    O
and    O
as    O
2"n    O
"    O
=    O
39    O
.    O

The    O
diploid    B-Body109224911
chromosome    O
number    O
of    O
"    O
E.    O
magnoliae    O
"    O
has    O
been    O
determined    O
as    O
2"n    O
"    O
=    O
40    O
,    O
the    O
haploid    B-Body109224911
chromosome    B-Body109224911
number    I-Body109224911
as    O
"    O
n    O
"    O
=    O
20    O
.    O

The    O
haploid    B-Body109224911
chromosome    O
number    O
of    O
"    O
E.    O
nocturnum    O
"    O
has    O
been    O
determined    O
as    O
"    O
n    O
"    O
=    O
20    O
.    O

The    O
diploid    B-Body109224911
chromosome    B-Body109224911
number    I-Body109224911
has    O
been    O
determined    O
both    O
as    O
2"n    O
"    O
=    O
40    O
and    O
as    O
2"n    O
"    O
=    O
80    O
.    O

In    O
1984    O
,    O
the    O
diploid    B-Body109224911
chromosome    O
number    O
of    O
an    O
individual    O
identified    O
as    O
"    O
E.    O
floribundum    O
"    O
Kunth    O
was    O
determined    O
as    O
2"n    O
"    O
=    O
40    O
.    O

In    O
conjugation    O
,    O
the    O
micronuclei    O
of    O
each    O
cell    O
undergo    O
meiosis    O
,    O
and    O
haploid    B-Body109224911
micronuclei    O
are    O
then    O
exchanged    O
from    O
one    O
cell    O
to    O
the    O
other    O
.    O

Experiments    O
on    O
"    O
Loxodes    O
"    O
have    O
shown    O
that    O
little    O
or    O
no    O
DNA    O
synthesis    O
occurs    O
in    O
their    O
macronuclei    O
,    O
and    O
that    O
the    O
DNA    O
content    O
of    O
a    O
macronucleus    O
is    O
only    O
slightly    O
more    O
than    O
that    O
of    O
a    O
diploid    B-Body109224911
micronucleus    O
(    O
"    O
paradiploid    O
"    O
)    O
.    O

"    O
Trifolium    O
occidentale    O
"    O
is    O
a    O
"    O
self    O
-    O
compatible    O
,    O
diploid    B-Body109224911
,    O
stoloniferous    O
"    O
perennial    O
herb    O
,    O
found    O
only    O
within    O
100    O
metres    O
of    O
the    O
coast    O
,    O
in    O
western    O
Europe    O
.    O

These    O
somatic    O
cells    O
are    O
diploid    B-Body109224911
containing    O
two    O
copies    O
of    O
each    O
chromosome    O
,    O
whereas    O
the    O
germ    O
cells    O
are    O
haploid    B-Body109224911
as    O
they    O
only    O
contain    O
one    O
copy    O
of    O
each    O
chromosome    O
.    O

On    O
the    O
basis    O
of    O
what    O
is    O
known    O
(    O
and    O
remembering    O
that    O
,    O
as    O
dogs    O
are    O
diploid    B-Body109224911
animals    O
,    O
each    O
gene    O
location    O
(    O
locus    B-Body109224911
)    O
appears    O
twice    O
in    O
every    O
animal    O
,    O
so    O
questions    O
of    O
dominance    O
also    O
must    O
be    O
resolved    O
)    O
,    O
the    O
gene    O
possibilities    O
allowed    O
by    O
the    O
Mastiff    O
standard    O
are    O
AyBDEmh(kbr    O
or    O
ky)mS.    O
This    O
describes    O
a    O
dog    O
which    O
is    O
fawn    O
with    O
a    O
dark    O
nose    O
,    O
non    O
-    O
dilute    O
,    O
black    O
-    O
masked    O
,    O
non    O
-    O
harlequin    O
,    O
brindled    O
or    O
not    O
brindled    O
,    O
non    O
-    O
merle    O
,    O
and    O
non    O
-    O
spotted    O
.    O

For    O
some    O
rare    O
genes    O
,    O
the    O
normal    O
diploid    B-Body109224911
level    O
of    O
gene    O
expression    O
is    O
essential    O
to    O
individual    O
survival    O
;    O
fewer    O
than    O
two    O
copies    O
of    O
such    O
a    O
gene    O
results    O
in    O
lethality    O
.    O

Humans    O
,    O
for    O
example    O
,    O
can    O
not    O
survive    O
,    O
even    O
as    O
heterozygotes    O
,    O
with    O
deletions    O
that    O
remove    O
more    O
than    O
about    O
3%    O
of    O
any    O
part    O
of    O
their    O
haploid    B-Body109224911
genome    O
.    O

Unfertilised    O
eggs    O
become    O
haploid    B-Body109224911
males    O
;    O
fertilised    O
eggs    O
grow    O
into    O
diploid    B-Body109224911
females    O
and    O
queens    O
.    O

It    O
also    O
should    O
be    O
borne    O
in    O
mind    O
that    O
every    O
sexually    O
reproducing    O
extant    O
species    O
of    O
vascular    O
plant    O
actually    O
has    O
an    O
alternation    O
of    O
generations    O
;    O
the    O
plants    O
we    O
see    O
about    O
us    O
generally    O
are    O
diploid    B-Body109224911
sporophytes    O
,    O
but    O
their    O
offspring    O
really    O
are    O
not    O
the    O
seeds    O
that    O
people    O
commonly    O
recognise    O
as    O
the    O
new    O
generation    O
.    O

The    O
seed    O
actually    O
is    O
the    O
offspring    O
of    O
the    O
haploid    B-Body109224911
generation    O
of    O
microgametophytes    O
(    O
pollen    O
)    O
and    O
megagametophytes    O
(    O
the    O
embryo    O
sacs    O
in    O
the    O
ovules    O
)    O
.    O

Fragaria    O
orientalis    O
is    O
a    O
diploid    B-Body109224911
species    O
of    O
wild    O
strawberry    O
native    O
to    O
E.    O
Asia    O
-    O
Eastern    O
Siberia    O
.    O

Most    O
eukaryotic    O
species    O
are    O
diploid    B-Body109224911
,    O
meaning    O
they    O
have    O
two    O
sets    O
of    O
chromosomes    O
,    O
whereas    O
prokaryotes    O
are    O
haploid    B-Body109224911
,    O
containing    O
a    O
single    O
chromosome    O
in    O
each    O
cell    O
.    O

Polysomy    O
types    O
are    O
categorized    O
based    O
on    O
the    O
number    O
of    O
extra    O
chromosomes    O
in    O
each    O
set    O
,    O
noted    O
as    O
a    O
diploid    B-Body109224911
(    O
2n    O
)    O
with    O
an    O
extra    O
chromosome    O
of    O
various    O
numbers    O
.    O

It    O
has    O
22    O
chromosome    O
pairs    O
(    O
not    O
counting    O
the    O
sex    O
chromosomes    O
)    O
,    O
with    O
a    O
diploid    B-Body109224911
chromosome    I-Body109224911
number    I-Body109224911
of    O
2n=46    O
.    O

The    O
diploid    O
chromosome    B-Body109224911
number    I-Body109224911
of    O
"    O
Margarya    O
melanioides    O
"    O
is    O
2n=18    O
.    O

In    O
domestic    O
livestock    O
in    O
Japan    O
,    O
diploid    B-Body109224911
(    O
2n    O
=    O
20    O
)    O
,    O
triploid    O
(    O
3n    O
=    O
30    O
)    O
and    O
chimeric    O
flukes    O
(    O
2n/3n    O
)    O
have    O
been    O
described    O
,    O
many    O
of    O
which    O
reproduce    O
parthenogenetically    O
.    O

In    O
gametophytic    O
self    O
-    O
incompatibility    O
(    O
GSI    O
)    O
,    O
the    O
SI    O
phenotype    O
of    O
the    O
pollen    O
is    O
determined    O
by    O
its    O
own    O
gametophytic    O
haploid    B-Body109224911
genotype    O
.    O

In    O
sporophytic    O
self    O
-    O
incompatibility    O
(    O
SSI    O
)    O
,    O
the    O
SI    O
phenotype    O
of    O
the    O
pollen    O
is    O
determined    O
by    O
the    O
diploid    B-Body109224911
genotype    O
of    O
the    O
anther    O
(    O
the    O
sporophyte    O
)    O
in    O
which    O
it    O
was    O
created    O
.    O

As    O
most    O
irises    O
are    O
diploid    B-Body109224911
,    O
having    O
two    O
sets    O
of    O
chromosomes    O
,    O
this    O
can    O
be    O
used    O
to    O
identify    O
hybrids    O
and    O
classification    O
of    O
groupings    O
.    O

When    O
a    O
male    O
"    O
P.    O
lucida    O
"    O
mates    O
with    O
a    O
female    O
"    O
P    O
monacha    O
"    O
,    O
the    O
offspring    O
are    O
diploid    B-Body109224911
and    O
are    O
all    O
female    O
.    O

This    O
large    O
monophyletic    O
subgenus    O
is    O
extremely    O
diverse    O
,    O
both    O
morphologically    O
and    O
ecologically    O
and    O
is    O
characterised    O
by    O
leaves    O
with    O
one    O
row    O
of    O
vascular    O
bundles    O
,    O
absence    O
of    O
palisade    O
parenchyma    O
and    O
a    O
subepidermal    O
position    O
of    O
laticifers    O
,    O
with    O
a    O
predominant    O
base    O
chromosome    B-Body109224911
number    I-Body109224911
x=7    O
.    O

Oogonial    O
stem    O
cells    O
(    O
OSCs    O
)    O
,    O
also    O
known    O
as    O
egg    O
precursor    O
cells    O
or    O
female    O
germline    O
cells    O
,    O
are    O
diploid    B-Body109224911
germline    O
cells    O
with    O
stem    O
cell    O
characteristics    O
:    O
the    O
ability    O
to    O
renew    O
and    O
differentiate    O
into    O
other    O
cell    O
types    O
,    O
different    O
from    O
their    O
tissue    O
of    O
origin    O
.    O

As    O
most    O
irises    O
are    O
diploid    B-Body109224911
,    O
having    O
two    O
sets    O
of    O
chromosomes    O
,    O
this    O
can    O
be    O
used    O
to    O
identify    O
hybrids    O
and    O
classification    O
of    O
groupings    O
.    O

Most    O
multicellular    O
organisms    O
have    O
two    O
sets    O
of    O
chromosomes    O
;    O
that    O
is    O
,    O
they    O
are    O
diploid    B-Body109224911
.    O

The    O
members    O
of    O
an    O
autosome    O
pair    O
in    O
a    O
diploid    B-Body109224911
cell    O
have    O
the    O
same    O
morphology    O
unlike    O
those    O
in    O
allosome    O
pairs    O
which    O
may    O
have    O
different    O
structure    O
.    O

For    O
example    O
,    O
humans    O
have    O
a    O
diploid    B-Body109224911
genome    O
that    O
usually    O
contains    O
22    O
pairs    O
of    O
autosomes    O
and    O
one    O
allosome    B-Body109224911
pair    O
(    O
46    O
chromosomes    O
total    O
)    O
.    O

The    O
nucleus    O
is    O
haploid    B-Body109224911
.    O

Generally    O
the    O
X    B-Body109224911
chromosome    I-Body109224911
constitutes    O
5    O
percent    O
of    O
the    O
haploid    B-Body109224911
chromosomal    O
complement    O
;    O
but    O
the    O
X    O
chromosome    O
of    O
the    O
blackbuck    O
this    O
percentage    O
is    O
14.96    O
.    O

database    O
search    O
-    O
degeneracy    O
(    O
biology    O
)    O
-    O
deletion    O
-    O
denaturation    O
-    O
denaturing    O
gel    O
-    O
deoxyribonuclease    O
(    O
DNase    O
)    O
-    O
deoxyribonucleic    O
acid    O
-    O
deoxyribonucleotide    O
-    O
diabetes    O
mellitus    O
-    O
dideoxy    O
sequencing    O
-    O
dideoxyribonucleotide    O
-    O
diploid    B-Body109224911
-    O
direct    O
repeat    O
-    O
DNA    O
ligase    O
-DNA    O
Bank    O
-    O
DNA    O
polymerase    O
-    O
DNA    O
replication    O
-    O
DNA    O
sequencing    O
-    O
DNase    O
-    O
dominant    O
-    O
dot    O
blot    O
-    O
double    O
helix    O
-    O
downstream    O
(    O
DNA    O
)    O
-    O
downstream    O
(    O
transduction    O
)    O
-    O
ds    O
-    O
duplex    O
-    O

hairpin    O
-    O
haploid    B-Body109224911
-    O
haploinsufficiency    O
-    O
helix    O
-    O
loop    O
-    O
helix    O
-    O
hematopoietic    O
stem    O
cell    O
-    O
hemophilia    O
-    O
heteroduplex    O
DNA    O
-    O
heterozygous    O
-    O
highly    O
conserved    O
sequence    O
-    O
Hirschsprung    O
's    O
disease    O
-    O
histone    O
-    O
hnRNA    O
-    O
holoprosencephaly    O
-    O
homologous    O
recombination    O
-    O
homology    O
-    O
homozygous    O
-    O
host    O
strain    O
(    O
bacterial    O
)    O
-    O
human    B-Body109224911
artificial    I-Body109224911
chromosome    I-Body109224911
-    O
Human    O
Genome    O
Project    O
-    O
human    O
immunodeficiency    O
virus    O
-    O
Huntington    O
's    O
disease    O
-    O
hybridization    O
-    O
hybridoma    O
-    O
hydrophilicity    O
plot    O
-    O

The    O
basal    O
diploid    B-Body109224911
number    O
of    O
chromosomes    O
is    O
2n    O
=    O
54    O
in    O
this    O
family    O
,    O
but    O
with    O
a    O
wide    O
variation    O
in    O
the    O
chromosome    O
number    O
in    O
this    O
fish    O
group    O
,    O
ranging    O
from    O
2n    O
=    O
36    O
in    O
the    O
Loricariinae    O
,    O
"    O
Rineloricaria    O
latirostris    O
"    O
,    O
to    O
2n    O
=    O
96    O
in    O
a    O
species    O
of    O
"    O
Upsilodus    O
"    O
(    O
"    O
Hemipsilichthys    O
"    O
)    O
.    O

Studies    O
conducted    O
with    O
representatives    O
of    O
some    O
genera    O
of    O
Hypostominae    O
showed    O
,    O
within    O
this    O
group    O
,    O
the    O
diploid    B-Body109224911
number    I-Body109224911
ranges    O
from    O
2n    O
=    O
52    O
to    O
2n    O
=    O
80    O
.    O

Studies    O
conducted    O
with    O
representatives    O
of    O
some    O
genera    O
of    O
Hypostominae    O
showed    O
that    O
within    O
this    O
group    O
,    O
the    O
diploid    B-Body109224911
number    I-Body109224911
ranges    O
from    O
2n    O
=    O
52    O
to    O
2n    O
=    O
80    O
.    O

"    O
Sidalcea    O
"    O
is    O
generally    O
diploid    B-Body109224911
(    O
2n    O
=    O
20    O
)    O
,    O
but    O
polyploidy    O
(    O
4n    O
,    O
6n    O
)    O
also    O
occurs    O
.    O

For    O
autosomal    O
genes    O
,    O
diploid    B-Body109224911
organisms    O
inherit    O
one    O
copy    O
from    O
each    O
parent    O
.    O

Gamete    O
–    O
A    O
haploid    B-Body109224911
reproductive    O
cell    O
.    O

In    O
this    O
family    O
,    O
the    O
number    O
of    O
haploid    B-Body109224911
chromosomes    O
lies    O
between    O
21    O
and    O
30    O
(    O
according    O
to    O
the    O
values    O
in    O
this    O
table    O
)    O
.    O

Males    O
are    O
haploid    B-Body109224911
,    O
smaller    O
in    O
size    O
,    O
and    O
flightless    O
.    O

In    O
the    O
family    O
Testacellidae    O
,    O
the    O
number    O
of    O
haploid    B-Body109224911
chromosomes    O
lies    O
between    O
31    O
and    O
35    O
(    O
according    O
to    O
the    O
values    O
in    O
this    O
table    O
)    O
.    O

The    O
ploidy    B-Body109224911
levels    O
and    O
karyogamy    O
events    O
are    O
only    O
theorized    O
and    O
have    O
yet    O
to    O
be    O
proven    O
.    O

"    O
Dryopteris    O
"    O
×    O
"    O
neo    O
-    O
wherryi    O
"    O
(    O
"    O
D.    O
goldiana    O
"    O
×    O
"    O
D.    O
marginalis    O
"    O
;    O
diploid    B-Body109224911
)    O

As    O
"    O
A.    O
pinnatifidum    O
"    O
proved    O
to    O
be    O
a    O
tetraploid    O
while    O
"    O
A.    O
montanum    O
"    O
was    O
a    O
diploid    B-Body109224911
,    O
a    O
hybrid    O
between    O
them    O
would    O
be    O
a    O
triploid    O
,    O
and    O
Wagner    O
showed    O
that    O
this    O
was    O
in    O
fact    O
the    O
case    O
for    O
"    O
A.    O
×    O
trudellii    O
"    O
.    O

In    O
this    O
family    O
,    O
the    O
number    O
of    O
haploid    B-Body109224911
chromosomes    O
varies    O
greatly    O
.    O

Fertilized    O
eggs    O
get    O
two    O
sets    O
of    O
chromosomes    O
,    O
one    O
from    O
each    O
parent    O
,    O
and    O
so    O
larva    O
develop    O
into    O
diploid    B-Body109224911
females    O
,    O
while    O
unfertilized    O
eggs    O
only    O
contain    O
one    O
set    O
from    O
the    O
mother    O
,    O
so    O
develop    O
into    O
haploid    B-Body109224911
males    O
or    O
drones    O
.    O

The    O
base    O
chromosome    B-Body109224911
number    I-Body109224911
of    O
"    O
Gastrolobium    O
"    O
is    O
2"n    O
"    O
=    O
16    O
.    O

Genera    O
within    O
Triticeae    O
contain    O
diploid    B-Body109224911
,    O
allotetraploid    O
and/or    O
allohexaploid    O
genomes    O
,    O
the    O
capacity    O
to    O
form    O
allopolyploid    O
genomes    O
varies    O
within    O
the    O
tribe    O
.    O

As    O
most    O
irises    O
are    O
diploid    B-Body109224911
,    O
having    O
two    O
sets    O
of    O
chromosomes    O
,    O
this    O
can    O
be    O
used    O
to    O
identify    O
hybrids    O
and    O
classification    O
of    O
groupings    O
.    O

The    O
flowering    O
period    O
extends    O
from    O
March    O
to    O
May.    O
There    O
are    O
diploid    B-Body109224911
and    O
triploid    O
plants    O
with    O
2n    O
=    O
24    O
and    O
36    O
chromosomes    O
.    O

Fertilization    O
takes    O
place    O
when    O
the    O
spermatozoon    O
has    O
successfully    O
entered    O
the    O
ovum    O
and    O
the    O
two    O
sets    O
of    O
genetic    O
material    O
carried    O
by    O
the    O
gametes    O
fuse    O
together    O
,    O
resulting    O
in    O
the    O
zygote    O
(    O
a    O
single    O
diploid    B-Body109224911
cell    O
)    O
.    O

The    O
diploid    B-Body109224911
chromosome    O
number    O
of    O
"    O
C.    O
trinae    O
"    O
has    O
been    O
determined    O
as    O
2"n    O
"    O
=    O
40    O
.    O

the    O
haploid    B-Body109224911
chromosome    B-Body109224911
number    I-Body109224911
has    O
been    O
determined    O
as    O
"    O
n    O
"    O
=    O
20    O
.    O

Such    O
forces    O
may    O
depend    O
,    O
for    O
example    O
,    O
on    O
the    O
ratio    O
of    O
protons    O
to    O
neutrons    O
in    O
an    O
atomic    O
nucleus    O
,    O
nuclear    O
spin    O
,    O
or    O
the    O
relative    O
amount    O
of    O
different    O
kinds    O
of    O
binding    O
energy    O
in    O
a    O
nucleus    O
(    O
see    O
the    O
semi-empirical    B-Body109224911
mass    I-Body109224911
formula    I-Body109224911
)    O
.    O

He    O
continued    O
to    O
study    O
the    O
atomic    O
nucleus    O
(    O
proposing    O
the    O
"liquid    B-Body109224911
drop"    I-Body109224911
model    I-Body109224911
)    O
,    O
but    O
also    O
worked    O
on    O
stellar    O
physics    O
with    O
Robert    O
Atkinson    O
and    O
Fritz    O
Houtermans    O
.    O

This    O
formula    O
is    O
successful    O
at    O
explaining    O
many    O
important    O
phenomena    O
of    O
nuclei    O
,    O
such    O
as    O
their    O
changing    O
amounts    O
of    O
binding    O
energy    O
as    O
their    O
size    O
and    O
composition    O
changes    O
(    O
see    O
semi-empirical    B-Body109224911
mass    I-Body109224911
formula    I-Body109224911
)    O
,    O
but    O
it    O
does    O
not    O
explain    O
the    O
special    O
stability    O
which    O
occurs    O
when    O
nuclei    O
have    O
special    O
"    O
magic    O
numbers    O
"    O
of    O
protons    O
or    O
neutrons    O
.    O

Mention    O
should    O
be    O
made    O
of    O
Frenkel    O
's    O
works    O
on    O
the    O
theory    O
of    O
metals    O
,    O
nuclear    O
physics    O
(    O
the    O
liquid    B-Body109224911
drop    I-Body109224911
model    I-Body109224911
of    O
the    O
nucleus    B-Body109224911
)    O
,    O
and    O
semiconductors    O
.    O

This    O
is    O
a    O
rarely    O
occurring    O
effect    O
of    O
the    O
liquid    B-Body109224911
drop    I-Body109224911
model    I-Body109224911
.    O

Using    O
the    O
liquid    B-Body109224911
drop    I-Body109224911
model    I-Body109224911
for    O
atomic    O
nuclei    O
,    O
one    O
can    O
derive    O
a    O
semiempirical    O
formula    O
for    O
the    O
binding    O
energy    O
of    O
a    O
nucleus    O
.    O

Hybrid    B-Body109224911
plasmid    I-Body109224911

(    O
124Xe    O
,    O
126Xe    O
,    O
and    O
134Xe    O
are    O
predicted    O
to    O
undergo    O
double    B-Body109224911
beta    I-Body109224911
decay    I-Body109224911
,    O
but    O
this    O
has    O
never    O
been    O
observed    O
in    O
these    O
isotopes    O
,    O
so    O
they    O
are    O
considered    O
to    O
be    O
stable    O
.    O
)    O

Beyond    O
these    O
stable    O
forms    O
,    O
over    O
30    O
unstable    O
isotopes    O
and    O
isomers    O
have    O
been    O
studied    O
,    O
the    O
longest    O
-    O
lived    O
of    O
which    O
is    O
136Xe    O
,    O
which    O
undergoes    O
double    B-Body109224911
beta    I-Body109224911
decay    I-Body109224911
with    O
a    O
half    O
-    O
life    O
of    O
with    O
the    O
next    O
longest    O
lived    O
being    O
127Xe    O
with    O
a    O
half    O
-    O
life    O
of    O
36.345    O
days    O
.    O

Two    O
of    O
these    O
have    O
been    O
found    O
to    O
be    O
radioactive    O
:    O
128Te    O
and    O
130Te    O
undergo    O
double    B-Body109224911
beta    I-Body109224911
decay    I-Body109224911
with    O
half    O
-    O
lives    O
of    O
,    O
respectively    O
,    O
2.2×1024    O
(    O
2.2    O
septillion    O
)    O
years    O
(    O
the    O
longest    O
half    O
-    O
life    O
of    O
all    O
nuclides    O
proven    O
to    O
be    O
radioactive    O
)    O
and    O
7.9×1020    O
(    O
790    O
quintillion    O
)    O
years    O
.    O

The    O
two    O
natural    O
radioactive    O
isotopes    O
are    O
113Cd    O
(    O
beta    O
decay    O
,    O
half    O
-    O
life    O
is    O
8.04    O
×    O
1015    O
years    O
)    O
and    O
116Cd    O
(    O
two    O
-    O
neutrino    O
double    B-Body109224911
beta    I-Body109224911
decay    I-Body109224911
,    O
half    O
-    O
life    O
is    O
2.8    O
×    O
1019    O
years    O
)    O
.    O

Molybdenum-100    O
has    O
a    O
half    O
-    O
life    O
of    O
approximately    O
1×1019    O
y    O
and    O
undergoes    O
double    B-Body109224911
beta    I-Body109224911
decay    I-Body109224911
into    O
ruthenium-100    O
.    O

Naturally    O
occurring    O
zirconium    O
(    O
40Zr    O
)    O
is    O
composed    O
of    O
four    O
stable    O
isotopes    O
(    O
of    O
which    O
one    O
may    O
in    O
the    O
future    O
be    O
found    O
radioactive    O
)    O
,    O
and    O
one    O
very    O
long    O
-    O
lived    O
radioisotope    O
(    O
96Zr    O
)    O
,    O
a    O
primordial    O
nuclide    O
that    O
decays    O
via    O
double    B-Body109224911
beta    I-Body109224911
decay    I-Body109224911
with    O
an    O
observed    O
half    O
-    O
life    O
of    O
2.0×1019    O
years    O
;    O
it    O
can    O
also    O
undergo    O
single    O
beta    O
decay    O
,    O
which    O
is    O
not    O
yet    O
observed    O
,    O
but    O
the    O
theoretically    O
predicted    O
value    O
of    O
t1/2    O
is    O
2.4×1020    O
years    O
.    O

The    O
last    O
three    O
also    O
occur    O
as    O
fission    O
products    O
,    O
along    O
with    O
79Se    O
,    O
which    O
has    O
a    O
half    O
-    O
life    O
of    O
327,000    O
years    O
,    O
and    O
82Se    O
,    O
which    O
has    O
a    O
very    O
long    O
half    O
-    O
life    O
(    O
~1020    O
years    O
,    O
decaying    O
via    O
double    B-Body109224911
beta    I-Body109224911
decay    I-Body109224911
to    O
82Kr    O
)    O
and    O
for    O
practical    O
purposes    O
can    O
be    O
considered    O
to    O
be    O
stable    O
.    O

Of    O
these    O
,    O
76Ge    O
is    O
very    O
slightly    O
radioactive    O
,    O
decaying    O
by    O
double    B-Body109224911
beta    I-Body109224911
decay    I-Body109224911
with    O
a    O
half    O
-    O
life    O
of    O
1.78    O
×    O
1021    O
years    O
(    O
130    O
billion    O
times    O
the    O
age    O
of    O
the    O
universe    O
)    O
.    O

50Cr    O
is    O
suspected    O
of    O
decaying    O
by    O
β+β+    B-Body109224911
to    O
50Ti    O
with    O
a    O
half    O
-    O
life    O
of    O
(    O
more    O
than    O
)    O
1.8x1017    O
years    O
.    O

The    O
interplay    O
between    O
the    O
breast    O
cancer    O
genes    O
BRCA2    O
on    O
chromosome    B-Body109224911
13    I-Body109224911
and    O
BRCA1    O
on    O
chromosome    B-Body109224911
17    I-Body109224911
help    O
to    O
illustrate    O
these    O
larger    O
concepts    O
.    O

In    O
1995    O
,    O
Danish    O
researchers    O
announced    O
they    O
had    O
found    O
a    O
site    O
on    O
human    B-Body109224911
chromosome    I-Body109224911
13    I-Body109224911
that    O
is    O
responsible    O
,    O
at    O
least    O
in    O
part    O
,    O
for    O
nighttime    O
wetting    O
.    O

Abnormalities    O
of    O
chromosome    B-Body109224911
13    I-Body109224911
have    O
been    O
observed    O
in    O
canine    O
osteoid    O
chondrosarcoma    O
and    O
lymphosarcoma    O
.    O

For    O
example    O
,    O
the    O
karyogram    O
of    O
someone    O
with    O
Patau    O
Syndrome    O
would    O
show    O
that    O
they    O
possess    O
three    O
copies    O
of    O
chromosome    B-Body109224911
13    I-Body109224911
.    O

Human    O
CARKD    O
gene    O
has    O
10    O
exons    O
and    O
resides    O
on    O
Chromosome    B-Body109224911
13    I-Body109224911
at    O
q34    O
.    O

MODY    O
4    O
arises    O
from    O
mutations    O
of    O
the    O
PDX1    O
homeobox    O
gene    O
on    O
chromosome    B-Body109224911
13    I-Body109224911
.    O

In    O
humans    O
,    O
Robertsonian    O
translocations    O
generally    O
occurs    O
in    O
the    O
five    O
acrocentric    O
chromosome    O
pairs    O
,    O
namely    O
13    B-Body109224911
,    O
14    B-Body109224911
,    O
15    B-Body109224911
,    O
21    B-Body109224911
and    O
22    B-Body109224911
.    O

A    O
definition    O
in    O
semiconductor    O
physics    O
,    O
carrier    O
lifetime    O
is    O
defined    O
as    O
the    O
average    O
time    O
it    O
takes    O
for    O
a    O
minority    B-Body109224911
carrier    I-Body109224911
to    O
recombine    O
.    O

This    O
chain    O
-    O
like    O
process    O
results    O
in    O
the    O
hole    O
moving    O
around    O
the    O
crystal    O
and    O
able    O
to    O
carry    O
a    O
current    O
thus    O
acting    O
as    O
a    O
charge    B-Body109224911
carrier    I-Body109224911
.    O

At    O
room    O
temperature    O
,    O
all    O
the    O
fifth    O
electrons    O
are    O
liberated    O
,    O
can    O
move    O
around    O
the    O
Si    O
crystal    O
and    O
can    O
carry    O
a    O
current    O
and    O
thus    O
act    O
as    O
charge    B-Body109224911
carrier    I-Body109224911
.    O

The    O
word    O
"    O
electricity    O
"    O
refers    O
generally    O
to    O
the    O
movement    O
of    O
electrons    O
(    O
or    O
other    O
charge    B-Body109224911
carrier    I-Body109224911
)    O
through    O
a    O
conductor    O
in    O
the    O
presence    O
of    O
potential    O
and    O
an    O
electric    O
field    O
.    O

Facilities    O
are    O
available    O
for    O
measuring    O
current    O
-    O
voltage    O
curves    O
,    O
as    O
a    O
function    O
of    O
temperature    O
if    O
necessary    O
,    O
for    O
determining    O
the    O
charge    B-Body109224911
carrier    I-Body109224911
,    O
and    O
for    O
measuringcapacity    O
-    O
voltage    O
and    O
impedance    O
curves    O
.    O

Charge    B-Body109224911
carrier    I-Body109224911

Quantum    O
heterostructure    O
is    O
a    O
heterostructure    O
in    O
a    O
substrate    O
(    O
usually    O
a    O
semiconductor    O
material    O
)    O
,    O
where    O
size    O
restricts    O
the    O
movements    O
of    O
the    O
charge    B-Body109224911
carrier    I-Body109224911
forcing    O
them    O
into    O
a    O
quantum    O
confinement    O
.    O

In    O
solids    O
,    O
the    O
ability    O
of    O
electrons    O
to    O
act    O
as    O
charge    B-Body109224911
carrier    I-Body109224911
depends    O
on    O
the    O
availability    O
of    O
vacant    O
electronic    O
states    O
.    O

Thus    O
,    O
the    O
densities    O
of    O
charge    B-Body109224911
carrier    I-Body109224911
in    O
the    O
elemental    O
semimetals    O
carbon    O
(    O
as    O
graphite    O
,    O
in    O
the    O
direction    O
of    O
its    O
planes    O
)    O
,    O
arsenic    O
,    O
antimony    O
and    O
bismuth    O
are    O
3    O
cm−3    O
,    O
2    O
cm−3    O
,    O
5    O
cm−3    O
and    O
3    O
cm−3    O
respectively    O
.    O

A    O
perfect    O
insulator    O
does    O
not    O
exist    O
,    O
because    O
even    O
insulators    O
contain    O
small    O
numbers    O
of    O
mobile    O
charges    O
(    O
charge    B-Body109224911
carrier    I-Body109224911
)    O
which    O
can    O
carry    O
current    O
.    O

Electrical    O
breakdown    O
occurs    O
when    O
the    O
electric    O
field    O
in    O
the    O
material    O
is    O
strong    O
enough    O
to    O
accelerate    O
free    O
charge    B-Body109224911
carrier    I-Body109224911
(    O
electrons    O
and    O
ions    O
,    O
which    O
are    O
always    O
present    O
at    O
low    O
concentrations    O
)    O
to    O
a    O
high    O
enough    O
velocity    O
to    O
knock    O
electrons    O
from    O
atoms    O
when    O
they    O
strike    O
them    O
,    O
ion    B-Body109224911
the    O
atoms    O
.    O

An    O
intrinsic    O
semiconductor    O
has    O
its    O
own    O
charge    B-Body109224911
carrier    I-Body109224911
and    O
is    O
not    O
an    O
efficient    O
semiconductor    O
,    O
for    O
example    O
,    O
silicon    O
.    O

Surface    O
photovoltage    O
(    O
SPV    O
)    O
measurements    O
are    O
a    O
widely    O
used    O
method    O
to    O
determine    O
the    O
minority    B-Body109224911
carrier    I-Body109224911
diffusion    O
length    O
of    O
semiconductors    O
.    O

More    O
specifically    O
,    O
it    O
is    O
the    O
product    O
of    O
the    O
charge    B-Body109224911
carrier    I-Body109224911
saturation    O
velocity    O
in    O
the    O
material    O
and    O
the    O
electric    O
breakdown    O
field    O
under    O
same    O
conditions    O
,    O
first    O
proposed    O
by    O
Edward    O
O.    O
Johnson    O
of    O
RCA    O
in    O
1965    O
.    O

Thermionic    O
emission    O
is    O
the    O
thermally    O
induced    O
flow    O
of    O
charge    B-Body109224911
carriers    I-Body109224911
from    O
a    O
surface    O
or    O
over    O
a    O
potential    O
-    O
energy    O
barrier    O
.    O

Collisions    O
between    O
ice    O
and    O
soft    O
hail    O
(    O
graupel    O
)    O
inside    O
cumulonimbus    O
clouds    O
causes    O
separation    O
of    O
positive    O
and    O
negative    O
charge    B-Body109224911
within    O
the    O
cloud    O
,    O
essential    O
for    O
the    O
generation    O
of    O
lightning    O
.    O

They    O
change    O
the    O
arrangement    O
of    O
the    O
atoms    O
in    O
the    O
crystal    O
lattice    O
,    O
creating    O
lasting    O
damage    O
,    O
and    O
increasing    O
the    O
number    O
of    O
recombination    O
centers    O
,    O
depleting    O
the    O
minority    B-Body109224911
carrier    I-Body109224911
and    O
worsening    O
the    O
analog    O
properties    O
of    O
the    O
affected    O
semiconductor    O
junctions    O
.    O

Single    O
-    O
event    O
snapback    O
,    O
similar    O
to    O
SEL    O
but    O
not    O
requiring    O
the    O
PNPN    O
structure    O
,    O
can    O
be    O
induced    O
in    O
N    O
-    O
channel    O
MOS    O
transistors    O
switching    O
large    O
currents    O
,    O
when    O
an    O
ion    O
hits    O
near    O
the    O
drain    O
junction    O
and    O
causes    O
avalanche    O
multiplication    O
of    O
the    O
charge    B-Body109224911
carrier    I-Body109224911
.    O

Charge    B-Body109224911
carrier    I-Body109224911
normally    O
move    O
at    O
an    O
average    O
drift    O
speed    O
proportional    O
to    O
the    O
electric    O
field    O
strength    O
they    O
experience    O
temporally    O
.    O

Photons    O
striking    O
the    O
photodiode    O
are    O
converted    O
into    O
two    O
carriers    B-Body109224911
of    I-Body109224911
electrical    I-Body109224911
charge    I-Body109224911
,    O
called    O
electron    O
-    O
hole    O
pairs    O
.    O

The    O
nuclear    O
force    O
occurs    O
by    O
the    O
exchange    O
of    O
virtual    O
light    O
mesons    O
,    O
such    O
as    O
the    O
virtual    O
pions    O
,    O
as    O
well    O
as    O
two    O
types    O
of    O
virtual    O
mesons    O
with    O
spin    O
(    O
vector    B-Body109224911
meson    I-Body109224911
)    O
,    O
the    O
rho    O
mesons    O
and    O
the    O
omega    O
mesons    O
.    O

Vector    B-Body109224911
meson    I-Body109224911
,    O
a    O
meson    O
with    O
total    O
spin    O
1    O
and    O
odd    O
parity    O

Physicists    O
use    O
it    O
for    O
the    O
description    O
of    O
massive    O
spin-1    O
particles    O
,    O
such    O
as    O
vector    B-Body109224911
meson    I-Body109224911
,    O
but    O
its    O
importance    O
for    O
spin    O
theory    O
is    O
much    O
higher    O
because    O
it    O
anchors    O
spin    O
states    O
to    O
the    O
geometry    O
of    O
the    O
physical    O
3-space    O
.    O

Coumaphos    O
is    O
a    O
nonvolatile    O
,    O
fat    O
-    O
soluble    O
phosphorothioate    B-Body109224911
with    O
ectoparasiticide    O
properties    O
:    O
it    O
kills    O
insects    O
and    O
mites    O
.    O

Pirimiphos    O
-    O
methyl    O
,    O
marketed    O
as    O
Actellic    O
,    O
and    O
Sybol    O
is    O
a    O
phosphorothioate    B-Body109224911
used    O
as    O
an    O
insecticide    O
.    O

Nusinersen    O
is    O
an    O
antisense    O
oligonucleotide    O
in    O
which    O
the    O
2’-hydroxy    O
groups    O
of    O
the    O
ribofuranosyl    O
rings    O
are    O
replaced    O
with    O
2’-"O"-2-methoxyethyl    O
groups    O
and    O
the    O
phosphate    O
linkages    O
are    O
replaced    O
with    O
phosphorothioate    B-Body109224911
linkages    O
.    O

Ultra-high-energy    B-Body109224911
cosmic    I-Body109224911
ray    I-Body109224911
:    O

The    O
experiment    O
is    O
designed    O
to    O
observe    O
air    O
showers    O
induced    O
by    O
ultra-high-energy    B-Body109224911
cosmic    I-Body109224911
ray    I-Body109224911
using    O
a    O
combination    O
of    O
ground    O
array    O
and    O
air    O
-    O
fluorescence    O
techniques    O
.    O

Malargüe    O
is    O
home    O
to    O
the    O
Pierre    O
Auger    O
Observatory    O
,    O
an    O
observatory    O
designed    O
to    O
detect    O
ultra-high-energy    B-Body109224911
cosmic    I-Body109224911
ray    I-Body109224911
.    O

The    O
Antarctic    O
Impulsive    O
Transient    O
Antenna    O
(    O
ANITA    O
)    O
experiment    O
has    O
been    O
designed    O
to    O
study    O
ultra-high-energy    B-Body109224911
(    O
UHE    O
)    O
cosmic    O
neutrinos    O
by    O
detecting    O
the    O
radio    O
pulses    O
emitted    O
by    O
their    O
interactions    O
with    O
the    O
Antarctic    O
ice    O
sheet    O
.    O

It    O
is    O
believed    O
that    O
these    O
high    O
-    O
energy    O
cosmic    O
neutrinos    O
result    O
from    O
interaction    O
of    O
ultra-high-energy    B-Body109224911
(    O
1020    O
eV    O
)    O
cosmic    O
rays    O
with    O
the    O
photons    O
of    O
the    O
cosmic    O
microwave    O
background    O
radiation    O
.    O

large    O
surface    O
array    O
designed    O
to    O
study    O
the    O
origin    O
of    O
ultra-high-energy    B-Body109224911
cosmic    I-Body109224911
ray    I-Body109224911
.    O

However    O
an    O
immense    O
number    O
of    O
ultra-high    B-Body109224911
energy    I-Body109224911
particles    I-Body109224911
and    O
events    O
have    O
occurred    O
in    O
the    O
history    O
of    O
our    O
universe    O
,    O
dwarfing    O
by    O
many    O
orders    O
of    O
magnitude    O
any    O
events    O
at    O
human    O
disposal    O
.    O

John    O
David    O
Linsley    O
(    O
12    O
March    O
1925    O
–    O
25    O
September    O
2002    O
)    O
was    O
an    O
American    O
physicist    O
who    O
performed    O
pioneering    O
research    O
on    O
cosmic    O
rays    O
,    O
particularly    O
ultra-high-energy    B-Body109224911
cosmic    I-Body109224911
ray    I-Body109224911
.    O

Linsley    O
's    O
observations    O
at    O
Volcano    O
Ranch    O
expanded    O
the    O
known    O
cosmic    O
ray    O
energy    O
spectrum    O
,    O
clarified    O
the    O
structure    O
of    O
air    O
showers    O
,    O
and    O
provided    O
the    O
first    O
evidence    O
on    O
ultra-high-energy    B-Body109224911
cosmic    I-Body109224911
ray    I-Body109224911
composition    O
and    O
arrival    O
directions    O
.    O

kryptonium    B-Body109224911
,    O
(    O
protonated    O
krypton    O
)    O

More    O
strongly    O
inelastic    O
measurements    O
can    O
provide    O
information    O
about    O
energy    O
loss    O
channels    O
on    O
the    O
surface    O
such    O
as    O
surface    B-Body109224911
phonon    I-Body109224911
.    O

Stanislav    O
Pavlovich    O
Mikheyev    O
(;    O
1940    O
–    O
23    O
April    O
2011    O
)    O
was    O
a    O
Russian    O
physicist    O
known    O
for    O
the    O
discovery    O
of    O
the    O
MSW    B-Body109224911
effect    I-Body109224911
.    O

In    O
1985    O
Stanislav    O
Mikheyev    O
and    O
Alexei    O
Smirnov    O
considered    O
the    O
propagation    O
of    O
oscillating    O
neutrinos    O
in    O
matter    O
with    O
varying    O
density    O
and    O
suggested    O
an    O
explanation    O
for    O
the    O
solar    O
neutrino    O
problem    O
(    O
the    O
MSW    B-Body109224911
effect    I-Body109224911
)    O
.    O

Mikheyev–Smirnov–Wolfenstein    B-Body109224911
effect    I-Body109224911
,    O
in    O
particle    O
physics    O

tetrafluoroammonium    B-Body109224911
,    O

Two    O
rounds    O
of    O
chain    O
extension    O
with    O
malonate    B-Body109224911
follow    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
3-oxo-3-ureidopropanoate    O
and    O
H2O    O
,    O
whereas    O
its    O
two    O
products    O
are    O
malonate    B-Body109224911
and    O
urea    O
.    O

The    O
transfer    O
of    O
malonate    B-Body109224911
to    O
acyl    O
-    O
carrier    O
-    O
protein    O
(    O
ACP    O
)    O
converts    O
the    O
acyl    O
groups    O
into    O
thioester    O
forms    O
which    O
are    O
characteristic    O
of    O
acyl    O
intermediates    O
in    O
fatty    O
acid    O
synthesis    O
and    O
which    O
are    O
strictly    O
required    O
for    O
the    O
condensation    O
reactions    O
catalyzed    O
by    O
β-ketoacyl    O
-    O
ACP    O
synthetase    O
.    O

The    O
newly    O
bound    O
malonyl    O
-    O
ACP    O
then    O
swings    O
back    O
to    O
the    O
KS    O
domain    O
and    O
transfers    O
the    O
malonate    B-Body109224911
group    O
for    O
chain    O
elongation    O
.    O

More    O
complex    O
bridging    O
ligands    O
are    O
also    O
well    O
known    O
including    O
oxalate    O
,    O
malonate    B-Body109224911
,    O
and    O
pyrazine    O
.    O

The    O
starting    O
unit    O
is    O
then    O
modified    O
by    O
a    O
series    O
of    O
Claisen    O
condensations    O
with    O
malonyl    B-Body109224911
or    O
methylmalonyl    O
substrates    O
,    O
which    O
are    O
attached    O
to    O
an    O
acyl    O
carrier    O
protein    O
(    O
ACP    O
)    O
and    O
extend    O
the    O
polyketide    O
by    O
two    O
carbons    O
each    O
.    O

Discrete    O
spectra    O
are    O
seen    O
in    O
many    O
other    O
phenomena    O
,    O
such    O
as    O
vibrating    O
strings    O
,    O
microwaves    O
in    O
a    O
metal    O
cavity    O
,    O
sound    O
waves    O
in    O
a    O
pulsating    O
star    O
,    O
and    O
resonances    B-Body109224911
in    O
high    O
-    O
energy    O
particle    O
physics    O
.    O

The    O
collaboration    O
is    O
known    O
for    O
their    O
reports    O
of    O
a    O
resonance    B-Body109224911
which    O
they    O
interpret    O
as    O
a    O
pentaquark    B-Body109224911
candidate    O
made    O
of    O
two    O
up    O
quarks    O
,    O
two    O
down    O
quarks    O
and    O
a    O
strange    O
antiquark    O
(    O
uudd    O
)    O
.    O

When    O
the    O
imaginary    O
part    O
is    O
large    O
compared    O
to    O
the    O
real    O
part    O
,    O
the    O
particle    O
is    O
usually    O
thought    O
of    O
as    O
a    O
resonance    B-Body109224911
more    O
than    O
a    O
particle    O
.    O

Helmholz    O
along    O
with    O
Burton    O
Moyer    O
made    O
one    O
of    O
the    O
first    O
measurements    O
of    O
resonances    B-Body109224911
in    O
subatomic    O
physics    O
in    O
the    O
pion    O
-    O
nucleon    O
interaction    O
.    O

For    O
example    O
,    O
the    O
s    O
-    O
channel    O
corresponds    O
to    O
the    O
particles    O
1,2    O
joining    O
into    O
an    O
intermediate    O
particle    O
that    O
eventually    O
splits    O
into    O
3,4    O
:    O
the    O
s    O
-    O
channel    O
is    O
the    O
only    O
way    O
that    O
resonances    B-Body109224911
and    O
new    O
unstable    B-Body109224911
particle    I-Body109224911
may    O
be    O
discovered    O
provided    O
their    O
lifetimes    O
are    O
long    O
enough    O
that    O
they    O
are    O
directly    O
detectable    O
.    O

ZZ    B-Body109224911
diboson    I-Body109224911

Other    O
additives    O
include    O
,    O
salt    O
,    O
stearate    B-Body109224911
,    O
tallow    O
,    O
tannin    O
,    O
leaves    O
and    O
bark    O
of    O
certain    O
trees    O
,    O
xanthan    O
gum    O
,    O
alum    O
,    O
natural    O
glues    O
,    O
gum    O
arabic    O
,    O
kelp    O
,    O
lime    O
,    O
powdered    O
milk    O
,    O
or    O
the    O
blood    O
of    O
livestock    O
.    O

In    O
contrast    O
,    O
hard    O
water    O
contains    O
calcium    O
and/or    O
magnesium    O
ions    O
which    O
form    O
insoluble    O
salt    B-Body109224911
,    O
effectively    O
removing    O
the    O
residual    O
soap    O
from    O
the    O
skin    O
but    O
potentially    O
leaving    O
a    O
coating    O
of    O
insoluble    O
stearates    O
on    O
tub    O
and    O
shower    O
surfaces    O
,    O
commonly    O
called    O
soap    O
scum    O
.    O

A    O
Photo-meson    B-Body109224911
comes    O
from    O
the    O
word    O
,    O
meson    O
;    O
"    O
An    O
elementary    O
particle    O
that    O
is    O
composed    O
of    O
a    O
quark    O
and    O
an    O
antiquark    O
,    O
such    O
as    O
a    O
kaon    O
or    O
pion    O
.    O

Despite    O
the    O
naive    O
relations    O
between    O
the    O
PMNS    B-Body109224911
and    O
CKM    O
angles    O
,    O

We    O
can    O
switch    O
between    O
these    O
states    O
using    O
the    O
CKM    O
matrix    O
for    O
the    O
quarks    O
,    O
or    O
the    O
PMNS    B-Body109224911
matrix    I-Body109224911
for    O
the    O
neutrinos    O
(    O
the    O
charged    O
leptons    O
on    O
the    O
other    O
hand    O
are    O
eigenstates    O
of    O
both    O
mass    O
and    O
flavour    O
)    O
.    O

The    O
CHOOZ    O
results    O
place    O
limits    O
on    O
the    O
PMNS    B-Body109224911
matrix    I-Body109224911
element    O
"    O
U"e32    O
.    O

Bruno    O
Pontecorvo    O
,    O
a    O
founder    O
of    O
neutrino    O
high    O
energy    O
physics    O
,    O
whose    O
work    O
led    O
to    O
the    O
discovery    O
of    O
PMNS    B-Body109224911
matrix    I-Body109224911

There    O
may    O
also    O
be    O
a    O
non    O
-    O
zero    O
CP    O
-    O
violating    O
phase    O
in    O
the    O
neutrino    B-Body109224911
mixing    I-Body109224911
matrix    I-Body109224911
,    O
but    O
this    O
is    O
currently    O
unmeasured    O
.    O

Induced    O
polyploidy    O
,    O
and    O
the    O
addition    O
or    O
removal    O
of    O
chromosomes    O
using    O
a    O
technique    O
called    O
chromosome    B-Body109224911
engineering    I-Body109224911
may    O
also    O
be    O
used    O
.    O

This    O
makes    O
the    O
"    O
isospin    B-Body109224911
symmetry    I-Body109224911
"    O
a    O
good    O
approximation    O
.    O

The    O
symmetry    O
relating    O
the    O
proton    O
and    O
neutron    O
is    O
known    O
as    O
isospin    B-Body109224911
and    O
denoted    O
"    O
I    O
"    O
(    O
or    O
sometimes    O
"    O
T    O
"    O
)    O
.    O

Isospin    B-Body109224911
is    O
conserved    O
in    O
strong    O
interactions    O
.    O

The    O
Δ    O
baryons    O
have    O
a    O
mass    O
of    O
about    O
,    O
a    O
spin    O
of    O
,    O
and    O
an    O
isospin    B-Body109224911
of    O
.    O

In    O
particle    O
physics    O
,    O
weak    O
isospin    O
is    O
a    O
quantum    O
number    O
relating    O
to    O
the    O
weak    O
interaction    O
,    O
and    O
parallels    O
the    O
idea    O
of    O
isospin    B-Body109224911
under    O
the    O
strong    O
interaction    O
.    O

Protons    O
and    O
neutrons    O
are    O
fermions    O
,    O
with    O
different    O
values    O
of    O
the    O
strong    B-Body109224911
isospin    I-Body109224911
quantum    O
number    O
,    O
so    O
two    O
protons    O
and    O
two    O
neutrons    O
can    O
share    O
the    O
same    O
space    O
wave    O
function    O
since    O
they    O
are    O
not    O
identical    O
quantum    O
entities    O
.    O

The    O
concept    O
of    O
hypercharge    O
combines    O
and    O
unifies    O
isospin    B-Body109224911
and    O
flavour    O
into    O
a    O
single    O
charge    O
operator    O
.    O

Isospin    B-Body109224911
is    O
defined    O
in    O
the    O
SU(2    O
)    O
model    O
while    O
the    O
SU(3    O
)    O
model    O
defines    O
hypercharge    O
.    O

All    O
particles    O
that    O
interact    O
with    O
the    O
Weak    O
Nuclear    O
Force    O
,    O
for    O
instance    O
,    O
fall    O
into    O
this    O
family    O
,    O
since    O
the    O
definition    O
of    O
weak    O
nuclear    O
charge    O
(    O
weak    O
isospin    B-Body109224911
)    O
involves    O
helicity    O
,    O
which    O
,    O
by    O
above    O
,    O
must    O
be    O
an    O
invariant    O
.    O

SU(2    O
)    O
symmetry    O
also    O
supports    O
concepts    O
of    O
isobaric    B-Body109224911
spin    I-Body109224911
and    O
weak    O
isospin    O
,    O
collectively    O
known    O
as    O
"    O
isospin    O
"    O
.    O

The    O
symbols    O
encountered    O
in    O
this    O
list    O
are    O
:    O
I    O
(    O
"    O
isospin    B-Body109224911
"    O
)    O
,    O
J    O
(    O
"    O
total    O
angular    O
momentum    O
quantum    O
number    O
"    O
)    O
,    O
P    O
(    O
"    O
parity    O
"    O
)    O
,    O
Q    O
(    O
"    O
charge    O
"    O
)    O
,    O
S    O
(    O
"    O
strangeness    O
"    O
)    O
,    O
C    O
(    O
"    O
charmness    B-Body109224911
"    O
)    O
,    O
B′    O
(    O
"    O
bottomness    B-Body109224911
"    O
)    O
,    O
T    O
(    O
"    O
topness    B-Body109224911
"    O
)    O
,    O
u    O
(    O
"    O
up    O
quark    O
"    O
)    O
,    O
d    O
(    O
"    O
down    O
quark    O
"    O
)    O
,    O
s    O
(    O
"    O
strange    O
quark    O
"    O
)    O
,    O
c    O
(    O
"    O
charm    O
quark    O
"    O
)    O
,    O
b    O
(    O
"    O
bottom    O
quark    O
"    O
)    O
,    O
t    O
(    O
"    O
top    O
quark    O
"    O
)    O
,    O
as    O
well    O
as    O
other    O
subatomic    O
particles    O
(    O
hover    O
for    O
name    O
)    O
.    O

After    O
the    O
successful    O
synthesis    O
of    O
copernicium-277    O
,    O
the    O
GSI    O
team    O
performed    O
a    O
reaction    O
using    O
a    O
68Zn    O
projectile    O
in    O
1997    O
in    O
an    O
effort    O
to    O
study    O
the    O
effect    O
of    O
isospin    B-Body109224911
(    O
neutron    O
richness    O
)    O
on    O
the    O
chemical    O
yield    O
.    O

Homogeneously    B-Body109224911
staining    I-Body109224911
regions    I-Body109224911
(    O
HSRs    B-Body109224911
)    O
are    O
chromosomal    O
segments    O
with    O
various    O
lengths    O
and    O
uniform    O
staining    O
intensity    O
after    O
G    B-Body109224911
banding    I-Body109224911
.    O

These    O
include    O
strange    B-Body109224911
star    I-Body109224911
(    O
composed    O
of    O
strange    B-Body109224911
matter    I-Body109224911
)    O
and    O
the    O
more    O
speculative    O
preon    O
stars    O
(    O
composed    O
of    O
preons    O
)    O
.    O

A    O
-    O
type    O
star    O
in    O
this    O
hypothetical    O
state    O
is    O
called    O
a    O
"    O
quark    B-Body109224911
star    I-Body109224911
"    O
or    O
more    O
specifically    O
a    O
"    O
strange    O
star    O
"    O
.    O

Hypernovae    O
are    O
produced    O
by    O
more    O
than    O
one    O
type    O
of    O
event    O
:    O
relativistic    O
jets    O
during    O
formation    O
of    O
a    O
black    O
hole    O
from    O
fallback    O
of    O
material    O
onto    O
the    O
neutron    O
star    O
core    O
,    O
the    O
collapsar    O
model    O
;    O
interaction    O
with    O
a    O
dense    O
envelope    O
of    O
circumstellar    O
material    O
,    O
the    O
CSM    O
model    O
;    O
the    O
highest    O
mass    O
pair    O
instability    O
supernovae    O
;    O
possibly    O
others    O
such    O
as    O
binary    O
and    O
quark    B-Body109224911
star    I-Body109224911
model    O
.    O

Dmitri    O
Ivanenko    O
,    O
proposed    O
the    O
first    O
atomic    B-Body109224911
nucleus    I-Body109224911
and    O
nuclear    O
shell    O
models    O
,    O
predicted    O
the    O
synchrotron    O
radiation    O
,    O
author    O
of    O
the    O
hypothesis    O
of    O
quark    B-Body109224911
star    I-Body109224911

Chandra    O
data    O
suggested    O
that    O
RX    O
J1856.5    O
-    O
3754    O
and    O
3C58    O
,    O
previously    O
thought    O
to    O
be    O
pulsars    O
,    O
might    O
be    O
even    O
denser    O
objects    O
:    O
quark    B-Body109224911
star    I-Body109224911
.    O

It    O
has    O
been    O
speculated    O
that    O
this    O
supernova    O
involved    O
the    O
formation    O
of    O
a    O
quark    B-Body109224911
star    I-Body109224911
.    O

Quark    B-Body109224911
star    I-Body109224911
–    O
hypothetical    O
type    O
of    O
exotic    O
star    O
composed    O
of    O
quark    O
matter    O
,    O
or    O
strange    O
matter    O
.    O

However    O
,    O
the    O
ratio    O
of    O
produced    O
W    B-Body109224911
chromosome    I-Body109224911
-    O
bearing    O
(    O
W    O
-    O
bearing    O
)    O
spermatozoa    O
fell    O
substantially    O
below    O
expectations    O
.    O

In    O
birds    O
,    O
Z-chromosome    B-Body109224911
genes    O
have    O
the    O
highest    O
variability    O
.    O

The    O
rule    O
includes    O
both    O
male    O
heterogametic    O
(    O
XY    O
or    O
XO    O
-    O
type    O
sex    O
determination    O
,    O
such    O
as    O
found    O
in    O
mammals    O
and    O
"    O
Drosophila    O
"    O
fruit    O
flies    O
)    O
and    O
female    O
heterogametic    O
(    O
ZW-type    B-Body109224911
sex    I-Body109224911
determination    I-Body109224911
,    O
as    O
found    O
in    O
birds    O
and    O
butterflies    O
)    O
,    O
and    O
some    O
dioecious    O
plants    O
such    O
as    O
"    O
campions    O
"    O
.    O

WZ    O
sex    O
-    O
determination    O
system    O
,    O
also    O
known    O
as    O
the    O
ZW    B-Body109224911
sex-determination    I-Body109224911
system    I-Body109224911

For    O
example    O
,    O
XY    O
males    O
and    O
ZW    B-Body109224911
females    O
are    O
called    O
the    O
heterogamous    O
sex    O
.    O

ZW    B-Body109224911
sex-determination    I-Body109224911
system    I-Body109224911

There    O
are    O
nine    O
other    O
major    O
chromosomal    O
differences    O
between    O
chimpanzees    O
and    O
humans    O
:    O
chromosome    O
segment    O
inversions    O
on    O
human    O
chromosomes    O
1    B-Body109224911
,    O
4    B-Body109224911
,    O
5    B-Body109224911
,    O
9    B-Body109224911
,    O
12    B-Body109224911
,    O
15    B-Body109224911
,    O
16    B-Body109224911
,    O
17    B-Body109224911
,    O
and    O
18    B-Body109224911
.    O

In    O
humans    O
it    O
is    O
found    O
on    O
chromosome    B-Body109224911
5    I-Body109224911
.    O

"    O
IRX1    O
"    O
is    O
located    O
on    O
the    O
forward    O
DNA    O
strand    O
(    O
see    O
Sense    O
(    O
molecular    O
biology    O
)    O
)    O
of    O
chromosome    B-Body109224911
5    I-Body109224911
,    O
from    O
position    O
3596054    O
-    O
3601403    O
at    O
the    O
5p15.3    O
location    O
.    O

The    O
human    O
XRCC4    O
gene    O
is    O
located    O
on    O
chromosome    B-Body109224911
5    I-Body109224911
,    O
specifically    O
at    O
5q14.2    O
.    O

Two    O
major    O
immune    O
system    O
genes    O
under    O
investigation    O
are    O
interleukin-12    O
subunit    O
beta    O
(    O
"    O
IL12B    O
"    O
)    O
on    O
chromosome    B-Body109224911
5q    I-Body109224911
,    O
which    O
expresses    O
interleukin-12B    O
;    O
and    O
"    O
IL23R    O
"    O
on    O
chromosome    O
1p    O
,    O
which    O
expresses    O
the    O
interleukin-23    O
receptor    O
,    O
and    O
is    O
involved    O
in    O
T    O
cell    O
differentiation    O
.    O

The    O
human    O
IL-3    O
gene    O
is    O
located    O
on    O
chromosome    B-Body109224911
5    I-Body109224911
,    O
only    O
9    O
kilobases    O
from    O
the    O
GM    O
-    O
CSF    O
gene    O
,    O
and    O
its    O
function    O
is    O
quite    O
similar    O
to    O
GM    O
-    O
CSF    O
.    O

Gardner    O
syndrome    O
is    O
caused    O
by    O
mutation    O
in    O
the    O
adenomatous    O
polyposis    O
coli    O
(    O
APC    O
gene    O
)    O
,    O
located    O
in    O
chromosome    O
5q21    B-Body109224911
(    O
band    O
q21    O
on    O
chromosome    O
5    O
)    O
.    O

Using    O
restriction    O
enzymes    O
,    O
it    O
was    O
discovered    O
that    O
a    O
mutation    O
on    O
chromosome    B-Body109224911
5    I-Body109224911
particularly    O
within    O
the    O
C1214    O
T    O
allele    O
caused    O
the    O
adult    O
onset    O
form    O
of    O
Sandhoff    O
Disease    O
.    O

In    O
1992    O
,    O
the    O
GM2A    O
gene    O
itself    O
was    O
localized    O
to    O
chromosome    B-Body109224911
5    I-Body109224911
,    O
and    O
the    O
precise    O
locus    O
was    O
determined    O
the    O
following    O
year    O
.    O

Pentaquark    B-Body109224911
and    O
other    O
exotic    B-Body109224911
hadron    I-Body109224911
:    O
What    O
combinations    O
of    O
quarks    O
are    O
possible    O
?    O

Existence    O
of    O
pentaquark    B-Body109224911
(    O
1964–2015    O
)    O
:    O
In    O
July    O
2015    O
,    O
the    O
LHCb    O
collaboration    O
at    O
CERN    O
identified    O
pentaquarks    O
in    O
the    O
channel    O
,    O
which    O
represents    O
the    O
decay    O
of    O
the    O
bottom    O
lambda    O
baryon    O
into    O
a    O
J/ψ    O
meson    O
,    O
a    O
kaon    O
and    O
a    O
proton    O
(    O
p    O
)    O
.    O

The    O
collaboration    O
is    O
known    O
for    O
their    O
reports    O
of    O
a    O
resonance    B-Body109224911
which    O
they    O
interpret    O
as    O
a    O
pentaquark    B-Body109224911
candidate    O
made    O
of    O
two    O
up    O
quarks    O
,    O
two    O
down    O
quarks    O
and    O
a    O
strange    O
antiquark    O
(    O
uudd    O
)    O
.    O

a    O
detailed    O
analysis    O
shows    O
that    O
the    O
correlation    O
matrix    O
is    O
phenomenologically    O
compatible    O
with    O
a    O
tribimaximal    B-Body109224911
pattern    O
,    O
and    O
only    O
marginally    O
with    O
a    O
bimaximal    O
pattern    O
.    O

The    O
larger    O
symmetry    O
was    O
named    O
the    O
Eightfold    B-Body109224911
Way    I-Body109224911
by    O
Murray    O
Gell    O
-    O
Mann    O
,    O
and    O
was    O
promptly    O
recognized    O
to    O
correspond    O
to    O
the    O
adjoint    O
representation    O
of    O
SU(3    O
)    O
.    O

Combinations    O
of    O
three    O
u    O
,    O
d    O
or    O
s    O
-    O
quarks    O
forming    O
baryons    O
with    O
spin-    O
form    O
the    O
"    O
baryon    B-Body109224911
decuplet    I-Body109224911
"    O
.    O

Combinations    O
of    O
three    O
u    O
,    O
d    O
or    O
s    O
-    O
quarks    O
forming    O
baryons    O
with    O
spin-    O
form    O
the    O
"    O
baryon    B-Body109224911
octet    I-Body109224911
"    O
.    O

Yuval    O
Ne'eman    O
–    O
the    O
"    O
Eightfold    B-Body109224911
way    I-Body109224911
"    O

In    O
physics    O
,    O
the    O
Eightfold    B-Body109224911
Way    I-Body109224911
is    O
a    O
theory    O
organizing    O
subatomic    O
hadrons    O
.    O

In    O
particle    O
physics    O
,    O
the    O
eightfold    B-Body109224911
way    I-Body109224911
is    O
used    O
to    O
classify    O
sub    O
-    O
atomic    O
particles    O
.    O

Ethers    O
can    O
be    O
alkylated    O
at    O
oxygen    O
only    O
with    O
difficulty    O
,    O
but    O
thioethers    O
are    O
readily    O
alkylated    O
to    O
give    O
stable    O
sulfonium    O
salts    O
,    O
such    O
as    O
trimethylsulfonium    B-Body109224911
iodide    I-Body109224911
:    O

This    O
group    O
investigated    O
proton    O
structure    O
and    O
discovered    O
that    O
proton    B-Body109224911
spin    I-Body109224911
was    O
not    O
carried    O
by    O
the    O
valence    B-Body109224911
quarks    I-Body109224911
,    O
which    O
overturned    O
the    O
previous    O
predictions    O
.    O

G    B-Body109224911
banding    I-Body109224911
,    O
in    O
cytogenetics    O

G-banding    B-Body109224911
,    O
G    B-Body109224911
banding    I-Body109224911
,    O
or    O
Giemsa    B-Body109224911
banding    I-Body109224911
is    O
a    O
technique    O
used    O
in    O
cytogenetics    O
to    O
produce    O
a    O
visible    O
karyotype    O
by    O
staining    O
condensed    O
chromosomes    O
.    O

Karyotypes    O
are    O
commonly    O
analyzed    O
using    O
Giemsa    O
banding    O
(    O
G-banded    B-Body109224911
karyotyping)    I-Body109224911
)    O
.    O

Alternately    O
,    O
"    O
heterogamy    O
"    O
or    O
"    O
heterogamous    O
"    O
is    O
often    O
used    O
as    O
a    O
synonym    O
of    O
heterogametic    B-Body109224911
,    O
meaning    O
the    O
presence    O
of    O
two    O
unlike    O
chromosomes    O
in    O
a    O
sex    O
.    O

Heterogametic    B-Body109224911

Homogametic    B-Body109224911

Haldane    O
's    O
rule    O
states    O
that    O
if    O
in    O
a    O
species    O
hybrid    O
only    O
one    O
sex    O
is    O
sterile    O
,    O
that    O
sex    O
is    O
usually    O
the    O
heterogametic    B-Body109224911
sex    I-Body109224911
.    O

Extending    O
the    O
bradyon    B-Body109224911
,    O
luxon    O
,    O
tachyon    B-Body109224911
classification    O
from    O
the    O
representation    O
theory    O
of    O
the    O
Poincaré    O
group    O
to    O
an    O
analogous    O
classification    O
,    O
here    O
,    O
one    O
may    O
term    O
these    O
states    O
as    O
"    O
synchrons    O
"    O
.    O

In    O
a    O
Lorentz    O
invariant    O
theory    O
,    O
the    O
same    O
formulas    O
that    O
apply    O
to    O
ordinary    O
slower    O
-    O
than    O
-    O
light    O
particles    O
(    O
sometimes    O
called    O
"    O
bradyon    B-Body109224911
"    O
in    O
discussions    O
of    O
tachyons    O
)    O
must    O
also    O
apply    O
to    O
tachyons    O
.    O

The    O
velocity    O
of    O
a    O
bradyon    B-Body109224911
with    O
the    O
relativistic    O
energy    O
–    O
momentum    O
relation    O

These    O
include    O
the    O
sup    O
squark    O
,    O
sdown    O
squark    O
,    O
scharm    O
squark    O
,    O
sstrange    O
squark    O
,    O
stop    B-Body109224911
squark    I-Body109224911
,    O
and    O
sbottom    O
squark    O
.    O

Spaces    O
with    O
a    O
discrete    O
spectrum    O
correspond    O
to    O
bound    B-Body109224911
state    I-Body109224911
in    O
quantum    O
mechanics    O
,    O
while    O
a    O
continuous    O
spectrum    O
is    O
associated    O
with    O
scattering    O
states    O
.    O

Poles    O
of    O
the    O
S    O
-    O
matrix    O
in    O
the    O
complex    O
-    O
energy    O
plane    O
are    O
identified    O
with    O
bound    B-Body109224911
state    I-Body109224911
,    O
virtual    O
states    O
or    O
resonances    B-Body109224911
.    O

Discrete    O
spectra    O
are    O
usually    O
associated    O
with    O
systems    O
that    O
are    O
bound    B-Body109224911
in    O
some    O
sense    O
(    O
mathematically    O
,    O
confined    O
to    O
a    O
compact    O
space    O
)    O
.    O

Absolutely    O
continuous    O
spectrum    O
of    O
a    O
physical    O
observable    O
corresponds    O
to    O
free    O
states    O
of    O
a    O
system    O
,    O
while    O
the    O
pure    O
point    O
spectrum    O
corresponds    O
to    O
bound    B-Body109224911
state    I-Body109224911
.    O

In    O
molecular    O
sciences    O
,    O
a    O
molecule    O
consists    O
of    O
a    O
stable    O
system    O
(    O
bound    B-Body109224911
state    I-Body109224911
)    O
composed    O
of    O
two    O
or    O
more    O
atoms    O
.    O

In    O
fact    O
,    O
it    O
includes    O
weakly    O
bound    O
species    O
that    O
would    O
not    O
traditionally    O
be    O
considered    O
molecules    O
,    O
such    O
as    O
the    O
helium    O
dimer    O
,    O
He2    O
,    O
which    O
has    O
one    O
vibrational    O
bound    B-Body109224911
state    I-Body109224911
and    O
is    O
so    O
loosely    O
bound    O
that    O
it    O
is    O
only    O
likely    O
to    O
be    O
observed    O
at    O
very    O
low    O
temperatures    O
.    O

What    O
is    O
the    O
spatial    O
configuration    O
which    O
they    O
adopt    O
in    O
their    O
bound    B-Body109224911
state    I-Body109224911
?    O

The    O
electron    O
and    O
image    O
charge    O
form    O
a    O
bound    B-Body109224911
state    I-Body109224911
,    O
just    O
as    O
an    O
electron    O
and    O
proton    O
do    O
in    O
a    O
hydrogen    O
atom    O
,    O
with    O
a    O
minimum    O
average    O
separation    O
.    O

One    O
of    O
the    O
key    O
problems    O
in    O
elementary    O
particle    O
physics    O
is    O
to    O
compute    O
the    O
mass    O
spectrum    O
and    O
structure    O
of    O
hadrons    O
,    O
such    O
as    O
the    O
proton    O
,    O
as    O
bound    B-Body109224911
state    I-Body109224911
of    O
quarks    O
and    O
gluons    O
.    O

Although    O
the    O
LSZ    O
reduction    O
formula    O
can    O
not    O
handle    O
bound    B-Body109224911
state    I-Body109224911
,    O
massless    O
particles    O
and    O
topological    O
solitons    O
,    O
it    O
can    O
be    O
generalized    O
to    O
cover    O
bound    O
states    O
,    O
by    O
use    O
of    O
composite    O
fields    O
which    O
are    O
often    O
nonlocal    O
.    O

In    O
particular    O
,    O
it    O
can    O
lead    O
to    O
a    O
relativistic    O
description    O
of    O
bound    B-Body109224911
systems    I-Body109224911
in    O
terms    O
of    O
quantum    O
-    O
mechanical    O
wave    O
functions    O
.    O

H−    O
is    O
unusual    O
because    O
,    O
in    O
its    O
free    O
form    O
,    O
it    O
has    O
no    O
bound    B-Body109224911
excited    O
states    O
,    O
as    O
was    O
finally    O
proven    O
in    O
1977    O
.    O

1    O
to    O
5    O
percent    O
polyester    O
adipate    B-Body109224911

Anyon    B-Body109224911

Anyon    B-Body109224911

These    O
exotic    O
particles    O
are    O
known    O
as    O
anyon    B-Body109224911
,    O
and    O
they    O
obey    O
fractional    B-Body109224911
statistics    I-Body109224911
.    O

This    O
is    O
called    O
anyon    B-Body109224911
statistics    O
.    O

Instead    O
,    O
the    O
eigenvalues    O
of    O
the    O
exchange    O
operator    O
may    O
be    O
complex    O
phase    O
factors    O
(    O
in    O
which    O
case    O
is    O
not    O
Hermitian    O
)    O
,    O
see    O
anyon    B-Body109224911
for    O
this    O
case    O
.    O

Recessive    O
lethal    O
"    O
balancer    B-Body109224911
chromosomes    I-Body109224911
"    O
carrying    O
visible    O
genetic    O
markers    O
can    O
be    O
used    O
to    O
keep    O
stocks    O
of    O
lethal    O
alleles    O
in    O
a    O
heterozygous    O
state    O
without    O
recombination    O
due    O
to    O
multiple    O
inversions    O
in    O
the    O
balancer    O
.    O

When    O
the    O
strange    O
quark    O
is    O
also    O
treated    O
as    O
massless    O
,    O
i.e.    O
,    O
,    O
all    O
eight    O
pseudoscalar    O
mesons    O
of    O
the    O
quark    B-Body109224911
model    I-Body109224911
become    O
Goldstone    O
bosons    O
.    O

This    O
pattern    O
of    O
SSB    O
solves    O
one    O
of    O
the    O
earlier    O
"    O
mysteries    O
"    O
of    O
the    O
quark    B-Body109224911
model    I-Body109224911
,    O
where    O
all    O
the    O
pseudoscalar    O
mesons    O
should    O
have    O
been    O
of    O
nearly    O
the    O
same    O
mass    O
.    O

The    O
name    O
pentaquark    O
was    O
coined    O
by    O
Claude    O
Gignoux    O
et    O
al    O
.    O
and    O
Harry    O
J.    O
Lipkin    O
in    O
1987    O
;    O
however    O
,    O
the    O
possibility    O
of    O
five    O
-    O
quark    O
particles    O
was    O
identified    O
as    O
early    O
as    O
1964    O
when    O
Murray    O
Gell    O
-    O
Mann    O
first    O
postulated    O
the    O
existence    B-Body109224911
of    I-Body109224911
quarks    I-Body109224911
.    O

Quark    B-Body109224911
model    I-Body109224911

Thus    O
,    O
isospin    O
was    O
introduced    O
as    O
a    O
concept    O
well    O
before    O
the    O
development    O
of    O
the    O
quark    B-Body109224911
model    I-Body109224911
,    O
in    O
the    O
1960s    O
,    O
which    O
provides    O
our    O
modern    O
understanding    O
.    O

This    O
multiplet    O
structure    O
was    O
combined    O
with    O
strangeness    O
in    O
Murray    O
Gell    O
-    O
Mann    O
's    O
eightfold    B-Body109224911
way    I-Body109224911
,    O
ultimately    O
leading    O
to    O
the    O
quark    B-Body109224911
model    I-Body109224911
and    O
quantum    O
chromodynamics    O
.    O

According    O
to    O
the    O
quark    B-Body109224911
model    I-Body109224911
,    O
the    O
properties    O
of    O
hadrons    O
are    O
primarily    O
determined    O
by    O
their    O
so    O
-    O
called    O
"    O
valence    B-Body109224911
quark    I-Body109224911
"    O
.    O

Quark    B-Body109224911
model    I-Body109224911

It    O
led    O
to    O
the    O
development    O
of    O
the    O
quark    B-Body109224911
model    I-Body109224911
.    O

Strong    O
interactions    O
:    O
Flavour    O
,    O
Quantum    O
chromodynamics    O
,    O
Quark    B-Body109224911
model    I-Body109224911

With    O
the    O
advent    O
of    O
the    O
quark    B-Body109224911
model    I-Body109224911
,    O
it    O
is    O
now    O
obvious    O
that    O
(    O
if    O
one    O
only    O
includes    O
the    O
up    O
,    O
down    O
and    O
strange    O
quarks    O
out    O
of    O
the    O
total    O
6    O
quarks    O
in    O
the    O
Standard    O
Model    O
)    O
,    O
hypercharge    O
"    O
Y    O
"    O
is    O
the    O
following    O
combination    O
of    O
the    O
numbers    O
of    O
up    O
(    O
"    O
n"u    O
)    O
,    O
down    O
(    O
"    O
n"d    O
)    O
,    O
strange    O
quarks    O
(    O
"    O
n"s    O
)    O
,    O
charm    O
quarks    O
(    O
"    O
n"c    O
)    O
,    O
top    O
quarks    O
(    O
"    O
n"t    O
)    O
and    O
bottom    O
quarks    O
(    O
"    O
n"b    O
)    O
:    O

This    O
group    O
investigated    O
proton    O
structure    O
and    O
discovered    O
that    O
proton    B-Body109224911
spin    I-Body109224911
was    O
not    O
carried    O
by    O
the    O
valence    B-Body109224911
quarks    I-Body109224911
,    O
which    O
overturned    O
the    O
previous    O
predictions    O
.    O

I    O
,    O
J    O
,    O
and    O
P    O
values    O
in    O
red    O
have    O
not    O
been    O
firmly    O
established    O
by    O
experiments    O
,    O
but    O
are    O
predicted    O
by    O
the    O
quark    B-Body109224911
model    I-Body109224911
and    O
are    O
consistent    O
with    O
the    O
measurements    O
.    O

Plasma-desorption    B-Body109224911
mass    I-Body109224911
spectrometry    I-Body109224911

advanced    O
cancer    O
treatment    O
,    O
where    O
ECR    O
ion    B-Body109224911
sources    I-Body109224911
are    O
crucial    O
for    O
proton    O
therapy    O
,    O

In    O
April    O
2014    O
,    O
PNL    O
was    O
awarded    O
$    O
1    O
million    O
from    O
the    O
U.S.    O
Department    O
of    O
Energy    O
to    O
design    O
a    O
high    O
-    O
current    O
negative    O
hydrogen    O
ion    B-Body109224911
source    I-Body109224911
under    O
the    O
SBIR    O
Phase    O
II    O
project    O
.    O

An    O
anode    O
ray    O
ion    B-Body109224911
source    I-Body109224911
typically    O
is    O
an    O
anode    O
coated    O
with    O
the    O
halide    O
salt    O
of    O
an    O
alkali    O
or    O
alkaline    O
earth    O
metal    O
.    O

Associative    B-Body109224911
ionization    I-Body109224911

Charge-exchange    B-Body109224911
ionization    I-Body109224911

Following    O
the    O
SDI    O
,    O
he    O
led    O
a    O
team    O
that    O
built    O
two    O
state    O
-    O
of    O
-    O
the    O
-    O
art    O
electron    B-Body109224911
beam    I-Body109224911
ion    I-Body109224911
source    I-Body109224911
(    O
EBIS    B-Body109224911
)    O
,    O
obtaining    O
highly    O
charged    O
ions    O
up    O
to    O
Xe+46    O
in    O
laboratory    O
experiments    O
and    O
a    O
design    O
capability    O
of    O
U+90    O
.    O

In    O
a    O
tandem    O
mass    O
spectrometer    O
,    O
ion    B-Body109224911
are    O
formed    O
in    O
the    O
ion    B-Body109224911
source    I-Body109224911
and    O
separated    O
by    O
mass    O
-    O
to    O
-    O
charge    O
ratio    O
in    O
the    O
first    O
stage    O
of    O
mass    O
spectrometry    O
(    O
MS1    O
)    O
.    O

Ion    O
implantation    O
equipment    O
typically    O
consists    O
of    O
an    O
ion    B-Body109224911
source    I-Body109224911
,    O
where    O
ions    O
of    O
the    O
desired    O
element    O
are    O
produced    O
,    O
an    O
accelerator    O
,    O
where    O
the    O
ions    O
are    O
electrostatically    O
accelerated    O
to    O
a    O
high    O
energy    O
,    O
and    O
a    O
target    O
chamber    O
,    O
where    O
the    O
ions    O
impinge    O
on    O
a    O
target    O
,    O
which    O
is    O
the    O
material    O
to    O
be    O
implanted    O
.    O

This    O
technique    O
is    O
based    O
on    O
measuring    O
D    O
/    O
H    O
ratios    O
of    O
fragments    O
from    O
the    O
ion    B-Body109224911
source    I-Body109224911
(    O
e.g.    O
CH3CH    O
of    O
propane    O
molecule    O
)    O
that    O
samples    O
hydrogen    O
atoms    O
from    O
different    O
parts    O
of    O
the    O
molecule    O
.    O

The    O
two    O
current    O
-    O
carrying    O
electrical    O
leads    O
must    O
to    O
be    O
connected    O
to    O
the    O
ion    B-Body109224911
source    I-Body109224911
and    O
the    O
substrate    O
,    O
closing    O
the    O
electric    O
circuit    O
which    O
in    O
part    O
is    O
given    O
by    O
the    O
ion    O
beam    O
.    O

Ion    O
-    O
beam    O
sputtering    O
(    O
IBS    O
)    O
is    O
a    O
method    O
in    O
which    O
the    O
target    O
is    O
external    O
to    O
the    O
ion    B-Body109224911
source    I-Body109224911
.    O

Tunnel    B-Body109224911
ionization    I-Body109224911
is    O
ionization    O
due    O
to    O
quantum    O
tunneling    O
.    O

Gurgen    O
Askaryan    O
,    O
predicted    O
self    O
focusing    O
of    O
light    O
,    O
discovered    O
Askaryan    B-Body109224911
effect    I-Body109224911
in    O
the    O
particle    O
physics    O

The    O
neutrinos    O
,    O
with    O
energies    O
on    O
the    O
order    O
of    O
1018    O
eV    O
,    O
produce    O
radio    O
pulses    O
in    O
the    O
ice    O
because    O
of    O
the    O
Askaryan    B-Body109224911
effect    I-Body109224911
.    O

The    O
typical    O
onium    B-Body109224911
compound    I-Body109224911
used    O
as    O
a    O
photoinitiator    O
contains    O
two    O
or    O
three    O
arene    O
groups    O
for    O
iodonium    O
and    O
sulfonium    O
respectively    O
.    O

In    O
general    O
,    O
the    O
mechanism    O
is    O
more    O
simplistic    O
than    O
the    O
onium    B-Body109224911
ions    O
previously    O
described    O
.    O

In    O
chemistry    O
,    O
an    O
onium    B-Body109224911
ion    I-Body109224911
,    O
is    O
a    O
cation    B-Body109224911
formally    O
obtained    O
by    O
the    O
protonation    O
of    O
mononuclear    O
parent    O
hydride    O
of    O
a    O
pnictogen    O
(    O
group    O
15    O
of    O
the    O
periodic    O
table    O
)    O
,    O
chalcogen    O
(    O
group    O
16    O
)    O
,    O
or    O
halogen    O
(    O
group    O
17    O
)    O
.    O

It    O
is    O
a    O
superacid    O
and    O
one    O
of    O
the    O
onium    B-Body109224911
ion    I-Body109224911
,    O
indeed    O
the    O
simplest    O
carbonium    O
ion    O
.    O

X-inactivation    B-Body109224911

This    O
can    O
be    O
explained    O
by    O
x-inactivation    B-Body109224911
,    O
as    O
females    O
carry    O
one    O
normal    O
and    O
one    O
mutant    O
gene    O
.    O

However    O
,    O
it    O
has    O
recently    O
been    O
argued    O
that    O
dominance    O
theory    O
can    O
not    O
explain    O
Haldane    O
's    O
rule    O
in    O
marsupials    O
since    O
both    O
sexes    O
experience    O
the    O
same    O
incompatibilities    O
due    O
to    O
paternal    O
X-inactivation    B-Body109224911
in    O
females    O
.    O

Because    O
of    O
the    O
lyonization    B-Body109224911
,    O
inactivation    O
,    O
and    O
formation    O
of    O
Barr    O
bodies    O
in    O
all    O
female    O
cells    O
,    O
only    O
one    O
X    B-Body109224911
chromosome    I-Body109224911
is    O
active    O
at    O
any    O
time    O
.    O

Female    O
carriers    O
of    O
an    O
X    O
-    O
linked    O
recessive    O
condition    O
,    O
such    O
as    O
DMD    O
,    O
can    O
show    O
symptoms    O
depending    O
on    O
their    O
pattern    O
of    O
X-inactivation    B-Body109224911
.    O

For    O
example    O
,    O
the    O
pattern    O
of    O
X    B-Body109224911
chromosome    I-Body109224911
inactivation    I-Body109224911
is    O
affected    O
by    O
placental    O
status    O
.    O

He    O
is    O
best    O
known    O
for    O
a    O
collaboration    O
with    O
Ronald    O
Davidson    O
and    O
Harold    O
Nitowsky    O
,    O
which    O
demonstrated    O
random    O
inactivation    B-Body109224911
of    O
one    O
of    O
the    O
two    O
X-chromosome    B-Body109224911
in    O
mammalian    O
female    O
cells    O
,    O
a    O
mechanism    O
of    O
dosage    O
compensation    O
.    O

Why    O
"    O
BRCA1    O
"    O
and    O
"    O
BRCA2    O
"    O
mutations    O
lead    O
preferentially    O
to    O
cancers    O
of    O
the    O
breast    O
and    O
ovary    O
is    O
not    O
known    O
,    O
but    O
lack    O
of    O
"    O
BRCA1    O
"    O
function    O
seems    O
to    O
lead    O
to    O
non    O
-    O
functional    O
X-chromosome    B-Body109224911
inactivation    I-Body109224911
.    O

An    O
interaction    O
of    O
interest    O
here    O
would    O
be    O
between    O
neocentromeres    O
and    O
the    O
XIST    O
gene    O
,    O
which    O
is    O
responsible    O
for    O
X-inactivation    B-Body109224911
.    O

Since    O
women    O
have    O
two    O
copies    O
of    O
the    O
gene    O
and    O
could    O
be    O
heterozygotic    O
for    O
the    O
presence    O
or    O
absence    O
of    O
the    O
functioning    O
gene    O
they    O
could    O
(    O
through    O
the    O
process    O
of    O
lyonisation    B-Body109224911
)    O
express    O
the    O
functioning    O
protein    O
on    O
just    O
some    O
of    O
their    O
red    O
blood    O
cells    O
.    O

Although    O
X    O
-    O
linked    O
,    O
approximately    O
one    O
third    O
of    O
patients    O
are    O
women    O
due    O
to    O
skewed    O
X-inactivation    B-Body109224911
.    O

Xist    O
(    O
X    O
-    O
inactive    O
-    O
specific    O
transcript    O
)    O
is    O
a    O
long    O
ncRNA    O
gene    O
on    O
the    O
X    B-Body109224911
chromosome    I-Body109224911
of    O
the    O
placental    O
mammals    O
that    O
acts    O
as    O
major    O
effector    O
of    O
the    O
X    B-Body109224911
chromosome    I-Body109224911
inactivation    I-Body109224911
process    O
forming    O
Barr    O
bodies    O
.    O

Mothers    O
of    O
XMEN    O
patients    O
exhibit    O
preferential    O
X    B-Body109224911
chromosome    I-Body109224911
inactivation    I-Body109224911
of    O
the    O
chromosome    O
with    O
the    O
mutation    O
in    O
their    O
hematopoietic    O
cells    O
and    O
are    O
asymptomatic    O
.    O

SCID    O
can    O
also    O
arise    O
through    O
de    O
novo    O
mutations    O
and    O
can    O
be    O
prevented    O
in    O
females    O
by    O
X-inactivation    B-Body109224911
.    O

DNA    O
methylation    O
is    O
essential    O
for    O
normal    O
development    O
and    O
is    O
associated    O
with    O
a    O
number    O
of    O
key    O
processes    O
including    O
genomic    O
imprinting    O
,    O
X-chromosome    B-Body109224911
inactivation    I-Body109224911
,    O
repression    O
of    O
transposable    O
elements    O
,    O
aging    O
and    O
carcinogenesis    O
.    O

The    O
Cooper    O
pairs    O
are    O
analogous    O
to    O
the    O
pseudoscalar    B-Body109224911
meson    I-Body109224911
.    O

In    O
1960    O
,    O
Riazuddin    O
used    O
Nucleon    O
-    O
nucleon    O
dispersion    O
relation    O
to    O
discriminate    O
proton    O
-    O
proton    O
scattering    O
in    O
Pseudoscalar    B-Body109224911
meson    I-Body109224911
.    O

With    O
and    O
,    O
it    O
gives    O
the    O
corresponding    O
dioxygenyl    B-Body109224911
salts    O
:    O

Dioxygenyl    B-Body109224911
ion    O
,    O

It    O
is    O
caused    O
by    O
a    O
mutation    O
in    O
the    O
"    O
TRPV4    O
"    O
gene    O
,    O
located    O
on    O
chromosome    B-Body109224911
12    I-Body109224911
in    O
humans    O
.    O

Parastremmatic    O
dwarfism    O
is    O
caused    O
by    O
a    O
missense    O
mutation    O
(    O
where    O
one    O
amino    O
acid    O
is    O
replaced    O
by    O
another    O
in    O
a    O
gene    O
sequence    O
)    O
in    O
the    O
"    O
TRPV4    O
"    O
gene    O
,    O
located    B-Body109224911
on    O
the    O
long    O
arm    O
of    O
human    O
chromosome    O
12    B-Body109224911
,    O
at    O
12q24.11    O
.    O

CD94/NKG2    O
family    O
includes    O
seven    O
members    O
:    O
NKG2A    O
,    O
B    O
,    O
C    O
,    O
D    O
,    O
E    O
,    O
F    O
and    O
H.    O
Genes    O
encoding    O
these    O
receptors    O
are    O
clustered    O
in    O
the    O
natural    O
killer    O
complex    O
(    O
NKC    O
)    O
on    O
human    O
chromosome    B-Body109224911
12    I-Body109224911
and    O
mouse    O
chromosome    O
6    O
together    O
with    O
Clr    O
(    O
C    O
-    O
lectin    O
related    O
)    O
genes    O
.    O

MODY    O
3    O
(    O
also    O
known    O
as    O
HNF1A    O
-    O
MODY    O
)    O
is    O
caused    O
by    O
mutations    O
of    O
the    O
HNF1-alpha    O
;    O
gene    O
,    O
a    O
homeobox    O
gene    O
on    O
chromosome    B-Body109224911
12    I-Body109224911
.    O

SART3    O
is    O
located    O
on    O
chromosome    B-Body109224911
12    I-Body109224911
,    O
and    O
a    O
mutation    O
is    O
likely    O
the    O
cause    O
of    O
disseminated    O
superficial    O
actinic    O
porokeratosis    O
.    O

Keratin    O
6C    O
(    O
protein    O
name    O
K6C    O
;    O
gene    O
name    O
"    O
KRT6C    O
"    O
)    O
,    O
is    O
a    O
type    O
II    O
cytokeratin    O
,    O
one    O
of    O
a    O
number    O
of    O
isoforms    O
of    O
keratin    O
6    O
encoded    O
by    O
separate    O
genes    O
located    O
within    O
the    O
type    O
II    O
keratin    O
gene    O
cluster    O
on    O
human    O
chromosome    B-Body109224911
12    I-Body109224911
.    O

The    O
genes    O
for    O
the    O
type    O
I    O
keratins    O
are    O
located    O
in    O
a    O
gene    O
cluster    O
on    O
human    O
chromosome    B-Body109224911
17    I-Body109224911
,    O
whereas    O
the    O
genes    O
for    O
type    O
II    O
keratins    O
are    O
located    O
in    O
a    O
cluster    O
on    O
human    O
chromosome    B-Body109224911
12    I-Body109224911
(    O
the    O
exception    O
being    O
K18    O
,    O
a    O
type    O
I    O
keratin    O
located    O
in    O
the    O
type    O
II    O
gene    O
cluster    O
)    O
.    O

If    O
Lorentz    O
symmetry    O
were    O
not    O
an    O
exact    O
symmetry    O
,    O
neutrinos    O
could    O
experience    O
Lorentz-violating    B-Body109224911
oscillations    I-Body109224911
.    O

The    O
breaking    O
of    O
rotation    O
and    O
boost    O
invariance    O
causes    O
direction    O
dependence    O
in    O
the    O
theory    O
as    O
well    O
as    O
unconventional    O
energy    O
dependence    O
that    O
introduces    O
novel    O
effects    O
,    O
including    O
Lorentz-violating    B-Body109224911
neutrino    I-Body109224911
oscillations    I-Body109224911
and    O
modifications    O
to    O
the    O
dispersion    O
relations    O
of    O
different    O
particle    O
species    O
,    O
which    O
naturally    O
could    O
make    O
particles    O
move    O
faster    O
than    O
light    O
.    O

Atoms    O
and    O
complexes    O
connected    O
by    O
non    O
-    O
covalent    O
interactions    O
,    O
such    O
as    O
hydrogen    O
bonds    O
or    O
ionic    B-Body109224911
bond    I-Body109224911
,    O
are    O
generally    O
not    O
considered    O
single    O
molecules    O
.    O

Molecules    O
are    O
held    O
together    O
by    O
either    O
covalent    O
bonding    O
or    O
ionic    B-Body109224911
bonding    I-Body109224911
.    O

This    O
is    O
called    O
an    O
(    O
mostly    O
)    O
ionic    B-Body109224911
bond    I-Body109224911
.    O

There    O
are    O
two    O
general    O
routes    O
for    O
photoinitiation    O
:    O
free    O
radical    O
and    O
ionic    B-Body109224911
.    O

Most    O
of    O
them    O
,    O
such    O
as    O
the    O
covalent    O
or    O
ionic    B-Body109224911
bond    I-Body109224911
,    O
are    O
of    O
electric    O
nature    O
.    O

Unlike    O
the    O
ionically    B-Body109224911
bonded    I-Body109224911
hydrides    O
of    O
the    O
heavier    O
Group    O
2    O
elements    O
,    O
beryllium    O
hydride    O
is    O
covalently    O
bonded    O
(    O
three    O
-    O
center    O
two    O
-    O
electron    O
bond    O
)    O
.    O

Molecules    O
,    O
by    O
definition    O
,    O
are    O
most    O
often    O
held    O
together    O
with    O
covalent    O
bonds    O
involving    O
single    O
,    O
double    O
,    O
and/or    O
triple    O
bonds    O
,    O
where    O
a    O
"    O
bond    O
"    O
is    O
a    O
shared    O
pair    O
of    O
electrons    O
(    O
the    O
other    O
method    O
of    O
bonding    O
between    O
atoms    O
is    O
called    O
ionic    B-Body109224911
bonding    I-Body109224911
and    O
involves    O
a    O
positive    O
cation    B-Body109224911
and    O
a    O
negative    O
anion    B-Body109224911
)    O
.    O

Ionic    B-Body109224911
bonding    I-Body109224911
is    O
a    O
type    O
of    O
chemical    O
bond    O
that    O
involves    O
the    O
electrostatic    O
attraction    O
between    O
oppositely    O
charged    O
ion    B-Body109224911
,    O
and    O
is    O
the    O
primary    O
interaction    O
occurring    O
in    O
ionic    O
compounds    O
.    O

This    O
transfer    O
of    O
electrons    O
is    O
known    O
as    O
electrovalence    B-Body109224911
in    O
contrast    O
to    O
covalence    O
.    O

The    O
actual    O
relative    O
strengths    O
will    O
vary    O
depending    O
on    O
the    O
molecules    O
involved    O
.    O
Ionic    B-Body109224911
bonding    I-Body109224911
and    O
covalent    O
bonding    O

It    O
has    O
an    O
empirical    O
formula    O
of    O
and    O
consists    O
of    O
a    O
lattice    O
of    O
Mg2    O
+    O
ions    O
and    O
O2−    O
ions    O
held    O
together    O
by    O
ionic    B-Body109224911
bond    I-Body109224911
.    O

For    O
example    O
,    O
in    O
a    O
crystal    O
of    O
sodium    O
chloride    O
(    O
common    O
salt    O
)    O
,    O
the    O
crystal    O
is    O
made    O
up    O
of    O
ion    B-Body109224911
sodium    O
and    O
chlorine    O
,    O
and    O
held    O
together    O
with    O
ionic    B-Body109224911
bond    I-Body109224911
.    O

The    O
flanking    O
leucine    O
-    O
zipper    O
layers    O
act    O
as    O
a    O
water    O
-    O
tight    O
seal    O
to    O
shield    O
the    O
ionic    B-Body109224911
interactions    I-Body109224911
from    O
the    O
surrounding    O
solvent    O
.    O

In    O
winemaking    O
,    O
fining    O
is    O
the    O
process    O
where    O
a    O
substance    O
(    O
fining    O
agent    O
)    O
is    O
added    O
to    O
the    O
wine    O
to    O
create    O
an    O
adsorbent    O
,    O
enzymatic    O
or    O
ionic    B-Body109224911
bond    I-Body109224911
with    O
the    O
suspended    O
particles    O
,    O
producing    O
larger    O
molecules    O
and    O
larger    O
particles    O
that    O
will    O
precipitate    O
out    O
of    O
the    O
wine    O
more    O
readily    O
and    O
rapidly    O
.    O

Ionically    B-Body109224911
bound    O
substances    O
that    O
are    O
less    O
than    O
1    O
kg    O
/    O
L    O
in    O
density    O

The    O
ions    O
,    O
of    O
course    O
,    O
have    O
ionic    B-Body109224911
bond    I-Body109224911
.    O

Also    O
,    O
ionic    B-Body109224911
bond    I-Body109224911
are    O
not    O
the    O
strongest    O
bonds    O
,    O
and    O
halides    O
can    O
not    O
normally    O
scratch    O
glass    O
plates    O
.    O

The    O
binding    O
of    O
norephinephrine    O
to    O
the    O
binding    O
site    O
consists    O
of    O
one    O
ionic    B-Body109224911
bond    I-Body109224911
,    O
three    O
hydrogen    O
bonds    O
and    O
van    O
der    O
Waals    O
interaction    O
in    O
two    O
places    O
.    O

The    O
bond    O
between    O
the    O
reacting    O
species    O
can    O
either    O
be    O
ionic    B-Body109224911
or    O
covalent    O
.    O

Generally    O
speaking    O
,    O
acids    O
and    O
bases    O
interact    O
and    O
the    O
most    O
stable    O
interactions    O
are    O
hard    O
-    O
hard    O
(    O
ionogenic    B-Body109224911
character    O
)    O
and    O
soft    O
-    O
soft    O
(    O
covalent    O
character    O
)    O
.    O

Changbaiite    O
is    O
classified    O
as    O
a    O
multiple    O
Oxide    O
XY2O6    O
and    O
it    O
generally    O
has    O
an    O
ionic    B-Body109224911
bond    I-Body109224911
.    O

It    O
explains    O
hybridization    O
theory    O
,    O
covalent    O
bonding    O
and    O
ionic    B-Body109224911
bonding    I-Body109224911
as    O
explained    O
through    O
electronegativity    O
,    O
and    O
resonance    O
as    O
a    O
means    O
to    O
explain    O
,    O
among    O
other    O
things    O
,    O
the    O
structure    O
of    O
benzene    O
.    O

Other    O
notable    O
achievements    O
are    O
the    O
Froissart    O
bound    O
,    O
and    O
the    O
prediction    O
of    O
the    O
pomeron    B-Body109224911
.    O

Pomeron    B-Body109224911

Vladimir    O
Gribov    O
,    O
introduced    O
pomeron    B-Body109224911
,    O
DGLAP    O
equations    O
and    O
Gribov    O
ambiguity    O

Observation    O
of    O
0νββ    O
would    O
establish    O
that    O
the    O
neutrino    O
is    O
a    O
Majorana    B-Body109224911
particle    I-Body109224911
and    O
demonstrate    O
violation    O
of    O
lepton    O
number    O
conservation    O
,    O
validating    O
the    O
seesaw    B-Body109224911
mechanism    I-Body109224911
as    O
the    O
explanation    O
for    O
the    O
neutrino    O
mass    O
scale    O
.    O

He    O
is    O
primarily    O
known    O
for    O
his    O
proposal    O
,    O
with    O
Harald    O
Fritzsch    O
,    O
of    O
SO(10    O
)    O
as    O
the    O
group    O
of    O
a    O
grand    O
unified    O
theory    O
and    O
for    O
his    O
independent    O
proposal    O
,    O
more    O
-    O
or    O
-    O
less    O
simultaneously    O
with    O
a    O
number    O
of    O
other    O
theorists    O
,    O
of    O
the    O
seesaw    B-Body109224911
mechanism    I-Body109224911
for    O
the    O
generation    O
of    O
neutrino    O
masses    O
.    O

In    O
2008    O
,    O
Riazuddin    O
pointed    O
out    O
that    O
the    O
neutrino    O
mass    O
has    O
μ    O
and    O
τ    O
symmetry    O
and    O
Lepton    O
number    O
remains    O
constant    O
,    O
a    O
new    O
type    O
of    O
Seesaw    B-Body109224911
mechanism    I-Body109224911
is    O
formed    O
,    O
the    O
so    O
-    O
called    O
Riazuddin    O
's    O
Seesaw    O
Model    O
,    O
the    O
Dirac    O
mass    O
matrix    O
provided    O
the    O
Yukawa    O
coupling    O
to    O
follow    O
the    O
Majorana    B-Body109224911
fermion    I-Body109224911
to    O
satisfy    O
the    O
Leptogenesis    O
asymmetry    O
.    O

In    O
the    O
theory    O
of    O
grand    O
unification    O
of    O
particle    O
physics    O
,    O
and    O
,    O
in    O
particular    O
,    O
in    O
theories    O
of    O
neutrino    O
masses    O
and    O
neutrino    B-Body109224911
oscillation    I-Body109224911
,    O
the    O
seesaw    B-Body109224911
mechanism    I-Body109224911
is    O
a    O
generic    O
model    O
used    O
to    O
understand    O
the    O
relative    O
sizes    O
of    O
observed    O
neutrino    O
masses    O
,    O
of    O
the    O
order    O
of    O
eV    O
,    O
compared    O
to    O
those    O
of    O
quarks    O
and    O
charged    O
leptons    O
,    O
which    O
are    O
millions    O
of    O
times    O
heavier    O
.    O

A    O
substantial    O
subset    O
of    O
men    O
with    O
this    O
uncommon    O
syndrome    O
have    O
microdeletions    O
in    O
the    O
Yq11    O
region    O
of    O
the    O
Y    O
chromosome    O
,    O
an    O
area    O
known    O
as    O
the    O
AZF    B-Body109224911
(    O
azoospermia    O
factor    O
)    O
region    O
.    O

Maximon    B-Body109224911
-    O
a    O
particle    O
of    O
maximum    O
mass    O
in    O
the    O
mass    O
spectrum    O
of    O
elementary    O
particles    O

For    O
example    O
,    O
the    O
kinetic    O
energy    O
of    O
an    O
electron    O
in    O
a    O
Fermi    B-Body109224911
gas    I-Body109224911
is    O
given    O
by    O

Fermi    B-Body109224911
gas    I-Body109224911

At    O
high    O
temperatures    O
,    O
heavy    O
fermion    O
compounds    O
behave    O
like    O
normal    O
metals    O
and    O
the    O
electrons    O
can    O
be    O
described    O
as    O
a    O
Fermi    B-Body109224911
gas    I-Body109224911
,    O
in    O
which    O
the    O
electrons    O
are    O
assumed    O
to    O
be    O
non    O
-    O
interacting    O
fermions    O
.    O

For    O
the    O
free-electron    B-Body109224911
gas    I-Body109224911
—    O
a    O
simple    O
model    O
system    O
that    O
neglects    O
electron    O
interaction    O
—    O
or    O
metals    O
that    O
could    O
be    O
described    O
by    O
it    O
,    O
the    O
electronic    O
specific    O
heat    O
is    O
given    O
by    O

.    O
Fermions    O
,    O
on    O
the    O
other    O
hand    O
,    O
are    O
forbidden    O
from    O
sharing    O
quantum    O
states    O
,    O
giving    O
rise    O
to    O
systems    O
such    O
as    O
the    O
Fermi    B-Body109224911
gas    I-Body109224911
.    O

Here    O
,    O
the    O
electrons    O
are    O
modelled    O
as    O
a    O
Fermi    B-Body109224911
gas    I-Body109224911
,    O
a    O
gas    O
of    O
particles    O
which    O
obey    O
the    O
quantum    O
mechanical    O
Fermi    O
–    O
Dirac    O
statistics    O
.    O

Kogut–Susskind    B-Body109224911
fermion    I-Body109224911

Upper    O
limits    O
on    O
electron    O
width    B-Body109224911
of    O
scalar    B-Body109224911
and    O
tensor    O
mesons    O
,    O
,    O
,    O
,    O
and    O

As    O
an    O
aside    O
,    O
the    O
right    O
-    O
handed    O
neutrino    O
originally    O
did    O
not    O
exist    O
in    O
the    O
standard    O
model    O
–    O
but    O
the    O
discovery    O
of    O
neutrino    B-Body109224911
oscillation    I-Body109224911
implies    O
that    O
neutrinos    O
must    O
have    O
mass    O
,    O
and    O
since    O
chirality    O
can    O
change    O
during    O
the    O
propagation    O
of    O
a    O
massive    O
particle    O
,    O
right    O
-    O
handed    O
neutrinos    O
must    O
exist    O
in    O
reality    O
.    O

In    O
order    O
to    O
study    O
neutrino    B-Body109224911
oscillation    I-Body109224911
and    O
various    O
fundamental    O
topics    O
of    O
modern    O
physics    O
,    O
neutrinos    O
of    O
astronomic    O
or    O
solar    O
sources    O
,    O
and    O
CERN    O
Neutrinos    O
to    O
Gran    O
Sasso    O
(    O
CNGS    O
)    O
produced    O
730    O
km    O
away    O
by    O
the    O
Super    O
Proton    O
Synchrotron    O
from    O
CERN    O
,    O
have    O
been    O
detected    O
through    O
the    O
reaction    O
:    O

MINOS+    O
was    O
a    O
continuation    O
of    O
the    O
MINOS    O
experiment    O
(    O
Main    O
injector    O
neutrino    O
oscillation    O
search    O
)    O
to    O
measure    O
neutrino    B-Body109224911
oscillation    I-Body109224911
with    O
improved    O
electronics    O
.    O

It    O
is    O
an    O
essential    O
process    O
to    O
experiments    O
involving    O
low    O
energy    O
neutrinos    O
(    O
<    O
60    O
MeV    O
)    O
such    O
as    O
those    O
studying    O
neutrino    B-Body109224911
oscillation    I-Body109224911
,    O
reactor    O
neutrinos    O
,    O
sterile    O
neutrinos    O
,    O
and    O
geoneutrinos.    B-Body109224911

CHOOZ    O
was    O
a    O
short    O
baseline    O
neutrino    B-Body109224911
oscillation    I-Body109224911
experiment    O
in    O
Chooz    O
,    O
France    O
.    O

These    O
'    O
thermal    O
'    O
neutrinos    O
form    O
as    O
neutrino    O
-    O
antineutrino    O
pairs    O
of    O
all    O
flavors    B-Body109224911
,    O
and    O
total    O
several    O
times    O
the    O
number    O
of    O
electron    O
-    O
capture    O
neutrinos    O
.    O

It    O
was    O
at    O
Super    O
-    O
K    O
that    O
the    O
first    O
definitive    O
evidence    O
for    O
neutrino    B-Body109224911
oscillations    I-Body109224911
was    O
measured    O
,    O
via    O
a    O
high    O
-    O
statistics    O
,    O
high    O
-    O
precision    O
measurement    O
of    O
the    O
atmospheric    O
neutrino    O
flux    O
.    O

If    O
a    O
neutrino    B-Body109224911
oscillates    I-Body109224911
,    O
according    O
to    O
the    O
laws    O
of    O
quantum    O
mechanics    O
,    O
then    O
it    O
must    O
have    O
a    O
mass    O
.    O

McDonald    O
is    O
a    O
co    O
-    O
recipient    O
of    O
the    O
2007    O
Benjamin    O
Franklin    O
Medal    O
in    O
Physics    O
,    O
the    O
2015    O
Nobel    O
Prize    O
in    O
Physics    O
,    O
and    O
the    O
2015    O
Fundamental    O
Physics    O
Prize    O
for    O
the    O
discovery    O
of    O
neutrino    B-Body109224911
oscillations    I-Body109224911
and    O
demonstrating    O
that    O
neutrinos    O
have    O
mass    O
.    O

2015    O
,    O
awarded    O
the    O
Nobel    O
Prize    O
in    O
Physics    O
jointly    O
with    O
Takaaki    O
Kajita    O
for    O
the    O
discovery    O
of    O
neutrino    B-Body109224911
oscillation    I-Body109224911
,    O
which    O
shows    O
that    O
neutrinos    O
have    O
mass    O
.    O

However    O
,    O
through    O
neutrino    B-Body109224911
oscillation    I-Body109224911
,    O
it    O
is    O
now    O
known    O
that    O
at    O
least    O
two    O
of    O
the    O
three    O
mass    O
eigenstates    O
of    O
the    O
left    O
-    O
helicity    O
neutrino    O
and    O
right    O
-    O
helicity    O
anti    O
-    O
neutrino    O
each    O
must    O
have    O
non    O
-    O
zero    O
mass    O
.    O

Neutrinos    O
have    O
heavier    O
masses    O
but    O
the    O
Neutrino    B-Body109224911
oscillations    I-Body109224911
do    O
not    O
completely    O
identify    O
the    O
overall    O
scale    O
of    O
their    O
exact    O
masses    O
because    O
they    O
are    O
exceedingly    O
tiny    O
.    O

Introduced    O
by    O
Takehiko    O
Asaka    O
and    O
Mikhail    O
Shaposhnikov    O
in    O
2005    O
.    O
,    O
it    O
has    O
provided    O
a    O
highly    O
constrained    O
model    O
for    O
many    O
topics    O
in    O
physics    O
and    O
cosmology    O
,    O
such    O
as    O
baryogenesis    O
and    O
neutrino    B-Body109224911
oscillations    I-Body109224911
.    O

Luk    O
has    O
conducted    O
research    O
on    O
neutrino    B-Body109224911
oscillation    I-Body109224911
and    O
CP    O
violation    O
.    O

Luk    O
has    O
published    O
numerous    O
papers    O
on    O
neutrino    B-Body109224911
oscillation    I-Body109224911
(    O
see    O
selected    O
publications    O
)    O
,    O
including    O
his    O
Panofsky    O
Prize    O
winning    O
research    O
at    O
the    O
Daya    O
Bay    O
Nuclear    O
Power    O
Plant    O
.    O

In    O
the    O
theory    O
of    O
grand    O
unification    O
of    O
particle    O
physics    O
,    O
and    O
,    O
in    O
particular    O
,    O
in    O
theories    O
of    O
neutrino    O
masses    O
and    O
neutrino    B-Body109224911
oscillation    I-Body109224911
,    O
the    O
seesaw    B-Body109224911
mechanism    I-Body109224911
is    O
a    O
generic    O
model    O
used    O
to    O
understand    O
the    O
relative    O
sizes    O
of    O
observed    O
neutrino    O
masses    O
,    O
of    O
the    O
order    O
of    O
eV    O
,    O
compared    O
to    O
those    O
of    O
quarks    O
and    O
charged    O
leptons    O
,    O
which    O
are    O
millions    O
of    O
times    O
heavier    O
.    O

It    O
used    O
muon    O
neutrinos    O
from    O
a    O
well    O
-    O
controlled    O
and    O
well    O
-    O
understood    O
beam    O
to    O
verify    O
the    O
oscillations    B-Body109224911
previously    O
observed    O
by    O
Super    O
-    O
Kamiokande    O
using    O
atmospheric    O
neutrinos    O
.    O

This    O
was    O
the    O
first    O
positive    O
measurement    O
of    O
neutrino    B-Body109224911
oscillations    I-Body109224911
in    O
which    O
both    O
the    O
source    O
and    O
detector    O
were    O
fully    O
under    O
experimenters    O
'    O
control    O
.    O

The    O
muon    O
neutrinos    O
travelled    O
through    O
Earth    O
,    O
which    O
allowed    O
them    O
to    O
oscillate    B-Body109224911
(    O
change    O
)    O
into    O
other    O
flavours    O
of    O
neutrinos    O
,    O
namely    O
into    O
electron    O
neutrinos    O
and    O
tau    O
neutrinos    O
.    O

Charmed    B-Body109224911
baryons    I-Body109224911
are    O
a    O
category    O
of    O
composite    O
particles    O
comprising    O
all    O
baryons    O
made    O
of    O
at    O
least    O
one    O
charm    O
quark    O
.    O

He    O
was    O
the    O
first    O
person    O
to    O
do    O
a    O
computer    O
simulation    O
of    O
the    O
behavior    O
of    O
a    O
single    O
gene    B-Body109224911
locus    I-Body109224911
(    O
previous    O
simulation    O
work    O
having    O
been    O
of    O
models    O
with    O
multiple    O
loci    O
)    O
.    O

In    O
humans    O
,    O
lactoferrin    O
gene    O
"    O
LTF    O
"    O
is    O
located    O
on    O
the    O
third    O
chromosome    O
in    O
the    O
locus    B-Body109224911
3q21-q23    O
.    O

A    O
polygenic    O
score    O
,    O
also    O
called    O
a    O
polygenic    O
risk    O
score    O
,    O
genetic    O
risk    O
score    O
,    O
or    O
genome    O
-    O
wide    O
score    O
,    O
is    O
a    O
number    O
based    O
on    O
variation    O
in    O
multiple    O
genetic    B-Body109224911
loci    I-Body109224911
and    O
their    O
associated    O
weights    O
(    O
see    O
regression    O
analysis    O
)    O
.    O

The    O
deleted    O
segment    O
of    O
reported    O
individuals    O
represent    O
about    O
one    O
half    O
of    O
the    O
p    B-Body109224911
arm    I-Body109224911
,    O
occurring    O
distal    O
to    O
the    O
bands    O
4p15.1-p15.2    O
.    O

Alvarez    O
et    O
al    O
.    O
analysed    O
three    O
loci    B-Body109224911
:    O
the    O
H3    O
gene    O
,    O
the    O
internal    O
transcribed    O
spacer    O
(    O
ITS    O
)    O
regions    O
of    O
the    O
nuclear    O
rRNA    O
gene    O
,    O
and    O
the    O
D1    O
and    O
D2    O
domains    O
of    O
the    O
28S    O
rRNA    O
gene    O
.    O

"    O
C12orf66    O
"    O
is    O
located    O
on    O
the    O
minus    O
strand    O
in    O
the    O
locus    B-Body109224911
12q14.2    O
.    O

Fazio    O
–    O
Londe    O
disease    O
is    O
linked    O
to    O
a    O
genetic    O
mutation    O
in    O
the    O
"    O
SLC52A3    O
"    O
gene    O
on    O
chromosome    B-Body109224911
20    I-Body109224911
(    O
locus    B-Body109224911
:    O
20p13    O
)    O
.    O

Through    O
genetic    O
mapping    O
,    O
the    O
researchers    O
had    O
identified    O
specific    O
regions    O
in    O
the    O
T4    O
chromosome    O
,    O
called    O
the    O
"    O
r"I    O
,    O
"    O
r"II    O
,    O
and    O
"    O
r"III    O
loci    B-Body109224911
,    O
associated    O
with    O
the    O
"    O
r    O
"    O
mutants    O
.    O

If    O
we    O
start    O
with    O
all    O
humans    O
alive    O
in    O
1995    O
and    O
trace    O
their    O
ancestry    O
by    O
one    O
particular    O
gene    O
(    O
actually    O
a    O
locus    B-Body109224911
)    O
,    O
we    O
find    O
that    O
the    O
farther    O
we    O
move    O
back    O
in    O
time    O
,    O
the    O
smaller    O
the    O
number    O
of    O
ancestors    O
become    O
.    O

"    O
ACTB    O
"    O
is    O
a    O
highly    O
complex    O
locus    B-Body109224911
.    O

DMD    O
is    O
caused    O
by    O
a    O
mutation    O
of    O
the    O
dystrophin    O
gene    O
at    O
locus    B-Body109224911
Xp21    O
,    O
located    O
on    O
the    O
short    O
arm    O
of    O
the    O
X    O
chromosome    O
.    O

The    O
result    O
is    O
a    O
haploid    O
egg    O
,    O
with    O
chromosomes    O
having    O
a    O
new    O
combination    O
of    O
alleles    O
at    O
the    O
various    O
loci    B-Body109224911
.    O

The    O
SDHD    O
gene    O
is    O
located    O
on    O
chromosome    B-Body109224911
11    I-Body109224911
at    O
locus    B-Body109224911
11q23    O
and    O
it    O
spans    O
8,978    O
base    O
pairs    O
.    O

Its    O
locus    B-Body109224911
is    O
at    O
11q13.1    O
.    O

Deletion    O
of    O
short    B-Body109224911
arm    I-Body109224911
of    O
chromosome    B-Body109224911
4    I-Body109224911

Deletion    O
of    O
short    B-Body109224911
arm    I-Body109224911
of    O
chromosome    B-Body109224911
5    I-Body109224911

locus    B-Body109224911

A    O
Mendelian    O
trait    O
is    O
one    O
that    O
is    O
controlled    O
by    O
a    O
single    O
locus    B-Body109224911
in    O
an    O
inheritance    O
pattern    O
.    O

In    O
three    O
of    O
the    O
cases    O
,    O
the    O
specific    O
amino    O
acids    O
affected    O
(    O
phenylalanine    O
,    O
proline    O
,    O
glycine    O
)    O
are    O
found    O
in    O
the    O
same    O
locus    B-Body109224911
in    O
humans    O
as    O
they    O
are    O
in    O
yeast    O
(    O
"    O
S.    O
Cerevisiae    O
"    O
)    O
and    O
the    O
brown    O
rat    O
(    O
"    O
R.    O
Norvegicus    O
"    O
)    O
.    O

These    O
findings    O
suggest    O
that    O
there    O
are    O
many    O
genetic    B-Body109224911
loci    I-Body109224911
,    O
in    O
the    O
general    O
population    O
,    O
each    O
with    O
small    O
effects    O
on    O
blood    O
pressure    O
.    O

The    O
result    O
will    O
be    O
a    O
set    O
of    O
annotations    O
including    O
all    O
protein    O
-    O
coding    O
loci    B-Body109224911
with    O
alternatively    O
transcribed    O
variants    O
,    O
non    O
-    O
coding    O
loci    O
with    O
transcript    O
evidence    O
,    O
and    O
pseudogenes    O
.    O

Capsaicin    O
is    O
believed    O
to    O
be    O
synthesized    O
in    O
the    O
interlocular    O
septum    O
of    O
chili    O
peppers    O
and    O
depends    O
on    O
the    O
gene    O
"    O
AT3    O
"    O
,    O
which    O
resides    O
at    O
the    O
"    O
pun1    O
"    O
locus    B-Body109224911
,    O
and    O
which    O
encodes    O
a    O
putative    O
acyltransferase    O
.    O

Infectious    O
diseases    O
of    O
humans    O
appear    O
highly    O
polygenic    O
with    O
many    O
loci    B-Body109224911
implicated    O
but    O
only    O
a    O
minority    O
of    O
these    O
convincingly    O
replicated    O
.    O

In    O
the    O
case    O
of    O
"    O
M.    O
tuberculosis    O
,    O
"    O
animal    O
model    O
studies    O
were    O
used    O
to    O
suggest    O
evidence    O
of    O
a    O
locus    B-Body109224911
which    O
was    O
correlated    O
with    O
susceptibility    O
,    O
further    O
studies    O
were    O
done    O
to    O
prove    O
the    O
link    O
between    O
the    O
suggested    O
locus    O
.    O

In    O
general    O
,    O
MSP    O
and    O
its    O
related    O
protocols    O
are    O
considered    O
to    O
be    O
the    O
most    O
sensitive    O
when    O
interrogating    O
the    O
methylation    O
status    O
at    O
a    O
specific    O
locus    B-Body109224911
.    O

In    O
the    O
genome    O
of    O
an    O
organism    O
,    O
each    O
gene    O
is    O
located    O
at    O
a    O
specific    O
place    O
called    O
the    O
locus    B-Body109224911
for    O
that    O
gene    O
.    O

In    O
humans    O
,    O
it    O
is    O
found    O
on    O
chromosome    B-Body109224911
7    I-Body109224911
in    O
a    O
locus    B-Body109224911
spanning    O
a    O
translocation    O
breakpoint    O
associated    O
with    O
autism    O
.    O

In    O
humans    O
,    O
it    O
is    O
found    O
on    O
chromosome    B-Body109224911
7    I-Body109224911
in    O
a    O
locus    B-Body109224911
spanning    O
a    O
translocation    O
breakpoint    O
associated    O
with    O
autism    O
.    O

In    O
humans    O
,    O
it    O
is    O
found    O
on    O
chromosome    B-Body109224911
7    I-Body109224911
in    O
a    O
locus    B-Body109224911
spanning    O
a    O
translocation    O
breakpoint    O
associated    O
with    O
autism    O
.    O

In    O
humans    O
,    O
it    O
is    O
found    O
on    O
chromosome    B-Body109224911
7    I-Body109224911
in    O
a    O
locus    B-Body109224911
spanning    O
a    O
translocation    O
breakpoint    O
associated    O
with    O
autism    O
.    O

Hypersensitivity    O
to    O
abacavir    O
is    O
strongly    O
associated    O
with    O
a    O
specific    O
allele    O
at    O
the    O
human    O
leukocyte    O
antigen    O
B    O
locus    B-Body109224911
namely    O
HLA    O
-    O
B*5701    O
.    O

Sporadic    O
(    O
non    O
-    O
inherited    O
)    O
cases    O
have    O
been    O
examined    O
to    O
identify    O
candidate    O
genetic    B-Body109224911
loci    I-Body109224911
involved    O
in    O
autism    O
.    O

Examples    O
of    O
autism    O
that    O
has    O
arisen    O
from    O
a    O
rare    O
or    O
de    O
novo    O
mutation    O
in    O
a    O
single    O
-    O
gene    O
or    O
locus    B-Body109224911
include    O
the    O
neurodevelopmental    O
disorders    O
fragile    O
X    O
syndrome    O
,    O
22q13    O
deletion    O
syndrome    O
,    O
and    O
16p11.2    O
deletion    O
syndrome    O
.    O

Calcium    O
/    O
calmodulin    O
-    O
dependent    O
protein    O
kinase    O
ID    O
is    O
a    O
protein    O
in    O
humans    O
that    O
is    O
encoded    O
by    O
the    O
CAMK1D    O
gene    O
on    O
chromosome    B-Body109224911
10    I-Body109224911
(    O
locus    B-Body109224911
10p13    O
)    O
.    O

In    O
this    O
instance    O
the    O
genetics    O
appears    O
to    O
be    O
simple    O
:    O
two    O
alleles    O
at    O
a    O
single    O
locus    B-Body109224911
,    O
producing    O
the    O
three    O
phenotypes    O
.    O

From    O
these    O
numbers    O
it    O
is    O
clear    O
that    O
the    O
b+/b    O
locus    B-Body109224911
lies    O
between    O
the    O
a+/a    O
locus    O
and    O
the    O
c+/c    O
locus    O
.    O

It    O
is    O
defined    O
as    O
the    O
distance    O
between    O
chromosome    O
positions    O
(    O
also    O
termed    O
loci    B-Body109224911
or    O
markers    O
)    O
for    O
which    O
the    O
expected    O
average    O
number    O
of    O
intervening    O
chromosomal    O
crossovers    O
in    O
a    O
single    O
generation    O
is    O
0.01    O
.    O

Exclusion    O
of    O
exon    O
9    O
is    O
mediated    O
by    O
a    O
polymorphic    B-Body109224911
locus    I-Body109224911
with    O
variable    O
TG    O
repeats    O
and    O
stretches    O
of    O
T    O
nucleotides    O
–    O
this    O
is    O
abbreviated    O
as    O
(    O
TG)mT(n    O
)    O
.    O

Around    O
one    O
-    O
third    O
of    O
people    O
with    O
psoriasis    O
report    O
a    O
family    O
history    O
of    O
the    O
disease    O
,    O
and    O
researchers    O
have    O
identified    O
genetic    O
loci    B-Body109224911
associated    O
with    O
the    O
condition    O
.    O

"    O
FAM203B    O
"    O
is    O
located    O
on    O
the    O
positive    O
DNA    O
strand    O
of    O
the    O
long    O
arm    O
of    O
chromosome    B-Body109224911
8    I-Body109224911
at    O
locus    B-Body109224911
24.3    O
(    O
8q24.3    O
)    O
from    O
76,368,898    O
-    O
76,371,411    O
in    O
the    O
human    O
genome    O
.    O

In    O
attention    O
-    O
deficit    O
/    O
hyperactivity    O
disorder    O
or    O
ADHD    O
,    O
polymorphisms    O
at    O
the    O
SNAP-25    O
gene    B-Body109224911
locus    I-Body109224911
in    O
humans    O
have    O
been    O
linked    O
to    O
the    O
disease    O
suggesting    O
a    O
potential    O
role    O
in    O
its    O
manifestation    O
.    O

In    O
a    O
series    O
of    O
papers    O
beginning    O
in    O
1924    O
,    O
another    O
British    O
geneticist    O
,    O
J.B.S.    O
Haldane    O
,    O
worked    O
out    O
the    O
mathematics    O
of    O
allele    O
frequency    O
change    O
at    O
a    O
single    O
gene    O
locus    B-Body109224911
under    O
a    O
broad    O
range    O
of    O
conditions    O
.    O

Recently    O
,    O
several    O
genetic    B-Body109224911
loci    I-Body109224911
have    O
been    O
identified    O
as    O
relevant    O
to    O
the    O
development    O
of    O
intracranial    O
aneurysms    O
.    O

Suppose    O
that    O
there    O
are    O
three    O
possible    O
genotypes    O
at    O
some    O
locus    B-Body109224911
,    O
and    O
we    O
refer    O
to    O
these    O
as    O
aa    O
,    O
Aa    O
and    O
AA    O
.    O

These    O
two    O
bulked    O
samples    O
can    O
then    O
be    O
analysed    O
using    O
techniques    O
such    O
as    O
Restriction    O
fragment    O
length    O
polymorphism    O
or    O
RAPD    O
to    O
detect    O
similarities    O
and    O
differences    O
in    O
the    O
various    O
loci    B-Body109224911
of    O
the    O
genome    O
.    O

Since    O
the    O
locus    B-Body109224911
encoding    O
human    O
SHROOM2    O
lies    O
within    O
the    O
critical    O
region    O
for    O
two    O
distinct    O
forms    O
of    O
ocular    O
albinism    O
,    O
it    O
is    O
possible    O
that    O
SHROOM2    O
mutations    O
may    O
contribute    O
to    O
human    O
visual    O
system    O
disorders    O
.    O

The    O
PBDX    O
gene    O
that    O
encodes    O
the    O
antigen    O
is    O
located    O
on    O
the    O
short    B-Body109224911
arm    I-Body109224911
of    O
the    O
X    B-Body109224911
chromosome    I-Body109224911
.    O

On    O
the    O
basis    O
of    O
what    O
is    O
known    O
(    O
and    O
remembering    O
that    O
,    O
as    O
dogs    O
are    O
diploid    B-Body109224911
animals    O
,    O
each    O
gene    O
location    O
(    O
locus    B-Body109224911
)    O
appears    O
twice    O
in    O
every    O
animal    O
,    O
so    O
questions    O
of    O
dominance    O
also    O
must    O
be    O
resolved    O
)    O
,    O
the    O
gene    O
possibilities    O
allowed    O
by    O
the    O
Mastiff    O
standard    O
are    O
AyBDEmh(kbr    O
or    O
ky)mS.    O
This    O
describes    O
a    O
dog    O
which    O
is    O
fawn    O
with    O
a    O
dark    O
nose    O
,    O
non    O
-    O
dilute    O
,    O
black    O
-    O
masked    O
,    O
non    O
-    O
harlequin    O
,    O
brindled    O
or    O
not    O
brindled    O
,    O
non    O
-    O
merle    O
,    O
and    O
non    O
-    O
spotted    O
.    O

Different    O
loci    B-Body109224911
are    O
not    O
in    O
agreement    O
along    O
the    O
cline    O

The    O
gene    O
has    O
7    O
exons    O
,    O
spans    O
5    O
kilobases    O
in    O
length    O
and    O
in    O
humans    O
it    O
is    O
located    O
on    O
the    O
long    B-Body109224911
arm    I-Body109224911
of    O
chromosome    B-Body109224911
4    I-Body109224911
region    O
22    O
(    O
4q1322.1    O
)    O
.    O

C6orf58    O
is    O
a    O
humangene    O
located    O
at    O
locus    B-Body109224911
6q22.33    O
of    O
chromosome    B-Body109224911
6    I-Body109224911
and    O
encodes    O
for    O
UPF0762    O
,    O
a    O
protein    O
which    O
is    O
subsequently    O
secreted    O
after    O
cleavage    O
of    O
a    O
signal    O
peptide    O

However    O
,    O
on    O
occasion    O
,    O
children    O
with    O
a    O
microdeletion    O
of    O
7p21    O
(    O
chromosome    O
containing    O
the    O
locus    B-Body109224911
responsible    O
for    O
SCS    O
)    O
develop    O
new    O
abnormalities    O
and    O
typically    O
show    O
significant    O
neurological    O
abnormalities    O
.    O

Parastremmatic    O
dwarfism    O
is    O
caused    O
by    O
a    O
missense    O
mutation    O
(    O
where    O
one    O
amino    O
acid    O
is    O
replaced    O
by    O
another    O
in    O
a    O
gene    O
sequence    O
)    O
in    O
the    O
"    O
TRPV4    O
"    O
gene    O
,    O
located    B-Body109224911
on    O
the    O
long    O
arm    O
of    O
human    O
chromosome    O
12    B-Body109224911
,    O
at    O
12q24.11    O
.    O

The    O
expressed    O
"    O
VSG    O
"    O
is    O
always    O
located    O
in    O
an    O
Expression    O
Site    O
(    O
ES    O
)    O
,    O
which    O
are    O
specialised    O
expression    O
loci    B-Body109224911
found    O
at    O
the    O
telomeres    O
of    O
some    O
of    O
the    O
large    O
and    O
intermediate    O
chromosomes    O
.    O

These    O
mechanisms    O
are    O
based    O
on    O
protein    O
-    O
protein    O
interactions    O
,    O
and    O
the    O
best    O
-    O
understood    O
mechanisms    O
are    O
controlled    O
by    O
a    O
single    O
locus    B-Body109224911
termed    O
S    O
,    O
which    O
has    O
many    O
different    O
alleles    O
in    O
the    O
species    O
population    O
.    O

In    O
an    O
ideal    O
error    O
free    O
world    O
with    O
high    O
read    O
coverage    O
,    O
the    O
task    O
of    O
variant    O
calling    O
from    O
the    O
results    O
of    O
a    O
NGS    O
data    O
alignment    O
would    O
be    O
simple    O
;    O
at    O
each    O
locus    B-Body109224911
(    O
position    O
on    O
the    O
genome    O
)    O
the    O
number    O
of    O
occurrences    O
of    O
each    O
distinct    O
nucleotide    O
among    O
the    O
reads    O
aligned    O
at    O
that    O
position    O
can    O
be    O
counted    O
,    O
and    O
the    O
true    O
genotype    O
would    O
be    O
obvious    O
;    O
either    O
AA    O
if    O
all    O
nucleotides    O
match    O
allele    O
A    O
,    O
BB    O
if    O
they    O
match    O
allele    O
B    O
,    O
or    O
AB    O
if    O
there    O
is    O
a    O
mixture    O
.    O

This    O
locus    B-Body109224911
represents    O
naturally    O
occurring    O
read    O
-    O
through    O
transcription    O
between    O
the    O
neighboring    O
COMM    O
domain    O
-    O
containing    O
protein    O
3    O
and    O
polycomb    O
complex    O
protein    O
BMI-1    O
genes    O
on    O
chromosome    B-Body109224911
10    I-Body109224911
.    O

If    O
both    O
alleles    O
at    O
a    O
gene    O
(    O
or    O
locus    B-Body109224911
)    O
on    O
the    O
homologous    O
chromosomes    O
are    O
the    O
same    O
,    O
they    O
and    O
the    O
organism    O
are    O
homozygous    O
with    O
respect    O
to    O
that    O
gene    O
(    O
or    O
locus    O
)    O
.    O

Class    O
switching    O
occurs    O
in    O
the    O
heavy    O
chain    O
gene    O
locus    B-Body109224911
by    O
a    O
mechanism    O
called    O
class    O
switch    O
recombination    O
(    O
CSR    O
)    O
.    O

lambda    O
-    O
Laser    O
capture    O
microdissection    O
-    O
leucine    O
zipper    O
-    O
leukemia    O
-    O
library    O
-    O
ligase    O
-    O
linear    O
epitope    O
-    O
linkage    O
-    O
linker    O
protein    O
-    O
lipofectin    O
-    O
locus    B-Body109224911
-    O
LOD    O
score    O
-    O
lymphocyte    O
-    O

The    O
point    O
gene    O
is    O
carried    O
on    O
the    O
C    O
locus    B-Body109224911
,    O
where    O
pure    O
albinism    O
is    O
also    O
carried    O
.    O

This    O
receptor    O
gene    O
is    O
a    O
candidate    O
locus    B-Body109224911
for    O
involvement    O
in    O
autistic    O
disorder    O
and    O
other    O
neuropsychiatric    O
disorders    O
.    O

Admixture    O
mapping    O
is    O
a    O
method    O
of    O
gene    O
mapping    O
that    O
uses    O
a    O
population    O
of    O
mixed    O
ancestry    O
(    O
an    O
admixed    O
population    O
)    O
to    O
find    O
the    O
genetic    O
loci    B-Body109224911
that    O
contribute    O
to    O
differences    O
in    O
diseases    O
or    O
other    O
phenotypes    O
found    O
between    O
the    O
different    O
ancestral    O
populations    O
.    O

3C    O
syndrome    O
is    O
an    O
autosomal    O
recessive    O
disease    O
,    O
caused    O
by    O
a    O
mutation    O
on    O
the    O
long    O
arm    O
of    O
chromosome    B-Body109224911
8    I-Body109224911
at    O
8q24.13    O
,    O
the    O
locus    B-Body109224911
for    O
KIAA0196    O
,    O
the    O
gene    O
for    O
the    O
protein    O
strumpellin    O
.    O

In    O
genetics    O
,    O
two    O
organisms    O
that    O
differ    O
in    O
only    O
one    O
locus    B-Body109224911
and    O
a    O
linked    O
segment    O
of    O
chromosome    O
are    O
defined    O
as    O
congenic    O
.    O

The    O
gene    O
spans    O
approximately    O
11.8    O
kb    O
and    O
is    O
mapped    O
to    O
the    O
long    O
arm    O
of    O
chromosome    B-Body109224911
10    I-Body109224911
(    O
10q22    O
)    O
.    O

Papillorenal    O
syndrome    O
is    O
an    O
autosomal    O
dominant    O
disorder    O
that    O
results    O
from    O
a    O
mutation    O
of    O
one    O
copy    O
of    O
the    O
"    O
Pax2    O
"    O
gene    O
,    O
located    O
on    O
chromosome    O
10q24.3-q25.1    B-Body109224911
.    O

Cytochrome    O
P450    O
17A1    O
,    O
also    O
called    O
steroid    O
17α-monooxygenase    O
,    O
17α-hydroxylase    O
,    O
17,20-lyase    O
,    O
or    O
17,20-desmolase    O
,    O
is    O
an    O
enzyme    O
of    O
the    O
hydroxylase    O
type    O
that    O
in    O
humans    O
is    O
encoded    O
by    O
the    O
"    O
CYP17A1    O
"    O
gene    O
on    O
chromosome    B-Body109224911
10    I-Body109224911
.    O

Calcium    O
/    O
calmodulin    O
-    O
dependent    O
protein    O
kinase    O
ID    O
is    O
a    O
protein    O
in    O
humans    O
that    O
is    O
encoded    O
by    O
the    O
CAMK1D    O
gene    O
on    O
chromosome    B-Body109224911
10    I-Body109224911
(    O
locus    B-Body109224911
10p13    O
)    O
.    O

FasR    O
is    O
located    O
on    O
chromosome    B-Body109224911
10    I-Body109224911
in    O
humans    O
and    O
19    O
in    O
mice    O
.    O

FAS    O
receptor    O
is    O
located    O
on    O
the    O
long    O
arm    O
of    O
chromosome    B-Body109224911
10    I-Body109224911
(    O
10q24.1    O
)    O
in    O
humans    O
and    O
on    O
chromosome    O
19    O
in    O
mice    O
.    O

This    O
locus    B-Body109224911
represents    O
naturally    O
occurring    O
read    O
-    O
through    O
transcription    O
between    O
the    O
neighboring    O
COMM    O
domain    O
-    O
containing    O
protein    O
3    O
and    O
polycomb    O
complex    O
protein    O
BMI-1    O
genes    O
on    O
chromosome    B-Body109224911
10    I-Body109224911
.    O

Ionic    B-Body109224911
transfer    I-Body109224911

These    O
reconstructed    O
charged    O
particles    O
can    O
be    O
used    O
to    O
identify    O
and    O
reconstruct    O
secondary    O
decays    O
,    O
including    O
those    O
arising    O
from    O
'    O
unseen    O
'    O
neutral    O
particles    O
,    O
as    O
can    O
be    O
done    O
for    O
B-tagging    B-Body109224911
(    O
in    O
experiments    O
like    O
CDF    O
or    O
at    O
the    O
LHC    O
)    O
and    O
to    O
fully    O
reconstruct    O
events    O
(    O
as    O
in    O
many    O
current    O
particle    O
physics    O
experiments    O
,    O
such    O
as    O
ATLAS    O
,    O
BaBar    O
,    O
Belle    O
and    O
CMS    O
)    O
.    O

Hydrogen    B-Body109224911
Molecular    I-Body109224911
Ion    I-Body109224911

One    O
example    O
is    O
solving    O
for    O
the    O
wavefunction    O
of    O
an    O
electron    O
moving    O
in    O
the    O
electromagnetic    O
field    O
of    O
two    O
positively    O
charged    O
nuclei    B-Body109224911
,    O
as    O
in    O
the    O
hydrogen    B-Body109224911
molecular    I-Body109224911
ion    I-Body109224911
,    O
H2    O
+    O
.    O

It    O
is    O
the    O
simplest    O
heteronuclear    O
ion    O
,    O
and    O
is    O
comparable    O
with    O
the    O
hydrogen    B-Body109224911
molecular    I-Body109224911
ion    I-Body109224911
,    O
.    O

The    O
simplest    O
of    O
molecules    O
is    O
the    O
hydrogen    B-Body109224911
molecule-ion    I-Body109224911
,    O
H2    O
+    O
,    O
and    O
the    O
simplest    O
of    O
all    O
the    O
chemical    O
bonds    O
is    O
the    O
one    O
-    O
electron    O
bond    O
.    O

Neonium    O
is    O
also    O
formed    O
by    O
excited    O
dihydrogen    B-Body109224911
cation    I-Body109224911
reacting    O
with    O
neon    O
:    O
Ne    O
+    O
H2    O
+    O
→    O
NeH+    O
+    O
H    O

Dihydrogen    B-Body109224911
cation    I-Body109224911

Syntelic    B-Body109224911
attachment    I-Body109224911
occurs    O
when    O
both    O
sister    O
chromosomes    O
are    O
attached    O
to    O
a    O
single    O
spindle    O
pole    O
.    O

Crypton    B-Body109224911
(particle)    I-Body109224911
,    O
a    O
theoretical    O
sub    O
-    O
atomic    O
particle    O

A    O
genetic    O
map    O
is    O
a    O
map    O
based    O
on    O
the    O
frequencies    O
of    O
recombination    O
between    O
markers    O
during    O
crossover    O
of    O
homologous    B-Body109224911
chromosome    I-Body109224911
.    O

Homologous    O
recombination    O
,    O
on    O
the    O
other    O
hand    O
,    O
involves    O
two    O
homologous    B-Body109224911
DNA    I-Body109224911
duplexes    O
connected    O
by    O
D    O
-    O
loops    O
or    O
Holliday    O
junctions    O
.    O

Segregation    O
of    O
homologous    B-Body109224911
chromosome    I-Body109224911
to    O
opposite    O
poles    O
of    O
the    O
cell    O
occurs    O
during    O
the    O
first    O
division    O
of    O
meiosis    O
.    O

Whereas    O
homologous    B-Body109224911
chromosomes    I-Body109224911
pair    O
and    O
separate    O
during    O
meiosis    O
I    O
in    O
sexual    O
species    O
,    O
identical    O
duplicate    O
sister    O
chromosomes    O
,    O
produced    O
through    O
premeiotic    O
replication    O
,    O
pair    O
and    O
separate    O
during    O
meiosis    O
I    O
in    O
true    O
parthenotes    O
.    O

TMCO4    O
is    O
consistently    O
predicted    O
to    O
be    O
located    O
in    O
the    O
endoplasmic    O
reticulum    O
membrane    O
across    O
many    O
homologs    B-Body109224911
.    O

An    O
offspring    O
thus    O
receives    O
a    O
pair    O
of    O
alleles    O
for    O
a    O
trait    O
by    O
inheriting    O
homologous    B-Body109224911
chromosome    I-Body109224911
from    O
the    O
parent    O
organisms    O
:    O
one    O
allele    O
for    O
each    O
trait    O
from    O
each    O
parent    O
.    O

Molecular    O
-    O
level    O
studies    O
of    O
recombination    O
during    O
budding    O
yeast    O
meiosis    O
have    O
shown    O
that    O
recombination    O
events    O
initiated    O
by    O
DSBs    O
in    O
regions    O
that    O
lack    O
corresponding    O
sequences    O
in    O
the    O
homolog    B-Body109224911
are    O
efficiently    O
repaired    O
by    O
inter    O
-    O
sister    O
chromatid    O
recombination    O
.    O

These    O
bands    O
were    O
the    O
same    O
in    O
appearance    O
on    O
the    O
homologous    B-Body109224911
chromosomes    I-Body109224911
,    O
thus    O
,    O
identification    O
became    O
easier    O
and    O
more    O
accurate    O
.    O

Homologs    B-Body109224911
of    O
the    O
Suz12    O
subunit    O
are    O
:    O
EMBRYONIC    O
FLOWER    O
2    O
(    O
EMF2    O
)    O
,    O
REDUCED    O
VERNALIZATION    O
RESPONSE    O
2    O
(    O
VRN2    O
)    O
,    O
FERTILIZATION    O
INDEPENDENT    O
SEED    O
2    O
(    O
FIS2    O
)    O
.    O

Polysomy    O
is    O
usually    O
caused    O
by    O
non    O
-    O
disjunction    O
(    O
the    O
failure    O
of    O
a    O
pair    O
of    O
homologous    B-Body109224911
chromosome    I-Body109224911
to    O
separate    O
)    O
during    O
meiosis    O
,    O
but    O
may    O
also    O
be    O
due    O
to    O
a    O
translocation    O
mutation    O
(    O
a    O
chromosome    O
abnormality    O
caused    O
by    O
rearrangement    O
of    O
parts    O
between    O
nonhomologous    O
chromosomes    O
)    O
.    O

These    O
chromosomes    O
are    O
referred    O
to    O
as    O
homologous    B-Body109224911
chromosome    I-Body109224911
.    O

Homologous    B-Body109224911
chromosome    I-Body109224911

Combined    O
cytological    O
and    O
autoradiographic    O
analyses    O
of    O
meiosis    O
showed    O
that    O
crossing    O
over    O
is    O
achieved    O
by    O
breakage    O
and    O
exchange    O
of    O
segments    O
of    O
nonsister    O
,    O
homologous    B-Body109224911
chromatids    I-Body109224911
,    O
and    O
each    O
such    O
exchange    O
event    O
results    O
in    O
the    O
formation    O
of    O
a    O
cytologically    O
visible    O
chiasma    O
.    O

A    O
Robertsonian    O
translocation    O
is    O
a    O
type    O
of    O
translocation    O
involving    O
two    O
homologous    O
(    O
paired    O
)    O
or    O
non    O
-    O
homologous    O
chromosomes    O
(    O
i.e.    O
two    O
different    O
chromosomes    O
,    O
not    O
belonging    O
to    O
a    O
homologous    B-Body109224911
pair    I-Body109224911
)    O
.    O

Relic    B-Body109224911
particles    I-Body109224911
are    O
superheavy    O
particles    O
hypothesized    O
to    O
be    O
remnants    O
of    O
early    O
cosmological    O
expansion    O
.    O

Staggered    B-Body109224911
fermion    I-Body109224911
:    O
a    O
way    O
to    O
reduce    O
the    O
number    O
of    O
doublers    O

Zc(3900)    B-Body109224911
,    O
a    O
subatomic    O
particle    O

Physicists    O
report    O
the    O
possible    O
detection    O
of    O
a    O
new    O
subatomic    O
particle    O
,    O
Zc(3900)    B-Body109224911
,    O
a    O
hadron    O
which    O
may    O
be    O
the    O
first    O
tetraquark    B-Body109224911
to    O
have    O
been    O
observed    O
experimentally    O
.    O

The    O
measurements    O
'    O
discrepancy    O
with    O
the    O
flux    O
predicted    O
from    O
the    O
Sun    O
's    O
luminosity    O
led    O
to    O
Davis    O
's    O
development    O
of    O
the    O
solar    B-Body109224911
neutrino    I-Body109224911
problem    I-Body109224911
.    O

Duba    O
participated    O
in    O
proving    O
the    O
solution    O
to    O
the    O
long    O
-    O
standing    O
Solar    B-Body109224911
neutrino    I-Body109224911
problem    I-Body109224911
at    O
the    O
Sudbury    O
Neutrino    O
Observatory    O
.    O

The    O
solar    B-Body109224911
neutrino    I-Body109224911
problem    I-Body109224911
excludes    O
the    O
second    O
inequality    O
,    O
therefore    O
"    O
U"e32    O
is    O
restricted    O
to    O
small    O
values    O
.    O

Super    O
-    O
K    O
also    O
confirmed    O
,    O
along    O
with    O
the    O
Sudbury    O
Neutrino    O
Observatory    O
(    O
SNO    O
)    O
,    O
the    O
solution    O
to    O
the    O
solar    B-Body109224911
neutrino    I-Body109224911
problem    I-Body109224911
.    O

John    O
Norris    O
Bahcall    O
(    O
December    O
30    O
,    O
1934    O
–    O
August    O
17    O
,    O
2005    O
)    O
was    O
an    O
American    O
astrophysicist    O
,    O
best    O
known    O
for    O
his    O
contributions    O
to    O
the    O
solar    B-Body109224911
neutrino    I-Body109224911
problem    I-Body109224911
,    O
the    O
development    O
of    O
the    O
Hubble    O
Space    O
Telescope    O
and    O
for    O
his    O
leadership    O
and    O
development    O
of    O
the    O
Institute    O
for    O
Advanced    O
Study    O
in    O
Princeton    O
.    O

He    O
spent    O
much    O
of    O
his    O
life    O
pursuing    O
the    O
solar    B-Body109224911
neutrino    I-Body109224911
problem    I-Body109224911
with    O
physical    O
chemist    O
Raymond    O
Davis    O
,    O
Jr.    O

:    O
(    O
vi    O
)    O
by    O
replacement    O
of    O
the    O
N    O
-    O
propionyl    B-Body109224911
group    O
by    O
another    O
acyl    O
group    O
;    O

The    O
backbone    O
is    O
synthesized    O
through    O
the    O
addition    O
of    O
two    O
carbon    O
units    O
via    O
addition    O
of    O
acetate    O
units    O
from    O
acetyl    O
-    O
CoA.    O
The    O
5    O
methyl    O
groups    O
are    O
added    O
via    O
S    O
-    O
adenosyl    O
methionine    O
(    O
SAM    O
)    O
methylation    O
,    O
as    O
opposed    O
to    O
incorporation    O
of    O
propionate    B-Body109224911
(    O
instead    O
of    O
acetate    O
)    O
to    O
the    O
growing    O
compound    O
during    O
biosynthesis    O
.    O

The    O
species    O
name    O
"    O
propionicus    O
"    O
is    O
derived    O
from    O
the    O
organisms    O
electron    O
donor    O
propionate    B-Body109224911
.    O

D.    O
propionicus    O
"    O
uses    O
the    O
methylmalony    O
-    O
CoA    O
pathway    O
to    O
ferment    O
3    O
moles    O
of    O
pyruvate    O
to    O
2    O
moles    O
of    O
acetate    O
and    O
1    O
mole    O
of    O
propionate    B-Body109224911
.    O

"    O
Desulfobulbus    O
"    O
"    O
propionicus    O
"    O
utilizes    O
propionate    B-Body109224911
,    O
lactate    O
,    O
pyruvate    O
,    O
and    O
alcohols    O
from    O
the    O
environment    O
as    O
not    O
only    O
electron    O
sources    O
,    O
but    O
for    O
carbon    O
sources    O
as    O
well    O
.    O

When    O
sulfate    O
is    O
absent    O
ethanol    O
is    O
fermented    O
to    O
propionate    B-Body109224911
and    O
acetate    O
.    O

Thermotoga    O
neapolitana    O
is    O
unable    O
to    O
metabolize    O
acetate    O
,    O
lactate    O
,    O
formate    B-Body109224911
,    O
pyruvate    O
,    O
propionate    B-Body109224911
,    O
mannitol    O
,    O
ethanol    O
,    O
methanol    O
,    O
glycerol    O
,    O
glutamate    O
,    O
or    O
glycine    O
.    O

A    O
propionate    B-Body109224911
ester    O
of    O
clobetasol    O
,    O
clobetasol    O
propionate    O
,    O
has    O
also    O
been    O
marketed    O
,    O
and    O
is    O
far    O
more    O
widely    O
used    O
in    O
comparison    O
.    O

The    O
Chromosomal    B-Body109224911
Rearrangements    I-Body109224911
In    I-Body109224911
Diseases    I-Body109224911
(    O
dbCRID    B-Body109224911
)    O
is    O
a    O
database    O
of    O
human    O
chromosome    O
rearrangements    O
events    O
and    O
diseases    O
related    O
to    O
them    O
.    O

Hyponitrite    B-Body109224911
ion    O

The    O
main    O
physics    O
goals    O
are    O
the    O
investigation    O
of    O
the    O
nucleon    B-Body109224911
spin    I-Body109224911
structure    I-Body109224911
and    O
hadron    B-Body109224911
spectroscopy    I-Body109224911
.    O

pi    O
scattering    O
,    O
hadron    B-Body109224911
spectroscopy    I-Body109224911
and    O
the    O
anomalous    O
magnetic    O
moment    O
of    O
the    O
muon    O
.    O

Chromosome    B-Body109224911
14    I-Body109224911
is    O
one    O
of    O
the    O
23    O
pairs    O
of    O
chromosomes    O
in    O
humans    O
.    O

UPF0172    O
protein    O
FAM158A    O
,    O
also    O
known    O
as    O
c14orf122    O
or    O
CGI112    O
,    O
is    O
a    O
protein    O
that    O
in    O
humans    O
is    O
encoded    O
by    O
the    O
FAM158A    O
gene    O
located    O
on    O
chromosome    B-Body109224911
14    I-Body109224911
.    O

It    O
occurs    O
when    O
one    O
or    O
both    O
of    O
the    O
telomeres    O
that    O
mark    O
the    O
ends    O
of    O
chromosome    B-Body109224911
14    I-Body109224911
are    O
lost    O
allowing    O
the    O
now    O
uncapped    O
ends    O
to    O
fuse    O
together    O
forming    O
a    O
ring    B-Body109224911
chromosome    I-Body109224911
.    O

The    O
syndrome    O
is    O
caused    O
by    O
the    O
loss    O
of    O
genetic    O
material    O
near    O
the    O
end    O
of    O
the    O
long    O
arm    O
(    O
q    O
)    O
of    O
chromosome    B-Body109224911
14    I-Body109224911
.    O

The    O
chromosomal    O
region    O
that    O
encodes    O
an    O
antibody    O
is    O
large    O
and    O
contains    O
several    O
distinct    O
gene    O
loci    O
for    O
each    O
domain    O
of    O
the    O
antibody    O
—    O
the    O
chromosome    O
region    O
containing    O
heavy    O
chain    O
genes    O
(    O
IGH@    O
)    O
is    O
found    O
on    O
chromosome    B-Body109224911
14    I-Body109224911
,    O
and    O
the    O
loci    O
containing    O
lambda    O
and    O
kappa    O
light    O
chain    O
genes    O
(    O
IGL@    O
and    O
IGK@    O
)    O
are    O
found    O
on    O
chromosomes    O
22    B-Body109224911
and    O
2    B-Body109224911
in    O
humans    O
.    O

In    O
humans    O
,    O
Robertsonian    O
translocations    O
generally    O
occurs    O
in    O
the    O
five    O
acrocentric    O
chromosome    O
pairs    O
,    O
namely    O
13    B-Body109224911
,    O
14    B-Body109224911
,    O
15    B-Body109224911
,    O
21    B-Body109224911
and    O
22    B-Body109224911
.    O

Premature    B-Body109224911
chromosome    I-Body109224911
condensation    I-Body109224911
(    O
PCC    B-Body109224911
)    O
,    O
also    O
known    O
as    O
premature    O
mitosis    O
,    O
occurs    O
in    O
eukaryotic    O
organisms    O
when    O
mitotic    O
cells    O
fuse    O
with    O
interphase    O
cells    O
.    O

He    O
is    O
one    O
of    O
the    O
main    O
protagonists    O
of    O
the    O
discovery    O
of    O
the    O
Higgs    B-Body109224911
boson    I-Body109224911
at    O
the    O
LHC    O
.    O

Among    O
his    O
contributions    O
there    O
are    O
the    O
first    O
precision    O
measurements    O
of    O
the    O
lifetime    O
of    O
charmed    O
mesons    O
,    O
precision    O
tests    O
of    O
the    O
Standard    O
Model    O
of    O
the    O
fundamental    O
interactions    O
,    O
search    O
for    O
the    O
Higgs    B-Body109224911
boson    I-Body109224911
,    O
and    O
for    O
various    O
signatures    O
of    O
Supersymmetry    O
or    O
new    O
physics    O
beyond    O
the    O
Standard    O
Model    O
.    O

On    O
December    O
13    O
,    O
2011    O
,    O
together    O
with    O
Fabiola    O
Gianotti    O
,    O
ATLAS    O
Spokesperson    O
,    O
he    O
presented    O
in    O
a    O
special    O
seminar    O
at    O
CERN    O
the    O
first    O
evidence    O
of    O
the    O
presence    O
of    O
the    O
Higgs    B-Body109224911
boson    I-Body109224911
around    O
a    O
mass    O
of    O
125    O
GeV    O
/    O
c2    O
.    O

The    O
first    O
theory    O
of    O
the    O
Higgs    B-Body109224911
boson    I-Body109224911
is    O
put    O
forward    O
by    O
Peter    O
Higgs    O
,    O
a    O
particle    O
-    O
physics    O
theorist    O
at    O
the    O
University    O
of    O
Edinburgh    O
,    O
and    O
five    O
other    O
physicists    O
.    O

On    O
July    O
4    O
,    O
2012    O
CERN    O
announced    O
the    O
discovery    O
of    O
the    O
Higgs    B-Body109224911
boson    I-Body109224911
.    O

Since    O
the    O
Higgs    B-Body109224911
boson    I-Body109224911
is    O
a    O
spin    O
-    O
zero    O
particle    O
,    O
it    O
is    O
the    O
first    O
observed    O
ostensibly    O
elementary    O
particle    O
to    O
be    O
described    O
by    O
the    O
Klein    O
–    O
Gordon    O
equation    O
.    O

Further    O
experimentation    O
and    O
analysis    O
is    O
required    O
to    O
discern    O
whether    O
the    O
Higgs    B-Body109224911
boson    I-Body109224911
observed    O
is    O
that    O
of    O
the    O
Standard    O
Model    O
,    O
or    O
a    O
more    O
exotic    O
,    O
possibly    O
composite    O
,    O
form    O
.    O

For    O
an    O
SU(2    O
)    O
gauge    O
theory    O
,    O
neglecting    O
,    O
we    O
have    O
the    O
following    O
equations    O
for    O
the    O
gauge    O
field    O
and    O
the    O
Higgs    B-Body109224911
field    I-Body109224911
in    O
the    O
gauge    O

where    O
,    O
,    O
the    O
-s    O
are    O
the    O
SU(2    O
)    O
generators    O
,    O
is    O
the    O
electroweak    O
coupling    O
constant    O
,    O
is    O
the    O
Higgs    B-Body109224911
VEV    O
absolute    O
value    O
.    O

However    O
,    O
one    O
of    O
the    O
interactions    O
is    O
with    O
the    O
Higgs    B-Body109224911
field    I-Body109224911
.    O

However    O
,    O
one    O
of    O
the    O
interactions    O
is    O
with    O
the    O
Higgs    B-Body109224911
field    I-Body109224911
.    O

In    O
2012    O
,    O
Stephen    O
Hawking    O
lost    O
$    O
100    O
to    O
Gordon    O
Kane    O
of    O
the    O
University    O
of    O
Michigan    O
because    O
of    O
the    O
Higgs    B-Body109224911
boson    I-Body109224911
discovery    O
.    O

Physicist    O
Peter    O
Higgs    O
,    O
namesake    O
of    O
the    O
Higgs    B-Body109224911
boson    I-Body109224911
,    O
was    O
quoted    O
in    O
2013    O
as    O
saying    O
that    O
academic    O
expectations    O
since    O
the    O
1990s    O
would    O
likely    O
have    O
prevented    O
him    O
from    O
both    O
making    O
his    O
groundbreaking    O
research    O
contributions    O
and    O
attaining    O
tenure    O
.    O

2012    O
–    O
European    O
physicists    O
have    O
statistically    O
demonstrated    O
the    O
existence    O
of    O
the    O
Higgs    B-Body109224911
boson    I-Body109224911
.    O

For    O
example    O
,    O
grid    O
computing    O
was    O
credited    O
by    O
CERN    O
director    O
Rolf    O
-    O
Dieter    O
Heuer    O
as    O
one    O
of    O
the    O
elements    O
essential    O
for    O
the    O
2012    O
discovery    O
of    O
the    O
Higgs    B-Body109224911
boson    I-Body109224911
.    O

In    O
the    O
Standard    O
Model    O
of    O
particle    O
physics    O
,    O
this    O
symmetry    O
is    O
described    O
as    O
arising    O
as    O
a    O
consequence    O
of    O
a    O
coupling    O
of    O
particles    O
with    O
rest    O
mass    O
to    O
a    O
postulated    O
additional    O
field    O
,    O
known    O
as    O
the    O
Higgs    B-Body109224911
field    I-Body109224911
.    O

In    O
the    O
Standard    O
Model    O
of    O
particle    O
physics    O
as    O
developed    O
in    O
the    O
1960s    O
,    O
this    O
term    O
arises    O
from    O
the    O
coupling    O
of    O
the    O
field    O
ψ    O
to    O
an    O
additional    O
field    O
Φ    O
,    O
the    O
Higgs    B-Body109224911
field    I-Body109224911
.    O

Although    O
tachyon    B-Body109224911
(    O
particles    O
that    O
move    O
faster    O
than    O
light    O
)    O
are    O
a    O
purely    O
hypothetical    O
concept    O
not    O
generally    O
believed    O
to    O
exist    O
,    O
fields    O
with    O
imaginary    O
mass    O
have    O
come    O
to    O
play    O
an    O
important    O
role    B-Body109224911
in    O
modern    O
physics    O
and    O
are    O
discussed    O
in    O
popular    O
books    O
on    O
physics    O
.    O

Well    O
known    O
examples    O
include    O
the    O
condensation    O
of    O
the    O
Higgs    B-Body109224911
boson    I-Body109224911
in    O
particle    O
physics    O
,    O
and    O
ferromagnetism    O
in    O
condensed    O
matter    O
physics    O
.    O

Working    O
with    O
Dimitri    O
Nanopoulos    O
and    O
Mary    O
Gaillard    O
,    O
he    O
proposed    O
in    O
1976    O
the    O
so    O
-    O
called    O
"    O
Higgs    O
-    O
strahlung    O
"    O
process    O
in    O
which    O
a    O
Higgs    B-Body109224911
boson    I-Body109224911
is    O
radiated    O
from    O
a    O
"    O
Z    O
"-    O
boson    O
(    O
this    O
proved    O
to    O
be    O
the    O
best    O
way    O
to    O
search    O
for    O
the    O
Higgs    O
boson    O
at    O
the    O
Large    O
Electron    O
–    O
Positron    O
Collider    O
)    O
,    O
and    O
in    O
the    O
same    O
year    O
estimated    O
the    O
direct    O
CP    O
-    O
violation    O
contribution    O
to    O
rare    O
neutral    O
kaon    O
decays    O
(    O
which    O
led    O
to    O
the    O
success    O
of    O
the    O
NA31    O
and    O
NA48    O
experiments    O
at    O
CERN    O
)    O
.    O

In    O
electroweak    O
theory    O
,    O
the    O
degrees    O
of    O
freedom    O
in    O
a    O
unitarity    O
gauge    O
are    O
the    O
massive    O
spin-1    O
W+    O
,    O
W−    O
and    O
Z    O
bosons    O
with    O
three    O
polarizations    O
each    O
,    O
the    O
photon    O
with    O
two    O
polarizations    O
,    O
and    O
the    O
scalar    O
Higgs    B-Body109224911
boson    I-Body109224911
.    O

Higgs    B-Body109224911
field    I-Body109224911
is    O
named    O
after    O
Peter    O
Higgs    O
but    O
was    O
first    O
theorized    O
by    O
Robert    O
Brout    O
and    O
François    O
Englert    O
,    O
albeit    O
not    O
published    O
before    O
Higgs    O
had    O
submitted    O
his    O
own    O
paper    O
.    O

#    O
God    O
Particle    O
–    O
The    O
Higgs    B-Body109224911
boson    I-Body109224911
,    O
thought    O
to    O
account    O
for    O
mass    O
.    O

He    O
is    O
most    O
noted    O
for    O
his    O
contributions    O
to    O
the    O
Standard    O
Model    O
and    O
Symmetry    O
breaking    O
as    O
well    O
as    O
the    O
1964    O
co    O
-    O
discovery    O
of    O
the    O
Higgs    O
mechanism    O
and    O
Higgs    B-Body109224911
boson    I-Body109224911
with    O
Gerald    O
Guralnik    O
and    O
Tom    O
Kibble    O
(    O
GHK    O
)    O
.    O

Higgs    B-Body109224911
boson    I-Body109224911

He    O
currently    O
runs    O
the    O
blog    O
Evolution    O
Blog    O
at    O
National    O
Geographic    O
's    O
ScienceBlogs    O
,    O
where    O
he    O
frequently    O
criticizes    O
creationism    O
,    O
has    O
contributed    O
to    O
the    O
pro    O
-    O
evolution    O
blog    O
'    O
'    O
The    O
Panda    O
's    O
Thumb    O
''    O
,    O
and    O
has    O
also    O
contributed    O
to    O
the    O
Huffington    O
Post    O
about    O
topics    O
such    O
as    O
the    O
Higgs    B-Body109224911
boson    I-Body109224911
,    O
in    O
addition    O
to    O
creationism    O
.    O

"    O
for    O
having    O
led    O
,    O
building    O
on    O
decades    O
of    O
dedicated    O
work    O
by    O
their    O
predecessors    O
,    O
the    O
culminating    O
efforts    O
in    O
the    O
direction    O
,    O
research    O
and    O
operation    O
of    O
the    O
CERN    O
Large    O
Hadron    O
Collider    O
(    O
LHC    O
)    O
,    O
which    O
resulted    O
in    O
many    O
significant    O
advances    O
in    O
high    O
energy    O
particle    O
physics    O
,    O
in    O
particular    O
,    O
the    O
first    O
evidence    O
of    O
a    O
Higgs-like    B-Body109224911
boson    I-Body109224911
in    O
July    O
2012    O
"    O
.    O

The    O
game    O
makers    O
'    O
framing    O
device    O
for    O
the    O
game    O
is    O
as    O
follows    O
:    O
Alongside    O
the    O
discovery    O
of    O
the    O
Higgs    B-Body109224911
Boson    I-Body109224911
by    O
the    O
physicists    O
at    O
CERN    O
in    O
2012    O
,    O
it    O
has    O
also    O
been    O
discovered    O
that    O
the    O
Earth    O
has    O
been    O
seeded    O
with    O
"    O
Exotic    O
Matter    O
"    O
,    O
or    O
XM    O
.    O

The    O
low    O
Higgs    B-Body109224911
mass    I-Body109224911
of    O
~125    O
GeV    O
makes    O
possible    O
a    O
Circular    O
Electron    O
Positron    O
Collider    O
(    O
CEPC    O
)    O
as    O
a    O
Higgs    O
Factory    O
,    O
which    O
has    O
the    O
advantage    O
of    O
higher    O
luminosity    O
to    O
cost    O
ratio    O
and    O
the    O
potential    O
to    O
be    O
upgraded    O
to    O
a    O
proton    O
-    O
proton    O
collider    O
to    O
reach    O
unprecedented    O
high    O
energy    O
and    O
discover    O
New    O
Physics    O
.    O

This    O
conclusion    O
was    O
made    O
using    O
a    O
Higgs    B-Body109224911
field    I-Body109224911
with    O
an    O
energy    O
graph    O
that    O
was    O
originally    O
proposed    O
by    O
Sidney    O
Coleman    O
and    O
Erick    O
Weinberg    O
.    O

For    O
instance    O
,    O
the    O
certainty    O
of    O
the    O
Higgs    B-Body109224911
boson    I-Body109224911
particle    O
's    O
existence    O
was    O
based    O
on    O
the    O
5σ    O
criterion    O
,    O
which    O
corresponds    O
to    O
a    O
"    O
p    O
"-    O
value    O
of    O
about    O
1    O
in    O
3.5    O
million    O
.    O

Examples    O
used    O
in    O
physics    O
include    O
the    O
temperature    O
distribution    O
throughout    O
space    O
,    O
the    O
pressure    O
distribution    O
in    O
a    O
fluid    O
,    O
and    O
spin    O
-    O
zero    O
quantum    O
fields    O
,    O
such    O
as    O
the    O
Higgs    B-Body109224911
field    I-Body109224911
.    O

These    O
include    O
the    O
charged    O
Higgs    B-Body109224911
field    I-Body109224911
of    O
the    O
Standard    O
Model    O
,    O
as    O
well    O
as    O
the    O
charged    O
pions    O
mediating    O
the    O
strong    O
nuclear    O
interaction    O
.    O

In    O
the    O
Standard    O
Model    O
of    O
elementary    O
particles    O
,    O
a    O
scalar    O
Higgs    B-Body109224911
field    I-Body109224911
is    O
used    O
to    O
give    O
the    O
leptons    O
and    O
massive    O
vector    O
bosons    O
their    O
mass    O
,    O
via    O
a    O
combination    O
of    O
the    O
Yukawa    O
interaction    O
and    O
the    O
spontaneous    O
symmetry    O
breaking    O
.    O

A    O
candidate    O
for    O
the    O
Higgs    B-Body109224911
boson    I-Body109224911
was    O
first    O
detected    O
at    O
CERN    O
in    O
2012    O
.    O

Professor    O
Tom    O
W.    O
B.    O
Kibble    O
,    O
CBE    O
FRS    O
-    O
theoretical    O
physicist    O
,    O
co    O
-    O
discovery    O
of    O
the    O
Higgs    O
mechanism    O
and    O
Higgs    B-Body109224911
boson    I-Body109224911
.    O

Peter    O
Higgs    O
-    O
proposer    O
of    O
the    O
Higgs    B-Body109224911
boson    I-Body109224911
and    O
2013    O
Nobel    O
Prize    O
in    O
Physics    O
laureate    O

The    O
Standard    O
Model    O
of    O
particle    O
physics    O
opens    O
the    O
possibility    O
of    O
calculating    O
,    O
from    O
the    O
masses    O
of    O
the    O
Higgs    B-Body109224911
boson    I-Body109224911
and    O
the    O
top    O
quark    O
,    O
whether    O
the    O
universe    O
's    O
present    O
electroweak    O
vacuum    O
state    O
is    O
likely    O
to    O
be    O
stable    O
or    O
merely    O
long    O
-    O
lived    O
.    O

Joseph    O
Lykken    O
has    O
said    O
that    O
study    O
of    O
the    O
exact    O
properties    O
of    O
the    O
Higgs    B-Body109224911
boson    I-Body109224911
could    O
shed    O
light    O
on    O
the    O
possibility    O
of    O
vacuum    O
collapse    O
.    O

In    O
approximate    O
calculations    O
in    O
several    O
quantum    O
field    O
theories    O
,    O
notably    O
quantum    O
electrodynamics    O
and    O
theories    O
of    O
the    O
Higgs    B-Body109224911
particle    I-Body109224911
,    O
the    O
running    O
coupling    O
appears    O
to    O
become    O
infinite    O
at    O
a    O
finite    O
momentum    O
scale    O
.    O

The    O
SSC    O
would    O
have    O
been    O
about    O
three    O
times    O
as    O
powerful    O
as    O
CERN    O
's    O
Large    O
Hadron    O
Collider    O
,    O
most    O
notable    O
for    O
discovering    O
a    O
particle    O
consistent    O
with    O
a    O
Higgs    B-Body109224911
boson    I-Body109224911
.    O

In    O
particular    O
,    O
since    O
has    O
weak    O
isospin    O
½    O
like    O
the    O
Higgs    B-Body109224911
field    I-Body109224911
"    O
H    O
"    O
,    O
and    O
"    O
η    O
"    O
has    O
weak    O
isospin    O
0    O
,    O
the    O
mass    O
parameter    O
"    O
M    O
"    O
can    O
be    O
generated    O
from    O
Yukawa    O
interactions    O
with    O
the    O
Higgs    B-Body109224911
field    I-Body109224911
,    O
in    O
the    O
conventional    O
standard    O
model    O
fashion    O
,    O

This    O
means    O
that    O
"    O
M    O
"    O
is    O
naturally    O
of    O
the    O
order    O
of    O
the    O
vacuum    O
expectation    O
value    O
of    O
the    O
standard    O
model    O
Higgs    B-Body109224911
field    I-Body109224911
,    O

Grand    O
unified    O
theories    O
predict    O
Higgs    B-Body109224911
boson    I-Body109224911
(    O
doublets    O
of    O
)    O
arise    O
from    O
representations    O
of    O
the    O
unified    O
group    O
that    O
contain    O
other    O
states    O
,    O
in    O
particular    O
,    O
states    O
that    O
are    O
triplets    O
of    O
color    O
.    O

Measure    O
the    O
mass    O
,    O
spin    O
,    O
and    O
interaction    O
strengths    O
of    O
the    O
Higgs    B-Body109224911
boson    I-Body109224911

The    O
measured    O
small    O
non    O
-    O
zero    O
value    O
of    O
the    O
cosmological    O
constant    O
could    O
originate    O
for    O
example    O
from    O
a    O
slight    O
curvature    O
of    O
the    O
shape    O
of    O
the    O
universe    O
(    O
which    O
is    O
not    O
excluded    O
within    O
0.4%    O
(    O
as    O
of    O
2017    O
)    O
)    O
since    O
a    O
curved    O
-    O
space    O
could    O
modify    O
the    O
Higgs    B-Body109224911
field    I-Body109224911
zero    O
-    O
mode    O
,    O
thereby    O
possibly    O
producing    O
a    O
non    O
-    O
zero    O
contribution    O
to    O
the    O
cosmological    O
constant    O
.    O

Brout    O
and    O
Englert    O
,    O
Higgs    O
,    O
and    O
Gerald    O
Guralnik    O
,    O
C.    O
R.    O
Hagen    O
,    O
and    O
Tom    O
Kibble    O
introduced    O
as    O
agent    O
of    O
the    O
vacuum    O
structure    O
a    O
scalar    O
field    O
(    O
most    O
often    O
called    O
the    O
Higgs    B-Body109224911
field    I-Body109224911
)    O
which    O
many    O
physicists    O
view    O
as    O
the    O
agent    O
responsible    O
for    O
the    O
masses    O
of    O
fundamental    O
particles    O
.    O

As    O
an    O
example    O
,    O
asymptotic    O
safety    O
in    O
combination    O
with    O
the    O
Standard    O
Model    O
allows    O
a    O
statement    O
about    O
the    O
mass    O
of    O
the    O
Higgs    B-Body109224911
boson    I-Body109224911
and    O
the    O
value    O
of    O
the    O
fine    O
structure    O
constant    O
.    O

The    O
Scottish    O
Government    O
announces    O
plans    O
for    O
a    O
national    O
physics    O
prize    O
named    O
in    O
honour    O
of    O
Peter    O
Higgs    O
,    O
who    O
first    O
theorized    O
the    O
Higgs    B-Body109224911
boson    I-Body109224911
in    O
1964    O
.    O

18    O
February    O
–    O
Studies    O
of    O
a    O
recently    O
discovered    O
Higgs    B-Body109224911
boson    I-Body109224911
-    O
like    O
particle    O
suggest    O
that    O
the    O
universe    O
may    O
end    O
in    O
a    O
false    O
vacuum    O
collapse    O
billions    O
of    O
years    O
from    O
now    O
.    O

CERN    O
scientists    O
confirm    O
,    O
with    O
a    O
very    O
high    O
degree    O
of    O
certainty    O
,    O
that    O
a    O
new    O
particle    O
identified    O
by    O
the    O
Large    O
Hadron    O
Collider    O
in    O
July    O
2012    O
is    O
the    O
long    O
-    O
sought    O
Higgs    B-Body109224911
boson    I-Body109224911
.    O

Higgs    B-Body109224911
Field    I-Body109224911

The    O
collider    O
is    O
intended    O
to    O
be    O
used    O
to    O
find    O
evidence    O
of    O
the    O
hypothetical    O
Higgs    B-Body109224911
boson    I-Body109224911
particle    O
.    O

Tetramethylammonium    O
(    O
TMA    O
)    O
or    O
(    O
Me4N+    O
)    O
is    O
the    O
simplest    O
quaternary    B-Body109224911
ammonium    I-Body109224911
cation    I-Body109224911
consisting    O
of    O
four    O
methyl    O
groups    O
attached    O
to    O
a    O
central    O
nitrogen    O
atom    O
,    O
and    O
is    O
isoelectronic    O
with    O
neopentane    O
.    O

It    O
is    O
positively    O
charged    O
and    O
must    O
exist    O
in    O
association    O
with    O
a    O
counter    O
-    O
ion    O
,    O
and    O
is    O
most    O
commonly    O
found    O
in    O
simple    O
salts    B-Body109224911
such    O
as    O
tetramethylammonium    O
chloride    O
,    O
tetramethylammonium    O
bromide    O
,    O
tetramethylammonium    O
iodide    O
and    O
tetramethylammonium    O
hydroxide    O
,    O
and    O
can    O
also    O
form    O
the    O
unusual    O
auride    O
.    O

In    O
general    O
,    O
although    O
TMA    O
salts    O
do    O
possess    O
some    O
of    O
the    O
phase    O
-    O
transfer    O
catalytic    O
properties    O
that    O
are    O
characteristic    O
of    O
quaternary    B-Body109224911
ammonium    I-Body109224911
compounds    I-Body109224911
,    O
they    O
tend    O
to    O
behave    O
atypically    O
because    O
of    O
the    O
relatively    O
high    O
"    O
hydrophilicity    O
"    O
of    O
the    O
TMA    O
cation    O
.    O

The    O
most    O
common    O
methods    O
involve    O
chiral    O
phase    O
transfer    O
catalysis    O
,    O
such    O
as    O
asymmetric    O
quaternary    B-Body109224911
ammonium    I-Body109224911
salt    I-Body109224911
derived    O
from    O
the    O
Cinchona    O
alkaloids    O
;    O
or    O
organocatalysis    O
,    O
which    O
uses    O
enamine    O
or    O
iminium    O
activation    O
with    O
chiral    O
secondary    O
amines    O
,    O
usually    O
derived    O
from    O
proline    O
.    O

Polyquaternium    O
is    O
a    O
neologism    O
used    O
to    O
emphasize    O
the    O
presence    O
of    O
quaternary    B-Body109224911
ammonium    I-Body109224911
centers    O
in    O
the    O
polymer    O
.    O

This    O
quaternary    B-Body109224911
ammonium    I-Body109224911
exists    O
as    O
the    O
zwitterion    B-Body109224911
at    O
neutral    O
pH.    O
Strong    O
acids    O
such    O
as    O
hydrochloric    O
acid    O
convert    O
TMG    O
to    O
various    O
salts    O
,    O
with    O
HCl    O
yielding    O
betaine    O
hydrochloride    O
:    O

Exhaustive    O
methylation    O
of    O
the    O
amin    O
followed    O
by    O
displacement    O
of    O
the    O
activated    O
quaternary    B-Body109224911
nitrogen    I-Body109224911
by    O
bromide    O
ion    O
affords    O
the    O
key    O
intermediate    O
(    O
7    O
)    O
.    O

The    O
active    O
moiety    O
is    O
tiemonium    O
,    O
a    O
quaternary    B-Body109224911
ammonium    I-Body109224911
cation    I-Body109224911
.    O

Direct    O
blue    O
86    O
is    O
the    O
sodium    O
salt    O
of    O
CuPc    O
-    O
sulfonic    O
acid    O
,    O
whereas    O
direct    O
blue    O
199    O
is    O
the    O
quaternary    B-Body109224911
ammonium    I-Body109224911
salt    I-Body109224911
of    O
the    O
CuPc    O
-    O
sulfonic    O
acid    O
.    O

The    O
quaternary    B-Body109224911
ammonium    I-Body109224911
salt    I-Body109224911
of    O
these    O
sulfonic    O
acids    O
are    O
used    O
as    O
solvent    O
dyes    O
because    O
of    O
their    O
solubility    O
in    O
organic    O
solvents    O
,    O
e.g.    O
Solvent    O
Blue    O
38    O
and    O
Solvent    O
Blue    O
48    O
.    O

Nikolai    O
Menshutkin    O
discovers    O
that    O
a    O
tertiary    O
amine    O
can    O
be    O
converted    O
into    O
a    O
quaternary    B-Body109224911
ammonium    I-Body109224911
salt    I-Body109224911
by    O
reaction    O
with    O
an    O
alkyl    O
halide    O
–    O
the    O
Menshutkin    O
reaction    O
.    O

Quats    B-Body109224911
are    O
anti    O
-    O
microbial    O
agents    O
that    O
are    O
found    O
in    O
bathroom    O
cleaners    O
,    O
fabric    O
softeners    O
,    O
and    O
degreasers    O
.    O

Berberine    O
is    O
a    O
quaternary    B-Body109224911
ammonium    I-Body109224911
salt    O
from    O
the    O
protoberberine    O
group    O
of    O
benzylisoquinoline    O
alkaloids    O
.    O

Because    O
MNTX    O
is    O
a    O
quaternary    B-Body109224911
ammonium    I-Body109224911
cation    I-Body109224911
,    O
it    O
can    O
not    O
cross    O
the    O
blood–    O

quaternary    B-Body109224911
ammonium    I-Body109224911
cation    I-Body109224911
,    O
or    O

Salts    O
of    O
quaternary    B-Body109224911
ammonium    I-Body109224911
cation    I-Body109224911
are    O
known    O
.    O

Phase    O
-    O
transfer    O
catalysts    O
for    O
anionic    O
reactants    O
are    O
often    O
quaternary    B-Body109224911
ammonium    I-Body109224911
salt    I-Body109224911
.    O

According    O
to    O
a    O
2013    O
article    O
published    O
in    O
"    O
Environmental    O
Science    O
:    O
Processes    O
Impacts    O
"    O
,    O
the    O
tailings    O
ponds    O
contain    O
toxic    O
chemicals    O
such    O
as    O
"    O
naphthenic    O
acids    O
(    O
NAs    O
)    O
and    O
process    O
chemicals    O
(    O
e.g.    O
,    O
alkyl    O
sulphates    O
,    O
quaternary    B-Body109224911
ammonium    I-Body109224911
compounds    I-Body109224911
,    O
and    O
alkylphenol    O
ethoxylates    O
)    O
.    O

These    O
species    O
are    O
not    O
amines    O
but    O
are    O
quaternary    B-Body109224911
ammonium    I-Body109224911
cation    I-Body109224911
and    O
have    O
a    O
charged    O
nitrogen    O
center    O
.    O

For    O
chiral    O
tertiary    O
amines    O
,    O
NRR′R″    O
can    O
only    O
be    O
resolved    O
when    O
the    O
R    O
,    O
R′    O
,    O
and    O
R″    O
groups    O
are    O
constrained    O
in    O
cyclic    O
structures    O
such    O
as    O
N    O
-    O
substituted    O
aziridines    O
(    O
quaternary    B-Body109224911
ammonium    I-Body109224911
salt    I-Body109224911
are    O
resolvable    O
)    O
.    O

Cetalkonium    O
chloride    O
(    O
CKC    O
)    O
is    O
a    O
quaternary    B-Body109224911
ammonium    I-Body109224911
compound    O
of    O
the    O
alkyl    O
-    O
benzyldimethylammonium    O
chloride    O
family    O
,    O
the    O
alkyl    O
group    O
having    O
a    O
chain    O
length    O
of    O
C16    O
(    O
16    O
carbons    O
)    O
.    O

The    O
thermochromic    O
droplets    O
are    O
actually    O
a    O
mixture    O
of    O
several    O
chemicals    O
—    O
crystal    O
violet    O
lactone    O
(    O
the    O
color    O
-    O
changing    O
dye    O
itself    O
)    O
,    O
benzotriazole    O
(    O
a    O
weak    O
acid    O
)    O
,    O
and    O
a    O
quaternary    B-Body109224911
ammonium    I-Body109224911
salt    I-Body109224911
of    O
a    O
fatty    O
acid    O
(    O
myristylammonium    O
oleate    O
)    O
dissolved    O
in    O
1-dodecanol    O
as    O
solvent    O
.    O

Planck    B-Body109224911
particle    I-Body109224911
:    O
The    O
Planck    O
mass    O
plays    O
an    O
important    O
role    O
in    O
parts    O
of    O
mathematical    O
physics    O
.    O

Planck    B-Body109224911
particle    I-Body109224911

This    O
quaternary    B-Body109224911
ammonium    I-Body109224911
exists    O
as    O
the    O
zwitterion    B-Body109224911
at    O
neutral    O
pH.    O
Strong    O
acids    O
such    O
as    O
hydrochloric    O
acid    O
convert    O
TMG    O
to    O
various    O
salts    O
,    O
with    O
HCl    O
yielding    O
betaine    O
hydrochloride    O
:    O

Next    O
,    O
the    O
molozonide    O
reverts    O
to    O
its    O
corresponding    O
carbonyl    O
oxide    O
(    O
also    O
called    O
the    O
Criegee    O
intermediate    O
or    O
Criegee    O
zwitterion    B-Body109224911
)    O
and    O
aldehyde    O
or    O
ketone    O
in    O
a    O
retro-1,3-dipolar    O
cycloaddition    O
.    O

Nontoxic    O
mechanical    O
strategies    O
that    O
prevent    O
organisms    O
from    O
attaching    O
include    O
choosing    O
a    O
material    O
or    O
coating    O
with    O
a    O
slippery    O
surface    O
,    O
creation    O
of    O
an    O
ultra    O
-    O
low    O
fouling    O
surface    O
with    O
the    O
use    O
of    O
zwitterion    B-Body109224911
,    O
or    O
creation    O
of    O
nanoscale    O
surface    O
topologies    O
similar    O
to    O
the    O
skin    O
of    O
sharks    O
and    O
dolphins    O
which    O
only    O
offer    O
poor    O
anchor    O
points    O
.    O

The    O
most    O
common    O
examples    O
of    O
these    O
coatings    O
are    O
based    O
on    O
highly    O
hydrated    O
zwitterion    B-Body109224911
,    O
such    O
as    O
glycine    O
betaine    O
and    O
sulfobetaine    O
.    O

An    O
amino    O
acid    O
is    O
also    O
amphoteric    O
with    O
the    O
added    O
complication    O
that    O
the    O
neutral    O
molecule    O
is    O
subject    O
to    O
an    O
internal    O
acid    O
–    O
base    O
equilibrium    O
in    O
which    O
the    O
basic    O
amino    O
group    O
attracts    O
and    O
binds    O
the    O
proton    O
from    O
the    O
acidic    O
carboxyl    O
group    O
,    O
forming    O
a    O
zwitterion    B-Body109224911
.    O

Like    O
other    O
amino    O
acids    O
,    O
tryptophan    O
is    O
a    O
zwitterion    B-Body109224911
at    O
physiological    O
pH    O
where    O
the    O
amino    O
group    O
is    O
protonated    O
(    O
–NH3    O
+    O
;    O
pKa    O
=    O
9.39    O
)    O
and    O
the    O
carboxylic    O
acid    O
is    O
deprotonated    O
(    O
–COO−    O
;    O
pKa    O
=    O
2.38    O
)    O
.    O

It    O
functions    O
as    O
an    O
osmosensory    O
and    O
osmoregulatory    O
transporter    O
,    O
responding    O
to    O
changes    O
in    O
osmotic    O
pressure    O
by    O
importing    O
compatible    O
solutes    O
such    O
as    O
proline    O
or    O
glycine    O
betaine    O
;    O
most    O
substrates    O
for    O
ProP    O
are    O
zwitterion    B-Body109224911
.    O

Biological    O
proteins    O
are    O
made    O
up    O
of    O
zwitterion    B-Body109224911
amino    O
acid    O
compounds    O
;    O
the    O
net    O
charge    O
of    O
these    O
proteins    O
can    O
be    O
positive    O
or    O
negative    O
depending    O
on    O
the    O
pH    O
of    O
the    O
environment    O
.    O

Glycine    O
may    O
exist    O
as    O
a    O
zwitterion    B-Body109224911
at    O
the    O
isoelectric    O
point    O
,    O
but    O
the    O
equilibrium    O
constant    O
for    O
the    O
isomerization    O
reaction    O
in    O
solution    O

Ampholytes    O
are    O
amphoteric    O
molecules    O
that    O
contain    O
both    O
acidic    O
and    O
basic    O
groups    O
and    O
will    O
exist    O
mostly    O
as    O
zwitterion    B-Body109224911
in    O
a    O
certain    O
range    O
of    O
pH.    O
The    O
pH    O
at    O
which    O
the    O
average    O
charge    O
is    O
zero    O
is    O
known    O
as    O
the    O
molecule    O
's    O
"    O
isoelectric    O
point    O
"    O
.    O

Zwitterion    B-Body109224911

Zwitterion    B-Body109224911

The    O
first    O
step    O
is    O
a    O
nucleophilic    O
attack    O
by    O
the    O
imine    O
nitrogen    O
on    O
the    O
carbonyl    O
carbon    O
to    O
generate    O
a    O
zwitterion    B-Body109224911
intermediate    O
.    O

The    O
study    O
of    O
zwitterion    B-Body109224911
species    O
like    O
amino    O
acids    O
is    O
important    O
for    O
similar    O
reasons    O
.    O

zwitterion    B-Body109224911
bonded    O
phases    O

An    O
example    O
of    O
this    O
would    O
be    O
the    O
use    O
of    O
a    O
12.5mM    O
(    O
rather    O
than    O
the    O
recommended    O
>    O
20mM    O
buffer    O
)    O
,    O
pH    O
9.2    O
mobile    O
phase    O
on    O
a    O
polymeric    O
,    O
zwitterion    B-Body109224911
,    O
betaine    O
-    O
sulfonate    O
surface    O
to    O
separate    O
phosphonyl    O
antibiotic    O
mixtures    O
(    O
each    O
containing    O
a    O
phosphate    O
group    O
)    O
.    O

These    O
authors    O
noted    O
that    O
repression    O
of    O
ERCC1    O
(    O
by    O
HGMA2    O
)    O
can    O
reduce    O
DNA    O
repair    O
,    O
leading    O
to    O
increased    O
genome    B-Body109224911
instability    I-Body109224911
.    O

Genomic    B-Body109224911
instability    I-Body109224911

Chromosomal    O
rearrangement    O
due    O
to    O
genome    B-Body109224911
instability    I-Body109224911
can    O
cause    O
gene    O
amplification    O
and    O
deletion    O
,    O
both    O
of    O
which    O
underlie    O
the    O
development    O
of    O
multidrug    O
resistance    O
.    O

Moreover    O
,    O
it    O
inhibits    O
DNA    O
repair    O
,    O
causing    O
genomic    B-Body109224911
instability    I-Body109224911
and    O
potentially    O
causing    O
the    O
feared    O
blast    O
crisis    O
in    O
CML    O
.    O

It    O
is    O
estimated    O
to    O
participate    O
in    O
cascades    O
associated    O
with    O
cardiovascular    O
diseases    O
and    O
hypertension    O
,    O
and    O
was    O
also    O
found    O
to    O
be    O
implicated    O
in    O
immunity    O
,    O
genomic    B-Body109224911
instability    I-Body109224911
,    O
cell    O
differentiation    O
,    O
inflammation    O
,    O
virus    O
associated    O
infections    O
and    O
cancer    O
.    O

Several    O
spindle    O
assembly    O
checkpoint    O
proteins    O
act    O
both    O
as    O
positive    O
and    O
negative    O
regulators    O
to    O
ensure    O
the    O
proper    O
chromosome    O
segregation    O
in    O
each    O
cell    O
cycle    O
preventing    O
chromosome    O
instability    O
(    O
CIN    O
)    O
also    O
known    O
as    O
genome    B-Body109224911
instability    I-Body109224911
.    O

Hence    O
,    O
this    O
enzyme    O
has    O
one    O
substrate    O
,    O
3-sulfolactate    O
,    O
and    O
two    O
products    O
,    O
pyruvate    O
and    O
bisulfite    B-Body109224911
.    O

Bisulfite    O
sequencing    O
(    O
also    O
known    O
as    O
bisulphite    O
sequencing    O
)    O
is    O
the    O
use    O
of    O
bisulfite    B-Body109224911
treatment    O
of    O
DNA    O
to    O
determine    O
its    O
pattern    O
of    O
methylation    O
.    O

Sodium    B-Body109224911
bisulfate    I-Body109224911
and    O
alkaline    O
treatment    O
does    O
this    O
by    O
converting    O
unmethylated    O
cytosine    O
residues    O
into    O
uracil    O
while    O
leaving    O
methylated    O
cytosine    O
unaltered    O
.    O

:    O
hydrogen    B-Body109224911
sulfite    I-Body109224911
(    O
or    O
bisulfite    B-Body109224911
)    O

Tetraquark    B-Body109224911

A    O
tetraquark    B-Body109224911
state    O
(    O
an    O
exotic    O
meson    O
)    O
,    O
named    O
the    O
Z(4430)    B-Body109224911
,    O
was    O
discovered    O
in    O
2007    O
by    O
the    O
Belle    O
Collaboration    O
and    O
confirmed    O
as    O
a    O
resonance    O
in    O
2014    O
by    O
the    O
LHCb    O
collaboration    O
.    O

In    O
principle    O
,    O
mesons    O
with    O
more    O
than    O
one    O
quark    O
-    O
antiquark    O
pair    O
may    O
exist    O
;    O
a    O
hypothetical    O
meson    O
with    O
two    O
pairs    O
is    O
called    O
a    O
tetraquark    B-Body109224911
.    O

Physicists    O
report    O
the    O
possible    O
detection    O
of    O
a    O
new    O
subatomic    O
particle    O
,    O
Zc(3900)    B-Body109224911
,    O
a    O
hadron    O
which    O
may    O
be    O
the    O
first    O
tetraquark    B-Body109224911
to    O
have    O
been    O
observed    O
experimentally    O
.    O

Liquid    B-Body109224911
junction    I-Body109224911
interface    I-Body109224911

the    O
one    O
scalar    B-Body109224911
boson    I-Body109224911
(    O
spin-0    O
)    O
(    O
the    O
Higgs    O
boson    O
)    O

The    O
observed    O
elementary    O
bosons    O
are    O
all    O
gauge    O
bosons    O
:    O
photons    O
,    O
W    O
and    O
Z    O
bosons    O
,    O
gluons    O
,    O
except    O
the    O
Higgs    B-Body109224911
boson    I-Body109224911
which    O
is    O
a    O
scalar    B-Body109224911
boson    I-Body109224911
.    O

It    O
would    O
consist    O
of    O
extremely    O
light    O
scalar    B-Body109224911
particle    I-Body109224911
with    O
masses    O
on    O
the    O
order    O
of    O
eV.    O
Fuzzy    O
cold    O
dark    O
matter    O
halos    O
in    O
dwarf    O
galaxies    O
would    O
manifest    O
wave    O
behavior    O
on    O
astrophysical    O
scales    O
,    O
and    O
the    O
cusps    O
would    O
be    O
avoided    O
through    O
the    O
Heisenberg    O
uncertainty    O
principle    O
.    O

JADE    O
's    O
most    O
important    O
scientific    O
achievement    O
was    O
the    O
discovery    O
of    O
the    O
gluon    O
in    O
three    B-Body109224911
jet    I-Body109224911
events    I-Body109224911
.    O

Nervous    O
system    O
tissue    O
can    O
be    O
contaminated    O
with    O
TSE    O
prions    O
,    O
which    O
cause    O
bovine    O
spongiform    O
encephalopathy    O
(    O
BSE    O
,    O
"    O
mad    O
cow    O
disease    O
"    O
)    O
;    O
in    O
some    O
jurisdictions    O
these    O
offal    O
are    O
classified    O
as    O
specified    B-Body109224911
risk    I-Body109224911
material    I-Body109224911
and    O
are    O
subject    O
to    O
special    O
regulations    O
.    O

Removal    O
of    O
a    O
single    O
proton    O
from    O
the    O
acid    O
gives    O
the    O
monovalent    O
hydrogenacetylenedicarboxylate    B-Body109224911
anion    O
,    O
HC4O4−.    O

Dyon    B-Body109224911

In    O
physics    O
,    O
a    O
dyon    B-Body109224911
is    O
a    O
hypothetical    O
particle    O
in    O
4-dimensional    O
theories    O
with    O
both    O
electric    O
and    O
magnetic    O
charges    O
.    O

Sex    B-Body109224911
chromosome    I-Body109224911
abnormality    O
,    O
female    O
phenotype    O
,    O
unspecified    O

Other    O
sex    B-Body109224911
chromosome    I-Body109224911
abnormalities    O
,    O
male    O
phenotype    O
,    O
not    O
elsewhere    O
classified    O

Male    O
with    O
structurally    O
abnormal    O
sex    B-Body109224911
chromosome    I-Body109224911

Male    O
with    O
sex    B-Body109224911
chromosome    I-Body109224911
mosaicism    O

sex    B-Body109224911
chromosome    I-Body109224911

"    O
C.    O
elegans    O
"    O
has    O
five    O
pairs    O
of    O
autosomes    O
and    O
one    O
pair    O
of    O
sex    B-Body109224911
chromosome    I-Body109224911
.    O

The    O
males    O
are    O
genetically    O
identical    O
to    O
their    O
mothers    O
except    O
they    O
have    O
one    O
fewer    O
sex    B-Body109224911
chromosome    I-Body109224911
.    O

The    O
form    O
of    O
the    O
sex    B-Body109224911
chromosome    I-Body109224911
has    O
been    O
used    O
to    O
distinguish    O
the    O
marsh    O
rice    O
rat    O
from    O
"    O
Oryzomys    O
couesi    O
"    O
,    O
but    O
there    O
are    O
no    O
consistent    O
differences    O
between    O
the    O
two    O
.    O

An    O
autosome    O
is    O
a    O
chromosome    O
that    O
is    O
not    O
an    O
allosome    B-Body109224911
(    O
a    O
sex    O
chromosome    O
)    O
.    O

For    O
example    O
,    O
humans    O
have    O
a    O
diploid    B-Body109224911
genome    O
that    O
usually    O
contains    O
22    O
pairs    O
of    O
autosomes    O
and    O
one    O
allosome    B-Body109224911
pair    O
(    O
46    O
chromosomes    O
total    O
)    O
.    O

Unusually    O
large    O
sex    B-Body109224911
chromosome    I-Body109224911
had    O
earlier    O
been    O
described    O
only    O
in    O
a    O
few    O
species    O
,    O
all    O
of    O
which    O
belonged    O
to    O
Rodentia    O
.    O

S1    O
end    O
mapping    O
-    O
S1    O
nuclease    O
-    O
screening    O
-    O
SDS    O
-    O
PAGE    O
-    O
secondary    O
structure    O
-    O
selection    O
-    O
sense    O
strand    O
-    O
sequence    O
-    O
sequence    O
motif    O
-    O
sequence    O
polymorphism    O
-    O
sequence    O
-    O
tagged    O
site    O
-    O
sequential    O
epitope    O
-    O
severe    O
combined    O
immunodeficiency    O
-    O
sex    B-Body109224911
chromosome    I-Body109224911
-    O
sex    O
-    O
linked    O
-    O
Shine    O
-    O
Dalgarno    O
sequence    O
-    O
shotgun    O
cloning    O
-    O
shotgun    O
cloning    O
or    O
sequencing    O
-    O
shotgun    O
sequencing    O
-    O
shuttle    O
vector    O
-    O
sickle    O
-    O
cell    O
disease    O
-    O
side    O
chain    O
-    O
sigma    O
factor    O
-    O
signal    O
peptidase    O
-    O
signal    O
sequence    O
-    O
silent    O
mutation    O
-    O
single    O
nucleotide    O
polymorphism    O
-    O
siRNA    O
-    O
site    O
-    O
directed    O
mutagenesis    O
-    O
site    O
-    O
specific    O
recombination    O
-    O
slot    O
blot    O
-    O
SNP    O
-    O
snRNA    O
-    O
snRNP    O
-    O
solution    O
hybridization    O
-    O
somatic    O
cells    O
-    O
Southern    O
blot    O
-    O
southwestern    O
blot    O
-    O
SP6    O
RNA    O
polymerase    O
-    O
spectral    O
karyotype    O
-    O
splicing    O
-    O
Simple    O
Sequence    O
Repeats    O
(    O
SSR    O
)    O
-    O
stable    O
transfection    O
-    O
start    O
codon    O
-    O
stem    O
-    O
loop    O
-    O
sticky    O
end    O
-    O
stop    O
codon    O
-    O
streptavidin    O
-    O
stringency    O
-    O
structural    O
motif    O
-    O
sub    O
-    O
cloning    O
-    O
substitution    O
-    O
suicide    O
gene    O
-    O
supercoil    O
-    O
syndrome    O
-    O

This    O
is    O
in    O
contrast    O
to    O
sex    O
-    O
linked    O
chromosomes    B-Body109224911
.    O

Fragments    O
of    O
DNA    O
,    O
produced    O
following    O
chromothriptic    B-Body109224911
shattering    O
of    O
chromosome    B-Body109224911
12    I-Body109224911
undergo    O
DNA    O
repair    O
to    O
form    O
of    O
a    O
circular    O
or    O
ring    B-Body109224911
chromosome    I-Body109224911
.    O

Her    O
research    O
there    O
,    O
undertaken    O
between    O
1920    O
and    O
1925    O
,    O
comprised    O
23    O
papers    O
on    O
various    O
topics    O
,    O
including    O
the    O
lignin    O
produced    O
during    O
sulfite    B-Body109224911
pulp    O
manufacturing    O
and    O
how    O
to    O
determine    O
the    O
lignin    O
content    O
of    O
a    O
particular    O
wood    O
,    O
the    O
composition    O
of    O
pine    O
and    O
spruce    O
needles    O
,    O
carbon    O
dioxide    O
's    O
role    O
in    O
plants    O
,    O
methods    O
for    O
separating    O
pulp    O
by    O
-    O
products    O
,    O
petroleum    O
,    O
and    O
coal    O
.    O

:    O
O    O
-    O
phospho    O
-    O
L    O
-    O
serine    O
+    O
sulfite    B-Body109224911
L    O
-    O
cysteate    O
+    O
phosphate    O

Minimal    O
or    O
no    O
added    O
sulphites    B-Body109224911
aka    O
sulfites    B-Body109224911
.    O

It    O
may    O
cause    O
allergic    O
reactions    O
in    O
those    O
who    O
are    O
sensitive    O
to    O
sulfites    B-Body109224911
,    O
including    O
respiratory    O
reactions    O
in    O
asthmatics    O
,    O
anaphylaxis    O
,    O
and    O
other    O
allergic    O
reactions    O
in    O
sensitive    O
individuals    O
.    O

They    O
are    O
caused    O
by    O
various    O
organic    O
chemicals    O
occurring    O
naturally    O
in    O
a    O
wide    O
variety    O
of    O
foods    O
,    O
both    O
of    O
animal    O
and    O
vegetable    O
origin    O
more    O
often    O
than    O
to    O
food    O
additives    O
,    O
preservatives    O
,    O
colourings    O
and    O
flavourings    O
,    O
such    O
as    O
sulfite    B-Body109224911
or    O
dyes    O
.    O

Other    O
natural    O
chemicals    O
which    O
commonly    O
cause    O
reactions    O
and    O
cross    O
reactivity    O
include    O
amines    O
,    O
nitrates    O
,    O
sulphites    B-Body109224911
and    O
some    O
antioxidants    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
L    O
-    O
cysteine    O
and    O
sulfite    B-Body109224911
,    O
whereas    O
its    O
two    O
products    O
are    O
L    O
-    O
cysteate    O
and    O
hydrogen    O
sulfide    O
.    O

It    O
results    O
in    O
high    O
blood    O
levels    O
of    O
sulfite    B-Body109224911
and    O
urate    O
,    O
in    O
much    O
the    O
same    O
way    O
as    O
molybdenum    O
cofactor    O
deficiency    O
.    O

The    O
resulting    O
deficiency    O
results    O
in    O
high    O
levels    O
of    O
sulfite    B-Body109224911
and    O
urate    O
,    O
and    O
neurological    O
damage    O
.    O

The    O
garments    O
in    O
question    O
were    O
alleged    O
to    O
contain    O
an    O
excess    O
of    O
sulphur    O
compounds    O
,    O
variously    O
described    O
as    O
sulphur    O
dioxide    O
and    O
sulphite    B-Body109224911
.    O

sulfite    B-Body109224911

:    O
sulfite    B-Body109224911

Reduced    O
sulfur    O
compounds    O
,    O
such    O
as    O
hydrogen    O
sulfide    O
,    O
elemental    O
sulfur    O
,    O
sulfite    B-Body109224911
,    O
thiosulfate    B-Body109224911
,    O
and    O
various    O
polythionates    O
(    O
e.g.    O
,    O
tetrathionate    O
)    O
,    O
are    O
used    O
by    O
various    O
lithotrophic    O
bacteria    O
and    O
are    O
all    O
oxidized    O
by    O
"    O
Acidithiobacillus    O
"    O
.    O

In    O
1890    O
,    O
the    O
Manufacturing    O
Investment    O
Company    O
built    O
a    O
sulfite    B-Body109224911
mill    O
,    O
but    O
it    O
failed    O
.    O

It    O
often    O
occurs    O
immediately    O
after    O
bottling    O
or    O
when    O
wines    O
(    O
usually    O
fragile    O
wines    O
)    O
are    O
given    O
an    O
additional    O
dose    O
of    O
sulfur    O
(    O
in    O
the    O
form    O
of    O
sulfur    O
dioxide    O
or    O
sulfite    B-Body109224911
solution    O
)    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
acetyl    O
phosphate    O
and    O
sulfite    B-Body109224911
,    O
whereas    O
its    O
two    O
products    O
are    O
2-sulfoacetaldehyde    O
and    O
phosphate    O
.    O

He    O
visited    O
Europe    O
in    O
1886    O
to    O
find    O
alternatives    O
to    O
wood    O
pulp    O
from    O
Quebec    O
,    O
and    O
afterward    O
in    O
1887    O
he    O
set    O
up    O
a    O
sulfite    B-Body109224911
mill    O
in    O
Cornwall    O
to    O
supply    O
high    O
quality    O
wood    O
pulp    O
to    O
his    O
plant    O
and    O
others    O
.    O

They    O
consist    O
of    O
complexation    O
of    O
radioactive    O
waste    O
with    O
phosphates    O
,    O
organic    O
compounds    O
and    O
sulfites    B-Body109224911
so    O
that    O
they    O
become    O
insoluble    O
and    O
less    O
exposed    O
to    O
radiotoxicity    O
.    O

What    O
separates    O
1pr3    O
T    O
from    O
its    O
sister    O
strains    O
is    O
its    O
ability    O
to    O
reduce    O
sulfite    B-Body109224911
and    O
thiosulfate    B-Body109224911
to    O
hydrogen    O
sulfide    O
(    O
H2S    O
)    O
;    O
reduce    O
nitrate    O
to    O
ammonia    O
;    O
lastly    O
,    O
its    O
presence    O
of    O
cytochrome    O
types    O
b-    O
and    O
c-    O
.    O

As    O
assumed    O
by    O
its    O
name    O
,    O
"    O
Desulfobulbus    O
"    O
"    O
propionicus    O
"    O
reduces    O
sulfate    O
,    O
sulfite    B-Body109224911
,    O
and    O
thiosulfate    B-Body109224911
to    O
hydrogen    O
sulfide    O
(    O
H2S    O
)    O
,    O
but    O
does    O
not    O
reduce    O
elemental    O
sulfur    O
,    O
malate    O
,    O
and    O
fumarate    O
.    O

Studies    O
have    O
shown    O
that    O
the    O
fungus    O
is    O
sensitive    O
to    O
low    O
concentrations    O
of    O
sulphite    B-Body109224911
(    O
SO32−    O
)    O
,    O
a    O
byproduct    O
of    O
sulphur    O
dioxide    O
pollution    O
,    O
suggesting    O
that    O
this    O
pollution    O
can    O
be    O
toxic    O
to    O
the    O
growth    O
of    O
the    O
fungus    O
(    O
and    O
the    O
subsequent    O
decomposition    O
of    O
leaf    O
litter    O
)    O
at    O
environmentally    O
relevant    O
concentrations    O
.    O

metallate    B-Body109224911

Edwards    O
syndrome    O
,    O
also    O
known    O
as    O
trisomy    O
18    O
,    O
is    O
a    O
genetic    O
disorder    O
caused    O
by    O
the    O
presence    O
of    O
all    O
,    O
or    O
part    O
of    O
a    O
third    O
copy    O
of    O
chromosome    B-Body109224911
18    I-Body109224911
.    O

A    O
pseudogene    O
is    O
found    O
on    O
chromosome    B-Body109224911
18    I-Body109224911
.    O

A    O
sub    O
-    O
section    O
of    O
Chromosome    B-Body109224911
18    I-Body109224911
(human)    I-Body109224911

There    O
are    O
nine    O
other    O
major    O
chromosomal    O
differences    O
between    O
chimpanzees    O
and    O
humans    O
:    O
chromosome    O
segment    O
inversions    O
on    O
human    O
chromosomes    O
1    B-Body109224911
,    O
4    B-Body109224911
,    O
5    B-Body109224911
,    O
9    B-Body109224911
,    O
12    B-Body109224911
,    O
15    B-Body109224911
,    O
16    B-Body109224911
,    O
17    B-Body109224911
,    O
and    O
18    B-Body109224911
.    O

Chromosome    B-Body109224911
18    I-Body109224911
is    O
one    O
of    O
the    O
23    O
pairs    O
of    O
chromosomes    O
in    O
humans    O
.    O

Finally    O
,    O
the    O
upgraded    O
ITS    O
will    O
give    O
us    O
the    O
chance    O
to    O
characterize    O
the    O
thermal    O
radiation    O
coming    O
from    O
the    O
QGP    B-Body109224911
and    O
the    O
in    O
-    O
medium    O
modification    O
of    O
hadronic    O
spectral    O
functions    O
as    O
related    O
to    O
chiral    O
symmetry    O
restoration    O
.    O

The    O
familiar    O
elementary    O
particles    O
now    O
form    O
as    O
a    O
soup    O
of    O
hot    O
ionized    O
gas    O
called    O
quark-gluon    B-Body109224911
plasma    I-Body109224911
;    O
hypothetical    O
components    O
of    O
Cold    O
dark    O
matter    O
(    O
such    O
as    O
axions    O
)    O
would    O
also    O
have    O
formed    O
at    O
this    O
time    O
.    O

The    O
temperature    O
is    O
still    O
too    O
high    O
for    O
quarks    O
to    O
coalesce    O
into    O
hadrons    O
,    O
and    O
the    O
quark-gluon    B-Body109224911
plasma    I-Body109224911
persists    O
(    O
Quark    O
epoch    O
)    O
.    O

Quark–gluon    B-Body109224911
plasma    I-Body109224911

When    O
the    O
QCD    O
matter    O
undergoes    O
a    O
phase    O
crossover    O
into    O
quark    B-Body109224911
gluon    I-Body109224911
plasma    I-Body109224911
,    O
the    O
energy    O
loss    O
in    O
the    O
medium    O
grows    O
significantly    O
,    O
effectively    O
quenching    O
the    O
outgoing    O
jet    O
.    O

For    O
example    O
,    O
in    O
a    O
quark–gluon    B-Body109224911
plasma    I-Body109224911
or    O
other    O
QCD    O
matter    O
,    O
at    O
every    O
point    O
in    O
space    O
there    O
is    O
a    O
chemical    O
potential    O
for    O
photons    O
,    O
a    O
chemical    O
potential    O
for    O
electrons    O
,    O
a    O
chemical    O
potential    O
for    O
baryon    O
number    O
,    O
electric    O
charge    O
,    O
and    O
so    O
forth    O
.    O

Can    O
be    O
used    O
to    O
simulate    O
an    O
equilibrium    O
or    O
non    O
-    O
equilibrium    O
quark-gluon    B-Body109224911
plasma    I-Body109224911
.    O

Quark–gluon    B-Body109224911
plasma    I-Body109224911
,    O
an    O
extremely    O
energetic    O
state    O
of    O
matter    O
where    O
nuclear    O
particles    O
dissociate    O
into    O
free    O
quarks    O
and    O
gluons    O

There    O
are    O
major    O
programs    O
at    O
accelerator    O
facilities    O
such    O
as    O
GSI    O
-    O
SIS    O
,    O
CERN    O
-    O
LHC    O
,    O
and    O
BNL    O
-    O
RHIC    O
to    O
investigate    O
the    O
properties    O
of    O
a    O
new    O
state    O
of    O
matter    O
,    O
the    O
quark-gluon    B-Body109224911
plasma    I-Body109224911
,    O
and    O
other    O
features    O
of    O
the    O
QCD    O
phase    O
diagram    O
.    O

The    O
power    O
spectrum    O
will    O
be    O
used    O
to    O
measure    O
the    O
baryon    B-Body109224911
acoustic    I-Body109224911
oscillation    I-Body109224911
(    O
BAO    O
)    O
scale    O
across    O
this    O
redshift    O
range    O
where    O
dark    O
energy    O
becomes    O
a    O
significant    O
contributor    O
to    O
the    O
evolution    O
of    O
the    O
Universe    O
.    O

Maps    O
of    O
large    O
-    O
scale    O
structure    O
can    O
be    O
used    O
to    O
measure    O
the    O
expansion    O
history    O
of    O
the    O
Universe    O
because    O
sound    O
waves    O
in    O
the    O
early    O
Universe    O
,    O
or    O
baryon    B-Body109224911
acoustic    I-Body109224911
oscillations    I-Body109224911
(    O
BAO    O
)    O
,    O
have    O
left    O
slight    O
overdensities    O
in    O
the    O
distribution    O
of    O
matter    O
on    O
scales    O
of    O
about    O
500    O
million    O
light    O
-    O
years    O
.    O

Additionally    O
,    O
the    O
Pathfinder    O
will    O
also    O
be    O
capable    O
of    O
making    O
a    O
competitive    O
measurement    O
of    O
the    O
baryon    B-Body109224911
acoustic    I-Body109224911
oscillations    I-Body109224911
(    O
BAO    O
)    O
and    O
will    O
become    O
a    O
useful    O
telescope    O
in    O
its    O
own    O
right    O
.    O

,    O
cosmology    O
(    O
BAO    B-Body109224911
)    O
,    O
and    O
they    O
allow    O
probing    O
of    O
the    O
faint    O
end    O
of    O
the    O
luminosity    O
function    O
at    O
high    O
redshift    O
.    O

The    O
WMAP    O
spacecraft    O
's    O
five    O
-    O
year    O
data    O
combined    O
with    O
type    O
Ia    O
supernova    O
data    O
and    O
information    O
about    O
the    O
baryon    B-Body109224911
acoustic    I-Body109224911
oscillation    I-Body109224911
scale    O
yielded    O
Nν    O
=    O
at    O
68%    O
c.l    O
.    O
,    O
providing    O
an    O
independent    O
confirmation    O
of    O
the    O
BBN    O
constraints    O
.    O

Hydrogen    B-Body109224911
ion    I-Body109224911
cluster    I-Body109224911

The    O
western    O
portion    O
is    O
colored    O
green    O
from    O
doubly    B-Body109224911
ionized    I-Body109224911
oxygen    I-Body109224911
,    O
the    O
southern    O
portion    O
is    O
red    O
from    O
hydrogen    O
alpha    O
emissions    O
,    O
and    O
the    O
center    O
region    O
is    O
colored    O
yellow    O
from    O
both    O
oxygen    O
and    O
hydrogen    O
emissions    O
.    O

In    O
1927    O
,    O
Ira    O
Sprague    O
Bowen    O
showed    O
that    O
the    O
lines    O
are    O
emitted    O
by    O
doubly    B-Body109224911
ionized    I-Body109224911
oxygen    I-Body109224911
(    O
O2    O
+    O
)    O
,    O
and    O
no    O
new    O
element    O
was    O
necessary    O
to    O
explain    O
them    O
.    O

They    O
were    O
shown    O
as    O
due    O
to    O
doubly    B-Body109224911
ionized    I-Body109224911
oxygen    I-Body109224911
at    O
extremely    O
low    O
density    O
,    O
rather    O
than    O
the    O
hypothetical    O
nebulium    O
.    O

WNT4    O
(    O
found    O
on    O
the    O
short    B-Body109224911
arm    I-Body109224911
(p)    I-Body109224911
of    O
chromosome    B-Body109224911
1    I-Body109224911
)    O
has    O
been    O
clearly    O
implicated    O
in    O
the    O
atypical    O
version    O
of    O
this    O
disorder    O
.    O

An    O
association    O
with    O
a    O
deletion    O
mutation    O
in    O
the    O
long    B-Body109224911
arm    I-Body109224911
(q)    I-Body109224911
of    O
chromosome    B-Body109224911
17    I-Body109224911
(    O
17q12    O
)    O
has    O
been    O
reported    O
.    O

The    O
gene    O
for    O
human    O
Hop    O
is    O
located    O
on    O
chromosome    B-Body109224911
11    I-Body109224911
and    O
consists    O
of    O
14    O
exons    O
.    O

The    O
SDHD    O
gene    O
is    O
located    O
on    O
chromosome    B-Body109224911
11    I-Body109224911
at    O
locus    B-Body109224911
11q23    O
and    O
it    O
spans    O
8,978    O
base    O
pairs    O
.    O

The    O
IL-5    O
gene    O
is    O
located    O
on    O
chromosome    B-Body109224911
11    I-Body109224911
in    O
the    O
mouse    O
,    O
and    O
chromosome    O
5    O
in    O
humans    O
,    O
in    O
close    O
proximity    O
to    O
the    O
genes    O
encoding    O
IL-3    O
,    O
IL-4    O
,    O
and    O
granulocyte    O
-    O
macrophage    O
colony    O
-    O
stimulating    O
factor    O
(    O
GM    O
-    O
CSF    O
)    O
,    O
which    O
are    O
often    O
co    O
-    O
expressed    O
in    O
TH2    O
cells    O
.    O

Two    O
novel    O
susceptibility    O
haplotypes    O
(    O
specifically    O
,    O
P2-S2-X1    O
and    O
P1-S2-X1    O
)    O
have    O
been    O
discovered    O
in    O
ApoAI    O
-    O
CIII    O
-    O
AIV    O
gene    O
cluster    O
on    O
chromosome    B-Body109224911
11    I-Body109224911
;    O
these    O
confer    O
approximately    O
threefold    O
higher    O
risk    O
of    O
coronary    O
heart    O
disease    O
in    O
normal    O
as    O
well    O
as    O
non    O
-    O
insulin    O
diabetes    O
mellitus    O
.    O

Archain    O
is    O
a    O
protein    O
located    O
on    O
chromosome    B-Body109224911
11    I-Body109224911
.    O

Genetically    O
,    O
the    O
syndrome    O
is    O
due    O
to    O
mutations    O
in    O
the    O
Wilms    O
tumor    O
suppressor    O
gene    O
,    O
WT1    O
,    O
which    O
is    O
on    O
chromosome    B-Body109224911
11    I-Body109224911
(    O
11p13    O
)    O
.    O

CCDC82    O
is    O
located    O
on    O
chromosome    B-Body109224911
11    I-Body109224911
at    O
11q21.5    O
.    O

In    O
humans    O
,    O
the    O
IGF2    O
gene    O
is    O
located    O
on    O
chromosome    B-Body109224911
11    I-Body109224911
,    O
a    O
region    O
which    O
contains    O
numerous    O
imprinted    O
genes    O
.    O

Sialate    O
O    O
-    O
acetylesterase    O
(    O
SIAE    O
)    O
is    O
a    O
protein    O
that    O
in    O
human    O
is    O
encoded    O
by    O
the    O
SIAE    O
gene    O
located    O
on    O
chromosome    B-Body109224911
11    I-Body109224911
.    O

In    O
1988    O
,    O
researchers    O
at    O
Uppsala    O
University    O
Hospital    O
and    O
the    O
Karolinska    O
Institute    O
in    O
Stockholm    O
mapped    O
the    O
"    O
MEN1    O
"    O
gene    O
to    O
the    O
long    O
arm    O
of    O
chromosome    B-Body109224911
11    I-Body109224911
.    O

The    O
gene    O
is    O
located    O
on    O
long    O
arm    O
of    O
chromosome    B-Body109224911
11    I-Body109224911
(    O
11q13    O
)    O
between    O
base    O
pairs    O
64,570,985    O
and    O
64,578,765    O
.    O

There    O
are    O
nine    O
other    O
major    O
chromosomal    O
differences    O
between    O
chimpanzees    O
and    O
humans    O
:    O
chromosome    O
segment    O
inversions    O
on    O
human    O
chromosomes    O
1    B-Body109224911
,    O
4    B-Body109224911
,    O
5    B-Body109224911
,    O
9    B-Body109224911
,    O
12    B-Body109224911
,    O
15    B-Body109224911
,    O
16    B-Body109224911
,    O
17    B-Body109224911
,    O
and    O
18    B-Body109224911
.    O

The    O
gene    O
encoding    O
miR-22    O
is    O
found    O
on    O
the    O
short    O
arm    O
of    O
chromosome    B-Body109224911
17    I-Body109224911
,    O
in    O
a    O
minimal    O
loss    O
of    O
heterozygosity    O
region    O
.    O

In    O
humans    O
,    O
it    O
is    O
found    O
in    O
a    O
region    O
of    O
chromosome    B-Body109224911
17    I-Body109224911
that    O
is    O
commonly    O
deleted    O
in    O
Smith    O
-    O
Magenis    O
syndrome    O
.    O

Venetoclax    O
is    O
a    O
Bcl-2    O
inhibitor    O
used    O
to    O
treat    O
people    O
with    O
CLL    O
who    O
have    O
17p    B-Body109224911
deletion    O
(    O
deletion    O
located    O
on    O
the    O
chromosome    O
17    O
short    O
arm    O
)    O
and    O
who    O
have    O
been    O
treated    O
with    O
at    O
least    O
one    O
prior    O
therapy    O
.    O

The    O
gene    O
for    O
human    O
CXCL16    O
is    O
located    O
on    O
chromosome    B-Body109224911
17    I-Body109224911
.    O

Chromosome    B-Body109224911
17    I-Body109224911
is    O
one    O
of    O
the    O
23    O
pairs    O
of    O
chromosomes    O
in    O
humans    O
.    O

Chromosomal    O
abnormalities    O
include    O
a    O
total    O
of    O
three    O
copies    O
of    O
the    O
X    B-Body109224911
chromosome    I-Body109224911
and    O
four    O
copies    O
of    O
chromosome    B-Body109224911
17    I-Body109224911
and    O
chromosome    B-Body109224911
22    I-Body109224911
.    O

Overexpression    O
of    O
the    O
HER2/neu    O
gene    O
on    O
chromosome    B-Body109224911
17    I-Body109224911
and    O
some    O
type    O
of    O
polysomy    O
has    O
been    O
reported    O
in    O
8    O
-    O
68%    O
of    O
breast    O
carcinomas    O
.    O

On    O
April    O
11    O
,    O
2016    O
,    O
the    O
FDA    O
approved    O
venetoclax    O
for    O
use    O
in    O
those    O
with    O
CLL    O
who    O
have    O
17p    B-Body109224911
deletion    O
(    O
deletion    O
located    O
on    O
the    O
chromosome    O
17    O
short    O
arm    O
)    O
and    O
who    O
have    O
been    O
treated    O
with    O
at    O
least    O
one    O
prior    O
therapy    O
.    O

TDF    O
functions    O
by    O
activating    O
the    O
SOX9    O
gene    O
on    O
chromosome    B-Body109224911
17    I-Body109224911
,    O
so    O
mutations    O
of    O
the    O
SOX9    O
gene    O
can    O
cause    O
humans    O
with    O
a    O
Y    O
chromosome    O
to    O
develop    O
as    O
females    O
.    O

The    O
gene    O
is    O
on    O
chromosome    B-Body109224911
17q    I-Body109224911
.    O

SFRS1    O
is    O
the    O
gene    O
that    O
codes    O
for    O
ASF    O
/    O
SF2    O
and    O
is    O
found    O
on    O
chromosome    B-Body109224911
17    I-Body109224911
.    O

Dicarbonyl    O
/    O
L    O
-    O
xylulose    O
reductase    O
,    O
also    O
known    O
as    O
carbonyl    O
reductase    O
II    O
,    O
is    O
an    O
enzyme    O
that    O
in    O
human    O
is    O
encoded    O
by    O
the    O
DCXR    O
gene    O
located    O
on    O
chromosome    B-Body109224911
17    I-Body109224911
.    O

The    O
genes    O
for    O
the    O
type    O
I    O
keratins    O
are    O
located    O
in    O
a    O
gene    O
cluster    O
on    O
human    O
chromosome    B-Body109224911
17    I-Body109224911
,    O
whereas    O
the    O
genes    O
for    O
type    O
II    O
keratins    O
are    O
located    O
in    O
a    O
cluster    O
on    O
human    O
chromosome    B-Body109224911
12    I-Body109224911
(    O
the    O
exception    O
being    O
K18    O
,    O
a    O
type    O
I    O
keratin    O
located    O
in    O
the    O
type    O
II    O
gene    O
cluster    O
)    O
.    O

In    O
physics    O
,    O
a    O
Dirac    B-Body109224911
fermion    I-Body109224911
is    O
a    O
fermion    O
which    O
is    O
not    O
its    O
own    O
antiparticle    O
.    O

In    O
quantum    O
field    O
theory    O
,    O
the    O
Nambu    O
–    O
Jona    O
-    O
Lasinio    O
model    O
(    O
or    O
more    O
precisely    O
:    O
"    O
the    O
Nambu    O
and    O
Jona    O
-    O
Lasinio    O
model    O
"    O
)    O
is    O
a    O
complicated    O
effective    O
theory    O
of    O
nucleons    O
and    O
mesons    O
constructed    O
from    O
interacting    O
Dirac    B-Body109224911
fermion    I-Body109224911
with    O
chiral    O
symmetry    O
,    O
paralleling    O
the    O
construction    O
of    O
Cooper    O
pairs    O
from    O
electrons    O
in    O
the    O
BCS    O
theory    O
of    O
superconductivity    O
.    O

As    O
an    O
example    O
of    O
an    O
'    O
t    O
Hooft    O
anomaly    O
,    O
we    O
consider    O
quantum    O
chromodynamics    O
with    O
massless    O
fermions    O
:    O
This    O
is    O
the    O
gauge    O
theory    O
with    O
massless    O
Dirac    B-Body109224911
fermion    I-Body109224911
.    O

The    O
action    O
of    O
a    O
free    O
Dirac    B-Body109224911
fermion    I-Body109224911
in    O
"    O
d    O
"    O
dimensions    O
,    O
of    O
mass    O
"    O
m    O
"    O
,    O
and    O
in    O
the    O
continuum    O
(    O
i.e.    O
without    O
discretization    O
)    O
is    O
commonly    O
given    O
as    O

His    O
ship    O
shattered    O
and    O
broken    O
,    O
Poole    O
begins    O
dying    O
,    O
but    O
at    O
the    O
last    O
moment    O
,    O
an    O
"    O
anti    O
-    O
Xeelee    O
"    O
(    O
whom    O
it    O
is    O
implied    O
is    O
a    O
being    O
created    O
by    O
the    O
Xeelee    O
to    O
be    O
like    O
them    O
,    O
except    O
travelling    O
like    O
a    O
tachyon    B-Body109224911
backwards    O
in    O
time    O
,    O
the    O
better    O
to    O
mould    O
the    O
Xeelee    O
's    O
early    O
evolutionary    O
history    O
)    O
takes    O
a    O
liking    O
to    O
Poole    O
,    O
and    O
converts    O
him    O
into    O
an    O
intangible    O
immortal    O
being    O
of    O
"    O
quantum    O
functions    O
"    O
.    O

A    O
tachyonic    O
field    O
,    O
or    O
simply    O
tachyon    B-Body109224911
,    O
is    O
a    O
quantum    O
field    O
with    O
an    O
imaginary    O
mass    O
.    O

Although    O
tachyon    B-Body109224911
(    O
particles    O
that    O
move    O
faster    O
than    O
light    O
)    O
are    O
a    O
purely    O
hypothetical    O
concept    O
not    O
generally    O
believed    O
to    O
exist    O
,    O
fields    O
with    O
imaginary    O
mass    O
have    O
come    O
to    O
play    O
an    O
important    O
role    B-Body109224911
in    O
modern    O
physics    O
and    O
are    O
discussed    O
in    O
popular    O
books    O
on    O
physics    O
.    O

The    O
term    O
"    O
tachyon    B-Body109224911
"    O
was    O
coined    O
by    O
Gerald    O
Feinberg    O
in    O
a    O
1967    O
paper    O
,    O
but    O
it    O
was    O
soon    O
realized    O
that    O
Feinberg    O
's    O
model    O
in    O
fact    O
did    O
not    O
allow    O
for    O
superluminal    O
speeds    O
.    O

Now    O
equipped    O
with    O
a    O
"    O
time    O
disc    O
"    O
,    O
Degaton    O
has    O
the    O
ability    O
to    O
live    O
"    O
between    O
seconds    O
"    O
,    O
apparently    O
ageless    O
in    O
an    O
intangible    O
state    O
,    O
which    O
he    O
can    O
only    O
be    O
removed    O
from    O
with    O
the    O
concentrated    O
tachyon    B-Body109224911
found    O
in    O
the    O
hourglass    O
of    O
Hourman    O
.    O

A    O
physical    O
object    O
or    O
particle    O
moving    O
faster    O
than    O
the    O
speed    O
of    O
light    O
would    O
have    O
space    O
-    O
like    O
four    O
-    O
momenta    O
(    O
such    O
as    O
the    O
hypothesized    O
tachyon    B-Body109224911
)    O
,    O
and    O
these    O
do    O
not    O
appear    O
to    O
exist    O
.    O

At    O
the    O
same    O
moment    O
the    O
Doctor    O
and    O
Janeway    O
detect    O
a    O
burst    O
of    O
tachyon    B-Body109224911
particles    O
in    O
Tuvok    O
's    O
vicinity    O
,    O
indicating    O
temporal    O
disturbances    O
.    O

The    O
novel    O
details    O
the    O
creation    O
of    O
a    O
tachyon    B-Body109224911
copy    O
of    O
Spock    O
to    O
investigate    O
the    O
destruction    O
of    O
the    O
Organians    O
;    O
without    O
the    O
intervention    O
of    O
the    O
Organians    O
,    O
war    O
erupts    O
between    O
the    O
Klingons    O
and    O
the    O
Federation    O
.    O

He    O
develops    O
a    O
method    O
to    O
make    O
a    O
temporary    O
tachyon    B-Body109224911
copy    O
of    O
a    O
crewman    O
that    O
could    O
be    O
transported    O
a    O
much    O
greater    O
distance    O
than    O
the    O
standard    O
range    O
of    O
a    O
transporter    O
beam    O
,    O
enabling    O
the    O
"    O
Enterprise    O
"    O
to    O
place    O
an    O
agent    O
on    O
Organia    O
long    O
before    O
the    O
ship    O
could    O
reach    O
the    O
planet    O
.    O

On    O
the    O
contrary    O
,    O
it    O
is    O
always    O
greater    O
than    O
for    O
a    O
tachyon    B-Body109224911
whose    O
energy    O
–    O
momentum    O
equation    O
is    O

Tachyon    B-Body109224911

Silver    O
Samurai    O
(    O
Kenuichio    O
Harada    O
)    O
,    O
the    O
illegitimate    O
son    O
of    O
Shingen    O
Yashida    O
,    O
is    O
a    O
Japanese    O
mutant    O
with    O
the    O
power    O
to    O
charge    O
almost    O
anything    O
,    O
most    O
notably    O
his    O
katana    O
,    O
with    O
mutant    O
energy    O
(    O
described    O
as    O
a    O
tachyon    B-Body109224911
field    I-Body109224911
)    O
.    O

The    O
company    O
says    O
that    O
they    O
chose    O
the    O
name    O
,    O
"    O
Team    O
Tachyon    O
"    O
,    O
because    O
a    O
tachyon    B-Body109224911
is    O
a    O
particle    O
that    O
exceeds    O
the    O
speed    O
of    O
light    O
.    O

Y(4140)    B-Body109224911

Caswell    O
and    O
Peter    O
Lepage    O
did    O
significant    O
work    O
in    O
1978    O
to    O
develop    O
new    O
and    O
powerful    O
tools    O
for    O
dealing    O
with    O
bound    O
states    O
such    O
as    O
positronium    O
and    O
charmonium    B-Body109224911
.    O

The    O
combination    O
of    O
a    O
top    O
quark    O
and    O
top    O
antiquark    O
is    O
not    O
a    O
T    O
meson    O
,    O
but    O
rather    O
toponium    B-Body109224911
.    O

The    O
theta    B-Body109224911
meson    I-Body109224911
is    O
a    O
hypothetical    O
form    O
of    O
quarkonium    B-Body109224911
(    O
i.e.    O
a    O
flavourless    O
meson    O
)    O
formed    O
by    O
a    O
top    O
quark    O
and    O
top    O
antiquark    O
.    O

In    O
the    O
1970s    O
he    O
worked    O
on    O
quantum    O
chromodynamics    O
and    O
quarkonium    B-Body109224911
-    O
spectroscopy    O
with    O
Estia    O
Eichten    O
,    O
Kenneth    O
Lane    O
,    O
Kurt    O
Gottfried    O
.    O

antiquark    O
systems    O
(    O
charmonium    B-Body109224911
)    O
,    O
with    O
Estia    O
J.    O
Eichten    O
,    O
Toichiro    O
Kinoshita    O
,    O
Ken    O
Lane    O
and    O
Kurt    O
Gottfried    O
.    O

It    O
was    O
here    O
that    O
he    O
first    O
saw    O
Lampbrush    B-Body109224911
chromosome    I-Body109224911
,    O
which    O
became    O
his    O
lifetime    O
obsession    O
.    O

It    O
occurs    O
when    O
one    O
or    O
both    O
of    O
the    O
telomeres    O
that    O
mark    O
the    O
ends    O
of    O
chromosome    B-Body109224911
14    I-Body109224911
are    O
lost    O
allowing    O
the    O
now    O
uncapped    O
ends    O
to    O
fuse    O
together    O
forming    O
a    O
ring    B-Body109224911
chromosome    I-Body109224911
.    O

Occasionally    O
,    O
individuals    O
with    O
SCS    O
have    O
a    O
chromosome    O
translocation    O
,    O
inversion    O
,    O
or    O
ring    B-Body109224911
chromosome    I-Body109224911
7    O
involving    O
7p21    O
resulting    O
in    O
atypical    O
findings    O
,    O
such    O
as    O
,    O
increased    O
developmental    O
delay    O
.    O

Ring    O
chromosome    O
20    O
,    O
ring    O
-    O
shaped    O
chromosome    O
20    O
or    O
r(20    O
)    O
syndrome    O
is    O
a    O
rare    O
human    O
chromosome    O
abnormality    O
where    O
the    O
two    O
arms    O
of    O
chromosome    B-Body109224911
20    I-Body109224911
fuse    O
to    O
form    O
a    O
ring    B-Body109224911
chromosome    I-Body109224911
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
N    O
-    O
formyl    O
-    O
L    O
-    O
methionylaminoacyl    O
-    O
tRNA    O
and    O
H2O    O
,    O
whereas    O
its    O
two    O
products    O
are    O
formate    B-Body109224911
and    O
L    O
-    O
methionylaminoacyl    O
-    O
tRNA    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
N    O
,    O
N    O
-    O
dimethylformamide    O
and    O
H2O    O
,    O
whereas    O
its    O
two    O
products    O
are    O
dimethylamine    O
and    O
formate    B-Body109224911
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
"    O
N    O
"-    O
benzylformamide    O
and    O
H2O    O
,    O
whereas    O
its    O
two    O
products    O
are    O
formate    B-Body109224911
and    O
benzylamine    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
formyl    O
-    O
L    O
-    O
methionyl    O
peptide    O
and    O
H2O    O
,    O
whereas    O
its    O
two    O
products    O
are    O
formate    B-Body109224911
and    O
methionyl    O
peptide    O
.    O

:    O
2-Amino-5-formylamino-6-(5-phospho    O
-    O
D    O
-    O
ribosylamino)pyrimidin-4(3H)-one    O
+    O
H2O    O
2,5-diamino-6-(5-phospho    O
-    O
D    O
-    O
ribosylamino)pyrimidin-4(3H)-one    O
+    O
formate    B-Body109224911

:    O
N    O
-    O
formylmaleamic    O
acid    O
+    O
H2O    O
maleamate    O
+    O
formate    B-Body109224911

One    O
millimole    O
of    O
phenytoin    O
is    O
produced    O
for    O
every    O
millimole    O
of    O
fosphenytoin    O
administered    O
;    O
the    O
hydrolysis    O
of    O
fosphenytoin    O
also    O
yields    O
phosphate    O
and    O
formaldehyde    O
,    O
the    O
latter    O
of    O
which    O
is    O
subsequently    O
metabolized    O
to    O
formate    B-Body109224911
,    O
which    O
is    O
in    O
turn    O
metabolized    O
by    O
a    O
folate    O
dependent    O
mechanism    O
.    O

Using    O
radical    O
non    O
-    O
redox    O
chemistry    O
,    O
it    O
catalyzes    O
the    O
reversible    O
conversion    O
of    O
pyruvate    O
and    O
coenzyme    O
-    O
A    O
into    O
formate    B-Body109224911
and    O
acetyl    O
-    O
CoA.    O
The    O
reaction    O
occurs    O
as    O
follows    O
:    O

Microorganisms    O
use    O
organic    O
compounds    O
as    O
lactate    O
,    O
acetate    O
or    O
formate    B-Body109224911
as    O
electron    O
donors    O
to    O
reduce    O
and    O
leave    O
radionuclides    O
in    O
insoluble    O
form    O
..    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
ATP    O
and    O
formate    B-Body109224911
,    O
whereas    O
its    O
two    O
products    O
are    O
ADP    O
and    O
formyl    O
phosphate    O
.    O

Thermotoga    O
neapolitana    O
is    O
unable    O
to    O
metabolize    O
acetate    O
,    O
lactate    O
,    O
formate    B-Body109224911
,    O
pyruvate    O
,    O
propionate    B-Body109224911
,    O
mannitol    O
,    O
ethanol    O
,    O
methanol    O
,    O
glycerol    O
,    O
glutamate    O
,    O
or    O
glycine    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S    O
-    O
formylglutathione    O
and    O
H2O    O
,    O
whereas    O
its    O
two    O
products    O
are    O
glutathione    O
and    O
formate    B-Body109224911
.    O

In    O
the    O
taxonomy    O
of    O
microorganisms    O
,    O
the    O
Methanomicrobiales    O
are    O
an    O
order    O
of    O
the    O
Methanomicrobia    O
.    O
"    O
Methanomicrobiales    O
"    O
are    O
strictly    O
carbon    O
dioxide    O
reducing    O
methanogens    O
,    O
using    O
hydrogen    O
or    O
formate    B-Body109224911
as    O
the    O
reducing    O
agent    O
.    O

fluoronium    B-Body109224911
,    O
(    O
protonated    O
hydrogen    O
fluoride    O
)    O

The    O
decomposition    O
of    O
aryldiazonium    O
tetrafluoroborates    O
in    O
the    O
Sandmeyer    O
or    O
Schiemann    O
reactions    O
exploit    O
fluoroborate    B-Body109224911
as    O
F−    O
sources    O
.    O

KBF4    B-Body109224911
,    O

It    O
is    O
protonated    O
by    O
HBF4    O
to    O
form    O
a    O
tetrafluoroborate    B-Body109224911
salt    O
:    O

The    O
first    O
multidecker    O
sandwich    O
complex    O
was    O
the    O
dicationic    O
triscyclopentadienyl    O
dinickel    O
complex    O
[    O
BF4    B-Body109224911
.    O

Tetrafluoroborate    B-Body109224911
salts    O
are    O
commonly    O
employed    O
as    O
non-coordinating    B-Body109224911
anion    I-Body109224911
.    O

It    O
is    O
a    O
salt    O
of    O
nitronium    O
cation    O
and    O
tetrafluoroborate    B-Body109224911
anion    O
.    O

In    O
humans    O
,    O
the    O
VAT1L    O
gene    O
is    O
located    O
on    O
chromosome    B-Body109224911
16    I-Body109224911
locus    O
q23.1    O
.    O

The    O
gene    O
for    O
CCL22    O
is    O
located    O
in    O
human    O
chromosome    B-Body109224911
16    I-Body109224911
in    O
a    O
cluster    O
with    O
other    O
chemokines    O
called    O
CX3CL1    O
and    O
CCL17    O
.    O

The    O
gene    O
for    O
CCL17    O
is    O
located    O
on    O
chromosome    B-Body109224911
16    I-Body109224911
,    O
in    O
humans    O
,    O
along    O
with    O
other    O
chemokines    O
called    O
CCL22    O
and    O
CX3CL1    O
.    O

Its    O
gene    O
is    O
located    O
on    O
human    O
chromosome    B-Body109224911
16    I-Body109224911
along    O
with    O
some    O
CC    O
chemokines    O
known    O
as    O
CCL17    O
and    O
CCL22    O
.    O

Magenis    O
's    O
first    O
major    O
research    O
project    O
involved    O
a    O
heritable    O
fragile    O
site    O
on    O
the    O
long    O
(    O
q    O
)    O
arm    O
of    O
chromosome    B-Body109224911
16    I-Body109224911
.    O

There    O
are    O
nine    O
other    O
major    O
chromosomal    O
differences    O
between    O
chimpanzees    O
and    O
humans    O
:    O
chromosome    O
segment    O
inversions    O
on    O
human    O
chromosomes    O
1    B-Body109224911
,    O
4    B-Body109224911
,    O
5    B-Body109224911
,    O
9    B-Body109224911
,    O
12    B-Body109224911
,    O
15    B-Body109224911
,    O
16    B-Body109224911
,    O
17    B-Body109224911
,    O
and    O
18    B-Body109224911
.    O

"    O
IRX1    O
"    O
,    O
"    O
IRX2    O
"    O
,    O
and    O
"    O
IRX4    O
"    O
are    O
found    O
on    O
human    O
chromosome    O
5    O
,    O
and    O
their    O
orientation    O
corresponds    O
to    O
that    O
of    O
"    O
IRX3    O
"    O
,    O
"    O
IRX5    O
"    O
,    O
and    O
"    O
IRX6    O
"    O
found    O
on    O
human    O
chromosome    B-Body109224911
16    I-Body109224911
.    O

Chromosome    B-Body109224911
16    I-Body109224911
is    O
one    O
of    O
the    O
23    O
pairs    O
of    O
chromosomes    O
in    O
humans    O
.    O

xenonium    B-Body109224911
,    O
(    O
protonated    O
xenon    O
)    O

Human    B-Body109224911
chromosome    I-Body109224911
2    I-Body109224911
is    O
a    O
fusion    O
of    O
two    O
chromosomes    O
2a    O
and    O
2b    O
that    O
remained    O
separate    O
in    O
the    O
other    O
primates    O
.    O

The    O
disorder    O
is    O
expressed    O
in    O
an    O
autosomal    O
dominant    O
fashion    O
and    O
may    O
result    O
from    O
a    O
de    O
novo    O
loss    O
of    O
function    O
mutation    O
or    O
total    O
deletion    O
of    O
the    O
ZEB2    O
gene    O
located    O
on    O
chromosome    B-Body109224911
2    I-Body109224911
.    O

Glycophorin    O
C    O
(    O
GPC    O
)    O
is    O
a    O
single    O
polypeptide    O
chain    O
of    O
128    O
amino    O
acids    O
and    O
is    O
encoded    O
by    O
a    O
gene    O
on    O
the    O
long    O
arm    O
of    O
chromosome    B-Body109224911
2    I-Body109224911
(    O
2q14-q21    O
)    O
.    O

For    O
example    O
,    O
in    O
the    O
Homininae    O
,    O
two    O
chromosomes    O
fused    O
to    O
produce    O
human    O
chromosome    B-Body109224911
2    I-Body109224911
;    O
this    O
fusion    O
did    O
not    O
occur    O
in    O
the    O
lineage    O
of    O
the    O
other    O
apes    O
,    O
and    O
they    O
retain    O
these    O
separate    O
chromosomes    O
.    O

Reprimo    O
(    O
RPRM    O
)    O
,    O
is    O
a    O
gene    O
located    O
at    O
human    O
chromosome    B-Body109224911
2q23    I-Body109224911
whose    O
expression    O
in    O
conjunction    O
with    O
p53    O
,    O
along    O
with    O
other    O
genes    O
which    O
are    O
p53-induced    O
,    O
is    O
associated    O
with    O
the    O
arrest    O
of    O
the    O
cell    O
cycle    O
at    O
the    O
G2    O
phase.''Reprimo    O
's    O
"    O
protein    O
product    O
is    O
a    O
highly    O
glycosylated    O
polypeptide    O
which    O
,    O
upon    O
its    O
expression    O
,    O
is    O
localized    O
to    O
the    O
cytoplasm    O
where    O
it    O
is    O
primarily    O
active    O
.    O

In    O
the    O
human    O
evolutionary    O
lineage    O
,    O
two    O
ancestral    O
ape    O
chromosomes    O
fused    O
at    O
their    O
telomeres    O
,    O
producing    O
human    B-Body109224911
chromosome    I-Body109224911
2    I-Body109224911
.    O

Human    B-Body109224911
chromosome    I-Body109224911
2    I-Body109224911

miR-375    O
is    O
found    O
on    O
human    O
chromosome    B-Body109224911
2    I-Body109224911
in    O
between    O
the    O
CRYBA2    O
and    O
CCDC108    O
genes    O
.    O

Feingold    O
syndrome    O
is    O
caused    O
by    O
mutations    O
in    O
the    O
neuroblastoma    O
-    O
derived    O
V    O
-    O
myc    O
avian    O
myelocytomatosis    O
viral    O
-    O
related    O
oncogene    O
(    O
MYCN    O
)    O
which    O
is    O
located    O
on    O
the    O
short    O
arm    O
of    O
chromosome    B-Body109224911
2    I-Body109224911
(    O
2p24.1    O
)    O
.    O

The    O
chromosomal    O
region    O
that    O
encodes    O
an    O
antibody    O
is    O
large    O
and    O
contains    O
several    O
distinct    O
gene    O
loci    O
for    O
each    O
domain    O
of    O
the    O
antibody    O
—    O
the    O
chromosome    O
region    O
containing    O
heavy    O
chain    O
genes    O
(    O
IGH@    O
)    O
is    O
found    O
on    O
chromosome    B-Body109224911
14    I-Body109224911
,    O
and    O
the    O
loci    O
containing    O
lambda    O
and    O
kappa    O
light    O
chain    O
genes    O
(    O
IGL@    O
and    O
IGK@    O
)    O
are    O
found    O
on    O
chromosomes    O
22    B-Body109224911
and    O
2    B-Body109224911
in    O
humans    O
.    O

The    O
bismuthide    B-Body109224911
ion    B-Body109224911
is    O
Bi3−.    O

Marfan    O
syndrome    O
is    O
caused    O
by    O
mutations    O
in    O
the    O
"    O
FBN1    O
"    O
gene    O
,    O
located    O
on    O
chromosome    B-Body109224911
15    I-Body109224911
,    O
which    O
encodes    O
fibrillin-1    O
,    O
a    O
glycoprotein    O
component    O
of    O
the    O
extracellular    O
matrix    O
.    O

This    O
mutation    O
,    O
on    O
chromosome    B-Body109224911
15    I-Body109224911
,    O
results    O
in    O
an    O
amino    O
acid    O
change    O
from    O
arginine    O
to    O
tryptophan    O
.    O

There    O
are    O
nine    O
other    O
major    O
chromosomal    O
differences    O
between    O
chimpanzees    O
and    O
humans    O
:    O
chromosome    O
segment    O
inversions    O
on    O
human    O
chromosomes    O
1    B-Body109224911
,    O
4    B-Body109224911
,    O
5    B-Body109224911
,    O
9    B-Body109224911
,    O
12    B-Body109224911
,    O
15    B-Body109224911
,    O
16    B-Body109224911
,    O
17    B-Body109224911
,    O
and    O
18    B-Body109224911
.    O

In    O
humans    O
,    O
miR-184    O
is    O
located    O
within    O
region    O
25.1    O
on    O
the    O
q    O
-    O
arm    O
of    O
chromosome    B-Body109224911
15    I-Body109224911
,    O
and    O
its    O
corresponding    O
transcript    O
is    O
comparatively    O
small    O
(    O
84bp    O
)    O
which    O
is    O
not    O
encoded    O
near    O
other    O
clustered    O
miRNAs    O
.    O

FAM214A    O
is    O
a    O
gene    O
with    O
unknown    O
function    O
found    O
at    O
the    O
q21.2-q21.3    O
locus    O
on    O
Chromosome    B-Body109224911
15    I-Body109224911
(human)    I-Body109224911
.    O

Chromosome    B-Body109224911
15    I-Body109224911
is    O
one    O
of    O
the    O
23    O
pairs    O
of    O
chromosomes    O
in    O
humans    O
.    O

In    O
humans    O
,    O
Robertsonian    O
translocations    O
generally    O
occurs    O
in    O
the    O
five    O
acrocentric    O
chromosome    O
pairs    O
,    O
namely    O
13    B-Body109224911
,    O
14    B-Body109224911
,    O
15    B-Body109224911
,    O
21    B-Body109224911
and    O
22    B-Body109224911
.    O

Such    O
batteries    O
feature    O
cathodes    O
composed    O
of    O
ferrate    B-Body109224911
salts    O
,    O
either    O
potassium    O
ferrate    O
or    O
barium    O
ferrate    O
.    O

One    O
of    O
the    O
earliest    O
synthetic    O
compounds    O
to    O
incorporate    O
an    O
oxo    O
ligand    O
is    O
sodium    O
ferrate    B-Body109224911
(    O
Na2FeO4    O
)    O
circa    O
1702    O
.    O

Luttinger's    B-Body109224911
theorem    I-Body109224911

A    O
bivalent    B-Body109224911
,    O
sometimes    O
referred    O
to    O
as    O
a    O
tetrad    B-Body109224911
,    O
is    O
the    O
association    O
of    O
a    O
pair    O
of    O
homologous    B-Body109224911
chromosome    I-Body109224911
physically    O
held    O
together    O
by    O
at    O
least    O
one    O
DNA    O
crossover    O
.    O

In    O
these    O
mice    O
,    O
the    O
prophase    O
I    O
stage    O
of    O
meiosis    O
is    O
defective    O
due    O
to    O
the    O
disruption    O
of    O
chromosome    B-Body109224911
pairing    I-Body109224911
.    O

In    O
metaphase    O
I    O
of    O
meiosis    O
I    O
,    O
the    O
pairs    O
of    O
homologous    O
chromosomes    O
,    O
also    O
known    O
as    O
bivalents    B-Body109224911
or    O
tetrads    O
,    O
line    O
up    O
in    O
a    O
random    O
order    O
along    O
the    O
metaphase    O
plate    O
.    O

The    O
MUGA    O
scan    O
is    O
performed    O
by    O
labeling    O
the    O
patient    O
's    O
red    O
blood    O
pool    O
with    O
a    O
radioactive    O
tracer    O
,    O
technetium-99m    O
-    O
pertechnetate    B-Body109224911
(    O
Tc-99    O
m    O
)    O
,    O
and    O
measuring    O
radioactivity    O
over    O
the    O
anterior    O
chest    O
as    O
the    O
radioactive    O
blood    O
flows    O
through    O
the    O
large    O
vessels    O
and    O
the    O
heart    O
chambers    O
.    O

A    O
subsequent    O
intravenous    O
injection    O
of    O
the    O
radioactive    O
substance    O
,    O
technetium-99m    O
-    O
pertechnetate    B-Body109224911
,    O
labels    O
the    O
red    O
blood    O
cells    O
"    O
in    O
vivo    O
"    O
.    O

When    O
the    O
99Mo    O
decays    O
,    O
it    O
forms    O
pertechnetate    B-Body109224911
TcO4−    O
,    O
which    O
,    O
because    O
of    O
its    O
single    O
charge    O
,    O
is    O
less    O
tightly    O
bound    O
to    O
the    O
alumina    O
.    O

Pertechnetate    B-Body109224911
is    O
actively    O
accumulated    O
and    O
secreted    O
by    O
the    O
mucoid    O
cells    O
of    O
the    O
gastric    O
mucosa    O
,    O
and    O
therefore    O
,    O
technetate(VII    O
)    O
radiolabeled    O
with    O
Tc99    O
m    O
is    O
injected    O
into    O
the    O
body    O
when    O
looking    O
for    O
ectopic    O
gastric    O
tissue    O
as    O
is    O
found    O
in    O
a    O
Meckel    O
's    O
diverticulum    O
with    O
Meckel    O
's    O
Scans    O
.    O

Molecularity    O
in    O
chemistry    O
is    O
the    O
number    O
of    O
colliding    O
molecular    B-Body109224911
entities    I-Body109224911
that    O
are    O
involved    O
in    O
a    O
single    O
reaction    O
step    O
.    O

This    O
molecular    B-Body109224911
entity    I-Body109224911
is    O
very    O
unstable    O
and    O
appears    O
in    O
chemical    O
reactions    O
as    O
a    O
reactive    O
intermediate    O
.    O

Current    B-Body109224911
quarks    I-Body109224911
(    O
also    O
called    O
naked    B-Body109224911
quarks    I-Body109224911
or    O
bare    B-Body109224911
quarks    I-Body109224911
)    O
are    O
defined    O
as    O
the    O
constituent    B-Body109224911
quark    I-Body109224911
cores    O
(    O
constituent    O
quarks    O
with    O
no    O
covering    O
)    O
of    O
a    O
valence    B-Body109224911
quark    I-Body109224911
.    O

These    O
nuclei    B-Body109224911
are    O
called    O
p    O
-    O
nuclei    O
.    O

In    O
a    O
p    O
-    O
process    O
protons    O
are    O
added    O
to    O
stable    O
or    O
weakly    O
radioactive    O
atomic    B-Body109224911
nuclei    I-Body109224911
.    O

He    O
subsequently    O
worked    O
on    O
the    O
theory    O
of    O
gravitational    O
collapse    O
,    O
the    O
theory    O
of    O
turbulence    O
,    O
high    O
-    O
energy    O
hadron    O
-    O
nucleus    B-Body109224911
collisions    O
,    O
nonequilibrium    O
critical    O
phenomena    O
,    O
liquids    O
,    O
glasses    O
,    O
polymers    O
,    O
and    O
other    O
subjects    O
.    O

Joaquin    O
Catalá    O
formed    O
a    O
group    O
in    O
Valencia    O
to    O
study    O
atomic    B-Body109224911
nuclei    I-Body109224911
and    O
elementary    O
particles    O
using    O
nuclear    O
emulsions    O
.    O

This    O
feature    O
was    O
"    O
revolutionary    O
"    O
because    O
it    O
was    O
inconsistent    O
with    O
the    O
expectation    O
that    O
an    O
electron    O
could    O
be    O
bound    O
to    O
an    O
atom's    B-Body109224911
nucleus    I-Body109224911
by    O
any    O
amount    O
of    O
energy    O
.    O

Materials    O
heated    O
beyond    O
a    O
few    O
tens    O
of    O
thousands    O
of    O
kelvins    O
dissociate    O
into    O
their    O
electrons    O
and    O
nuclei    B-Body109224911
,    O
producing    O
a    O
gas    O
-    O
like    O
state    O
of    O
matter    O
known    O
as    O
plasma    O
.    O

Then    O
shortly    O
before    O
1900    O
,    O
as    O
scientists    O
still    O
debated    O
over    O
the    O
very    O
existence    O
of    O
atoms    O
,    O
J.    O
J.    O
Thomson    O
and    O
Ernest    O
Rutherford    O
sparked    O
a    O
revolution    O
with    O
experiments    O
confirming    O
the    O
existence    O
and    O
properties    O
of    O
electrons    O
,    O
protons    O
,    O
and    O
nuclei    B-Body109224911
.    O

The    O
Bohr    O
model    O
proposed    O
electrons    O
in    O
circular    O
orbit    O
around    O
the    O
nucleus    B-Body109224911
with    O
quantized    O
values    O
of    O
angular    O
momentum    O
.    O

He    O
pioneered    O
work    O
on    O
the    O
fundamental    O
structure    O
of    O
the    O
atomic    B-Body109224911
nucleus    I-Body109224911
based    O
on    O
platonic    O
solids    O
.    O

During    O
the    O
early    O
1930s    O
Walton    O
and    O
John    O
Cockcroft    O
collaborated    O
to    O
build    O
an    O
apparatus    O
that    O
split    O
the    O
nuclei    B-Body109224911
of    O
lithium    O
atoms    O
by    O
bombarding    O
them    O
with    O
a    O
stream    O
of    O
protons    O
accelerated    O
inside    O
a    O
high    O
-    O
voltage    O
tube    O
(    O
700    O
kilovolts    O
)    O
.    O

Walton    O
and    O
John    O
Cockcroft    O
were    O
recipients    O
of    O
the    O
1951    O
Nobel    O
Prize    O
in    O
Physics    O
for    O
their    O
"    O
work    O
on    O
the    O
transmutation    O
of    O
the    O
atomic    B-Body109224911
nuclei    I-Body109224911
by    O
artificially    O
accelerated    O
atomic    O
particles    O
"    O
(    O
popularly    O
known    O
as    O
"    O
splitting    O
the    O
atom    O
"    O
)    O
.    O

More    O
generally    O
,    O
they    O
had    O
built    O
an    O
apparatus    O
which    O
showed    O
that    O
nuclei    B-Body109224911
of    O
various    O
lightweight    O
elements    O
(    O
such    O
as    O
lithium    O
)    O
could    O
be    O
split    O
by    O
fast    O
-    O
moving    O
protons    O
.    O

The    O
distribution    O
of    O
energy    O
among    O
the    O
various    O
translational    O
,    O
vibrational    O
,    O
rotational    O
,    O
electronic    O
,    O
and    O
nuclear    B-Body109224911
modes    O
of    O
a    O
system    O
determines    O
the    O
macroscopic    O
temperature    O
.    O

One    O
example    O
is    O
the    O
case    O
of    O
nuclear    B-Body109224911
spins    O
in    O
a    O
strong    O
external    O
magnetic    O
field    O
.    O

The    O
mass    O
number    O
(    O
symbol    O
"    O
A    O
"    O
)    O
,    O
also    O
called    O
atomic    O
mass    O
number    O
or    O
nucleon    O
number    O
,    O
is    O
the    O
total    O
number    O
of    O
protons    O
and    O
neutrons    O
(    O
together    O
known    O
as    O
nucleons    O
)    O
in    O
an    O
atomic    B-Body109224911
nucleus    I-Body109224911
.    O

Scattering    O
also    O
includes    O
the    O
interaction    O
of    O
billiard    O
balls    O
on    O
a    O
table    O
,    O
the    O
Rutherford    O
scattering    O
(    O
or    O
angle    O
change    O
)    O
of    O
alpha    O
particles    O
by    O
gold    O
nuclei    B-Body109224911
,    O
the    O
Bragg    O
scattering    O
(    O
or    O
diffraction    O
)    O
of    O
electrons    O
and    O
X    O
-    O
rays    O
by    O
a    O
cluster    O
of    O
atoms    O
,    O
and    O
the    O
inelastic    O
scattering    O
of    O
a    O
fission    O
fragment    O
as    O
it    O
traverses    O
a    O
thin    O
foil    O
.    O

The    O
number    O
of    O
principal    O
energy    O
levels    O
for    O
electrons    O
around    O
the    O
nucleus    B-Body109224911

1911    O
–    O
Ernest    O
Rutherford    O
formulates    O
a    O
theory    O
about    O
the    O
structure    O
of    O
the    O
atomic    B-Body109224911
nucleus    I-Body109224911
based    O
on    O
his    O
experiments    O
with    O
alpha    O
particles    O
.    O

The    O
electrons    O
in    O
the    O
inner    O
shells    O
are    O
strongly    O
bound    O
and    O
do    O
not    O
play    O
a    O
significant    O
role    O
in    O
the    O
chemical    O
binding    O
of    O
atoms    O
;    O
they    O
also    O
partially    O
screen    O
the    O
nucleus    O
,    O
thus    O
forming    O
with    O
the    O
nucleus    B-Body109224911
an    O
almost    O
inert    O
core    O
.    O

She    O
also    O
demonstrated    O
that    O
the    O
excited    O
states    O
of    O
the    O
10B    O
nucleus    B-Body109224911
were    O
not    O
evenly    O
spaced    O
as    O
previously    O
thought    O
.    O

The    O
rapidly    O
shrinking    O
core    O
heats    O
up    O
,    O
producing    O
high    O
-    O
energy    O
gamma    O
rays    O
that    O
decompose    O
iron    O
nuclei    B-Body109224911
into    O
helium    O
nuclei    O
and    O
free    O
neutrons    O
via    O
photodisintegration    O
.    O

The    O
atomic    B-Body109224911
nucleus    I-Body109224911
is    O
the    O
small    O
,    O
dense    O
region    O
consisting    O
of    O
protons    O
and    O
neutrons    O
at    O
the    O
center    O
of    O
an    O
atom    O
,    O
discovered    O
in    O
1911    O
by    O
Ernest    O
Rutherford    O
based    O
on    O
the    O
1909    O
Geiger–    O

In    O
chemistry    O
and    O
atomic    O
physics    O
,    O
an    O
electron    O
shell    O
,    O
or    O
a    O
principal    O
energy    O
level    O
,    O
may    O
be    O
thought    O
of    O
as    O
an    O
orbit    O
followed    O
by    O
electrons    O
around    O
an    O
atom    O
's    O
nucleus    B-Body109224911
.    O

His    O
work    O
first    O
came    O
to    O
prominence    O
in    O
physics    O
when    O
in    O
1929    O
with    O
Dmitry    O
Ivanenko    O
he    O
published    O
a    O
paper    O
demonstrating    O
that    O
atomic    B-Body109224911
nuclei    I-Body109224911
could    O
not    O
be    O
made    O
from    O
protons    O
and    O
electrons    O
.    O

In    O
particular    O
,    O
all    O
properties    O
of    O
a    O
body    O
that    O
are    O
associated    O
with    O
energy    O
,    O
such    O
as    O
its    O
temperature    O
or    O
the    O
binding    O
energy    O
of    O
systems    O
such    O
as    O
nuclei    B-Body109224911
or    O
molecules    O
,    O
contribute    O
to    O
that    O
body    O
's    O
mass    O
,    O
and    O
hence    O
act    O
as    O
sources    O
of    O
gravity    O
.    O

The    O
neutron    O
porosity    O
log    O
works    O
by    O
bombarding    O
a    O
formation    O
with    O
high    O
energy    O
epithermal    O
neutrons    O
that    O
lose    O
energy    O
through    O
elastic    O
scattering    O
to    O
near    O
thermal    O
levels    O
before    O
being    O
absorbed    O
by    O
the    O
nuclei    B-Body109224911
of    O
the    O
formation    O
atoms    O
.    O

Center    O
-    O
to    O
-    O
center    O
distances    O
of    O
the    O
atoms    O
are    O
proportional    O
to    O
the    O
distances    O
between    O
the    O
atomic    B-Body109224911
nuclei    I-Body109224911
,    O
all    O
in    O
the    O
same    O
scale    O
.    O

For    O
example    O
,    O
the    O
binding    O
energy    O
of    O
atomic    B-Body109224911
nuclei    I-Body109224911
is    O
often    O
lost    O
in    O
the    O
form    O
of    O
gamma    O
rays    O
when    O
the    O
nuclei    O
are    O
formed    O
,    O
leaving    O
nuclides    O
which    O
have    O
less    O
mass    O
than    O
the    O
free    O
particles    O
(    O
nucleons    O
)    O
of    O
which    O
they    O
are    O
composed    O
.    O

Certain    O
atomic    B-Body109224911
nuclei    I-Body109224911
are    O
able    O
to    O
absorb    O
and    O
emit    O
radio    O
frequency    O
energy    O
when    O
placed    O
in    O
an    O
external    O
magnetic    O
field    O
.    O

The    O
term    O
"    O
unstable    O
molecule    O
"    O
is    O
used    O
for    O
very    O
reactive    O
species    O
,    O
i.e.    O
,    O
short    O
-    O
lived    O
assemblies    O
(    O
resonances    O
)    O
of    O
electrons    O
and    O
nuclei    B-Body109224911
,    O
such    O
as    O
radicals    O
,    O
molecular    O
ion    B-Body109224911
,    O
Rydberg    O
molecules    O
,    O
transition    O
states    O
,    O
van    O
der    O
Waals    O
complexes    O
,    O
or    O
systems    O
of    O
colliding    O
atoms    O
as    O
in    O
Bose    O
–    O
Einstein    O
condensate    O
.    O

For    O
instance    O
,    O
the    O
motion    O
of    O
a    O
spacecraft    O
,    O
regarding    O
its    O
orbit    O
and    O
attitude    O
(    O
rotation    O
)    O
,    O
is    O
described    O
by    O
the    O
relativistic    O
theory    O
of    O
classical    O
mechanics    O
,    O
while    O
the    O
analogous    O
movements    O
of    O
an    O
atomic    B-Body109224911
nucleus    I-Body109224911
are    O
described    O
by    O
quantum    O
mechanics    O
.    O

One    O
usually    O
solves    O
this    O
problem    O
by    O
expanding    O
the    O
molecular    O
orbitals    O
as    O
linear    O
combinations    O
of    O
Gaussian    O
functions    O
centered    O
on    O
the    O
atomic    B-Body109224911
nuclei    I-Body109224911
(    O
see    O
linear    O
combination    O
of    O
atomic    O
orbitals    O
and    O
basis    O
set    O
(    O
chemistry    O
)    O
)    O
.    O

When    O
an    O
electric    O
field    O
is    O
applied    O
to    O
a    O
dielectric    O
material    O
its    O
molecules    O
respond    O
by    O
forming    O
microscopic    O
electric    O
dipoles    O
–    O
their    O
atomic    B-Body109224911
nuclei    I-Body109224911
move    O
a    O
tiny    O
distance    O
in    O
the    O
direction    O
of    O
the    O
field    O
,    O
while    O
their    O
electrons    O
move    O
a    O
tiny    O
distance    O
in    O
the    O
opposite    O
direction    O
.    O

To    O
a    O
good    O
approximation    O
,    O
a    O
hydrogen    O
atom    O
can    O
be    O
thought    O
of    O
as    O
consisting    O
of    O
an    O
electron    O
orbiting    O
its    O
nucleus    B-Body109224911
.    O

The    O
experiment    O
studies    O
the    O
hadronic    O
final    O
states    O
produced    O
in    O
interactions    O
of    O
various    O
beam    O
particles    O
(    O
pions    O
,    O
protons    O
and    O
beryllium    O
,    O
argon    O
,    O
and    O
xenon    O
nuclei    B-Body109224911
)    O
with    O
a    O
variety    O
of    O
fixed    O
nuclear    O
targets    O
at    O
the    O
SPS    O
energies    O
.    O

In    O
nucleus    B-Body109224911
–    O
nucleus    O
(    O
heavy    O
ion    O
)    O
collisions    O
,    O
in    O
particular    O
the    O
measurement    O
of    O
fluctuations    O
and    O
long    O
range    O
correlations    O
,    O
with    O
the    O
aim    O
to    O
identify    O
the    O
properties    O
of    O
the    O
onset    O
of    O
deconfinement    O
and    O
find    O
evidence    O
for    O
the    O
critical    O
point    O
of    O
strongly    O
interacting    O
matter    O
.    O

The    O
Fermi    O
contact    O
interaction    O
is    O
the    O
magnetic    O
interaction    O
between    O
an    O
electron    O
and    O
an    O
atomic    B-Body109224911
nucleus    I-Body109224911
when    O
the    O
electron    O
is    O
inside    O
that    O
nucleus    O
.    O

The    O
term    O
is    O
typically    O
distinct    O
from    O
radioactive    O
decay    O
,    O
in    O
which    O
an    O
unstable    O
atomic    B-Body109224911
nucleus    I-Body109224911
is    O
transformed    O
into    O
a    O
lighter    O
nucleus    O
accompanied    O
by    O
the    O
emission    O
of    O
particles    O
or    O
radiation    O
,    O
although    O
the    O
two    O
are    O
conceptually    O
similar    O
and    O
are    O
often    O
described    O
using    O
the    O
same    O
terminology    O
.    O

Such    O
a    O
slow    O
process    O
tends    O
to    O
favor    O
isotopes    O
with    O
atomic    O
mass    O
numbers    O
(    O
A    O
=    O
protons    O
+    O
neutrons    O
)    O
around    O
90    O
,    O
138    O
and    O
208    O
,    O
which    O
have    O
unusually    O
stable    O
atomic    B-Body109224911
nuclei    I-Body109224911
with    O
50    O
,    O
82    O
,    O
and    O
126    O
neutrons    O
,    O
respectively    O
.    O

The    O
first    O
atoms    O
of    O
lawrencium    O
were    O
produced    O
by    O
bombarding    O
a    O
three    O
-    O
milligram    O
target    O
consisting    O
of    O
three    O
isotopes    O
of    O
the    O
element    O
californium    O
with    O
boron-10    O
and    O
boron-11    O
nuclei    B-Body109224911
from    O
the    O
Heavy    O
Ion    O
Linear    O
Accelerator    O
(    O
HILAC    O
)    O
.    O

Its    O
nucleus    B-Body109224911
contains    O
17    O
protons    O
and    O
20    O
neutrons    O
for    O
a    O
total    O
of    O
37    O
nucleons    O
.    O

Alpha    O
particles    O
consist    O
of    O
two    O
protons    O
and    O
two    O
neutrons    O
bound    O
together    O
into    O
a    O
particle    O
identical    O
to    O
a    O
helium    O
nucleus    B-Body109224911
.    O

Understanding    O
the    O
structure    O
of    O
the    O
atomic    B-Body109224911
nucleus    I-Body109224911
is    O
one    O
of    O
the    O
central    O
challenges    O
in    O
nuclear    O
physics    O
.    O

This    O
radiation    O
originates    O
from    O
outside    O
the    O
solar    O
system    O
and    O
consists    O
of    O
ion    B-Body109224911
charged    O
atomic    B-Body109224911
nuclei    I-Body109224911
from    O
hydrogen    O
,    O
helium    O
and    O
uranium    O
.    O

Most    O
practices    O
of    O
nanotechnology    O
and    O
materials    O
science    O
today    O
have    O
foci    O
distinct    O
from    O
Feynman    O
's    O
ultimate    O
vision    O
of    O
manipulating    O
individual    O
atomic    O
position    O
and    O
spin    O
,    O
which    O
may    O
be    O
better    O
described    O
by    O
"    O
Atomic    O
engineering    O
"    O
,    O
that    O
addresses    O
characteristic    O
length    O
scales    O
from    O
1    O
femtometer    O
(    O
the    O
atomic    B-Body109224911
nucleus    I-Body109224911
size    O
)    O
to    O
1    O
nanometer    O
(    O
about    O
5    O
atoms    O
across    O
in    O
linear    O
dimension    O
)    O
.    O

Rapid    O
crystallization    O
would    O
follow    O
,    O
producing    O
deposits    O
on    O
any    O
suitable    O
nuclei    B-Body109224911
,    O
and    O
the    O
crystals    O
then    O
formed    O
might    O
have    O
a    O
radial    O
disposition    O
on    O
the    O
surfaces    O
on    O
which    O
they    O
grew    O
.    O

Mention    O
should    O
be    O
made    O
of    O
Frenkel    O
's    O
works    O
on    O
the    O
theory    O
of    O
metals    O
,    O
nuclear    O
physics    O
(    O
the    O
liquid    B-Body109224911
drop    I-Body109224911
model    I-Body109224911
of    O
the    O
nucleus    B-Body109224911
)    O
,    O
and    O
semiconductors    O
.    O

The    O
Primakoff    O
effect    O
,    O
named    O
after    O
Henry    O
Primakoff    O
,    O
is    O
the    O
resonant    O
production    O
of    O
neutral    O
pseudoscalar    O
mesons    O
by    O
high    O
-    O
energy    O
photons    O
interacting    O
with    O
an    O
atomic    B-Body109224911
nucleus    I-Body109224911
.    O

This    O
polarization    O
of    O
the    O
negative    O
ion    O
leads    O
to    O
a    O
build    O
-    O
up    O
of    O
extra    O
charge    O
density    O
between    O
the    O
two    O
nuclei    B-Body109224911
,    O
i.e.    O
,    O
to    O
partial    O
covalency    O
.    O

Species    O
of    O
identical    O
particles    O
include    O
,    O
but    O
are    O
not    O
limited    O
to    O
elementary    O
particles    O
such    O
as    O
electrons    O
,    O
composite    O
subatomic    O
particles    O
such    O
as    O
atomic    B-Body109224911
nuclei    I-Body109224911
,    O
as    O
well    O
as    O
atoms    O
and    O
molecules    O
.    O

To    O
modify    O
a    O
material    O
so    O
that    O
it    O
keeps    O
emitting    O
radiation    O
(    O
induce    O
radiation    O
)    O
the    O
atomic    O
cores    O
(    O
nucleus    B-Body109224911
)    O
of    O
the    O
atoms    O
in    O
the    O
target    O
material    O
must    O
be    O
modified    O
.    O

These    O
radiated    O
particles    O
at    O
these    O
strengths    O
can    O
never    O
be    O
strong    O
enough    O
to    O
modify    O
the    O
nucleus    B-Body109224911
of    O
the    O
targeted    O
atom    O
in    O
the    O
food    O
,    O
regardless    O
of    O
how    O
many    O
particles    O
hit    O
the    O
target    O
material    O
,    O
and    O
radioactivity    O
can    O
not    O
be    O
induced    O
without    O
modifying    O
the    O
nucleus    O
.    O

It    O
must    O
first    O
transfer    O
some    O
or    O
all    O
of    O
its    O
energy    O
via    O
the    O
strong    O
force    O
to    O
a    O
charged    O
atomic    B-Body109224911
nucleus    I-Body109224911
.    O

In    O
analogy    O
with    O
the    O
mini    O
-    O
simulations    O
that    O
lattice    O
-    O
gauge    O
theorists    O
run    O
today    O
to    O
build    O
up    O
nuclei    B-Body109224911
from    O
the    O
underlying    O
theory    O
of    O
strong    O
interactions    O
(    O
known    O
as    O
Quantum    O
chromodynamics    O
)    O
,    O
several    O
observational    O
consequences    O
of    O
a    O
grid    O
-    O
like    O
space    O
-    O
time    O
have    O
been    O
studied    O
in    O
their    O
work    O
.    O

A    O
helion    O
is    O
a    O
short    O
name    O
for    O
the    O
naked    O
nucleus    B-Body109224911
of    O
helium    O
,    O
a    O
doubly    O
positively    O
charged    O
"    O
helium    O
ion    O
"    O
.    O

Dmitri    O
Ivanenko    O
,    O
proposed    O
the    O
first    O
atomic    B-Body109224911
nucleus    I-Body109224911
and    O
nuclear    O
shell    O
models    O
,    O
predicted    O
the    O
synchrotron    O
radiation    O
,    O
author    O
of    O
the    O
hypothesis    O
of    O
quark    B-Body109224911
star    I-Body109224911

Pyotr    O
Kapitsa    O
,    O
originated    O
the    O
techniques    O
for    O
creating    O
ultrastrong    O
magnetic    O
fields    O
,    O
co    O
-    O
discovered    O
a    O
way    O
to    O
measure    O
the    O
magnetic    O
field    O
of    O
an    O
atomic    B-Body109224911
nucleus    I-Body109224911
discovered    O
superfluidity    O
,    O
Nobel    O
Prize    O
winner    O

Nikolay    O
Semyonov    O
,    O
physical    O
chemist    O
,    O
co    O
-    O
discovered    O
a    O
way    O
to    O
measure    O
the    O
magnetic    O
field    O
of    O
an    O
atomic    B-Body109224911
nucleus    I-Body109224911
,    O
Nobel    O
Prize    O
in    O
Chemistry    O
winner    O

He    O
was    O
the    O
joint    O
winner    O
of    O
the    O
1961    O
Nobel    O
Prize    O
in    O
Physics    O
(    O
together    O
with    O
Rudolf    O
Mössbauer    O
)    O
"    O
for    O
his    O
pioneering    O
studies    O
of    O
electron    O
scattering    O
in    O
atomic    B-Body109224911
nuclei    I-Body109224911
and    O
for    O
his    O
consequent    O
discoveries    O
concerning    O
the    O
structure    O
of    O
nucleons    O
"    O
.    O

1961    O
Nobel    O
Prize    O
in    O
Physics    O
,    O
joint    O
winner    O
with    O
Rudolf    O
Mössbauer    O
,    O
"    O
for    O
his    O
[    O
Hofstadter    O
's    O
]    O
pioneering    O
studies    O
of    O
electron    O
scattering    O
in    O
atomic    B-Body109224911
nuclei    I-Body109224911
and    O
for    O
his    O
consequent    O
discoveries    O
concerning    O
the    O
structure    O
of    O
nucleons    O
.    O
"    O

Protons    O
and    O
neutrons    O
form    O
the    O
atomic    B-Body109224911
nucleus    I-Body109224911
,    O
which    O
accumulates    O
electrons    O
to    O
form    O
atoms    O
.    O

The    O
ground    O
state    O
electronic    O
density    O
of    O
an    O
atom    O
is    O
conjectured    O
to    O
be    O
a    O
monotonically    O
decaying    O
function    O
of    O
the    O
distance    O
from    O
the    O
nucleus    B-Body109224911
.    O

Strong    O
nuclear    O
force    O
:    O
Unlike    O
gravity    O
and    O
electromagnetism    O
,    O
the    O
strong    O
nuclear    O
force    O
is    O
a    O
short    O
distance    O
force    O
that    O
takes    O
place    O
between    O
fundamental    O
particles    O
within    O
a    O
nucleus    B-Body109224911
.    O

Wigner    O
received    O
a    O
share    O
of    O
the    O
Nobel    O
Prize    O
in    O
Physics    O
in    O
1963    O
"    O
for    O
his    O
contributions    O
to    O
the    O
theory    O
of    O
the    O
atomic    B-Body109224911
nucleus    I-Body109224911
and    O
the    O
elementary    O
particles    O
,    O
particularly    O
through    O
the    O
discovery    O
and    O
application    O
of    O
fundamental    O
symmetry    O
principles    O
"    O
,    O
the    O
other    O
half    O
of    O
the    O
award    O
was    O
shared    O
between    O
Maria    O
Goeppert    O
-    O
Mayer    O
and    O
J.    O
Hans    O
D.    O
Jensen    O
.    O

Because    O
the    O
nucleus    B-Body109224911
of    O
this    O
isotope    O
consists    O
of    O
only    O
a    O
single    O
proton    O
,    O
it    O
is    O
given    O
the    O
formal    O
name    O
"    O
protium    O
"    O
.    O

Fermilab    O
E-906/SeaQuest    O
is    O
a    O
particle    O
physics    O
experiment    O
which    O
will    O
use    O
Drell    O
–    O
Yan    O
process    O
to    O
measure    O
the    O
contributions    O
of    O
antiquarks    O
to    O
the    O
structure    O
of    O
the    O
proton    O
or    O
neutron    O
and    O
how    O
this    O
structure    O
is    O
modified    O
when    O
the    O
proton    O
or    O
neutron    O
is    O
included    O
within    O
an    O
atomic    B-Body109224911
nucleus    I-Body109224911
.    O

In    O
studying    O
a    O
free    O
nucleon    O
and    O
a    O
nucleon    O
bound    O
in    O
a    O
nucleus    O
,    O
the    O
European    O
Muon    O
Collaboration    O
found    O
that    O
nucleons    O
inside    O
a    O
nucleus    B-Body109224911
have    O
a    O
different    O
distribution    O
of    O
momentum    O
among    O
their    O
component    O
quarks    O
.    O

Coulomb    O
repulsion    O
occurs    O
between    O
positively    O
charged    O
primary    O
ions    B-Body109224911
and    O
the    O
nuclei    B-Body109224911
of    O
surface    O
atoms    O
.    O

The    O
wavy    O
line    O
represents    O
a    O
photon    O
and    O
the    O
double    O
line    O
an    O
electron    O
in    O
the    O
external    O
field    O
of    O
a    O
nucleus    B-Body109224911
.    O

Hyperfine    O
structure    O
,    O
with    O
energy    O
shifts    O
typically    O
orders    O
of    O
magnitudes    O
smaller    O
than    O
those    O
of    O
a    O
fine    O
-    O
structure    O
shift    O
,    O
results    O
from    O
the    O
interactions    O
of    O
the    O
nucleus    B-Body109224911
(    O
or    O
nuclei    O
,    O
in    O
molecules    O
)    O
with    O
internally    O
generated    O
electric    O
and    O
magnetic    O
fields    O
.    O

FRIB    O
will    O
provide    O
intense    O
beams    O
of    O
rare    O
isotopes    O
(    O
that    O
is    O
,    O
short    O
-    O
lived    O
atomic    B-Body109224911
nuclei    I-Body109224911
not    O
normally    O
found    O
on    O
Earth    O
)    O
.    O

Pinawa    O
was    O
re    O
-    O
established    O
about    O
10    O
km    O
from    O
the    O
original    O
Hydro    O
town    O
in    O
1963    O
when    O
Atomic    O
Energy    O
of    O
Canada    O
Limited    O
built    O
the    O
Whiteshell    O
Laboratories    O
nuclear    B-Body109224911
research    O
facility    O
in    O
the    O
area    O
.    O

In    O
collaboration    O
with    O
Gregory    O
Breit    O
,    O
he    O
developed    O
the    O
Breit    O
–    O
Rabi    O
equation    O
and    O
predicted    O
that    O
the    O
Stern    O
–    O
Gerlach    O
experiment    O
could    O
be    O
modified    O
to    O
confirm    O
the    O
properties    O
of    O
the    O
atomic    B-Body109224911
nucleus    I-Body109224911
.    O

In    O
collaboration    O
with    O
Gregory    O
Breit    O
,    O
he    O
developed    O
the    O
Breit    O
-    O
Rabi    O
equation    O
,    O
and    O
predicted    O
that    O
the    O
Stern    O
–    O
Gerlach    O
experiment    O
could    O
be    O
modified    O
to    O
confirm    O
the    O
properties    O
of    O
the    O
atomic    B-Body109224911
nucleus    I-Body109224911
.    O

Radioactive    O
decay    O
(    O
also    O
known    O
as    O
nuclear    O
decay    O
or    O
radioactivity    O
)    O
is    O
the    O
process    O
by    O
which    O
an    O
unstable    O
atomic    B-Body109224911
nucleus    I-Body109224911
loses    O
energy    O
(    O
in    O
terms    O
of    O
mass    O
in    O
its    O
rest    O
frame    O
)    O
by    O
emitting    O
radiation    O
,    O
such    O
as    O
an    O
alpha    O
particle    O
,    O
beta    O
particle    O
with    O
neutrino    O
or    O
only    O
a    O
neutrino    O
in    O
the    O
case    O
of    O
electron    O
capture    O
,    O
gamma    O
ray    O
,    O
or    O
electron    O
in    O
the    O
case    O
of    O
internal    O
conversion    O
.    O

In    O
the    O
case    O
of    O
an    O
excited    O
atomic    B-Body109224911
nucleus    I-Body109224911
decaying    O
by    O
gamma    O
radiation    O
in    O
a    O
spontaneous    O
emission    O
of    O
electromagnetic    O
radiation    O
,    O
the    O
arbitrarily    O
small    O
disturbance    O
comes    O
from    O
quantum    O
vacuum    O
fluctuations    O
.    O

If    O
irradiated    O
with    O
select    O
projectile    O
nuclei    B-Body109224911
at    O
kinetic    O
energies    O
"    O
E"kin    O
these    O
target    O
elements    O
can    O
undergo    O
a    O
nuclear    O
reaction    O
under    O
resonance    O
conditions    O
for    O
a    O
sharply    O
defined    O
resonance    O
energy    O
.    O

This    O
radiation    O
primarily    O
consists    O
of    O
positively    O
charged    O
ions    O
from    O
protons    O
to    O
iron    O
and    O
larger    O
nuclei    B-Body109224911
derived    O
sources    O
outside    O
our    O
solar    O
system    O
.    O

The    O
rms    O
charge    O
radius    O
is    O
a    O
measure    O
of    O
the    O
size    O
of    O
an    O
atomic    B-Body109224911
nucleus    I-Body109224911
,    O
particularly    O
of    O
a    O
proton    O
or    O
a    O
deuteron    O
.    O

Unlike    O
an    O
x    O
-    O
ray    O
photon    O
with    O
a    O
similar    O
wavelength    O
,    O
which    O
interacts    O
with    O
the    O
electron    O
cloud    O
surrounding    O
the    O
nucleus    B-Body109224911
,    O
neutrons    O
primarily    O
interact    O
with    O
the    O
nucleus    O
itself    O
.    O

The    O
main    O
objective    O
of    O
ANS    O
is    O
to    O
promote    O
the    O
advancement    O
of    O
science    O
and    O
engineering    O
relating    O
to    O
the    O
atomic    B-Body109224911
nucleus    I-Body109224911
.    O

Aage    O
Niels    O
Bohr    O
(;    O
19    O
June    O
1922    O
–    O
8    O
September    O
2009    O
)    O
was    O
a    O
Danish    O
nuclear    O
physicist    O
who    O
shared    O
the    O
Nobel    O
Prize    O
in    O
Physics    O
in    O
1975    O
with    O
Ben    O
Mottelson    O
and    O
James    O
Rainwater    O
"    O
for    O
the    O
discovery    O
of    O
the    O
connection    O
between    O
collective    O
motion    O
and    O
particle    O
motion    O
in    O
atomic    B-Body109224911
nuclei    I-Body109224911
and    O
the    O
development    O
of    O
the    O
theory    O
of    O
the    O
structure    O
of    O
the    O
atomic    O
nucleus    O
based    O
on    O
this    O
connection    O
"    O
.    O

By    O
the    O
late    O
1940s    O
it    O
was    O
known    O
that    O
the    O
properties    O
of    O
atomic    B-Body109224911
nuclei    I-Body109224911
could    O
not    O
be    O
explained    O
by    O
the    O
then    O
-    O
current    O
models    O
such    O
as    O
the    O
liquid    O
drop    O
model    O
developed    O
by    O
Niels    O
Bohr    O
amongst    O
others    O
.    O

The    O
Nucleus    B-Body109224911
invokes    O
Continuous    O
Struggle    O
and    O
Commitment    O
to    O
Improve    O
Life    O
.    O

hadron    O
colliders    O
such    O
as    O
the    O
LHC    O
for    O
protons    O
or    O
,    O
alternatively    O
,    O
for    O
lead    O
nuclei    B-Body109224911
.    O

The    O
metaphor    O
is    O
extended    O
by    O
the    O
story    O
explicitly    O
likening    O
one    O
character    O
to    O
a    O
neutron    O
,    O
another    O
to    O
a    O
nucleus    B-Body109224911
,    O
and    O
the    O
President    O
to    O
a    O
neutron    O
moderator    O
.    O

The    O
atomic    O
radius    O
is    O
the    O
distance    O
from    O
the    O
atomic    B-Body109224911
nucleus    I-Body109224911
to    O
the    O
outermost    O
stable    O
electron    O
orbital    O
in    O
an    O
atom    O
that    O
is    O
at    O
equilibrium    O
.    O

In    O
atomic    O
,    O
molecular    O
,    O
and    O
optical    O
physics    O
and    O
quantum    O
chemistry    O
,    O
the    O
molecular    O
Hamiltonian    O
is    O
the    O
Hamiltonian    O
operator    O
representing    O
the    O
energy    O
of    O
the    O
electrons    O
and    O
nuclei    B-Body109224911
in    O
a    O
molecule    O
.    O

Because    O
of    O
its    O
nuclear    O
properties    O
lithium-7    O
is    O
less    O
common    O
than    O
helium    O
,    O
beryllium    O
,    O
carbon    O
,    O
nitrogen    O
,    O
or    O
oxygen    O
in    O
the    O
Universe    O
,    O
even    O
though    O
the    O
latter    O
four    O
all    O
have    O
heavier    O
nuclei    B-Body109224911
.    O

234Th    O
is    O
an    O
isotope    O
of    O
thorium    O
whose    O
nuclei    B-Body109224911
contain    O
144    O
neutrons    O
.    O
Th-234    O

Unlike    O
the    O
more    O
abundant    O
nitrogen-14    O
,    O
that    O
has    O
an    O
integer    O
nuclear    B-Body109224911
spin    O
and    O
thus    O
a    O
quadrupole    O
moment    O
,    O
15N    O
has    O
a    O
fractional    O
nuclear    O
spin    O
of    O
one    O
-    O
half    O
,    O
which    O
offers    O
advantages    O
for    O
NMR    O
such    O
as    O
narrower    O
line    O
width    O
.    O

Although    O
all    O
heavier    O
helium    O
isotopes    O
decay    O
with    O
a    O
half    O
-    O
life    O
of    O
less    O
than    O
one    O
second    O
,    O
researchers    O
have    O
created    O
new    O
isotopes    O
through    O
particle    O
accelerator    O
collisions    O
to    O
create    O
unusual    O
atomic    B-Body109224911
nuclei    I-Body109224911
for    O
elements    O
such    O
as    O
helium    O
,    O
lithium    O
and    O
nitrogen    O
.    O

gluon    O
plasma    O
and    O
its    O
properties    O
are    O
key    O
issues    O
in    O
quantum    O
chromodynamics    O
for    O
understanding    O
color    B-Body109224911
confinement    I-Body109224911
and    O
chiral    O
symmetry    O
restoration    O
.    O
Recreating    O
this    O
primordial    O
form    O
of    O
matter    O
and    O
understanding    O
how    O
it    O
evolves    O

There    O
are    O
other    O
kinds    O
of    O
"    O
sanity    O
checks    O
"    O
that    O
can    O
be    O
performed    O
on    O
a    O
quantum    O
field    O
theory    O
to    O
determine    O
whether    O
it    O
fits    O
qualitative    O
phenomena    O
such    O
as    O
quark    B-Body109224911
confinement    I-Body109224911
and    O
asymptotic    O
freedom    O
.    O

T.    O
Kugo    O
and    O
I.    O
Ojima    O
are    O
commonly    O
credited    O
with    O
the    O
discovery    O
of    O
the    O
principal    O
QCD    O
color    B-Body109224911
confinement    I-Body109224911
criterion    O
.    O

In    O
QCD    O
,    O
color    B-Body109224911
confinement    I-Body109224911
has    O
led    O
physicists    O
to    O
abandon    O
the    O
source    O
theory    O
or    O
S    O
-    O
matrix    O
based    O
approach    O
for    O
the    O
strong    O
interactions    O
.    O

Colour    B-Body109224911
confinement    I-Body109224911
:    O
Why    O
has    O
there    O
never    O
been    O
measured    O
a    O
free    O
quark    O
or    O
gluon    O
,    O
but    O
only    O
objects    O
that    O
are    O
built    O
out    O
of    O
them    O
,    O
such    O
as    O
mesons    O
and    O
baryons    O
?    O

They    O
seem    O
to    O
play    O
an    O
important    O
role    O
in    O
the    O
confinement    B-Body109224911
of    O
quarks    O
.    O

Particles    O
carrying    O
a    O
color    O
charge    O
,    O
such    O
as    O
quarks    O
,    O
can    O
not    O
exist    O
in    O
free    O
form    O
because    O
of    O
QCD    O
confinement    B-Body109224911
which    O
only    O
allows    O
for    O
colorless    O
states    O
.    O

Most    O
importantly    O
,    O
lattice    O
QCD    O
provides    O
a    O
framework    O
for    O
investigation    O
of    O
non    O
-    O
perturbative    O
phenomena    O
such    O
as    O
confinement    B-Body109224911
and    O
quark–    O

QCD    B-Body109224911
string    I-Body109224911

While    O
the    O
latter    O
is    O
well    O
understood    O
in    O
the    O
framework    O
of    O
the    O
Standard    O
Model    O
at    O
high    O
energies    O
,    O
it    O
is    O
much    O
more    O
complicated    O
in    O
low    O
energies    O
due    O
to    O
color    B-Body109224911
confinement    I-Body109224911
and    O
asymptotic    O
freedom    O
.    O

Quark    B-Body109224911
confinement    I-Body109224911

Unlike    O
quantum    O
electrodynamics    O
(    O
QED    O
)    O
,    O
the    O
strong    O
coupling    O
constant    O
of    O
the    O
constituents    O
of    O
a    O
proton    O
makes    O
the    O
calculation    O
of    O
hadronic    O
properties    O
,    O
such    O
as    O
the    O
proton    O
mass    O
and    O
color    B-Body109224911
confinement    I-Body109224911
,    O
a    O
most    O
difficult    O
problem    O
to    O
solve    O
.    O

However    O
,    O
in    O
reality    O
,    O
quark    B-Body109224911
confinement    I-Body109224911
prevents    O
quarks    O
from    O
being    O
separated    O
by    O
any    O
observable    O
distance    O
.    O

Acetylenedicarboxylate    B-Body109224911
(    O
often    O
abbreviated    O
as    O
ADC    B-Body109224911
or    O
adc    B-Body109224911
)    O
is    O
a    O
divalent    O
anion    B-Body109224911
with    O
formula    O
C4O42−    O
or    O
[    O
O2C    O
–    O
C≡C    O
–    O
CO2]2−    O
;    O
or    O
any    O
salt    O
or    O
ester    O
thereof    O
.    O

---    O
radiation    B-Body109224911
hybrid    I-Body109224911
mapping    I-Body109224911

The    O
Twente    O
One    O
is    O
the    O
second    O
solar    O
car    O
developed    O
by    O
the    O
University    O
of    O
Twente    O
and    O
Saxion    B-Body109224911
University    I-Body109224911
(    O
at    O
Enschede    O
,    O
Deventer    O
and    O
Apeldoorn    O
)    O
in    O
2007    O
,    O
and    O
succeeds    O
the    O
SolUTra    O
.    O

In    O
astronomy    O
and    O
cosmology    O
,    O
baryonic    B-Body109224911
dark    I-Body109224911
matter    I-Body109224911
is    O
dark    O
matter    O
composed    O
of    O
baryons    O
.    O

The    O
title    O
references    O
quarks    O
which    O
are    O
sub    O
-    O
atomic    O
particles    O
;    O
"    O
strangeness    O
"    O
and    O
"    O
charm    B-Body109224911
"    O
are    O
playful    O
terms    O
used    O
by    O
physicists    O
to    O
refer    O
to    O
how    O
many    O
strange    O
and    O
charm    O
quarks    O
are    O
within    O
a    O
particle    O
.    O

For    O
all    O
the    O
quark    O
flavour    O
quantum    O
numbers    O
(    O
strangeness    O
,    O
charm    B-Body109224911
,    O
topness    B-Body109224911
and    O
bottomness    B-Body109224911
)    O
the    O
convention    O
is    O
that    O
the    O
flavour    O
charge    O
and    O
the    O
electric    O
charge    O
of    O
a    O
quark    O
have    O
the    O
same    O
sign    O
.    O

The    O
symbols    O
encountered    O
in    O
this    O
list    O
are    O
:    O
I    O
(    O
"    O
isospin    B-Body109224911
"    O
)    O
,    O
J    O
(    O
"    O
total    O
angular    O
momentum    O
quantum    O
number    O
"    O
)    O
,    O
P    O
(    O
"    O
parity    O
"    O
)    O
,    O
Q    O
(    O
"    O
charge    O
"    O
)    O
,    O
S    O
(    O
"    O
strangeness    O
"    O
)    O
,    O
C    O
(    O
"    O
charmness    B-Body109224911
"    O
)    O
,    O
B′    O
(    O
"    O
bottomness    B-Body109224911
"    O
)    O
,    O
T    O
(    O
"    O
topness    B-Body109224911
"    O
)    O
,    O
u    O
(    O
"    O
up    O
quark    O
"    O
)    O
,    O
d    O
(    O
"    O
down    O
quark    O
"    O
)    O
,    O
s    O
(    O
"    O
strange    O
quark    O
"    O
)    O
,    O
c    O
(    O
"    O
charm    O
quark    O
"    O
)    O
,    O
b    O
(    O
"    O
bottom    O
quark    O
"    O
)    O
,    O
t    O
(    O
"    O
top    O
quark    O
"    O
)    O
,    O
as    O
well    O
as    O
other    O
subatomic    O
particles    O
(    O
hover    O
for    O
name    O
)    O
.    O

An    O
electride    B-Body109224911
,    O
[    O
Na(NH3)6]+e−    O
,    O
is    O
formed    O
as    O
a    O
reaction    O
intermediate    O
.    O

An    O
electride    B-Body109224911
is    O
an    O
ionic    O
compound    O
in    O
which    O
an    O
electron    O
is    O
the    O
anion    B-Body109224911
.    O

Electride    B-Body109224911
,    O
another    O
very    O
simple    O
anion    O

The    O
multiple    O
cloning    O
site    O
(    O
MCS    O
)    O
is    O
derived    O
from    O
pBluescript    B-Body109224911
.    O

Current    O
research    O
and    O
development    O
is    O
focused    O
around    O
energy    O
resolving    O
pixel    O
detectors    O
,    O
such    O
as    O
CERN    O
's    O
Medipix    B-Body109224911
detector    O
and    O
Science    O
and    O
Technology    O
Facilities    O
Council    O
's    O
HEXITEC    O
detector    O
.    O

In    O
1994    O
,    O
yeast    O
geneticist    O
Reed    O
Wickner    O
correctly    O
hypothesized    O
that    O
[    O
PSI+    O
]    O
as    O
well    O
as    O
another    O
mysterious    O
heritable    O
trait    O
,    O
[    O
URE3    O
]    O
,    O
resulted    O
from    O
prion    O
forms    O
of    O
the    O
normal    O
cellular    O
proteins    O
,    O
Sup35p    O
and    O
Ure2p    B-Body109224911
,    O
respectively    O
.    O

CO    O
,    O
AuPPh3    O
,    O
H−    B-Body109224911
,    O
SnPh3    O
,    O
GePh3    O
,    O
M(CO)n    O
3    O
3    O
]    O
]    O
−    O
]    O
]    O
3SO2−    O
,    O
NC5H5    O
3CO    O
]    O
]    O
−    O
]    O
]    O
,    O
NCO−    O
−    O
]    O
]    O
3−    O
]    O
]    O

negatively-charged    B-Body109224911
hydrogen    I-Body109224911
ions    I-Body109224911
(    O
H−    O
)    O
were    O
shown    O
to    O
be    O
a    O
major    O
contributor    O
to    O
Milne    O
's    O
results    O
.    O

A    O
necessary    O
step    O
for    O
improving    O
space    O
radiation    O
cancer    O
risk    O
assessment    O
is    O
to    O
perform    O
studies    O
on    O
the    O
molecular    O
pathways    O
that    O
can    O
cause    O
cancer    O
initiation    O
and    O
progression    O
,    O
and    O
to    O
extend    O
these    O
studies    O
to    O
learn    O
how    O
such    O
pathways    O
can    O
be    O
disrupted    O
by    O
HZE    B-Body109224911
ions    I-Body109224911
,    O
including    O
both    O
genetic    O
and    O
epigenetic    O
modifications    O
that    O
are    O
noted    O
as    O
the    O
hallmarks    O
of    O
cancer    O
(    O
Figure    O
4    O
-    O
8    O
)    O
.    O

While    O
in    O
space    O
,    O
astronauts    O
are    O
exposed    O
to    O
radiation    O
which    O
is    O
mostly    O
composed    O
of    O
high    O
-    O
energy    O
protons    O
,    O
helium    O
nuclei    O
(    O
alpha    O
particles    O
)    O
,    O
and    O
high    O
-    O
atomic    O
-    O
number    O
ions    O
(    O
HZE    B-Body109224911
ions    I-Body109224911
)    O
,    O
as    O
well    O
as    O
secondary    O
radiation    O
from    O
nuclear    O
reactions    O
from    O
spacecraft    O
parts    O
or    O
tissue    O
.    O

Cosmic    O
rays    O
come    O
from    O
all    O
directions    O
and    O
consist    O
of    O
approximately    O
85%    O
protons    O
,    O
14%    O
alpha    O
particles    O
,    O
and    O
1%    O
heavy    B-Body109224911
ions    I-Body109224911
,    O
together    O
with    O
x    O
-    O
ray    O
and    O
gamma    O
-    O
ray    O
radiation    O
.    O

In    O
physics    O
,    O
a    O
magnetic    B-Body109224911
photon    I-Body109224911
is    O
a    O
hypothetical    O
particle    O
.    O

Chromosome    B-Body109224911
instability    I-Body109224911

Breakage    O
-    O
fusion    O
-    O
bridge    O
(    O
BFB    O
)    O
cycle    O
(    O
also    O
breakage    O
-    O
rejoining    O
-    O
bridge    O
cycle    O
)    O
is    O
a    O
mechanism    O
of    O
chromosomal    B-Body109224911
instability    I-Body109224911
,    O
discovered    O
by    O
Barbara    O
McClintock    O
in    O
the    O
late    O
1930s    O
.    O

Shigaite    O
consists    O
of    O
oxycation    B-Body109224911
sheets    O
of    O
[    O
AlMn2    O
+    O
2(OH)6]1    O
+    O
intercalated    O
with    O
oxyanion    B-Body109224911
sheets    O
of    O
[    O
Na(H2O)6{H2O}6(SO4)2]3−.    O
Linkage    O
between    O
the    O
sheets    O
and    O
within    O
the    O
oxyanion    O
sheet    O
results    O
largely    O
through    O
hydrogen    O
bonding    O
.    O

The    O
gene    O
responsible    O
for    O
the    O
formation    O
of    O
the    O
blue    O
photopigment    O
is    O
in    O
a    O
position    O
far    O
away    O
,    O
on    O
chromosome    B-Body109224911
7    I-Body109224911
and    O
the    O
gene    O
responsible    O
for    O
the    O
formation    O
of    O
rhodopsin    O
(    O
the    O
rod    O
photopigment    O
)    O
is    O
located    O
on    O
chromosome    B-Body109224911
3    I-Body109224911
.    O

In    O
humans    O
,    O
it    O
is    O
found    O
on    O
chromosome    B-Body109224911
7    I-Body109224911
in    O
a    O
locus    B-Body109224911
spanning    O
a    O
translocation    O
breakpoint    O
associated    O
with    O
autism    O
.    O

In    O
humans    O
,    O
it    O
is    O
found    O
on    O
chromosome    B-Body109224911
7    I-Body109224911
in    O
a    O
locus    B-Body109224911
spanning    O
a    O
translocation    O
breakpoint    O
associated    O
with    O
autism    O
.    O

In    O
humans    O
,    O
it    O
is    O
found    O
on    O
chromosome    B-Body109224911
7    I-Body109224911
in    O
a    O
locus    B-Body109224911
spanning    O
a    O
translocation    O
breakpoint    O
associated    O
with    O
autism    O
.    O

In    O
humans    O
,    O
it    O
is    O
found    O
on    O
chromosome    B-Body109224911
7    I-Body109224911
in    O
a    O
locus    B-Body109224911
spanning    O
a    O
translocation    O
breakpoint    O
associated    O
with    O
autism    O
.    O

The    O
"    O
Ob(Lep    O
)    O
"    O
gene    O
(    O
Ob    O
for    O
obese    O
,    O
Lep    O
for    O
leptin    O
)    O
is    O
located    O
on    O
chromosome    B-Body109224911
7    I-Body109224911
in    O
humans    O
.    O

Congenital    O
chloride    O
diarrhea    O
(    O
CCD    O
,    O
also    O
congenital    O
chloridorrhea    O
or    O
Darrow    O
Gamble    O
syndrome    O
)    O
is    O
a    O
genetic    O
disorder    O
due    O
to    O
an    O
autosomal    O
recessive    O
mutation    O
on    O
chromosome    B-Body109224911
7    I-Body109224911
.    O

In    O
squamous    O
cell    O
carcinoma    O
,    O
a    O
protein    O
from    O
the    O
epidermal    O
growth    O
factor    O
receptor    O
(    O
EGFR    O
)    O
gene    O
is    O
often    O
overexpressed    O
in    O
conjunction    O
with    O
polysomy    O
of    O
chromosome    B-Body109224911
7    I-Body109224911
,    O
so    O
chromosome    O
7    O
can    O
be    O
used    O
to    O
predict    O
the    O
presence    O
of    O
EGFR    O
in    O
squamous    O
cell    O
carcinoma    O
.    O

The    O
mouse    O
TWIST    O
gene    O
is    O
located    O
on    O
chromosome    O
12    O
in    O
mice    O
,    O
which    O
corresponds    O
to    O
the    O
short    O
arm    O
of    O
chromosome    B-Body109224911
7    I-Body109224911
in    O
humans    O
.    O

MODY    O
2    O
is    O
due    O
to    O
any    O
of    O
several    O
mutations    O
in    O
the    O
"    O
GCK    O
"    O
gene    O
on    O
chromosome    B-Body109224911
7    I-Body109224911
for    O
glucokinase    O
.    O

The    O
human    O
"    O
PION    O
"    O
gene    O
is    O
located    O
on    O
the    O
long    O
(    O
q    O
)    O
arm    O
of    O
chromosome    B-Body109224911
7    I-Body109224911
at    O
band    O
11.23    O
,    O
from    O
base    O
pair    O
76,778,007    O
to    O
base    O
pair    O
76,883,653    O
.    O

In    O
2005    O
,    O
the    O
BaBar    O
experiment    O
announced    O
the    O
discovery    O
of    O
a    O
new    O
state    O
:    O
Y(4260)    B-Body109224911
.    O

The    O
relevance    O
of    O
this    O
result    O
is    O
due    O
to    O
the    O
fact    O
that    O
a    O
Yang    O
–    O
Mills    O
theory    O
that    O
describes    O
strong    O
interaction    O
and    O
asymptotic    O
freedom    O
permits    O
proper    O
treatment    O
of    O
experimental    O
results    O
coming    O
from    O
deep    B-Body109224911
inelastic    I-Body109224911
scattering    I-Body109224911
.    O

Deep    B-Body109224911
inelastic    I-Body109224911
scattering    I-Body109224911

The    O
term    O
"    O
deep    B-Body109224911
inelastic    I-Body109224911
scattering    I-Body109224911
"    O
refers    O
to    O
a    O
special    O
kind    O
of    O
scattering    O
experiment    O
in    O
particle    O
physics    O
.    O

In    O
deep    B-Body109224911
inelastic    I-Body109224911
scattering    I-Body109224911
the    O
hadron    O
structure    O
is    O
probed    O
with    O
electrons    O
,    O
muons    O
or    O
neutrinos    O
.    O

In    O
1983    O
,    O
the    O
EMC    O
described    O
deep    B-Body109224911
inelastic    I-Body109224911
scattering    I-Body109224911
of    O
muons    O
on    O
deuteron    O
and    O
on    O
iron    O
.    O

Similarly    O
all    O
vector    B-Body109224911
boson    I-Body109224911
can    O
be    O
shown    O
to    O
have    O
odd    O
intrinsic    O
parity    O
,    O
and    O
all    O
axial-vectors    B-Body109224911
to    O
have    O
even    O
intrinsic    O
parity    O
.    O

In    O
1997    O
,    O
a    O
patient    O
was    O
identified    O
who    O
carried    O
a    O
rare    O
balanced    O
chromosomal    O
translocation    O
involving    O
chromosome    B-Body109224911
19    I-Body109224911
and    O
the    O
X    B-Body109224911
chromosome    I-Body109224911
.    O

Glutaryl    O
-    O
CoA    O
dehydrogenase    O
(    O
GCDH    O
)    O
is    O
an    O
enzyme    O
encoded    O
by    O
the    O
GCDH    O
gene    O
on    O
chromosome    B-Body109224911
19    I-Body109224911
.    O

It    O
is    O
located    O
on    O
chromosome    B-Body109224911
19    I-Body109224911
.    O

The    O
insulin    O
receptor    O
gene    O
is    O
located    O
on    O
the    O
short    O
arm    O
(    O
p    O
)    O
of    O
chromosome    B-Body109224911
19    I-Body109224911
.    O

"    O
CCDC94    O
"    O
is    O
a    O
21,975    O
basepair    O
gene    O
orientated    O
on    O
the    O
plus    O
strand    O
(    O
see    O
Sense    O
)    O
of    O
chromosome    B-Body109224911
19    I-Body109224911
from    O
4,247,111    O
-    O
4,269,085    O
.    O

Chromosome    B-Body109224911
19    I-Body109224911
is    O
one    O
of    O
the    O
23    O
pairs    O
of    O
chromosomes    O
in    O
humans    O
.    O

Subsequent    O
analysis    O
has    O
shown    O
that    O
the    O
transformation    O
was    O
brought    O
about    O
by    O
inserting    O
~4.5    O
kilobases    O
from    O
the    O
left    O
arm    O
of    O
the    O
viral    O
genome    O
,    O
which    O
became    O
incorporated    O
into    O
human    B-Body109224911
chromosome    I-Body109224911
19    I-Body109224911
.    O

The    O
Lewis    O
antigen    O
system    O
is    O
a    O
human    O
blood    O
group    O
system    O
based    O
upon    O
genes    O
on    O
chromosome    B-Body109224911
19    I-Body109224911
p13.3    O
(    O
FUT3    O
or    O
Lewis    O
gene    O
)    O
and    O
19q13.3    O
,    O
(    O
FUT2    O
or    O
secretor    O
gene    O
)    O
.    O

A1BG    O
is    O
located    O
on    O
the    O
negative    O
DNA    O
strand    O
of    O
chromosome    B-Body109224911
19    I-Body109224911
from    O
58,858,172    O
–    O
58,864,865    O
.    O

The    O
Z0    B-Body109224911
sex-determination    I-Body109224911
system    I-Body109224911
is    O
a    O
system    O
that    O
determines    O
the    O
sex    O
of    O
offspring    O
in    O
several    O
moths    O
.    O

ethenium    B-Body109224911
,    O
(    O
protonated    O
ethene    O
)    O

hydrazinium    O
dication    B-Body109224911
,    O
+    O
H3NNH3    O
+    O
(    O
doubly    O
protonated    O
hydrazine    O
)    O

The    O
dication    B-Body109224911
form    O
,    O
HNNH2    O
+    O
,    O
is    O
calculated    O
to    O
have    O
the    O
strongest    O
known    O
chemical    O
bond    O
.    O

A    O
floating    O
-    O
point    O
system    O
can    O
be    O
used    O
to    O
represent    O
,    O
with    O
a    O
fixed    O
number    O
of    O
digits    O
,    O
numbers    O
of    O
different    O
orders    O
of    O
magnitude    O
:    O
e.g.    O
the    O
distance    O
between    O
galaxies    O
or    O
the    O
diameter    B-Body109224911
of    I-Body109224911
an    I-Body109224911
atomic    I-Body109224911
nucleus    I-Body109224911
can    O
be    O
expressed    O
with    O
the    O
same    O
unit    O
of    O
length    O
.    O

For    O
all    O
the    O
quark    O
flavour    O
quantum    O
numbers    O
(    O
strangeness    O
,    O
charm    B-Body109224911
,    O
topness    B-Body109224911
and    O
bottomness    B-Body109224911
)    O
the    O
convention    O
is    O
that    O
the    O
flavour    O
charge    O
and    O
the    O
electric    O
charge    O
of    O
a    O
quark    O
have    O
the    O
same    O
sign    O
.    O

The    O
symbols    O
encountered    O
in    O
this    O
list    O
are    O
:    O
I    O
(    O
"    O
isospin    B-Body109224911
"    O
)    O
,    O
J    O
(    O
"    O
total    O
angular    O
momentum    O
quantum    O
number    O
"    O
)    O
,    O
P    O
(    O
"    O
parity    O
"    O
)    O
,    O
Q    O
(    O
"    O
charge    O
"    O
)    O
,    O
S    O
(    O
"    O
strangeness    O
"    O
)    O
,    O
C    O
(    O
"    O
charmness    B-Body109224911
"    O
)    O
,    O
B′    O
(    O
"    O
bottomness    B-Body109224911
"    O
)    O
,    O
T    O
(    O
"    O
topness    B-Body109224911
"    O
)    O
,    O
u    O
(    O
"    O
up    O
quark    O
"    O
)    O
,    O
d    O
(    O
"    O
down    O
quark    O
"    O
)    O
,    O
s    O
(    O
"    O
strange    O
quark    O
"    O
)    O
,    O
c    O
(    O
"    O
charm    O
quark    O
"    O
)    O
,    O
b    O
(    O
"    O
bottom    O
quark    O
"    O
)    O
,    O
t    O
(    O
"    O
top    O
quark    O
"    O
)    O
,    O
as    O
well    O
as    O
other    O
subatomic    O
particles    O
(    O
hover    O
for    O
name    O
)    O
.    O

Pyridine    O
is    O
often    O
used    O
as    O
an    O
organic    O
base    O
in    O
chemical    O
reactions    O
,    O
thus    O
the    O
pyridinium    O
ion    B-Body109224911
is    O
produced    O
as    O
the    O
counter    O
ion    O
to    O
the    O
leaving    O
group    O
in    O
the    O
reaction    O
.    O

It    O
contains    O
simple    O
tetrahedral    O
borate    O
anions    B-Body109224911
,    O
instead    O
of    O
more    O
common    O
among    O
minerals    O
,    O
planar    O
BO3    O
groups    O
.    O

In    O
solid    O
state    O
physics    O
and    O
physical    O
chemistry    O
,    O
the    O
fine    O
electronic    O
structure    O
of    O
an    O
atom    O
or    O
ion    B-Body109224911
is    O
the    O
structure    O
of    O
the    O
energy    O
levels    O
induced    O
by    O
intrinsic    O
interactions    O
between    O
spin    O
and    O
electron    O
magnetic    O
moments    O
(    O
LS    O
coupling    O
and    O
jj    O
coupling    O
)    O
of    O
electrons    O
and    O
external    O
interactions    O
of    O
electrons    O
with    O
the    O
electric    O
field    O
potential    O
of    O
lattice    O
surroundings    O
in    O
crystal    O
.    O

The    O
"    O
m    O
"    O
refers    O
to    O
the    O
molecular    O
or    O
atomic    O
mass    O
number    O
and    O
"    O
z    O
"    O
to    O
the    O
charge    O
number    O
of    O
the    O
ion    B-Body109224911
;    O
however    O
,    O
the    O
quantity    O
of    O
"    O
m"/"z    O
"    O
is    O
dimensionless    O
by    O
definition    O
.    O

In    O
1913    O
,    O
Thomson    O
measured    O
the    O
mass    O
-    O
to    O
-    O
charge    O
ratio    O
of    O
ion    B-Body109224911
with    O
an    O
instrument    O
he    O
called    O
a    O
parabola    O
spectrograph    O
.    O

Ionic    B-Body109224911
potential    I-Body109224911
is    O
the    O
ratio    O
of    O
electric    O
charge    O
to    O
the    O
radius    O
of    O
an    O
ion    B-Body109224911
.    O

This    O
reaction    O
is    O
catalysed    O
by    O
a    O
reactive    O
center    O
in    O
photosystem    O
II    O
containing    O
four    O
manganese    O
ions    B-Body109224911
.    O

The    O
gamma    O
rays    O
penetrate    O
the    O
atmosphere    O
and    O
collide    O
with    O
air    O
molecules    O
,    O
depositing    O
their    O
energy    O
to    O
produce    O
huge    O
quantities    O
of    O
positive    O
ion    B-Body109224911
and    O
recoil    O
electrons    O
(    O
also    O
known    O
as    O
Compton    O
electrons    O
)    O
.    O

Transfection    O
can    O
be    O
carried    O
out    O
using    O
calcium    O
phosphate    O
(    O
i.e.    O
tricalcium    O
phosphate    O
)    O
,    O
by    O
electroporation    O
,    O
by    O
cell    O
squeezing    O
or    O
by    O
mixing    O
a    O
cationic    B-Body109224911
lipid    O
with    O
the    O
material    O
to    O
produce    O
liposomes    O
which    O
fuse    O
with    O
the    O
cell    O
membrane    O
and    O
deposit    O
their    O
cargo    O
inside    O
.    O

Lipofection    O
generally    O
uses    O
a    O
positively    O
charged    O
(    O
cationic    B-Body109224911
)    O
lipid    O
(    O
cationic    O
liposomes    O
or    O
mixtures    O
)    O
to    O
form    O
an    O
aggregate    O
with    O
the    O
negatively    O
charged    O
(    O
anionic    B-Body109224911
)    O
genetic    O
material    O
.    O

His    O
1863    O
publication    O
included    O
a    O
chart    O
(    O
which    O
contained    O
ion    B-Body109224911
and    O
compounds    O
,    O
in    O
addition    O
to    O
elements    O
)    O
,    O
but    O
his    O
original    O
paper    O
in    O
the    O
'    O
'    O
Comptes    O
rendus    O
de    O
l'Académie    O
des    O
sciences    O
''    O
used    O
geological    O
rather    O
than    O
chemical    O
terms    O
and    O
did    O
not    O
include    O
a    O
diagram    O
.    O

Metallate    B-Body109224911
is    O
the    O
name    O
given    O
to    O
any    O
complex    O
anion    B-Body109224911
containing    O
a    O
metal    O
ligated    O
to    O
several    O
atoms    O
or    O
small    O
groups    O
.    O

In    O
chemistry    O
,    O
a    O
polyoxometalate    O
(    O
abbreviated    O
POM    O
)    O
is    O
a    O
polyatomic    B-Body109224911
ion    I-Body109224911
,    O
usually    O
an    O
anion    B-Body109224911
,    O
that    O
consists    O
of    O
three    O
or    O
more    O
transition    O
metal    O
oxyanions    B-Body109224911
linked    O
together    O
by    O
shared    O
oxygen    O
atoms    O
to    O
form    O
closed    O
3-dimensional    O
frameworks    O
.    O

They    O
are    O
usually    O
colorless    O
or    O
orange    O
,    O
diamagnetic    O
anion    B-Body109224911
.    O

Researchers    O
there    O
bombarded    O
242Pu    O
with    O
accelerated    O
22Ne    O
ion    B-Body109224911
and    O
separated    O
the    O
reaction    O
products    O
by    O
gradient    O
thermochromatography    O
after    O
conversion    O
to    O
chlorides    O
by    O
interaction    O
with    O
ZrCl4    O
.    O

The    O
divalent    B-Body109224911
cation    I-Body109224911
binding    O
site    O
is    O
located    O
just    O
below    O
that    O
for    O
the    O
adenosine    O
nucleotide    O
.    O
"    O

Caesium    O
vapor    O
is    O
used    O
to    O
optimize    O
the    O
electrode    O
work    O
functions    O
and    O
provide    O
an    O
ion    B-Body109224911
supply    O
(    O
by    O
surface    O
ionization    O
or    O
electron    O
impact    O
ionization    O
in    O
a    O
plasma    O
)    O
to    O
neutralize    O
the    O
electron    O
space    O
charge    O
.    O

A    O
hydrogen    O
bond    O
,    O
as    O
the    O
term    O
is    O
used    O
here    O
,    O
involves    O
a    O
long    O
range    O
interaction    O
between    O
hydrogen    O
of    O
a    O
hydroxyl    O
group    O
coordinated    O
to    O
a    O
cation    B-Body109224911
and    O
an    O
oxygen    O
atom    O
coordinated    O
to    O
another    O
cation    O
.    O

X    O
-    O
ray    O
experiments    O
were    O
performed    O
by    O
C.    O
J.    O
Ksanda    O
and    O
Tom    O
F.    O
W.    O
Barth    O
and    O
it    O
was    O
concluded    O
that    O
dickite    O
is    O
composed    O
of    O
tiny    O
layers    O
of    O
cations    B-Body109224911
and    O
anions    B-Body109224911
which    O
are    O
parallel    O
to    O
the    O
a    O
-    O
b    O
plane    O
stacked    O
on    O
top    O
of    O
one    O
another    O
which    O
they    O
found    O
to    O
be    O
exactly    O
as    O
Gruner    O
had    O
described    O
.    O

All    O
attempts    O
to    O
create    O
a    O
free    O
borabenzene    O
have    O
resulted    O
in    O
formations    O
of    O
complexes    O
with    O
anion    B-Body109224911
or    O
neutral    O
ligands    O
(    O
even    O
a    O
nitrogen    O
molecule    O
can    O
coordinate    O
to    O
a    O
borabenzene    O
)    O
.    O

However    O
,    O
the    O
complexes    O
with    O
anion    B-Body109224911
ligands    O
,    O
called    O
boratabenzenes    O
,    O
show    O
rich    O
chemistry    O
including    O
the    O
coordination    O
chemistry    O
as    O
anion    B-Body109224911
"    O
π"-type    O
ligands    O
.    O

Boratabenzenes    O
have    O
a    O
negative    O
charge    O
on    O
their    O
six    O
-    O
membered    O
rings    O
and    O
act    O
as    O
strong    O
"    O
π"-donating    O
ligands    O
like    O
a    O
cyclopentadienyl    O
anion    B-Body109224911
,    O
which    O
is    O
often    O
used    O
in    O
transition    O
metal    O
complexes    O
.    O

Cell    O
membranes    O
are    O
generally    O
impermeable    O
to    O
ion    B-Body109224911
,    O
thus    O
they    O
must    O
diffuse    O
through    O
the    O
membrane    O
through    O
transmembrane    O
protein    O
channels    O
.    O

The    O
ion    O
channel    O
hypothesis    O
was    O
first    O
proposed    O
by    O
Arispe    O
and    O
colleagues    O
in    O
1993    O
upon    O
discovery    O
that    O
Aβ    O
could    O
form    O
unregulated    O
cation    B-Body109224911
-    O
selective    O
ion    O
channels    O
when    O
incorporated    O
into    O
planar    O
lipid    O
bilayers    O
.    O

In    O
addition    O
to    O
urinary    O
losses    O
from    O
polyuria    O
and    O
volume    O
contraction    O
,    O
also    O
an    O
obligate    O
loss    O
of    O
potassium    O
from    O
kidney    O
tubules    O
occurs    O
as    O
a    O
cationic    B-Body109224911
partner    O
to    O
the    O
negatively    O
charged    O
ketone    O
,    O
β-hydroxybutyrate    O
.    O

3    O
)    O
During    O
metabolic    O
alkalosis    O
,    O
the    O
acute    O
rise    O
of    O
plasma    O
HCO3−    O
concentration    O
(    O
caused    O
by    O
vomiting    O
,    O
for    O
example    O
)    O
will    O
exceed    O
the    O
capacity    O
of    O
the    O
renal    O
proximal    O
tubule    O
to    O
reabsorb    O
this    O
anion    B-Body109224911
,    O
and    O
potassium    O
will    O
be    O
excreted    O
as    O
an    O
obligate    O
cation    B-Body109224911
partner    O
to    O
the    O
bicarbonate    O
.    O

The    O
composition    O
of    O
the    O
extracellular    O
space    O
includes    O
metabolites    O
,    O
ion    B-Body109224911
,    O
various    O
proteins    O
and    O
non    O
-    O
protein    O
substances    O
(    O
e.g.    O
DNA    O
,    O
RNA    O
,    O
lipids    O
,    O
microbial    O
products    O
etc    O
.    O
)    O
that    O
might    O
affect    O
cellular    O
function    O
.    O

Like    O
the    O
O2    O
,    O
this    O
atmosphere    O
is    O
produced    O
by    O
the    O
disintegration    O
of    O
water    O
molecules    O
,    O
though    O
in    O
this    O
case    O
the    O
disintegration    O
is    O
done    O
by    O
energetic    O
ion    B-Body109224911
that    O
bombard    O
water    O
molecules    O
ejected    O
by    O
Saturn    O
's    O
moon    O
Enceladus    O
.    O

The    O
site    O
was    O
one    O
of    O
six    O
similar    O
sites    O
scattered    O
about    O
North    O
America    O
used    O
to    O
collect    O
measurements    O
of    O
electron    O
density    O
,    O
positive    B-Body109224911
ion    I-Body109224911
composition    O
and    O
distribution    O
,    O
energetic    O
electron    O
precipitation    O
,    O
solar    O
X    O
-    O
rays    O
,    O
and    O
Lyman    O
alpha    O
flux    O
.    O

The    O
original    O
product    O
consisted    O
of    O
powdered    O
sodium    O
hexametaphosphate    O
(    O
amorphous    O
sodium    O
polyphospate    O
)    O
,    O
which    O
in    O
water    O
would    O
complex    O
with    O
ambient    O
calcium    O
ion    B-Body109224911
and    O
certain    O
other    O
cation    B-Body109224911
,    O
preventing    O
formation    O
of    O
unwanted    O
salts    O
and    O
interference    O
by    O
those    O
cations    O
with    O
the    O
actions    O
of    O
soap    O
or    O
other    O
detergents    O
.    O

Interestingly    O
,    O
the    O
chloroacetate    O
anion    B-Body109224911
is    O
the    O
most    O
toxic    O
,    O
with    O
a    O
rat    O
,    O
oral    O
of    O
about    O
0.5    O
g    O
/    O
kg    O
.    O

Barium    O
nitrate    O
with    O
chemical    O
formula    O
Ba(NO3)2    O
is    O
a    O
salt    O
composed    O
of    O
barium    O
and    O
the    O
nitrate    O
ion    B-Body109224911
.    O

Dry    O
etching    O
refers    O
to    O
the    O
removal    O
of    O
material    O
,    O
typically    O
a    O
masked    O
pattern    O
of    O
semiconductor    O
material    O
,    O
by    O
exposing    O
the    O
material    O
to    O
a    O
bombardment    O
of    O
ions    B-Body109224911
(    O
usually    O
a    O
plasma    O
of    O
reactive    O
gases    O
such    O
as    O
fluorocarbons    O
,    O
oxygen    O
,    O
chlorine    O
,    O
boron    O
trichloride    O
;    O
sometimes    O
with    O
addition    O
of    O
nitrogen    O
,    O
argon    O
,    O
helium    O
and    O
other    O
gases    O
)    O
that    O
dislodge    O
portions    O
of    O
the    O
material    O
from    O
the    O
exposed    O
surface    O
.    O

An    O
anode    O
ray    O
(    O
also    O
positive    O
ray    O
or    O
canal    O
ray    O
)    O
is    O
a    O
beam    O
of    O
positive    O
ion    B-Body109224911
that    O
is    O
created    O
by    O
certain    O
types    O
of    O
gas    O
discharge    O
tubes    O
.    O

When    O
the    O
high    O
voltage    O
is    O
applied    O
to    O
the    O
tube    O
,    O
its    O
electric    O
field    O
accelerates    O
the    O
small    O
number    O
of    O
ion    B-Body109224911
(    O
electrically    O
charged    O
atoms    O
)    O
always    O
present    O
in    O
the    O
gas    O
,    O
created    O
by    O
natural    O
processes    O
such    O
as    O
radioactivity    O
.    O

Basic    O
aromatic    O
compounds    O
get    O
protonated    O
and    O
form    O
aromatic    O
cation    B-Body109224911
(    O
e.g.    O
pyridinium    O
)    O
under    O
acidic    O
conditions    O
.    O

Thus    O
,    O
the    O
net    O
charge    O
of    O
the    O
alumina    O
tetrahedra    O
is    O
-1    O
which    O
is    O
balanced    O
by    O
a    O
sodium    O
ion    B-Body109224911
during    O
the    O
production    O
of    O
the    O
catalyst    O
.    O

Other    O
work    O
using    O
chorismate    O
mutase    O
from    O
"    O
Bacillus    O
subtilis    O
"    O
showed    O
evidence    O
that    O
when    O
a    O
cation    B-Body109224911
was    O
aptly    O
placed    O
in    O
the    O
active    O
site    O
,    O
the    O
electrostatic    O
interactions    O
between    O
it    O
and    O
the    O
negatively    O
charged    O
transition    O
state    O
promoted    O
catalysis    O
.    O

Other    O
work    O
using    O
chorismate    O
mutase    O
from    O
"    O
Bacillus    O
subtilis    O
"    O
showed    O
evidence    O
that    O
when    O
a    O
cation    B-Body109224911
was    O
aptly    O
placed    O
in    O
the    O
active    O
site    O
,    O
the    O
electrostatic    O
interactions    O
between    O
it    O
and    O
the    O
negatively    O
charged    O
transition    O
state    O
promoted    O
catalysis    O
.    O

They    O
both    O
employ    O
a    O
divalent    O
cation    B-Body109224911
in    O
the    O
stabilization    O
of    O
an    O
enolate    O
during    O
catalysis    O
,    O
and    O
both    O
are    O
able    O
to    O
deprotonate    O
the    O
C-4    O
hydroxyl    O
group    O
of    O
a    O
phosphoketose    O
substrate    O
.    O

Multiple    O
Coulomb    O
scattering    O
in    O
muons    O
as    O
well    O
as    O
nuclear    O
scattering    O
in    O
protons    O
and    O
ion    B-Body109224911
can    O
reduce    O
the    O
cooling    O
or    O
even    O
lead    O
to    O
net    O
heating    O
transverse    O
to    O
the    O
direction    O
of    O
beam    O
motion    O
.    O

Metals    O
are    O
usually    O
inclined    O
to    O
form    O
cations    B-Body109224911
through    O
electron    O
loss    O
,    O
reacting    O
with    O
oxygen    O
in    O
the    O
air    O
to    O
form    O
oxides    O
over    O
various    O
timescales    O
(    O
iron    O
rusts    O
over    O
years    O
,    O
while    O
potassium    O
burns    O
in    O
seconds    O
)    O
.    O

All    O
silicate    O
minerals    O
have    O
a    O
base    O
unit    O
of    O
a    O
[    O
SiO4]4−    O
silica    O
tetrahedron    O
—    O
that    O
is    O
,    O
a    O
silicon    O
cation    O
coordinated    O
by    O
four    O
oxygen    O
anion    B-Body109224911
,    O
which    O
gives    O
the    O
shape    O
of    O
a    O
tetrahedron    O
.    O

This    O
crystal    O
structure    O
is    O
based    O
on    O
regular    O
internal    O
atomic    O
or    O
ion    B-Body109224911
arrangement    O
that    O
is    O
often    O
expressed    O
in    O
the    O
geometric    O
form    O
that    O
the    O
crystal    O
takes    O
.    O

These    O
charged    O
particles    O
(    O
ions    B-Body109224911
)    O
are    O
found    O
in    O
the    O
fluid    O
surrounding    O
the    O
entire    O
nervous    O
system    O
.    O

Molecules    O
are    O
distinguished    O
from    O
ion    B-Body109224911
by    O
their    O
lack    O
of    O
electrical    O
charge    O
.    O

The    O
term    O
"    O
unstable    O
molecule    O
"    O
is    O
used    O
for    O
very    O
reactive    O
species    O
,    O
i.e.    O
,    O
short    O
-    O
lived    O
assemblies    O
(    O
resonances    O
)    O
of    O
electrons    O
and    O
nuclei    B-Body109224911
,    O
such    O
as    O
radicals    O
,    O
molecular    O
ion    B-Body109224911
,    O
Rydberg    O
molecules    O
,    O
transition    O
states    O
,    O
van    O
der    O
Waals    O
complexes    O
,    O
or    O
systems    O
of    O
colliding    O
atoms    O
as    O
in    O
Bose    O
–    O
Einstein    O
condensate    O
.    O

This    O
definition    O
often    O
breaks    O
down    O
since    O
many    O
substances    O
in    O
ordinary    O
experience    O
,    O
such    O
as    O
rocks    O
,    O
salts    O
,    O
and    O
metals    O
,    O
are    O
composed    O
of    O
large    O
crystalline    O
networks    O
of    O
chemically    O
bonded    O
atoms    O
or    O
ion    B-Body109224911
,    O
but    O
are    O
not    O
made    O
of    O
discrete    O
molecules    O
.    O

Ionic    O
bonding    O
is    O
a    O
type    O
of    O
chemical    O
bond    O
that    O
involves    O
the    O
electrostatic    O
attraction    O
between    O
oppositely    O
charged    O
ion    B-Body109224911
,    O
and    O
is    O
the    O
primary    O
interaction    O
occurring    O
in    O
ionic    O
compounds    O
.    O

The    O
ions    O
are    O
atoms    O
that    O
have    O
lost    O
one    O
or    O
more    O
electrons    O
(    O
termed    O
cation    B-Body109224911
)    O
and    O
atoms    O
that    O
have    O
gained    O
one    O
or    O
more    O
electrons    O
(    O
termed    O
anion    B-Body109224911
)    O
.    O

As    O
a    O
chemist    O
,    O
Faraday    O
discovered    O
benzene    O
,    O
investigated    O
the    O
clathrate    O
hydrate    O
of    O
chlorine    O
,    O
invented    O
an    O
early    O
form    O
of    O
the    O
Bunsen    O
burner    O
and    O
the    O
system    O
of    O
oxidation    O
numbers    O
,    O
and    O
popularised    O
terminology    O
such    O
as    O
"    O
anode    O
"    O
,    O
"    O
cathode    O
"    O
,    O
"    O
electrode    O
"    O
and    O
"    O
ion    B-Body109224911
"    O
.    O

Faraday    O
is    O
also    O
responsible    O
for    O
discovering    O
the    O
laws    O
of    O
electrolysis    O
,    O
and    O
for    O
popularizing    O
terminology    O
such    O
as    O
anode    O
,    O
cathode    O
,    O
electrode    O
,    O
and    O
ion    B-Body109224911
,    O
terms    O
proposed    O
in    O
large    O
part    O
by    O
William    O
Whewell    O
.    O

In    O
order    O
to    O
satisfy    O
this    O
liquid    O
neat    O
oligomer    O
can    O
be    O
doped    O
with    O
either    O
anionic    B-Body109224911
or    O
cationic    B-Body109224911
photoinitiators    O
that    O
will    O
initiate    O
polymerization    O
only    O
when    O
radiated    O
with    O
light    O
.    O

The    O
proposed    O
mechanism    O
for    O
cationic    B-Body109224911
photopolymerization    O
begins    O
with    O
the    O
photoexcitation    O
of    O
the    O
initiator    O
.    O

Once    O
excited    O
,    O
both    O
homolytic    O
cleavage    O
and    O
dissociation    O
of    O
a    O
counter    O
anion    B-Body109224911
takes    O
place    O
,    O
generating    O
cationic    O
radical    O
(    O
R    O
)    O
,    O
an    O
aryl    O
radical(R    O
'    O
)    O
and    O
unaltered    O
counter    O
anion    O
(    O
X    O
)    O
.    O

One    O
characteristic    O
that    O
is    O
crucial    O
to    O
the    O
performance    O
of    O
the    O
onium    O
photoinitiators    O
is    O
that    O
the    O
counter    O
anion    B-Body109224911
is    O
non    O
-    O
nucleophilic    O
.    O

For    O
the    O
anionic    B-Body109224911
case    O
,    O
excitation    O
of    O
a    O
metal    O
center    O
is    O
followed    O
by    O
either    O
heterolytic    O
bond    O
cleavage    O
or    O
electron    O
transfer    O
generating    O
the    O
active    O
anionic    O
initiator    O
.    O

In    O
the    O
presence    O
of    O
a    O
cationic    B-Body109224911
photoinitiator    O
photopolymer    O
SU-8    O
forms    O
networks    O
with    O
other    O
polymers    O
in    O
solution    O
.    O

The    O
plasma    O
source    O
,    O
known    O
as    O
etch    O
species    O
,    O
can    O
be    O
either    O
charged    O
(    O
ion    B-Body109224911
)    O
or    O
neutral    O
(    O
atoms    O
and    O
radicals    O
)    O
.    O

The    O
active    O
site    O
of    O
HPPD    O
has    O
not    O
been    O
completely    O
mapped    O
,    O
but    O
it    O
is    O
known    O
that    O
the    O
site    O
consists    O
of    O
an    O
iron    O
ion    B-Body109224911
surrounded    O
by    O
amino    O
acids    O
extending    O
inward    O
from    O
beta    O
sheets    O
(    O
with    O
the    O
exception    O
of    O
the    O
C    O
-    O
terminal    O
helix    O
)    O
.    O

The    O
quadruplex    O
structure    O
is    O
further    O
stabilized    O
by    O
the    O
presence    O
of    O
a    O
cation    B-Body109224911
,    O
especially    O
potassium    O
,    O
which    O
sits    O
in    O
a    O
central    O
channel    O
between    O
each    O
pair    O
of    O
tetrads    O
.    O

The    O
ion    B-Body109224911
dominance    O
ordering    O
shows    O
that    O
sodium    O
cation    B-Body109224911
is    O
most    O
commonly    O
predominating    O
over    O
calcium    O
and    O
magnesium    O
-    O
whereas    O
chloride    O
is    O
predominant    O
over    O
sulfate    O
and    O
bicarbonate    O
.    O

The    O
metal    O
ions    B-Body109224911
that    O
can    O
bind    O
to    O
these    O
sites    O
are    O
either    O
zinc    O
or    O
magnesium    O
.    O

In    O
a    O
colloidal    O
dispersed    O
system    O
,    O
ion    B-Body109224911
dissolution    O
arises    O
,    O
where    O
the    O
dispersed    O
particles    O
exist    O
in    O
equilibrium    O
with    O
their    O
saturated    O
counterpart    O
,    O
i.e.    O

The    O
charge    O
must    O
be    O
zero    O
,    O
and    O
this    O
does    O
not    O
necessarily    O
mean    O
the    O
number    O
of    O
cation    B-Body109224911
versus    O
anion    B-Body109224911
in    O
the    O
solution    O
are    O
equal    O
.    O

Laboratory    O
tests    O
used    O
to    O
disagnose    O
a    O
soil    O
as    O
dispersive    O
focus    O
on    O
the    O
cation    O
exchange    O
capacity    O
of    O
a    O
soil    O
sample    O
and    O
its    O
cation    B-Body109224911
breakdown    O
.    O

Neomycin    O
B    O
,    O
diphenylfuran    O
cation    B-Body109224911
,    O
and    O
proflavine    O
are    O
small    O
molecules    O
that    O
can    O
prevent    O
Rev    O
from    O
binding    O
to    O
the    O
RRE    O
sequence    O
.    O

Thiocarbonate    O
describes    O
a    O
family    O
of    O
anion    B-Body109224911
with    O
the    O
general    O
chemical    O
formula    O
(    O
"    O
x    O
"    O
=    O
0    O
,    O
1    O
,    O
or    O
2    O
)    O
.    O

Appearance    O
energy    O
(    O
also    O
known    O
as    O
appearance    O
potential    O
)    O
is    O
the    O
minimum    O
energy    O
that    O
must    O
be    O
supplied    O
to    O
a    O
gas    O
phase    O
atom    O
or    O
molecule    O
in    O
order    O
to    O
produce    O
an    O
ion    B-Body109224911
.    O

As    O
fixation    O
agents    O
used    O
in    O
pulp    O
and    O
paper    O
production    O
are    O
minerals    O
like    O
talc    O
and    O
bentonite    O
or    O
different    O
cationic    B-Body109224911
polymers    O
like    O
polyDADMAC    O
.    O

In    O
paper    O
making    O
,    O
the    O
most    O
widely    O
used    O
detackifier    O
is    O
talc    O
,    O
anionic    B-Body109224911
dispersants    O
,    O
ethoxylated    O
surfactants    O
,    O
and    O
cellulose    O
based    O
detackifiers    O
.    O

|    O
ions    B-Body109224911

This    O
drives    O
more    O
paracellular    O
reabsorption    O
of    O
Na+    O
,    O
as    O
well    O
as    O
other    O
cation    B-Body109224911
such    O
as    O
magnesium    O
(    O
Mg2    O
+    O
)    O
and    O
importantly    O
calcium    O
Ca2    O
+    O
due    O
to    O
charge    O
repulsion    O
.    O

The    O
resulting    O
fragment    O
ion    B-Body109224911
(    O
called    O
b    O
-    O
ions    O
and    O
y    O
-    O
ions    O
)    O
have    O
mass    O
differences    O
corresponding    O
to    O
the    O
residue    O
masses    O
of    O
the    O
respective    O
amino    O
acids    O
.    O

The    O
Y3    O
+    O
ion    B-Body109224911
is    O
colorless    O
in    O
solution    O
because    O
of    O
the    O
absence    O
of    O
electrons    O
in    O
the    O
d    O
and    O
f    O
electron    O
shells    O
.    O

The    O
rarity    O
of    O
tellurium    O
—    O
of    O
which    O
telluride    O
is    O
the    O
anion    B-Body109224911
form    O
—    O
is    O
comparable    O
to    O
that    O
of    O
platinum    O
in    O
the    O
earth    O
's    O
crust    O
and    O
contributes    O
significantly    O
to    O
the    O
module    O
's    O
cost    O
.    O

Chemi    O
-    O
ionization    O
is    O
the    O
formation    O
of    O
an    O
ion    B-Body109224911
through    O
the    O
reaction    O
of    O
a    O
gas    O
phase    O
atom    O
or    O
molecule    O
with    O
an    O
atom    O
or    O
molecule    O
in    O
an    O
excited    O
state    O
while    O
also    O
creating    O
new    O
bonds    O
.    O

where    O
G    O
is    O
the    O
excited    O
state    O
species    O
(    O
indicated    O
by    O
the    O
super    O
-    O
scripted    O
asterisk    O
)    O
,    O
and    O
M    O
is    O
the    O
species    O
that    O
is    O
ionized    O
by    O
the    O
loss    O
of    O
an    O
electron    O
to    O
form    O
the    O
radical    O
cation    B-Body109224911
(    O
indicated    O
by    O
the    O
super    O
-    O
scripted    O
"    O
plus    O
-    O
dot    O
"    O
)    O
.    O

TRPV1    O
,    O
which    O
can    O
also    O
be    O
stimulated    O
with    O
heat    O
,    O
protons    O
and    O
physical    O
abrasion    O
,    O
permits    O
cation    B-Body109224911
to    O
pass    O
through    O
the    O
cell    O
membrane    O
when    O
activated    O
.    O

Body    O
-    O
Mounted    O
Instruments    O
.    O
Detectors    O
for    O
electrons    O
,    O
ion    B-Body109224911
,    O
neutral    O
gas    O
,    O
dust    O
,    O
and    O
cosmic    O
rays    O
were    O
mounted    O
on    O
the    O
spacecraft    O
body    O
around    O
the    O
quiet    O
section    O
.    O

It    O
is    O
a    O
white    O
solid    O
ionic    O
compound    O
consisting    O
of    O
sodium    O
cation    B-Body109224911
and    O
hydroxide    O
anion    B-Body109224911
.    O

In    O
crystallography    O
,    O
crystal    O
structure    O
is    O
a    O
description    O
of    O
the    O
ordered    O
arrangement    O
of    O
atoms    O
,    O
ion    B-Body109224911
or    O
molecules    O
in    O
a    O
crystalline    O
material    O
.    O

The    O
crystallographic    O
directions    O
are    O
geometric    O
lines    O
linking    O
nodes    O
(    O
atoms    O
,    O
ion    B-Body109224911
or    O
molecules    O
)    O
of    O
a    O
crystal    O
.    O

Alums    O
are    O
double    O
sulfate    O
salts    O
,    O
with    O
the    O
general    O
formula    O
,    O
where    O
"    O
A    O
"    O
is    O
a    O
monovalent    O
cation    B-Body109224911
such    O
as    O
potassium    O
or    O
ammonium    O
and    O
"    O
M    O
"    O
is    O
a    O
trivalent    O
metal    O
ion    O
such    O
as    O
aluminium    O
or    O
chromium(III    O
)    O
.    O

Double    O
sulfates    O
with    O
the    O
general    O
formula    O
,    O
are    O
known    O
where    O
"    O
A    O
"    O
is    O
a    O
monovalent    O
cation    B-Body109224911
such    O
as    O
sodium    O
,    O
potassium    O
,    O
rubidium    O
,    O
caesium    O
,    O
or    O
thallium(I    O
)    O
,    O
or    O
a    O
compound    O
cation    O
such    O
as    O
ammonium    O
,    O
methylammonium    O
,    O
hydroxylammonium    O
or    O
hydrazinium    O
,    O
"    O
B    O
"    O
is    O
a    O
trivalent    O
metal    O
ion    O
,    O
such    O
as    O
aluminium    O
,    O
chromium    O
,    O
titanium    O
,    O
manganese    O
,    O
vanadium    O
,    O
iron(III    O
)    O
,    O
cobalt(III    O
)    O
,    O
gallium    O
,    O
molybdenum    O
,    O
indium    O
,    O
ruthenium    O
,    O
rhodium    O
,    O
or    O
iridium    O
.    O

The    O
specific    O
combinations    O
of    O
univalent    O
cation    O
,    O
trivalent    O
cation    O
,    O
and    O
anion    B-Body109224911
depends    O
on    O
the    O
sizes    O
of    O
the    O
ion    B-Body109224911
.    O

In    O
the    O
ISR    O
mode    O
using    O
the    O
high    O
power    O
transmitter    O
,    O
Jicamarca    O
measures    O
the    O
electron    O
density    O
,    O
electron    O
and    O
ion    B-Body109224911
temperature    O
,    O
ion    O
composition    O
and    O
vertical    O
and    O
zonal    O
electric    O
fields    O
in    O
the    O
equatorial    O
ionosphere    O
.    O

Topside    O
:    O
What    O
controls    O
the    O
light    O
ion    B-Body109224911
distribution    O
?    O

F    O
region    O
:    O
Do    O
current    O
theories    O
fully    O
explain    O
electron    O
and    O
ion    B-Body109224911
thermal    O
balance    O
?    O

Electrophoresis    O
has    O
been    O
used    O
to    O
fractionate    O
small    O
ion    B-Body109224911
,    O
charged    O
organic    O
molecules    O
,    O
proteins    O
,    O
and    O
DNA    O
.    O

The    O
most    O
familiar    O
of    O
these    O
is    O
probably    O
the    O
presence    O
of    O
ion    B-Body109224911
of    O
calcium    O
(    O
Ca2    O
+    O
)    O
and    O
magnesium    O
(    O
Mg2    O
+    O
)    O
which    O
interfere    O
with    O
the    O
cleaning    O
action    O
of    O
soap    O
,    O
and    O
can    O
form    O
hard    O
sulfate    O
and    O
soft    O
carbonate    O
deposits    O
in    O
water    O
heaters    O
or    O
boilers    O
.    O

ion    O
exchange-    O
a    O
reversible    O
chemical    O
reaction    O
where    O
ion    B-Body109224911
with    O
the    O
same    O
charge    O
are    O
switched    O
;    O
this    O
principle    O
is    O
used    O
in    O
the    O
purification    O
of    O
waste    O
water    O

If    O
the    O
ion    B-Body109224911
gains    O
electrons    O
from    O
its    O
environment    O
,    O
the    O
alpha    O
particle    O
becomes    O
a    O
normal    O
(    O
electrically    O
neutral    O
)    O
helium    O
atom    O
.    O

In    O
this    O
cation    B-Body109224911
,    O
the    O
chloride    O
spontaneously    O
dissociates    O
.    O

However    O
,    O
in    O
a    O
real    O
solid    O
these    O
particles    O
could    O
just    O
as    O
easily    O
be    O
ions    B-Body109224911
.    O

Thus    O
,    O
this    O
allows    O
for    O
the    O
decarboxylation    O
of    O
glutaconyl    O
-    O
CoA    O
,    O
an    O
enzyme    O
-    O
bound    O
intermediate    O
,    O
by    O
breaking    O
the    O
Cγ-Cδ    O
bond    O
,    O
resulting    O
in    O
formation    O
of    O
a    O
dienolate    B-Body109224911
anion    I-Body109224911
,    O
a    O
proton    O
,    O
and    O
CO2    O
.    O

In    O
CF    O
,    O
genomic    O
DNA    O
is    O
heat    O
-    O
denatured    O
and    O
allowed    O
to    O
renature    O
to    O
a    O
Cot    O
value    O
(    O
Cot    O
=    O
DNA    O
concentration    O
x    O
time    O
x    O
a    O
factor    O
based    O
on    O
the    O
cation    B-Body109224911
concentration    O
of    O
the    O
buffer    O
)    O
at    O
which    O
the    O
majority    O
of    O
repetitive    O
elements    O
have    O
reassociated    O
but    O
single    O
and    O
low    O
-    O
copy    O
elements    O
remain    O
single    O
stranded    O
.    O

The    O
C0    O
t    O
value    O
is    O
the    O
product    O
of    O
C0    O
(    O
the    O
initial    O
concentration    O
of    O
DNA    O
)    O
,    O
t    O
(    O
time    O
in    O
seconds    O
)    O
,    O
and    O
a    O
constant    O
that    O
depends    O
on    O
the    O
concentration    O
of    O
cation    B-Body109224911
in    O
the    O
buffer    O
.    O

The    O
NA60    O
experiment    O
was    O
a    O
high    O
energy    O
heavy    O
ion    B-Body109224911
experiment    O
at    O
the    O
CERN    O
Super    O
Proton    O
Synchrotron    O
.    O

Within    O
the    O
atmosphere    O
,    O
the    O
effect    O
is    O
caused    O
by    O
the    O
large    O
volume    O
of    O
ion    B-Body109224911
air    O
created    O
by    O
the    O
energy    O
of    O
the    O
explosion    O
,    O
while    O
above    O
the    O
atmosphere    O
it    O
is    O
due    O
to    O
the    O
action    O
of    O
high    O
-    O
energy    O
beta    O
particles    O
released    O
from    O
the    O
decaying    O
bomb    O
debris    O
.    O

This    O
radiation    O
originates    O
from    O
outside    O
the    O
solar    O
system    O
and    O
consists    O
of    O
ion    B-Body109224911
charged    O
atomic    B-Body109224911
nuclei    I-Body109224911
from    O
hydrogen    O
,    O
helium    O
and    O
uranium    O
.    O

Highly    O
charged    O
ions    O
(    O
HCI    O
)    O
are    O
ion    B-Body109224911
in    O
very    O
high    O
charge    O
states    O
due    O
to    O
the    O
loss    O
of    O
many    O
or    O
most    O
of    O
their    O
bound    O
electrons    O
by    O
energetic    O
collisions    O
or    O
high    O
-    O
energy    O
photon    O
absorption    O
.    O

Reverse    O
osmosis    O
is    O
a    O
water    O
purification    O
technology    O
that    O
uses    O
a    O
semipermeable    O
membrane    O
to    O
remove    O
ions    B-Body109224911
,    O
molecules    O
,    O
and    O
larger    O
particles    O
from    O
drinking    O
water    O
.    O

The    O
nameplate    O
"    O
Ioniq    O
"    O
is    O
a    O
portmanteau    O
of    O
"    O
ion    B-Body109224911
"    O
and    O
"    O
unique    O
"    O
.    O

"    O
B    O
"    O
is    O
a    O
coefficient    O
which    O
characterises    O
the    O
ion    B-Body109224911
-    O
solvent    O
interactions    O
at    O
a    O
defined    O
temperature    O
and    O
pressure    O
.    O

TrkH    O
from    O
"    O
Escherichia    O
coli    O
"    O
is    O
a    O
transmembrane    O
protein    O
and    O
determines    O
the    O
specificity    O
and    O
kinetics    O
of    O
cation    B-Body109224911
transport    O
by    O
the    O
TrK    O
system    O
in    O
this    O
organism    O
.    O

from    O
which    O
they    O
developed    O
a    O
new    O
process    O
using    O
high    O
charge    O
state    O
ions    B-Body109224911
for    O
fabricating    O
nanoelectronic    O
devices    O
,    O

Conversely    O
,    O
the    O
ion    B-Body109224911
is    O
formed    O
in    O
the    O
mixtures    O
used    O
in    O
lasers    O
.    O

Once    O
the    O
collagen    O
has    O
been    O
removed    O
from    O
bone    O
,    O
the    O
hydroxyapatite    O
content    O
is    O
degraded    O
by    O
inorganic    O
mineral    O
weathering    O
,    O
meaning    O
that    O
important    O
ions    B-Body109224911
,    O
such    O
as    O
calcium    O
,    O
are    O
lost    O
to    O
the    O
environment    O
.    O

In    O
response    O
to    O
sound    O
,    O
outer    O
hair    O
cells    O
lengthen    O
then    O
shorten    O
through    O
a    O
process    O
controlled    O
and    O
powered    O
by    O
the    O
flow    O
of    O
electrically    O
charged    O
molecules    O
such    O
as    O
potassium    O
ion    B-Body109224911
.    O

The    O
treatment    O
works    O
on    O
the    O
principle    O
that    O
charged    O
ion    B-Body109224911
in    O
the    O
skin    O
are    O
either    O
attracted    O
or    O
repelled    O
from    O
the    O
electrodes    O
,    O
resulting    O
in    O
certain    O
chemical    O
effects    O
.    O

The    O
semi    O
arid    O
conditions    O
of    O
the    O
area    O
,    O
saline    O
and    O
alkaline    O
soils    O
/    O
groundwater    O
conditions    O
and    O
weathering    O
of    O
the    O
silicate    O
rock    O
exposed    O
in    O
the    O
drainage    O
basin    O
are    O
assessed    O
as    O
the    O
reasons    O
for    O
the    O
supply    O
of    O
major    O
ion    B-Body109224911
.    O

This    O
composition    O
is    O
chiefly    O
the    O
result    O
of    O
the    O
ion    B-Body109224911
composition    O
of    O
seawater    O
.    O

A    O
zinc    O
finger    O
is    O
a    O
small    O
protein    O
structural    O
motif    O
that    O
is    O
characterized    O
by    O
the    O
coordination    O
of    O
one    O
or    O
more    O
zinc    O
ion    B-Body109224911
in    O
order    O
to    O
stabilize    O
the    O
fold    O
.    O

Cooperative    O
luminescence    O
is    O
the    O
radiative    O
process    O
in    O
which    O
two    O
excited    O
ion    B-Body109224911
simultaneously    O
make    O
downward    O
transition    O
to    O
emit    O
one    O
photon    O
with    O
the    O
sum    O
of    O
their    O
excitation    O
energies    O
.    O

In    O
a    O
tandem    O
mass    O
spectrometer    O
,    O
ion    B-Body109224911
are    O
formed    O
in    O
the    O
ion    B-Body109224911
source    I-Body109224911
and    O
separated    O
by    O
mass    O
-    O
to    O
-    O
charge    O
ratio    O
in    O
the    O
first    O
stage    O
of    O
mass    O
spectrometry    O
(    O
MS1    O
)    O
.    O

These    O
anion    B-Body109224911
can    O
be    O
generated    O
in    O
a    O
helium    O
gas    O
by    O
laser    O
vaporization    O
of    O
an    O
aluminium    O
/    O
lithium    O
carbonate    O
composite    O
or    O
a    O
copper    O
or    O
sodium    O
/    O
aluminium    O
alloy    O
,    O
separated    O
and    O
selected    O
by    O
mass    O
spectrometry    O
and    O
analyzed    O
by    O
photoelectron    O
spectroscopy    O
.    O

For    O
typical    O
ionic    O
solids    O
,    O
the    O
cation    B-Body109224911
are    O
smaller    O
than    O
the    O
anion    B-Body109224911
,    O
and    O
each    O
cation    O
is    O
surrounded    O
by    O
coordinated    O
anions    O
which    O
form    O
a    O
polyhedron    O
.    O

These    O
bow    O
-    O
ties    O
are    O
linked    O
together    O
into    O
sheets    O
by    O
the    O
"    O
B    O
"    O
cation    B-Body109224911
.    O

A    O
ketyl    O
group    O
in    O
organic    O
chemistry    O
is    O
an    O
anion    B-Body109224911
radical    O
that    O
contains    O
a    O
group    O
=    O
C−O•    O
in    O
which    O
an    O
oxygen    O
radical    O
is    O
bonded    O
directly    O
to    O
carbon    O
,    O
negatively    O
charged    O
.    O

This    O
finding    O
provided    O
a    O
basis    O
for    O
the    O
current    O
understanding    O
that    O
electrical    O
energy    O
(    O
carried    O
by    O
ion    B-Body109224911
)    O
,    O
and    O
not    O
air    O
or    O
fluid    O
,    O
is    O
the    O
impetus    O
behind    O
muscle    O
movement    O
.    O

PIH    O
has    O
now    O
been    O
demonstrated    O
in    O
natrolites    O
containing    O
Li    O
,    O
K    O
,    O
Rb    O
and    O
Ag    O
as    O
monovalent    O
cations    B-Body109224911
as    O
well    O
as    O
in    O
large    O
-    O
pore    O
zeolites    O
,    O
pyrochlores    O
,    O
clays    O
and    O
graphite    O
oxide    O
.    O

It    O
readily    O
loses    O
two    O
protons    O
to    O
yield    O
the    O
divalent    O
anion    B-Body109224911
C3O52−    O
,    O
called    O
mesoxalate    O
,    O
oxomalonate    O
,    O
or    O
ketomalonate    O
.    O

For    O
type    O
-    O
I    O
ionic    O
binary    O
compounds    O
,    O
the    O
cation    B-Body109224911
(    O
a    O
metal    O
in    O
most    O
cases    O
)    O
is    O
named    O
first    O
,    O
and    O
the    O
anion    B-Body109224911
(    O
usually    O
a    O
nonmetal    O
)    O
is    O
named    O
second    O
.    O

Further    O
,    O
the    O
LDA    O
provides    O
a    O
poor    O
description    O
of    O
electron    O
-    O
rich    O
species    O
such    O
as    O
anion    B-Body109224911
where    O
it    O
is    O
often    O
unable    O
to    O
bind    O
an    O
additional    O
electron    O
,    O
erroneously    O
predicating    O
species    O
to    O
be    O
unstable    O
.    O

#    O
Single    O
atom    O
anion    B-Body109224911
are    O
named    O
with    O
an    O
"    O
-ide    O
"    O
suffix    O
:    O
for    O
example    O
,    O
H−    O
is    O
hydride    O
.    O

#    O
Compounds    O
with    O
a    O
positive    O
ion    B-Body109224911
(    O
cation    B-Body109224911
)    O
:    O
The    O
name    O
of    O
the    O
compound    O
is    O
simply    O
the    O
cation    O
's    O
name    O
(    O
usually    O
the    O
same    O
as    O
the    O
element    O
's    O
)    O
,    O
followed    O
by    O
the    O
anion    O
.    O

In    O
chemistry    O
,    O
an    O
onium    B-Body109224911
ion    I-Body109224911
,    O
is    O
a    O
cation    B-Body109224911
formally    O
obtained    O
by    O
the    O
protonation    O
of    O
mononuclear    O
parent    O
hydride    O
of    O
a    O
pnictogen    O
(    O
group    O
15    O
of    O
the    O
periodic    O
table    O
)    O
,    O
chalcogen    O
(    O
group    O
16    O
)    O
,    O
or    O
halogen    O
(    O
group    O
17    O
)    O
.    O

Compounds    O
of    O
an    O
onium    O
cation    O
and    O
some    O
other    O
negative    B-Body109224911
ion    I-Body109224911
are    O
known    O
as    O
onium    O
compounds    O
or    O
onium    O
salts    O
.    O

Lewis    O
bases    O
form    O
onium    O
ions    O
when    O
the    O
central    O
atom    O
gains    O
one    O
more    O
bond    O
and    O
becomes    O
a    O
positive    O
cation    B-Body109224911
.    O

Lewis    O
acids    O
form    O
-ate    O
ions    O
when    O
the    O
central    O
atom    O
gains    O
one    O
more    O
bond    O
and    O
becomes    O
a    O
negative    O
anion    B-Body109224911
.    O

SEER    O
's    O
research    O
claims    O
that    O
the    O
benefits    O
of    O
adding    O
rockdust    O
to    O
soil    O
include    O
increased    O
moisture    O
-    O
holding    O
properties    O
in    O
the    O
soil    O
,    O
improved    O
cation    B-Body109224911
exchange    O
capacity    O
and    O
better    O
soil    O
structure    O
and    O
drainage    O
.    O

The    O
elements    O
high    O
in    O
available    O
2    O
+    O
valence    O
electrons    O
,    O
calcium    O
,    O
iron    O
and    O
magnesium    O
in    O
particular    O
contribute    O
to    O
paramagnetism    O
in    O
soil    O
which    O
aid    O
in    O
cation    B-Body109224911
exchange    O
capacity    O
.    O

Transformation    O
into    O
carbon    O
dioxide    O
and    O
water    O
,    O
otherwise    O
known    O
as    O
mineralization    O
,    O
of    O
CWAs    O
has    O
been    O
observed    O
as    O
a    O
result    O
of    O
the    O
radicals    O
and    O
anions    B-Body109224911
.    O

Substitutions(represented    O
by    O
the    O
leaves    O
on    O
the    O
stalk    O
)    O
–    O
the    O
spacer    O
can    O
be    O
modified    O
both    O
in    O
charge    B-Body109224911
,    O
and    O
polarity    O
.    O

Carbamoyl    O
phosphate    O
is    O
an    O
anion    B-Body109224911
of    O
biochemical    O
significance    O
.    O

Shermer    O
's    O
embrace    O
of    O
scientific    O
skepticism    O
crystallized    O
during    O
his    O
time    O
as    O
a    O
cyclist    O
,    O
explaining    O
,    O
"    O
I    O
became    O
a    O
skeptic    O
on    O
Saturday    O
,    O
August    O
6    O
,    O
1983    O
,    O
on    O
the    O
long    O
climbing    O
road    O
to    O
Loveland    O
Pass    O
,    O
Colorado    O
"    O
,    O
after    O
months    O
of    O
training    O
under    O
the    O
guidance    O
of    O
a    O
"    O
nutritionist    O
"    O
with    O
an    O
unaccredited    O
PhD.    O
After    O
years    O
of    O
practicing    O
acupuncture    O
,    O
chiropractic    O
,    O
massage    O
therapy    O
,    O
negative    B-Body109224911
ion    I-Body109224911
,    O
rolfing    O
,    O
pyramid    O
power    O
,    O
fundamentalist    O
Christianity    O
,    O
and    O
"    O
a    O
host    O
of    O
weird    O
things    O
"    O
(    O
with    O
the    O
exception    O
of    O
drugs    O
)    O
to    O
improve    O
his    O
life    O
and    O
training    O
,    O
Shermer    O
stopped    O
rationalizing    O
the    O
failure    O
of    O
these    O
practices    O
.    O

Depending    O
on    O
influx    O
of    O
ion    B-Body109224911
,    O
PDS    O
can    O
be    O
theoretically    O
categorized    O
into    O
two    O
type    O
.    O

Following    O
exposure    O
to    O
ionizing    O
radiation    O
(    O
e.g.    O
,    O
electrons    O
,    O
ions    B-Body109224911
,    O
X    O
-    O
rays    O
,    O
extreme    O
ultraviolet    O
,    O
vacuum    O
ultraviolet    O
)    O
,    O
secondary    O
electron    O
emission    O
from    O
the    O
surface    O
of    O
a    O
thin    O
insulating    O
layer    O
results    O
in    O
the    O
establishment    O
of    O
a    O
positive    O
charge    O
on    O
the    O
surface    O
.    O

An    O
IMS    O
measures    O
how    O
fast    O
a    O
given    O
ion    B-Body109224911
moves    O
in    O
a    O
uniform    O
electric    O
field    O
through    O
a    O
given    O
atmosphere    O
.    O

The    O
energy    O
required    O
to    O
remove    O
one    O
or    O
more    O
electrons    O
to    O
make    O
a    O
cation    B-Body109224911
is    O
a    O
sum    O
of    O
successive    O
ionization    O
energies    O
;    O
for    O
example    O
,    O
the    O
energy    O
needed    O
to    O
form    O
Mg2    O
+    O
is    O
the    O
ionization    O
energy    O
required    O
to    O
remove    O
the    O
first    O
electron    O
from    O
Mg    O
,    O
plus    O
the    O
ionization    O
energy    O
required    O
to    O
remove    O
the    O
second    O
electron    O
from    O
Mg+    O
.    O

Molecules    O
,    O
by    O
definition    O
,    O
are    O
most    O
often    O
held    O
together    O
with    O
covalent    O
bonds    O
involving    O
single    O
,    O
double    O
,    O
and/or    O
triple    O
bonds    O
,    O
where    O
a    O
"    O
bond    O
"    O
is    O
a    O
shared    O
pair    O
of    O
electrons    O
(    O
the    O
other    O
method    O
of    O
bonding    O
between    O
atoms    O
is    O
called    O
ionic    B-Body109224911
bonding    I-Body109224911
and    O
involves    O
a    O
positive    O
cation    B-Body109224911
and    O
a    O
negative    O
anion    B-Body109224911
)    O
.    O

Basic    O
IUPAC    O
inorganic    O
nomenclature    O
has    O
two    O
main    O
parts    O
:    O
the    O
cation    B-Body109224911
and    O
the    O
anion    B-Body109224911
.    O

The    O
cation    O
is    O
the    O
name    O
for    O
the    O
positively    O
charged    O
ion    B-Body109224911
and    O
the    O
anion    O
is    O
the    O
name    O
for    O
the    O
negatively    O
charged    O
ion    O
.    O

Ionic    B-Body109224911
bonding    I-Body109224911
is    O
a    O
type    O
of    O
chemical    O
bond    O
that    O
involves    O
the    O
electrostatic    O
attraction    O
between    O
oppositely    O
charged    O
ion    B-Body109224911
,    O
and    O
is    O
the    O
primary    O
interaction    O
occurring    O
in    O
ionic    O
compounds    O
.    O

The    O
ions    O
are    O
atoms    O
that    O
have    O
gained    O
one    O
or    O
more    O
electrons    O
(    O
known    O
as    O
anion    B-Body109224911
,    O
which    O
are    O
negatively    O
charged    O
)    O
and    O
atoms    O
that    O
have    O
lost    O
one    O
or    O
more    O
electrons    O
(    O
known    O
as    O
cation    B-Body109224911
,    O
which    O
are    O
positively    O
charged    O
)    O
.    O

Atoms    O
that    O
are    O
strongly    O
electronegative    O
(    O
as    O
is    O
the    O
case    O
with    O
halogens    O
)    O
often    O
have    O
only    O
one    O
or    O
two    O
empty    O
orbitals    O
in    O
their    O
valence    O
shell    O
,    O
and    O
frequently    O
bond    O
with    O
other    O
molecules    O
or    O
gain    O
electrons    O
to    O
form    O
anions    B-Body109224911
.    O

As    O
a    O
result    O
,    O
weakly    O
electronegative    O
atoms    O
tend    O
to    O
distort    O
their    O
electrons    O
cloud    O
and    O
form    O
cations    B-Body109224911
.    O

Ion    B-Body109224911
in    O
crystal    O
lattices    O
of    O
purely    O
ionic    O
compounds    O
are    O
spherical    O
;    O
however    O
,    O
if    O
the    O
positive    O
ion    O
is    O
small    O
and/or    O
highly    O
charged    O
,    O
it    O
will    O
distort    O
the    O
electron    O
cloud    O
of    O
the    O
negative    O
ion    O
,    O
an    O
effect    O
summarised    O
in    O
Fajans    O
'    O
rules    O
.    O

When    O
an    O
activated    O
T    O
cell    O
contacts    O
such    O
cells    O
,    O
it    O
releases    O
cytotoxins    O
,    O
such    O
as    O
perforin    O
,    O
which    O
form    O
pores    O
in    O
the    O
target    O
cell    O
's    O
plasma    O
membrane    O
,    O
allowing    O
ion    B-Body109224911
,    O
water    O
and    O
toxins    O
to    O
enter    O
.    O

Electrical    O
breakdown    O
occurs    O
when    O
the    O
electric    O
field    O
in    O
the    O
material    O
is    O
strong    O
enough    O
to    O
accelerate    O
free    O
charge    B-Body109224911
carrier    I-Body109224911
(    O
electrons    O
and    O
ions    O
,    O
which    O
are    O
always    O
present    O
at    O
low    O
concentrations    O
)    O
to    O
a    O
high    O
enough    O
velocity    O
to    O
knock    O
electrons    O
from    O
atoms    O
when    O
they    O
strike    O
them    O
,    O
ion    B-Body109224911
the    O
atoms    O
.    O

At    O
heights    O
of    O
above    O
,    O
in    O
the    O
thermosphere    O
,    O
the    O
atmosphere    O
is    O
so    O
thin    O
that    O
free    O
electrons    O
can    O
exist    O
for    O
short    O
periods    O
of    O
time    O
before    O
they    O
are    O
captured    O
by    O
a    O
nearby    O
positive    O
ion    B-Body109224911
.    O

Nonhomogeneous    O
structure    O
of    O
the    O
electron    O
/    O
ion    B-Body109224911
-    O
plasma    O
produces    O
rough    O
echo    O
traces    O
,    O
seen    O
predominantly    O
at    O
night    O
and    O
at    O
higher    O
latitudes    O
,    O
and    O
during    O
disturbed    O
conditions    O
.    O

Both    O
α    O
and    O
β    O
subunits    O
bind    O
several    O
divalent    O
cation    B-Body109224911
.    O

The    O
cations    B-Body109224911
in    O
the    O
β    O
subunits    O
are    O
more    O
interesting    O
:    O
they    O
are    O
directly    O
involved    O
in    O
coordinating    O
at    O
least    O
some    O
of    O
the    O
ligands    O
that    O
integrins    O
bind    O
.    O

Their    O
functions    O
include    O
establishing    O
a    O
resting    O
membrane    O
potential    O
,    O
shaping    O
action    O
potentials    O
and    O
other    O
electrical    O
signals    O
by    O
gating    O
the    O
flow    O
of    O
ion    B-Body109224911
across    O
the    O
cell    O
membrane    O
,    O
controlling    O
the    O
flow    O
of    O
ions    O
across    O
secretory    O
and    O
epithelial    O
cells    O
,    O
and    O
regulating    O
cell    O
volume    O
.    O

However    O
,    O
some    O
channels    O
may    O
be    O
permeable    O
to    O
the    O
passage    O
of    O
more    O
than    O
one    O
type    O
of    O
ion    O
,    O
typically    O
sharing    O
a    O
common    O
charge    O
:    O
positive    O
(    O
cation    B-Body109224911
)    O
or    O
negative    O
(    O
anion    B-Body109224911
)    O
.    O

Intermolecular    O
forces    O
(    O
IMFs    O
)    O
are    O
the    O
forces    O
which    O
mediate    O
interaction    O
between    O
molecules    O
,    O
including    O
forces    O
of    O
attraction    O
or    O
repulsion    O
which    O
act    O
between    O
molecules    O
and    O
other    O
types    O
of    O
neighboring    O
particles    O
,    O
e.g.    O
,    O
atoms    O
or    O
ion    B-Body109224911
.    O

Ion    O
implantation    O
is    O
low    O
-    O
temperature    O
process    O
by    O
which    O
ion    B-Body109224911
of    O
one    O
element    O
are    O
accelerated    O
into    O
a    O
solid    O
target    O
,    O
thereby    O
changing    O
the    O
physical    O
,    O
chemical    O
,    O
or    O
electrical    O
properties    O
of    O
the    O
target    O
.    O

In    O
a    O
bimolecular    O
elementary    O
reaction    O
,    O
two    O
atoms    O
,    O
molecules    O
,    O
ion    B-Body109224911
or    O
radicals    O
,    O
A    O
and    O
B    O
,    O
react    O
together    O
to    O
form    O
the    O
product(s    O
)    O

This    O
is    O
another    O
factor    O
which    O
slows    O
the    O
motion    O
of    O
ion    B-Body109224911
within    O
a    O
solution    O
.    O

Secondly    O
,    O
the    O
involved    O
plasma    O
,    O
itself    O
a    O
field    O
of    O
ion    B-Body109224911
,    O
has    O
a    O
relatively    O
negligible    O
mass    O
.    O

Chloride    O
levels    O
were    O
low    O
,    O
and    O
thus    O
the    O
bulk    O
of    O
the    O
anions    B-Body109224911
present    O
were    O
not    O
initially    O
identified    O
.    O

This    O
reactivity    O
can    O
be    O
used    O
to    O
separate    O
different    O
cation    B-Body109224911
,    O
such    O
as    O
zinc(II    O
)    O
,    O
which    O
dissolves    O
in    O
base    O
,    O
from    O
manganese(II    O
)    O
,    O
which    O
does    O
not    O
dissolve    O
in    O
base    O
.    O

Spring    O
Hill    O
,    O
Tennessee    O
,    O
(    O
Spring    O
Hill    O
Manufacturing    O
)    O
–    O
S    O
-    O
Series    O
(    O
1991    O
-    O
2002    O
)    O
,    O
Vue    O
(    O
2002–2007    O
)    O
,    O
ION    B-Body109224911
(    O
2003–2007    O
)    O

It    O
has    O
been    O
found    O
that    O
some    O
non    O
-    O
consecutive    O
steps    O
of    O
the    O
cycle    O
can    O
be    O
catalyzed    O
by    O
minerals    O
through    O
photochemistry    O
,    O
while    O
entire    O
two    O
three    O
-    O
step    O
sequences    O
can    O
be    O
promoted    O
by    O
metal    O
ions    B-Body109224911
and    O
iron    O
(    O
as    O
reducing    O
agent    O
)    O
under    O
acidic    O
conditions    O
.    O

Zintl    O
noted    O
that    O
there    O
was    O
an    O
atomic    O
volume    O
contraction    O
when    O
these    O
compounds    O
were    O
formed    O
and    O
realised    O
this    O
could    O
indicate    O
cation    B-Body109224911
formation    O
.    O

The    O
structure    O
of    O
the    O
anion    B-Body109224911
(    O
nowadays    O
called    O
the    O
Zintl    O
ion    O
)    O
should    O
then    O
be    O
considered    O
on    O
the    O
basis    O
of    O
the    O
resulting    O
electronic    O
state    O
.    O

The    O
polyiodides    O
can    O
be    O
made    O
by    O
addition    O
of    O
stoichiometric    O
amounts    O
of    O
I2    O
to    O
solutions    O
containing    O
I−    O
and    O
,    O
with    O
the    O
presence    O
of    O
large    O
counter-cations    B-Body109224911
to    O
stabilize    O
them    O
.    O

The    O
more    O
complex    O
two-    O
or    O
three    O
-    O
dimensional    O
network    O
structures    O
of    O
chains    O
and    O
cages    O
are    O
formed    O
as    O
the    O
ions    O
interact    O
with    O
each    O
other    O
,    O
with    O
their    O
shapes    O
depending    O
on    O
their    O
associated    O
cation    B-Body109224911
quite    O
strongly    O
.    O

For    O
example    O
,    O
in    O
a    O
crystal    O
of    O
sodium    O
chloride    O
(    O
common    O
salt    O
)    O
,    O
the    O
crystal    O
is    O
made    O
up    O
of    O
ion    B-Body109224911
sodium    O
and    O
chlorine    O
,    O
and    O
held    O
together    O
with    O
ionic    B-Body109224911
bond    I-Body109224911
.    O

In    O
this    O
view    O
,    O
the    O
cell    O
was    O
seen    O
to    O
be    O
enclosed    O
by    O
a    O
thin    O
surface    O
,    O
the    O
plasma    O
membrane    O
,    O
and    O
cell    O
water    O
and    O
solutes    O
such    O
as    O
a    O
potassium    O
ion    B-Body109224911
existed    O
in    O
a    O
physical    O
state    O
like    O
that    O
of    O
a    O
dilute    O
solution    O
.    O

Since    O
membranes    O
are    O
generally    O
less    O
permeable    O
to    O
anions    B-Body109224911
,    O
Leonor    O
Michaelis    O
concluded    O
that    O
ions    B-Body109224911
are    O
adsorbed    O
to    O
the    O
walls    O
of    O
the    O
pores    O
,    O
changing    O
the    O
permeability    O
of    O
the    O
pores    O
to    O
ions    O
by    O
electrostatic    O
repulsion    O
.    O

The    O
most    O
commonly    O
occurring    O
cation    B-Body109224911
in    O
the    O
water    O
of    O
the    O
tunnel    O
is    O
magnesium    O
,    O
which    O
occurs    O
in    O
concentrations    O
of    O
52    O
mg    O
/    O
l    O
.    O

Common    O
anion    B-Body109224911
in    O
the    O
tunnel    O
's    O
water    O
include    O
sulfate    O
and    O
chloride    O
.    O

The    O
water    O
carries    O
away    O
the    O
ion    B-Body109224911
dissolved    O
in    O
solution    O
and    O
the    O
broken    O
down    O
fragments    O
that    O
are    O
the    O
products    O
of    O
weathering    O
.    O

A    O
further    O
suggestion    O
is    O
that    O
positive    B-Body109224911
ions    I-Body109224911
increase    O
in    O
abundance    O
during    O
a    O
full    O
Moon    O
and    O
that    O
this    O
should    O
be    O
expected    O
to    O
influence    O
human    O
behavior    O
.    O

In    O
the    O
technique    O
of    O
ERDA    O
,    O
an    O
energetic    O
ion    O
beam    O
is    O
directed    O
at    O
a    O
sample    O
to    O
be    O
characterized    O
and    O
(    O
as    O
in    O
Rutherford    O
backscattering    O
)    O
there    O
is    O
an    O
elastic    O
nuclear    O
interaction    O
between    O
the    O
ions    B-Body109224911
of    O
beam    O
and    O
the    O
atoms    O
of    O
the    O
target    O
sample    O
.    O

Depending    O
on    O
the    O
kinetics    O
of    O
the    O
ions    B-Body109224911
,    O
cross    O
section    O
area    O
,    O
and    O
the    O
loss    O
of    O
energy    O
of    O
the    O
ions    O
in    O
the    O
matter    O
,    O
Elastic    O
Recoil    O
Detection    O
Analysis    O
helps    O
determine    O
the    O
quantification    O
of    O
the    O
elemental    O
analysis    O
.    O

The    O
metatellurate    O
ion    O
is    O
and    O
the    O
orthotellurate    O
ion    B-Body109224911
is    O
.    O

The    O
borate    O
minerals    O
are    O
minerals    O
which    O
contain    O
a    O
borate    O
anion    B-Body109224911
group    O
.    O

Phosphate    O
minerals    O
are    O
those    O
minerals    O
that    O
contain    O
the    O
tetrahedrally    O
coordinated    O
phosphate    O
(    O
PO43−    O
)    O
anion    B-Body109224911
along    O
with    O
the    O
freely    O
substituting    O
arsenate    O
(    O
AsO43−    O
)    O
and    O
vanadate    O
(    O
VO43−    O
)    O
.    O

These    O
ciliated    O
tubules    O
pump    O
water    O
carrying    O
surplus    O
ion    B-Body109224911
,    O
metabolic    O
waste    O
,    O
toxins    O
from    O
food    O
,    O
and    O
useless    O
hormones    O
out    O
of    O
the    O
organism    O
by    O
directing    O
them    O
down    O
funnel    O
-    O
shaped    O
bodies    O
called    O
nephrostomes    O
.    O

Carbonate    O
minerals    O
are    O
those    O
minerals    O
containing    O
the    O
carbonate    O
ion    B-Body109224911
,    O
CO32−.    O

Zinc    O
atoms    O
dissolve    O
into    O
the    O
liquid    O
electrolyte    O
as    O
electrically    O
charged    O
ions    B-Body109224911
(    O
Zn2    O
+    O
)    O
,    O
leaving    O
2    O
negatively    O
charged    O
electrons    O
(    O
e−    O
)    O
behind    O
in    O
the    O
metal    O
:    O

In    O
electrochemistry    O
,    O
ion    B-Body109224911
do    O
"    O
not    O
"    O
always    O
tend    O
to    O
go    O
from    O
higher    O
to    O
lower    O
chemical    O
potential    O
,    O
but    O
they    O
"    O
do    O
"    O
always    O
go    O
from    O
higher    O
to    O
lower    O
"    O
electrochemical    O
potential    O
"    O
.    O

To    O
date    O
,    O
homoaromatic    O
compounds    O
are    O
known    O
to    O
exist    O
as    O
cationic    B-Body109224911
and    O
anionic    B-Body109224911
species    O
,    O
and    O
some    O
studies    O
support    O
the    O
existence    O
of    O
neutral    O
homoaromatic    O
molecules    O
,    O
though    O
these    O
are    O
less    O
common    O
.    O

The    O
reaction    O
process    O
begins    O
when    O
a    O
strong    O
base    O
is    O
used    O
to    O
form    O
a    O
carbanion    B-Body109224911
at    O
the    O
halogenated    O
position    O
.    O

As    O
the    O
battery    O
is    O
being    O
used    O
,    O
lithium    O
ion    B-Body109224911
combine    O
with    O
oxygen    O
from    O
the    O
air    O
to    O
form    O
particles    O
of    O
lithium    O
oxides    O
,    O
which    O
attach    O
to    O
carbon    O
fibers    O
on    O
the    O
electrode    O
.    O

Soil    O
acidification    O
is    O
the    O
buildup    O
of    O
hydrogen    O
cation    B-Body109224911
,    O
also    O
called    O
protons    O
,    O
reducing    O
the    O
soil    O
pH.    O

Plants    O
take    O
bases    O
from    O
the    O
soil    O
as    O
they    O
grow    O
,    O
donating    O
a    O
proton    O
in    O
exchange    O
for    O
each    O
base    O
cation    B-Body109224911
.    O

ion    B-Body109224911
concentration    O
,    O

An    O
electride    B-Body109224911
is    O
an    O
ionic    O
compound    O
in    O
which    O
an    O
electron    O
is    O
the    O
anion    B-Body109224911
.    O

In    O
these    O
salts    O
,    O
the    O
electron    O
is    O
delocalized    O
between    O
the    O
cation    B-Body109224911
.    O

It    O
crystallizes    O
in    O
a    O
cubic    O
rocksalt    O
lattice    O
like    O
sodium    O
chloride    O
,    O
with    O
octahedral    O
cation    B-Body109224911
and    O
anion    B-Body109224911
centers    O
.    O

The    O
chemical    O
process    O
which    O
produces    O
electricity    O
in    O
a    O
Leclanché    O
cell    O
begins    O
when    O
zinc    O
atoms    O
on    O
the    O
surface    O
of    O
the    O
anode    O
oxidize    O
,    O
i.e.    O
they    O
give    O
up    O
both    O
their    O
valence    O
electrons    O
to    O
become    O
positively    O
charged    O
ions    B-Body109224911
.    O

He    O
studied    O
their    O
photochromic    O
properties    O
when    O
doped    O
with    O
various    O
transition    O
-    O
metal    O
ion    B-Body109224911
;    O
their    O
chemical    O
binding    O
,    O
ferroelectric    O
and    O
soft    O
-    O
mode    O
properties    O
;    O
and    O
the    O
critical    O
and    O
multicritical    O
phenomena    O
of    O
their    O
structural    O
phase    O
transitions    O
.    O

The    O
reaction    O
proceeds    O
in    O
95%    O
yield    O
,    O
and    O
the    O
cation    B-Body109224911
can    O
be    O
isolated    O
with    O
a    O
variety    O
of    O
anions    O
.    O

It    O
has    O
2    O
cofactors    O
:    O
mercaptoethanol    O
,    O
and    O
Cation    B-Body109224911
.    O

Barium    O
bromide    O
reacts    O
with    O
the    O
sulfate    O
ion    B-Body109224911
from    O
sulfuric    O
acid    O
to    O
produce    O
a    O
precipitate    O
of    O
barium    O
sulfate    O
.    O

where    O
is    O
the    O
number    O
of    O
electrons    O
per    O
unit    O
volume    O
,    O
the    O
ion    B-Body109224911
number    O
density    O
,    O
the    O
Planck    O
constant    O
,    O
the    O
frequency    O
of    O
the    O
emitted    O
radiation    O
corresponding    O
to    O
the    O
energy    O
jump    O
,    O
the    O
coefficient    O
of    O
collisional    O
de    O
-    O
excitation    O
relative    O
to    O
the    O
ion    O
transition    O
,    O
the    O
radiative    O
losses    O
for    O
plasma    O
recombination    O
and    O
the    O
bremsstrahlung    O
contribution    O
.    O

Other    O
abnormalities    O
include    O
tighter    O
tethering    O
of    O
the    O
band    O
3    O
protein    O
to    O
the    O
cell    O
membrane    O
,    O
increased    O
tyrosine    O
phosphorylation    O
of    O
the    O
band    O
3    O
protein    O
,    O
reduced    O
sulfate    O
anion    B-Body109224911
transport    O
through    O
the    O
cell    O
membrane    O
,    O
and    O
more    O
rapid    O
ATP    O
consumption    O
.    O

The    O
electrical    O
potential    O
is    O
much    O
higher    O
inside    O
the    O
source    O
region    O
than    O
in    O
the    O
exhaust    O
,    O
and    O
this    O
serves    O
both    O
to    O
confine    O
most    O
of    O
the    O
electrons    O
,    O
and    O
to    O
accelerate    O
the    O
ions    B-Body109224911
away    O
from    O
the    O
source    O
region    O
.    O

Carbonate    O
hardness    O
,    O
or    O
carbonate    O
alkalinity    O
is    O
a    O
measure    O
of    O
the    O
alkalinity    O
of    O
water    O
caused    O
by    O
the    O
presence    O
of    O
carbonate    O
and    O
bicarbonate    O
anions    B-Body109224911
.    O

A    O
voltage    O
between    O
substrate    O
and    O
oxide    O
surfaces    O
arises    O
due    O
to    O
an    O
ion    B-Body109224911
sheath    O
.    O

The    O
Madelung    O
constant    O
is    O
used    O
in    O
determining    O
the    O
electrostatic    O
potential    O
of    O
a    O
single    O
ion    B-Body109224911
in    O
a    O
crystal    O
by    O
approximating    O
the    O
ions    O
by    O
point    O
charges    O
.    O

Because    O
the    O
anions    B-Body109224911
and    O
cations    B-Body109224911
in    O
an    O
ionic    O
solid    O
are    O
attracting    O
each    O
other    O
by    O
virtue    O
of    O
their    O
opposing    O
charges    O
,    O
separating    O
the    O
ions    O
requires    O
a    O
certain    O
amount    O
of    O
energy    O
.    O

The    O
first    O
is    O
that    O
it    O
is    O
normally    O
a    O
trianionic    B-Body109224911
ligand    O
with    O
transition    O
metals    O
,    O
while    O
porphyrin    O
is    O
typically    O
a    O
dianionic    O
ligand    O
.    O

They    O
have    O
large    O
central    O
vacuoles    O
,    O
which    O
allow    O
the    O
cells    O
to    O
store    O
and    O
regulate    O
ions    B-Body109224911
,    O
waste    O
products    O
,    O
and    O
water    O
.    O

Layers    O
with    O
distorted    O
octahedral    O
gaps    O
separate    O
those    O
with    O
the    O
anion    B-Body109224911
.    O

The    O
(    O
NH4)+    O
ions    B-Body109224911
appear    O
a    O
little    O
below    O
and    O
above    O
the    O
(    O
SiF6)2−.    O
In    O
all    O
three    O
phases    O
,    O
12    O
fluorine    O
atoms    O
neighbor    O
the    O
(    O
NH4)+    O
.    O

Interactions    O
between    O
cation    B-Body109224911
and    O
anion    B-Body109224911
are    O
especially    O
important    O
in    O
how    O
ammonium    O
salts    O
change    O
phase    O
.    O

In    O
chemistry    O
,    O
peroxydicarbonate    O
(    O
sometimes    O
peroxodicarbonate    O
)    O
is    O
a    O
divalent    O
anion    B-Body109224911
with    O
formula    O
.    O

In    O
chemistry    O
,    O
peroxycarbonate    O
(    O
sometimes    O
peroxocarbonate    O
)    O
is    O
a    O
divalent    O
anion    B-Body109224911
with    O
formula    O
.    O

The    O
middle    O
of    O
the    O
bifunnel    O
contains    O
two    O
sites    O
in    O
which    O
divalent    O
cations    B-Body109224911
bind    O
(    O
Mn+2    O
or    O
Mg+2    O
)    O
.    O

NBD    O
-    O
TMA    O
was    O
designed    O
as    O
a    O
probe    O
for    O
monitoring    O
renal    O
transport    O
of    O
organic    O
cation    B-Body109224911
.    O

Ionization    O
refers    O
to    O
the    O
process    O
whereby    O
an    O
atom    O
or    O
molecule    O
loses    O
an    O
electron    O
,    O
resulting    O
in    O
two    O
oppositely    O
charged    O
particles    O
,    O
(    O
1    O
)    O
a    O
negatively    O
charged    O
electron    O
and    O
(    O
2    O
)    O
a    O
positively    O
charged    O
ion    B-Body109224911
.    O

They    O
are    O
water    O
-    O
soluble    O
anion    B-Body109224911
and    O
can    O
be    O
leached    O
into    O
the    O
water    O
during    O
cooking    O
.    O

Alloy    O
20    O
resists    O
pitting    O
and    O
chloride    O
ion    B-Body109224911
corrosion    O
and    O
its    O
copper    O
content    O
protects    O
it    O
from    O
sulfuric    O
acid    O
.    O

LEIS    O
involves    O
directing    O
a    O
stream    O
of    O
charged    O
particles    O
known    O
as    O
ions    B-Body109224911
at    O
a    O
surface    O
and    O
making    O
observations    O
of    O
the    O
positions    O
,    O
velocities    O
,    O
and    O
energies    O
of    O
the    O
ions    O
that    O
have    O
interacted    O
with    O
the    O
surface    O
.    O

#    O
Ion    B-Body109224911
Gun    I-Body109224911
,    O
used    O
to    O
direct    O
a    O
beam    O
of    O
ions    B-Body109224911
at    O
a    O
target    O
sample    O
.    O

Coulomb    O
repulsion    O
occurs    O
between    O
positively    O
charged    O
primary    O
ions    B-Body109224911
and    O
the    O
nuclei    B-Body109224911
of    O
surface    O
atoms    O
.    O

Tetrachloroaluminate    B-Body109224911
[    O
AlCl4]−    O
is    O
an    O
anion    B-Body109224911
formed    O
from    O
aluminium    O
and    O
chlorine    O
.    O

Triarylmethane    O
dyes    O
can    O
be    O
grouped    O
into    O
families    O
according    O
to    O
the    O
nature    O
of    O
the    O
substituents    O
on    O
the    O
aryl    O
groups    O
.    O
In    O
some    O
cases    O
,    O
the    O
anion    B-Body109224911
associated    O
with    O
the    O
cationic    O
dyes    O
(    O
say    O
crystal    O
violet    O
)    O
vary    O
even    O
though    O
the    O
name    O
of    O
the    O
dye    O
does    O
not    O
.    O

Donnan    O
potential    O
appears    O
as    O
a    O
result    O
of    O
Donnan    O
equilibrium    O
,    O
named    O
after    O
Frederick    O
G.    O
Donnan    O
,    O
which    O
refers    O
to    O
the    O
distribution    O
of    O
ion    B-Body109224911
species    O
between    O
two    O
ionic    O
solutions    O
separated    O
by    O
a    O
semipermeable    O
membrane    O
or    O
boundary    O
.    O

One    O
of    O
the    O
primary    O
roles    O
for    O
phosphatidylethanolamine    O
in    O
bacterial    O
membranes    O
is    O
to    O
spread    O
out    O
the    O
negative    O
charge    O
caused    O
by    O
anion    B-Body109224911
membrane    O
phospholipids    O
.    O

Ammonium    O
iron(II    O
)    O
sulfate    O
,    O
or    O
Mohr    O
's    O
salt    O
,    O
is    O
the    O
inorganic    O
compound    O
with    O
the    O
formula    O
(    O
NH4)2Fe(SO4)2·6H2O.    O
Containing    O
two    O
different    O
cation    B-Body109224911
,    O
Fe2    O
+    O
and    O
NH4    O
+    O
,    O
it    O
is    O
classified    O
as    O
a    O
double    O
salt    O
of    O
ferrous    O
sulfate    O
and    O
ammonium    O
sulfate    O
.    O

The    O
runoff    O
then    O
flows    O
into    O
a    O
catch    O
basin    O
,    O
where    O
plants    O
use    O
the    O
salt    O
ions    B-Body109224911
(    O
e.g.    O
K+    O
,    O
P3−    O
,    O
N3−    O
)    O
for    O
their    O
growth    O
.    O

It    O
obtains    O
minerals    O
using    O
mud    O
-    O
puddling    O
behavior    O
and    O
seem    O
to    O
be    O
prefer    O
ammonium    O
ion    B-Body109224911
rather    O
than    O
sodium    O
.    O

The    O
electrolyte    O
provides    O
a    O
means    O
for    O
ion    B-Body109224911
migration    O
whereby    O
ions    O
move    O
to    O
prevent    O
charge    O
build    O
-    O
up    O
that    O
would    O
otherwise    O
stop    O
the    O
reaction    O
.    O

A    O
cationic    B-Body109224911
site    O
adjacent    O
to    O
a    O
hydrophobic    O
stretch    O
on    O
the    O
protein    O
surface    O
may    O
constitute    O
a    O
phospholipid    O
binding    O
site    O
.    O

Anion    B-Body109224911
exchanger    O
proteins    O
exchange    O
HCO3    O
−    O
for    O
Cl−    O
in    O
a    O
reversible    O
,    O
electroneutral    O
manner    O
.    O

A    O
lone    O
electron    O
(    O
for    O
example    O
in    O
reactions    O
involving    O
metal    O
ion    B-Body109224911
)    O

In    O
atomic    O
physics    O
,    O
hyperfine    O
structure    O
refers    O
to    O
small    O
shifts    O
and    O
splittings    O
in    O
the    O
energy    O
levels    O
of    O
atoms    O
,    O
molecules    O
and    O
ion    B-Body109224911
,    O
due    O
to    O
interaction    O
between    O
the    O
state    O
of    O
the    O
nucleus    O
and    O
the    O
state    O
of    O
the    O
electron    O
clouds    O
.    O

The    O
hyperfine    O
states    O
of    O
a    O
trapped    O
ion    B-Body109224911
are    O
commonly    O
used    O
for    O
storing    O
qubits    O
in    O
ion    O
-    O
trap    O
quantum    O
computing    O
.    O

The    O
hydrogen    O
ion    O
is    O
recommended    O
by    O
IUPAC    O
as    O
a    O
general    O
term    O
for    O
all    O
ion    B-Body109224911
of    O
hydrogen    O
and    O
its    O
isotopes    O
.    O

The    O
hydrogen    O
anion    O
,    O
with    O
its    O
loosely    O
held    O
two    O
-    O
electron    O
cloud    O
,    O
has    O
a    O
larger    O
radius    O
than    O
the    O
neutral    O
atom    O
,    O
which    O
in    O
turn    O
is    O
much    O
larger    O
than    O
the    O
bare    O
proton    O
of    O
the    O
cation    B-Body109224911
.    O

Hydrogen    O
anion    B-Body109224911
are    O
formed    O
when    O
additional    O
electrons    O
are    O
acquired    O
:    O

In    O
biochemistry    O
,    O
a    O
binding    O
site    O
is    O
a    O
region    O
on    O
a    O
protein    O
or    O
piece    O
of    O
DNA    O
or    O
RNA    O
to    O
which    O
ligands    O
(    O
specific    O
molecules    O
and/or    O
ion    B-Body109224911
)    O
may    O
form    O
a    O
chemical    O
bond    O
.    O

A    O
membrane    O
transport    O
protein    O
(    O
or    O
simply    O
transporter    O
)    O
is    O
a    O
membrane    O
protein    O
involved    O
in    O
the    O
movement    O
of    O
ion    B-Body109224911
,    O
small    O
molecules    O
,    O
or    O
macromolecules    O
,    O
such    O
as    O
another    O
protein    O
,    O
across    O
a    O
biological    O
membrane    O
.    O

"    O
The    O
Astonishing    O
Hypothesis    O
"    O
posits    O
that    O
"    O
a    O
person    O
's    O
mental    O
activities    O
are    O
entirely    O
due    O
to    O
the    O
behavior    O
of    O
nerve    O
cells    O
,    O
glial    O
cells    O
,    O
and    O
the    O
atoms    O
,    O
ion    B-Body109224911
,    O
and    O
molecules    O
that    O
make    O
them    O
up    O
and    O
influence    O
them    O
.    O
"    O

Water    O
ionizes    O
into    O
hydronium    O
(    O
H3O+    O
)    O
cation    B-Body109224911
and    O
hydroxide    O
(    O
OH−    O
)    O
anion    B-Body109224911
.    O

Normal    O
transmission    O
across    O
a    O
glutamatergic    O
synapse    O
relies    O
on    O
the    O
neurotransmitter    O
glutamate    O
,    O
the    O
glutamate    O
-    O
specific    O
AMPA    O
receptor    O
(    O
AMPAR    O
)    O
,    O
and    O
calcium    O
ion    B-Body109224911
.    O

The    O
change    O
in    O
charge    O
typically    O
occurs    O
due    O
to    O
an    O
influx    O
of    O
sodium    O
ion    B-Body109224911
into    O
a    O
cell    O
,    O
although    O
it    O
can    O
be    O
mediated    O
by    O
an    O
influx    O
of    O
any    O
kind    O
of    O
cation    B-Body109224911
or    O
efflux    O
of    O
any    O
kind    O
of    O
anion    B-Body109224911
.    O

To    O
maintain    O
this    O
electrical    O
imbalance    O
,    O
microscopic    O
positively    O
and    O
negatively    O
charged    O
particles    O
called    O
ion    B-Body109224911
are    O
transported    O
across    O
the    O
cell    O
's    O
plasma    O
membrane    O
.    O

There    O
are    O
many    O
other    O
diseases    O
likely    O
to    O
have    O
been    O
caused    O
by    O
common    O
anion    B-Body109224911
found    O
in    O
natural    O
drinking    O
water    O
.    O

It    O
is    O
the    O
salt    O
of    O
the    O
ammonium    O
cation    B-Body109224911
and    O
the    O
thiocyanate    O
anion    B-Body109224911
.    O

A    O
semipermeable    O
membrane    O
is    O
a    O
type    O
of    O
biological    O
or    O
synthetic    O
,    O
polymeric    O
membrane    O
that    O
will    O
allow    O
certain    O
molecules    O
or    O
ion    B-Body109224911
to    O
pass    O
through    O
it    O
by    O
diffusion    O
—    O
or    O
occasionally    O
by    O
more    O
specialized    O
processes    O
of    O
facilitated    O
diffusion    O
,    O
passive    O
transport    O
or    O
active    O
transport    O
.    O

The    O
most    O
common    O
case    O
is    O
water    O
softening    O
consisting    O
of    O
removal    O
of    O
Ca2    O
+    O
and    O
Mg2    O
+    O
ion    B-Body109224911
replacing    O
them    O
with    O
benign    O
(    O
soap    O
friendly    O
)    O
Na+    O
or    O
K+    O
ions    O
.    O

The    O
charge    O
carriers    O
can    O
be    O
electrons    O
or    O
ion    B-Body109224911
,    O
and    O
in    O
older    O
literature    O
are    O
sometimes    O
referred    O
to    O
as    O
"    O
thermions    O
"    O
.    O

In    O
addition    O
,    O
the    O
tubule    O
also    O
secretes    O
hydronium    O
and    O
ammonium    O
cations    B-Body109224911
to    O
regulate    O
pH.    O

CYTH    O
-    O
like    O
superfamily    O
enzymes    O
,    O
which    O
include    O
polyphosphate    O
polymerases    O
,    O
hydrolyze    O
triphosphate    O
-    O
containing    O
substrates    O
and    O
require    O
metal    O
cations    B-Body109224911
as    O
cofactors    O
.    O

Ionizer    O
purifiers    O
use    O
charged    O
electrical    O
surfaces    O
or    O
needles    O
to    O
generate    O
electrically    O
charged    O
air    O
or    O
gas    O
ion    B-Body109224911
.    O

Bacher    O
decided    O
to    O
create    O
a    O
work    O
listing    O
the    O
energy    O
,    O
coupling    O
constant    O
,    O
parity    O
and    O
electron    O
configurations    O
of    O
all    O
the    O
known    O
atoms    O
and    O
ion    B-Body109224911
,    O
working    O
with    O
Goudsmit    O
back    O
in    O
Ann    O
Arbor    O
.    O

They    O
are    O
dependent    O
on    O
calcium    O
(    O
Ca2    O
+    O
)    O
ion    B-Body109224911
to    O
function    O
,    O
hence    O
their    O
name    O
.    O

One    O
Ca    O
cation    B-Body109224911
and    O
three    O
H2O    O
molecules    O
are    O
in    O
four    O
ion    B-Body109224911
sites    O
in    O
the    O
channels    O
parallel    O
to    O
the    O
c    O
crystal    O
axis    O
.    O

The    O
desperate    O
Simon    O
Williams    O
agrees    O
and    O
is    O
transformed    O
into    O
an    O
ion    B-Body109224911
-    O
powered    O
being    O
with    O
superhuman    O
powers    O
.    O

The    O
expulsion    O
of    O
the    O
proton    O
at    O
160    O
mM    O
(    O
pH    O
0.8    O
)    O
concentration    O
results    O
from    O
movement    O
of    O
lysine    O
791    O
into    O
the    O
ion    B-Body109224911
binding    O
site    O
in    O
the    O
E2P    O
configuration    O
.    O

By    O
convention    O
all    O
binary    O
hydrogen    O
compounds    O
are    O
called    O
hydrides    O
even    O
when    O
the    O
hydrogen    O
atom    O
in    O
it    O
is    O
not    O
an    O
anion    B-Body109224911
.    O

All    O
silicates    O
have    O
a    O
basic    O
structural    O
unit    O
that    O
is    O
a    O
tetrahedron    O
with    O
an    O
oxygen    O
ion    B-Body109224911
O    O
at    O
each    O
apex    O
,    O
and    O
a    O
silicon    O
ion    O
Si    O
in    O
the    O
middle    O
,    O
forming    O
(    O
SiO4)4−.    O
In    O
tectosilicates    O
(    O
framework    O
silicates    O
)    O
each    O
oxygen    O
ion    O
is    O
shared    O
between    O
two    O
tetrahedra    O
,    O
linking    O
all    O
the    O
tetrahedra    O
together    O
to    O
form    O
a    O
framework    O
.    O

If    O
all    O
the    O
cations    B-Body109224911
(    O
positive    O
ions    O
)    O
are    O
Si    O
then    O
the    O
positive    O
charges    O
on    O
the    O
Si    O
's    O
exactly    O
balance    O
the    O
negative    O
charges    O
on    O
the    O
O    O
's    O
.    O

The    O
resulting    O
arrangement    O
forms    O
continuous    O
channels    O
that    O
can    O
accommodate    O
a    O
large    O
variety    O
of    O
cations    B-Body109224911
and    O
anions    B-Body109224911
.    O

The    O
stannite    O
ion    B-Body109224911
is    O
,    O
or    O
similar    O
.    O

An    O
unexpected    O
series    O
of    O
experimental    O
results    O
for    O
the    O
rate    O
of    O
decay    O
of    O
heavy    O
highly    O
charged    O
radioactive    O
ion    B-Body109224911
circulating    O
in    O
a    O
storage    O
ring    O
has    O
provoked    O
theoretical    O
activity    O
in    O
an    O
effort    O
to    O
find    O
a    O
convincing    O
explanation    O
.    O

The    O
chemistry    O
is    O
based    O
upon    O
the    O
interaction    O
of    O
caesium    O
and    O
strontium    O
with    O
polyethylene    O
glycol    O
)    O
and    O
a    O
cobalt    O
carborane    O
anion    B-Body109224911
(    O
known    O
as    O
chlorinated    O
cobalt    O
dicarbollide    O
)    O
.    O

Equivalently    O
,    O
electron    O
affinity    O
can    O
also    O
be    O
defined    O
as    O
the    O
amount    O
of    O
energy    O
"    O
required    O
"    O
to    O
detach    O
an    O
electron    O
from    O
a    O
singly    O
charged    O
negative    B-Body109224911
ion    I-Body109224911
,    O
i.e.    O
the    O
energy    O
change    O
for    O
the    O
process    O

An    O
azadithiolate    O
cofactor    O
is    O
an    O
anion    B-Body109224911
with    O
the    O
formula    O
NH(CH2S)22−.    O
It    O
is    O
used    O
as    O
a    O
cofactor    O
in    O
the    O
[    O
FeFe    O
]    O
hydrogenases    O
,    O
bacterial    O
enzymes    O
responsible    O
for    O
the    O
reversible    O
reduction    O
of    O
2    O
H+    O
to    O
H2    O
.    O

At    O
room    O
temperature    O
aluminosilicates    O
typically    O
have    O
a    O
ratio    O
of    O
aluminium    O
to    O
silicon    O
that    O
is    O
close    O
to    O
1    O
as    O
a    O
result    O
of    O
alternating    O
linkages    O
of    O
Al    O
and    O
Si    O
ion    B-Body109224911
with    O
O    O
,    O
or    O
Loewenstein    O
’s    O
rule    O
.    O

The    O
sodalite    O
family    O
of    O
minerals    O
has    O
a    O
tetrahedral    O
framework    O
structure    O
,    O
with    O
highly    O
charged    O
cation    B-Body109224911
such    O
as    O
Al3    O
+    O
or    O
Si4    O
+    O
connecting    O
through    O
a    O
common    O
O2−.    O

Additionally    O
,    O
because    O
of    O
bicchulite    O
’s    O
sodalite    O
-    O
type    O
framework    O
it    O
contains    O
beta    O
cages    O
,    O
which    O
are    O
known    O
to    O
have    O
a    O
high    O
degree    O
of    O
flexibility    O
,    O
and    O
as    O
a    O
result    O
,    O
the    O
structure    O
can    O
collapse    O
by    O
various    O
mechanisms    O
to    O
accommodate    O
different    O
cations    O
and    O
anion    B-Body109224911
in    O
the    O
beta    O
cage    O
.    O

K2MnO4    O
is    O
a    O
salt    O
,    O
consisting    O
of    O
K+    O
cation    B-Body109224911
and    O
MnO42−    O
anion    B-Body109224911
.    O

This    O
salt    O
consists    O
of    O
the    O
tetrapropylammonium    O
cation    B-Body109224911
and    O
the    O
perruthenate    O
,    O
RuO4−    O
anion    B-Body109224911
.    O

The    O
compound    O
consists    O
of    O
the    O
polymer    O
[    O
AsO2    O
]    O
associated    O
with    O
sodium    O
cations    B-Body109224911
,    O
Na+    O
.    O

The    O
C    O
-    O
terminal    O
domain    O
makes    O
numerous    O
electrostatic    O
interactions    O
with    O
an    O
anion    B-Body109224911
-    O
binding    O
exosite    O
of    O
thrombin    O
,    O
while    O
the    O
last    O
five    O
residues    O
are    O
in    O
a    O
helical    O
loop    O
that    O
forms    O
many    O
hydrophobic    O
contacts    O
.    O

In    O
strongly    O
acidic    O
conditions    O
,    O
the    O
gallium    O
ion    B-Body109224911
,    O
Ga3    O
+    O
is    O
formed    O
.    O

The    O
sulfide    O
minerals    O
are    O
a    O
class    O
of    O
minerals    O
containing    O
sulfide    O
(    O
S2−    O
)    O
as    O
the    O
major    O
anion    B-Body109224911
.    O

Elster    O
and    O
Geitel    O
,    O
who    O
also    O
worked    O
on    O
thermionic    O
emission    O
,    O
proposed    O
a    O
theory    O
to    O
explain    O
thunderstorms    O
'    O
electrical    O
structure    O
(    O
1885    O
)    O
and    O
,    O
later    O
,    O
discovered    O
atmospheric    O
radioactivity    O
(    O
1899    O
)    O
from    O
the    O
existence    O
of    O
positive    O
and    O
negative    O
ion    B-Body109224911
in    O
the    O
atmosphere    O
.    O

In    O
the    O
Earth    O
-    O
ionosphere    O
cavity    O
,    O
the    O
electric    O
field    O
and    O
conduction    O
current    O
in    O
the    O
lower    O
atmosphere    O
are    O
primarily    O
controlled    O
by    O
ion    B-Body109224911
.    O

When    O
a    O
high    O
-    O
energy    O
particle    O
travels    O
through    O
a    O
semiconductor    O
,    O
it    O
leaves    O
an    O
ion    B-Body109224911
track    O
behind    O
.    O

Porins    O
typically    O
control    O
the    O
diffusion    O
of    O
small    O
metabolites    O
like    O
sugars    O
,    O
ion    B-Body109224911
,    O
and    O
amino    O
acids    O
.    O

For    O
example    O
,    O
peas    O
grown    O
in    O
space    O
exhibited    O
increased    O
levels    O
of    O
phosphorus    O
and    O
potassium    O
and    O
decreased    O
levels    O
of    O
the    O
divalent    O
cations    B-Body109224911
calcium    O
,    O
magnesium    O
,    O
manganese    O
,    O
zinc    O
,    O
and    O
iron    O
(    O
Halstead    O
and    O
Scott    O
1990    O
)    O
.    O

Another    O
application    O
of    O
current    O
integration    O
is    O
in    O
ion    O
beam    O
deposition    O
,    O
where    O
the    O
measured    O
charge    O
directly    O
corresponds    O
to    O
the    O
number    O
of    O
ions    O
deposited    O
on    O
a    O
substrate    O
,    O
assuming    O
the    O
charge    O
state    O
of    O
the    O
ion    B-Body109224911
is    O
known    O
.    O

The    O
interaction    O
between    O
male    O
and    O
female    O
determinants    O
transmits    O
a    O
cellular    O
signal    O
into    O
the    O
pollen    O
tube    O
,    O
resulting    O
in    O
strong    O
influx    O
of    O
calcium    O
cation    B-Body109224911
;    O
this    O
interferes    O
with    O
the    O
intracellular    O
concentration    O
gradient    O
of    O
calcium    O
ion    B-Body109224911
which    O
exists    O
inside    O
the    O
pollen    O
tube    O
,    O
essential    O
for    O
its    O
elongation    O
.    O

HOIC    O
and    O
its    O
predecessor    O
,    O
the    O
LOIC    O
,    O
are    O
named    O
after    O
an    O
ion    O
cannon    O
,    O
a    O
fictional    O
directed    O
-    O
energy    O
weapon    O
described    O
as    O
firing    O
beams    O
of    O
ion    B-Body109224911
from    O
a    O
space    O
-    O
based    O
platform    O
onto    O
Earth    O
-    O
based    O
targets    O
.    O

As    O
the    O
plasma    O
is    O
generated    O
remotely    O
,    O
and    O
not    O
from    O
the    O
target    O
itself    O
(    O
as    O
in    O
conventional    O
magnetron    O
sputtering    O
)    O
,    O
the    O
ion    B-Body109224911
current    O
to    O
the    O
target    O
is    O
independent    O
of    O
the    O
voltage    O
applied    O
to    O
the    O
target    O
.    O

Ionic    O
conduction    O
(    O
denoted    O
by    O
-lambda    O
)    O
is    O
the    O
movement    O
of    O
an    O
ion    B-Body109224911
from    O
one    O
site    O
to    O
another    O
through    O
defects    O
in    O
the    O
crystal    O
lattice    O
of    O
a    O
solid    O
or    O
aqueous    O
solution    O
.    O

The    O
highly    O
conductive    O
phase    O
of    O
AgI    O
is    O
now    O
known    O
as    O
alpha    O
-    O
AgI.    O
It    O
was    O
shown    O
that    O
a    O
sublattice    O
cationic    B-Body109224911
disorder    O
takes    O
place    O
in    O
alpha    O
-    O
AgI.    O

;    O
Liquid    O
:    O
Liquid    O
ammonia    O
possesses    O
strong    O
ion    B-Body109224911
powers    O
reflecting    O
its    O
high    O
ε    O
of    O
22    O
.    O

For    O
discussion    O
of    O
these    O
"    O
anionic    B-Body109224911
amides    O
"    O
,    O
see    O
Alkali    O
metal    O
amides    O
.    O

Some    O
chemists    O
make    O
a    O
pronunciation    O
distinction    O
between    O
the    O
two    O
,    O
saying    O
for    O
the    O
carbonyl    O
–    O
nitrogen    O
compound    O
and    O
for    O
the    O
anion    B-Body109224911
.    O

The    O
binding    O
of    O
a    O
divalent    O
cation    B-Body109224911
,    O
almost    O
always    O
magnesium    O
,    O
strongly    O
affects    O
the    O
interaction    O
of    O
ATP    O
with    O
various    O
proteins    O
Due    O
to    O
the    O
strength    O
of    O
the    O
ATP    O
-    O
Mg2    O
+    O
interaction    O
,    O
ATP    O
exists    O
in    O
the    O
cell    O
mostly    O
as    O
a    O
complex    O
with    O
bonded    O
to    O
the    O
phosphate    O
oxygen    O
centers    O
.    O

Actinides    O
with    O
the    O
highest    O
mass    O
numbers    O
are    O
synthesized    O
by    O
bombarding    O
uranium    O
,    O
plutonium    O
,    O
curium    O
and    O
californium    O
with    O
ion    B-Body109224911
of    O
nitrogen    O
,    O
oxygen    O
,    O
carbon    O
,    O
neon    O
or    O
boron    O
in    O
a    O
particle    O
accelerator    O
.    O

Methylmercury    O
(    O
sometimes    O
methyl    O
mercury    O
)    O
is    O
an    O
organometallic    O
cation    B-Body109224911
with    O
the    O
formula    O
.    O

It    O
is    O
composed    O
of    O
a    O
methyl    O
group    O
(    O
3-    O
)    O
bonded    O
to    O
a    O
mercury    O
ion    B-Body109224911
;    O
its    O
chemical    O
formula    O
is    O
+    O
(    O
sometimes    O
written    O
as    O
MeHg+    O
)    O
.    O

As    O
a    O
positively    O
charged    O
ion    O
it    O
readily    O
combines    O
with    O
anion    B-Body109224911
such    O
as    O
chloride    O
(    O
−    O
)    O
,    O
hydroxide    O
(    O
−    O
)    O
and    O
nitrate    O
(    O
3−    O
)    O
.    O

X    O
stands    O
for    O
any    O
anion    B-Body109224911
.    O

Charlotte    O
Froese    O
Fischer    O
(    O
born    O
1929    O
)    O
is    O
a    O
Canadian    O
-    O
American    O
applied    O
mathematician    O
and    O
computer    O
scientist    O
who    O
gained    O
world    O
recognition    O
for    O
the    O
development    O
and    O
implementation    O
of    O
the    O
Multi    O
-    O
Configurational    O
Hartree    O
–    O
Fock    O
(    O
MCHF    O
)    O
approach    O
to    O
atomic    O
-    O
structure    O
calculations    O
and    O
for    O
her    O
theoretical    O
prediction    O
concerning    O
the    O
existence    O
of    O
the    O
negative    O
calcium    O
ion    B-Body109224911
.    O

In    O
salts    O
,    O
the    O
mesylate    O
is    O
present    O
as    O
the    O
CH3SO3−    O
anion    B-Body109224911
.    O

Structural    O
formula    O
of    O
the    O
mesylate    O
anion    B-Body109224911
.    O

In    O
the    O
solid    O
state    O
,    O
the    O
thiosulfate    B-Body109224911
anion    B-Body109224911
is    O
tetrahedral    O
in    O
shape    O
and    O
is    O
notionally    O
derived    O
by    O
replacing    O
one    O
of    O
the    O
oxygen    O
atoms    O
by    O
a    O
sulfur    O
atom    O
in    O
a    O
sulfate    O
anion    O
.    O

In    O
chemistry    O
,    O
methanium    O
is    O
a    O
complex    O
positive    B-Body109224911
ion    I-Body109224911
with    O
formula    O
+    O
,    O
namely    O
a    O
molecule    O
with    O
one    O
carbon    O
atom    O
bonded    O
to    O
three    O
hydrogen    O
atoms    O
and    O
one    O
hydrogen    O
molecule    O
,    O
bearing    O
a    O
+    O
1    O
electric    O
charge    O
.    O

Double    O
salts    O
are    O
salts    O
containing    O
more    O
than    O
one    O
cation    B-Body109224911
or    O
anion    B-Body109224911
,    O
and    O
are    O
obtained    O
by    O
combination    O
of    O
two    O
different    O
salts    O
which    O
were    O
crystallized    O
in    O
the    O
same    O
regular    O
ionic    O
lattice    O
.    O

In    O
α-TiCl3    O
,    O
the    O
chloride    O
anion    B-Body109224911
are    O
hexagonal    O
close    O
-    O
packed    O
.    O

This    O
large    O
distance    O
between    O
titanium    O
cation    B-Body109224911
precludes    O
direct    O
metal    O
-    O
metal    O
bonding    O
.    O

The    O
compound    O
consists    O
of    O
separate    O
tetrahedral    O
ammonium    O
cation    B-Body109224911
and    O
octahedral    O
[    O
PtCl6]2−    O
anion    B-Body109224911
.    O

Lithium    O
amide    O
is    O
an    O
inorganic    O
compound    O
with    O
the    O
chemical    O
formula    O
Li+NH2−    O
,    O
i.e.    O
it    O
is    O
composed    O
of    O
a    O
lithium    O
cation    B-Body109224911
,    O
and    O
the    O
conjugate    O
base    O
of    O
ammonia    O
.    O

The    O
biological    O
activity    O
of    O
"    O
M.    O
galopus    O
"    O
mycelium    O
can    O
increase    O
the    O
availability    O
of    O
phosphorus    O
and    O
other    O
nutrients    O
,    O
both    O
as    O
a    O
result    O
of    O
soil    O
acidification    O
due    O
to    O
cation    B-Body109224911
uptake    O
and    O
via    O
the    O
release    O
of    O
weathering    O
agents    O
such    O
low    O
molecular    O
mass    O
organic    O
acids    O
.    O

The    O
bond    O
breaks    O
,    O
forming    O
a    O
negatively    O
charged    O
species    O
(    O
an    O
anion    B-Body109224911
)    O
and    O
a    O
positively    O
charged    O
species    O
(    O
a    O
cation    B-Body109224911
)    O
.    O

Because    O
initial    O
formation    O
of    O
a    O
cation    B-Body109224911
is    O
necessary    O
for    O
E1    O
reactions    O
to    O
occur    O
,    O
E1    O
reactions    O
are    O
often    O
observed    O
as    O
side    O
reactions    O
to    O
SN1    O
mechanisms    O
.    O

A    O
nitrenium    O
ion    O
(    O
also    O
called    O
:    O
aminylium    O
ion    O
)    O
in    O
organic    O
chemistry    O
is    O
a    O
reactive    O
intermediate    O
based    O
on    O
nitrogen    O
with    O
both    O
an    O
electron    O
lone    O
pair    O
and    O
a    O
positive    B-Body109224911
charge    I-Body109224911
and    O
with    O
two    O
substituents    O
(    O
R2N+    O
)    O
.    O

During    O
an    O
ion    B-Body109224911
storm    O
,    O
Captain    O
James    O
T.    O
Kirk    O
of    O
the    O
Federation    O
starship    O
USS    O
"    O
Enterprise    O
"    O
is    O
forced    O
to    O
eject    O
a    O
research    O
pod    O
containing    O
Lieutenant    O
Commander    O
Benjamin    O
Finney    O
to    O
prevent    O
the    O
destruction    O
of    O
the    O
ship    O
;    O
Finney    O
is    O
presumed    O
dead    O
.    O

Lactoferricin    O
is    O
an    O
amphipathic    O
,    O
cationic    B-Body109224911
peptide    O
with    O
anti    O
-    O
microbial    O
and    O
anti    O
-    O
cancer    O
properties    O
.    O

The    O
electron    O
affinity    O
of    O
an    O
atom    O
can    O
be    O
described    O
either    O
as    O
the    O
energy    O
released    O
by    O
an    O
atom    O
when    O
an    O
electron    O
is    O
added    O
to    O
it    O
,    O
or    O
conversely    O
as    O
the    O
energy    O
required    O
to    O
detach    O
an    O
electron    O
from    O
a    O
singly    O
charged    O
anion    B-Body109224911
.    O

It    O
reacts    O
with    O
strong    O
Lewis    O
acids    O
to    O
form    O
salts    O
of    O
the    O
KrF+    O
and    O
Kr    O
cation    B-Body109224911
.    O

Nonoxynols    O
also    O
known    O
as    O
nonaethylene    O
glycol    O
or    O
polyethylene    O
glycol    O
nonyl    O
phenyl    O
ether    O
are    O
mixtures    O
of    O
nonionic    B-Body109224911
surfactants    O
used    O
as    O
detergents    O
,    O
emulsifiers    O
,    O
wetting    O
agents    O
or    O
defoaming    O
agents    O
.    O

Those    O
Lepidoptera    O
that    O
are    O
attracted    O
to    O
dung    O
(    O
e.g.    O
"    O
Zeuxidia    O
"    O
spp    O
.    O
)    O
or    O
carrion    O
seem    O
to    O
prefer    O
ammonium    O
ion    B-Body109224911
rather    O
than    O
sodium    O
.    O

The    O
photodynamics    O
of    O
ethylene    O
involves    O
both    O
covalent    O
and    O
ion    B-Body109224911
electronic    O
excited    O
states    O
and    O
the    O
return    O
to    O
the    O
ground    O
state    O
proceeds    O
through    O
a    O
pyramidalized    O
geometry    O
.    O

The    O
hydrogen    O
anion    O
is    O
a    O
negative    O
ion    B-Body109224911
of    O
hydrogen    O
,    O
H−.    O
The    O
hydrogen    O
anion    O
is    O
an    O
important    O
constituent    O
of    O
the    O
atmosphere    O
of    O
stars    O
,    O
such    O
as    O
the    O
Sun    O
.    O

IPP    O
isomerase    O
also    O
requires    O
a    O
divalent    O
cation    B-Body109224911
to    O
fold    O
into    O
its    O
active    O
conformation    O
.    O

GLAST    O
mediates    O
the    O
transport    O
of    O
glutamic    O
and    O
aspartic    O
acid    O
with    O
the    O
cotransport    O
of    O
three    O
Na+    O
and    O
one    O
H+    O
cations    B-Body109224911
and    O
counter    O
transport    O
of    O
one    O
K+    O
cation    O
.    O

First    O
,    O
it    O
is    O
activated    O
by    O
potassium    O
ions    B-Body109224911
binding    O
near    O
the    O
CoA    O
binding    O
site    O
and    O
the    O
catalytic    O
site    O
.    O

X    O
-    O
rays    O
going    O
through    O
a    O
gas    O
will    O
ionize    O
it    O
,    O
producing    O
positive    O
ions    B-Body109224911
and    O
free    O
electrons    O
.    O

amino    O
or    O
anionic    B-Body109224911
bonded    O
phases    O

cationic    B-Body109224911
bonded    O
phases    O

The    O
anion    B-Body109224911
is    O
a    O
coordination    O
complex    O
that    O
is    O
octahedral    O
in    O
shape    O
,    O
similar    O
to    O
most    O
stannates    O
,    O
such    O
as    O
the    O
hexachlorostannate    O
anion    O
.    O

Bromium    O
azide    O
adds    O
to    O
alkenes    O
both    O
through    O
ion    B-Body109224911
and    O
free    O
-    O
radical    O
addition    O
,    O
each    O
giving    O
an    O
opposite    O
orientation    O
in    O
the    O
products    O
.    O

Magnesium    O
oxalate    O
is    O
an    O
inorganic    O
compound    O
comprising    O
a    O
magnesium    O
cation    B-Body109224911
with    O
a    O
2    O
+    O
charge    O
bonded    O
to    O
an    O
oxalate    O
anion    B-Body109224911
.    O

His    O
mathematical    O
research    O
involved    O
delay    O
differential    O
equations    O
and    O
their    O
applications    O
,    O
including    O
the    O
prediction    O
and    O
modeling    O
of    O
the    O
path    O
of    O
ionic    B-Body109224911
particles    I-Body109224911
in    O
electromagnetic    O
fields    O
.    O

Hexachloroplatinate    O
is    O
an    O
anion    B-Body109224911
with    O
the    O
chemical    O
formula    O
[    O
PtCl6]2−.    O

The    O
nucleation    O
process    O
of    O
water    O
droplets    O
/    O
ice    O
micro    O
-    O
crystals    O
from    O
water    O
vapor    O
reproduced    O
in    O
the    O
CLOUD    O
experiment    O
and    O
also    O
directly    O
observed    O
in    O
the    O
Earth    O
atmosphere    O
do    O
not    O
only    O
involve    O
ion    B-Body109224911
formation    O
due    O
to    O
cosmic    O
rays    O
but    O
also    O
a    O
range    O
of    O
complex    O
chemical    O
reactions    O
with    O
sulfuric    O
acid    O
,    O
ammonia    O
and    O
organic    O
compounds    O
emitted    O
in    O
the    O
air    O
by    O
human    O
activities    O
and    O
by    O
organisms    O
living    O
on    O
land    O
or    O
in    O
the    O
oceans    O
(    O
plankton    O
)    O
.    O

;    O
1883:Svante    O
Arrhenius    O
develops    O
ion    B-Body109224911
theory    O
to    O
explain    O
conductivity    O
in    O
electrolytes    O
.    O

Carrier    O
proteins    O
are    O
proteins    O
involved    O
in    O
the    O
movement    O
of    O
ions    B-Body109224911
,    O
small    O
molecules    O
,    O
or    O
macromolecules    O
,    O
such    O
as    O
another    O
protein    O
,    O
across    O
a    O
biological    O
membrane    O
.    O

In    O
a    O
study    O
in    O
which    O
b-    O
and    O
c    O
-    O
polyethylenimine    O
coated    O
AgNPs    O
were    O
attached    O
to    O
strands    O
of    O
Lambda    O
DNA    O
,    O
the    O
cationic    B-Body109224911
b    O
-    O
polyethylenimine    O
coated    O
AgNP    O
was    O
found    O
to    O
lower    O
the    O
melting    O
point    O
of    O
the    O
DNA    O
50    O
°C    O
lower    O
than    O
its    O
anionic    B-Body109224911
counterpart[29    O
]    O
.    O

An    O
arsenide    O
mineral    O
is    O
a    O
mineral    O
that    O
contains    O
arsenide    O
as    O
its    O
main    O
anion    B-Body109224911
.    O

According    O
to    O
this    O
model    O
corannulene    O
is    O
made    O
up    O
of    O
an    O
aromatic    O
6    O
electron    O
cyclopentadienyl    O
anion    O
surrounded    O
by    O
an    O
aromatic    O
14    O
electron    O
annulenyl    O
cation    B-Body109224911
.    O

It    O
is    O
a    O
soluble    O
halogen    O
,    O
fairly    O
non    O
-    O
reactive    O
,    O
exists    O
mainly    O
as    O
a    O
non    O
-    O
sorbing    O
anion    B-Body109224911
,    O
and    O
is    O
produced    O
by    O
cosmogenic    O
,    O
thermonuclear    O
,    O
and    O
in    O
-    O
situ    O
reactions    O
.    O

129I    O
differs    O
from    O
36Cl    O
in    O
that    O
its    O
half    O
-    O
life    O
is    O
longer    O
(    O
15.7    O
vs.    O
0.301    O
million    O
years    O
)    O
,    O
it    O
is    O
highly    O
biophilic    O
,    O
and    O
occurs    O
in    O
multiple    O
ion    B-Body109224911
forms    O
(    O
commonly    O
,    O
I−    O
and    O
IO3−    O
)    O
,    O
which    O
have    O
different    O
chemical    O
behaviors    O
.    O

The    O
degree    B-Body109224911
of    I-Body109224911
ionization    I-Body109224911
(    O
also    O
known    O
as    O
"    O
ionization    O
yield    O
"    O
in    O
the    O
literature    O
)    O
refers    O
to    O
the    O
proportion    O
of    O
neutral    O
particles    O
,    O
such    O
as    O
those    O
in    O
a    O
gas    O
or    O
aqueous    O
solution    O
,    O
that    O
are    O
ionized    O
to    O
charged    O
particles    O
.    O

Hereditary    O
benign    O
intraepithelial    O
dyskeratosis    O
is    O
a    O
rare    O
autosomal    O
dominant    O
disease    O
of    O
the    O
conjunctiva    O
and    O
the    O
oral    O
mucosa    O
caused    O
by    O
a    O
duplication    O
of    O
chromosome    B-Body109224911
4q35    I-Body109224911
.    O

There    O
are    O
nine    O
other    O
major    O
chromosomal    O
differences    O
between    O
chimpanzees    O
and    O
humans    O
:    O
chromosome    O
segment    O
inversions    O
on    O
human    O
chromosomes    O
1    B-Body109224911
,    O
4    B-Body109224911
,    O
5    B-Body109224911
,    O
9    B-Body109224911
,    O
12    B-Body109224911
,    O
15    B-Body109224911
,    O
16    B-Body109224911
,    O
17    B-Body109224911
,    O
and    O
18    B-Body109224911
.    O

The    O
gene    O
for    O
CXCL6    O
is    O
located    O
on    O
human    O
chromosome    B-Body109224911
4    I-Body109224911
in    O
a    O
cluster    O
with    O
other    O
CXC    O
chemokine    O
genes    O
.    O

It    O
runs    O
on    O
the    O
positive    O
strand    O
of    O
chromosome    B-Body109224911
4    I-Body109224911
.    O

The    O
gene    O
has    O
7    O
exons    O
,    O
spans    O
5    O
kilobases    O
in    O
length    O
and    O
in    O
humans    O
it    O
is    O
located    O
on    O
the    O
long    B-Body109224911
arm    I-Body109224911
of    O
chromosome    B-Body109224911
4    I-Body109224911
region    O
22    O
(    O
4q1322.1    O
)    O
.    O

FAM114A1    O
is    O
located    O
on    O
the    O
short    O
arm    O
of    O
Chromosome    B-Body109224911
4    I-Body109224911
(    O
4.p14    O
)    O
in    O
humans    O
on    O
the    O
forward    O
strand    O
sense    O
,    O
it    O
starts    O
at    O
base    O
pair    O
38869354    O
and    O
ends    O
at    O
38947365    O
.    O

The    O
MNS    O
antigen    O
system    O
is    O
a    O
human    O
blood    O
group    O
system    O
based    O
upon    O
two    O
genes    O
(    O
glycophorin    O
A    O
and    O
glycophorin    O
B    O
)    O
on    O
chromosome    B-Body109224911
4    I-Body109224911
.    O

The    O
two    O
groups    O
are    O
very    O
closely    O
located    O
together    O
on    O
chromosome    B-Body109224911
4    I-Body109224911
and    O
are    O
inherited    O
as    O
a    O
haplotype    O
.    O

Stannide    B-Body109224911

When    O
a    O
reasonable    O
form    O
is    O
assumed    O
for    O
the    O
additional    O
repulsive    O
energy    O
,    O
the    O
total    O
lattice    O
energy    O
can    O
be    O
modelled    O
using    O
the    O
Born    O
–    O
Landé    O
equation    O
,    O
the    O
Born–Mayer    B-Body109224911
equation    I-Body109224911
,    O
or    O
in    O
the    O
absence    O
of    O
structural    O
information    O
,    O
the    O
Kapustinskii    O
equation    O
.    O

Job    O
Dekker    O
,    O
developer    O
of    O
the    O
Chromosome    B-Body109224911
conformation    I-Body109224911
capture    I-Body109224911
method    O
.    O

In    O
particular    O
,    O
data    O
from    O
Hi-C    B-Body109224911
and    O
related    O
technologies    O
can    O
be    O
readily    O
analysed    O
using    O
circuit    O
topology    O
framework    O
.    O

A    O
fungal    B-Body109224911
prion    I-Body109224911
is    O
a    O
prion    O
that    O
infects    O
fungal    O
hosts    O
.    O

Fungal    B-Body109224911
prions    I-Body109224911

The    O
Duffy    O
antigen    O
/    O
chemokine    O
receptor    O
gene    O
(    O
gp    O
-    O
Fy    O
;    O
CD234    O
)    O
is    O
located    O
on    O
the    O
long    O
arm    O
of    O
chromosome    B-Body109224911
1    I-Body109224911
(    O
1.q22    O
-    O
1.q23    O
)    O
and    O
was    O
cloned    O
in    O
1993    O
.    O

1p36    O
deletion    O
syndrome    O
–    O
a    O
partial    O
monosomy    O
caused    O
by    O
a    O
deletion    O
at    O
the    O
end    O
of    O
the    O
short    O
p    O
arm    O
of    O
chromosome    B-Body109224911
1    I-Body109224911

The    O
location    O
of    O
the    O
gene    O
in    O
humans    O
is    O
on    O
the    O
first    B-Body109224911
chromosome    I-Body109224911
at    O
q21    O
.    O

WNT4    O
(    O
found    O
on    O
the    O
short    B-Body109224911
arm    I-Body109224911
(p)    I-Body109224911
of    O
chromosome    B-Body109224911
1    I-Body109224911
)    O
has    O
been    O
clearly    O
implicated    O
in    O
the    O
atypical    O
version    O
of    O
this    O
disorder    O
.    O

There    O
are    O
nine    O
other    O
major    O
chromosomal    O
differences    O
between    O
chimpanzees    O
and    O
humans    O
:    O
chromosome    O
segment    O
inversions    O
on    O
human    O
chromosomes    O
1    B-Body109224911
,    O
4    B-Body109224911
,    O
5    B-Body109224911
,    O
9    B-Body109224911
,    O
12    B-Body109224911
,    O
15    B-Body109224911
,    O
16    B-Body109224911
,    O
17    B-Body109224911
,    O
and    O
18    B-Body109224911
.    O

In    O
humans    O
,    O
the    O
complex    O
is    O
located    O
on    O
a    O
1.9    O
Mbp    O
stretch    O
within    O
chromosome    B-Body109224911
1    I-Body109224911
.    O

miR-137    O
is    O
located    O
on    O
chromosome    B-Body109224911
1p22    I-Body109224911
within    O
the    O
non    O
-    O
protein    O
-    O
coding    O
RNA    O
gene    O
AK094607    O
.    O

In    O
humans    O
,    O
miR-200a    O
,    O
miR-200b    O
,    O
and    O
miR-429    O
are    O
located    O
on    O
chromosome    B-Body109224911
1    I-Body109224911
and    O
miR-200c    O
and    O
miR-141    O
are    O
on    O
chromosome    B-Body109224911
12    I-Body109224911
.    O

p90    O
Rsk-1    O
is    O
located    O
at    O
1p    B-Body109224911
.    O

All    O
of    O
these    O
genes    O
are    O
located    O
in    O
histone    O
cluster    O
1    O
on    O
chromosome    B-Body109224911
6    I-Body109224911
and    O
cluster    O
2    O
and    O
cluster    O
3    O
on    O
chromosome    B-Body109224911
1    I-Body109224911
.    O

"    O
PIK3CD    O
"    O
maps    O
to    O
human    O
chromosome    B-Body109224911
1    I-Body109224911
and    O
encodes    O
the    O
p110δ    O
catalytic    O
PI(3)K    O
subunit    O
.    O

Aneuploidy    O
of    O
autosomes    O
is    O
not    O
well    O
tolerated    O
and    O
usually    O
results    O
in    O
miscarriage    O
of    O
the    O
developing    O
fetus    O
.    O
Fetuses    O
with    O
aneuploidy    O
of    O
gene    O
-    O
rich    O
chromosomes    O
—    O
such    O
as    O
chromosome    B-Body109224911
1    I-Body109224911

In    O
the    O
human    O
genome    O
DUF1220    O
sequences    O
are    O
located    O
primarily    O
on    O
chromosome    B-Body109224911
1    I-Body109224911
in    O
region    O
1q21.1-q21.2    O
,    O
with    O
several    O
copies    O
also    O
found    O
at    O
1p36    O
,    O
1p13.3    O
,    O
and    O
1p12    O
.    O

During    O
the    O
elongation    O
phase    O
of    O
replication    O
,    O
the    O
enzymes    O
that    O
were    O
assembled    O
at    O
oriC    O
during    O
initiation    O
proceed    O
along    O
each    O
arm    O
(    O
"    O
replichore    B-Body109224911
"    O
)    O
of    O
the    O
chromosome    O
,    O
in    O
opposite    O
directions    O
away    O
from    O
the    O
oriC    O
,    O
replicating    O
the    O
DNA    O
to    O
create    O
two    O
identical    O
copies    O
.    O

Its    O
entire    O
genome    O
was    O
sequenced    O
in    O
2002    O
,    O
revealing    O
that    O
the    O
species    O
has    O
a    O
single    O
circular    B-Body109224911
chromosome    I-Body109224911
with    O
9,105,828    O
base    O
pairs    O
.    O

A    O
circular    B-Body109224911
bacterial    I-Body109224911
chromosome    I-Body109224911
is    O
a    O
bacterial    O
chromosome    O
in    O
the    O
form    O
of    O
a    O
molecule    O
of    O
circular    O
DNA    O
.    O

Oops-Leon    B-Body109224911
,    O
an    O
erroneously    O
-    O
claimed    O
discovery    O
of    O
a    O
similar    O
particle    O
at    O
a    O
lower    O
mass    O
in    O
1976    O
.    O

Strangelet    B-Body109224911
.    O

However    O
,    O
the    O
neutrinos    O
escape    O
,    O
violating    O
lepton    O
number    O
,    O
so    O
the    O
phase    O
space    O
for    O
quark    O
matter    O
in    O
compact    O
stars    O
only    O
has    O
two    O
dimensions    O
,    O
temperature    O
(    O
"    O
T    O
"    O
)    O
and    O
quark    O
number    O
chemical    O
potential    O
μ.    O
A    O
strangelet    B-Body109224911
is    O
not    O
in    O
the    O
thermodynamic    O
limit    O
of    O
large    O
volume    O
,    O
so    O
it    O
is    O
like    O
an    O
exotic    O
nucleus    O
:    O
it    O
may    O
carry    O
electric    O
charge    O
.    O

There    O
is    O
no    O
known    O
defense    O
from    O
a    O
quark    O
bomb    O
(    O
see    O
also    O
Strangelet    B-Body109224911
)    O
.    O

:    O
This    O
is    O
the    O
only    O
scenario    O
in    O
which    O
Dr.    O
Howell    O
reaches    O
his    O
laboratory    O
unhindered    O
,    O
with    O
people    O
protesting    O
outside    O
and    O
shouting    O
,    O
"    O
Stop    O
the    O
experiment    O
!    O
"    O
On    O
numerous    O
television    O
screens    O
,    O
several    O
scientists    O
talk    O
about    O
a    O
new    O
type    O
of    O
matter    O
,    O
the    O
strangelet    B-Body109224911
,    O
and    O
just    O
how    O
unlikely    O
it    O
is    O
for    O
one    O
to    O
be    O
formed    O
.    O

Other    O
types    O
of    O
inorganic    O
compounds    O
include    O
the    O
inorganic    O
salts    O
and    O
complexes    O
of    O
the    O
carbon    O
-    O
containing    O
cyanide    O
,    O
cyanate    O
,    O
fulminate    O
,    O
thiocyanate    O
and    O
cyanamide    O
ions    B-Body109224911
.    O

However    O
,    O
there    O
are    O
molecular    B-Body109224911
ion    I-Body109224911
which    O
contain    O
neon    O
,    O
as    O
well    O
as    O
temporary    O
excited    O
neon    O
-    O
containing    O
molecules    O
called    O
excimers    O
.    O

In    O
the    O
naming    O
of    O
inorganic    O
compounds    O
it    O
is    O
a    O
suffix    O
that    O
indicates    O
a    O
polyatomic    B-Body109224911
anion    I-Body109224911
with    O
a    O
central    O
tellurium    O
atom    O
.    O

An    O
oxycation    B-Body109224911
is    O
a    O
polyatomic    B-Body109224911
ion    I-Body109224911
with    O
a    O
positive    O
charge    O
that    O
contains    O
oxygen    O
.    O

The    O
atoms    O
of    O
polyatomic    B-Body109224911
ion    I-Body109224911
are    O
held    O
together    O
covalently    O
.    O

However    O
,    O
APPI    O
ionizes    O
a    O
broad    O
range    O
of    O
compound    O
classes    O
and    O
produces    O
both    O
protonated    O
and    O
molecular    B-Body109224911
ion    I-Body109224911
peaks    O
,    O
resulting    O
in    O
a    O
complex    O
mass    O
spectrum    O
.    O

to    O
emissions    O
from    O
the    O
interstellar    O
medium    O
using    O
a    O
radio    O
telescope    O
.    O
was    O
the    O
first    O
stable    O
polyatomic    B-Body109224911
molecule    O
to    O
be    O
identified    O
in    O
the    O
interstellar    O
medium    O
.    O

Polyatomic    B-Body109224911
ion    I-Body109224911

This    O
was    O
the    O
first    O
polyatomic    B-Body109224911
molecule    O
to    O
be    O
so    O
detected    O
.    O

Photino    B-Body109224911

The    O
axino    B-Body109224911
is    O
a    O
hypothetical    O
elementary    O
particle    O
predicted    O
by    O
some    O
theories    O
of    O
particle    O
physics    O
.    O

PPNG    O
involves    O
the    O
acquisition    O
of    O
a    O
plasmid-borne    B-Body109224911
beta    O
-    O
lactamase    O
.    O
"    O

The    O
gene    O
for    O
CCL27    O
is    O
located    O
on    O
human    O
chromosome    B-Body109224911
9    I-Body109224911
.    O

This    O
chromosome    O
is    O
defective    O
and    O
unusually    O
short    O
because    O
of    O
reciprocal    O
translocation    O
of    O
genetic    O
material    O
between    O
chromosome    B-Body109224911
9    I-Body109224911
and    O
chromosome    O
22    O
,    O
and    O
contains    O
a    O
fusion    O
gene    O
called    O
"    O
BCR    O
-    O
ABL1    O
"    O
.    O

There    O
are    O
nine    O
other    O
major    O
chromosomal    O
differences    O
between    O
chimpanzees    O
and    O
humans    O
:    O
chromosome    O
segment    O
inversions    O
on    O
human    O
chromosomes    O
1    B-Body109224911
,    O
4    B-Body109224911
,    O
5    B-Body109224911
,    O
9    B-Body109224911
,    O
12    B-Body109224911
,    O
15    B-Body109224911
,    O
16    B-Body109224911
,    O
17    B-Body109224911
,    O
and    O
18    B-Body109224911
.    O

At    O
the    O
site    O
of    O
fusion    O
,    O
there    O
are    O
approximately    O
150,000    O
base    O
pairs    O
of    O
sequence    O
not    O
found    O
in    O
chimpanzee    O
chromosomes    O
2A    O
and    O
2B.    O
Additional    O
linked    O
copies    O
of    O
the    O
PGML    O
/    O
FOXD    O
/    O
CBWD    O
genes    O
exist    O
elsewhere    O
in    O
the    O
human    O
genome    O
,    O
particularly    O
near    O
the    O
p    O
end    O
of    O
chromosome    B-Body109224911
9    I-Body109224911
.    O

In    O
Hodgkin    O
's    O
lymphoma    O
,    O
Reed    O
-    O
Sternberg    O
cells    O
harbor    O
amplification    O
of    O
chromosome    B-Body109224911
9    I-Body109224911
,    O
which    O
encodes    O
PD    O
-    O
L1    O
and    O
PD    O
-    O
L2    O
and    O
leads    O
to    O
their    O
constitutive    O
expression    O
.    O

miR-126    O
is    O
located    O
within    O
the    O
7th    O
intron    O
of    O
the    O
EGFL7    O
gene    O
which    O
resides    O
on    O
human    O
chromosome    B-Body109224911
9    I-Body109224911
.    O

KIAA1958    O
is    O
located    O
on    O
the    O
long    O
arm    O
of    O
chromosome    B-Body109224911
9    I-Body109224911
(    O
9.q32    O
)    O
in    O
humans    O
on    O
the    O
plus    O
strand    O
from    O
115249248    O
to    O
115427597    O
.    O

This    O
abnormality    O
was    O
discovered    O
by    O
Peter    O
Nowell    O
in    O
1960    O
and    O
is    O
a    O
consequence    O
of    O
fusion    O
between    O
the    O
Abelson    O
(    O
Abl    O
)    O
tyrosine    O
kinase    O
gene    O
at    O
chromosome    B-Body109224911
9    I-Body109224911
and    O
the    O
break    O
point    O
cluster    O
(    O
Bcr    O
)    O
gene    O
at    O
chromosome    B-Body109224911
22    I-Body109224911
,    O
resulting    O
in    O
a    O
chimeric    O
oncogene    O
(    O
Bcr    O
-    O
Abl    O
)    O
and    O
a    O
constitutively    O
active    O
Bcr    O
-    O
Abl    O
tyrosine    O
kinase    O
that    O
has    O
been    O
implicated    O
in    O
the    O
pathogenesis    O
of    O
CML    O
.    O

Full    O
trisomy    O
9    O
is    O
a    O
lethal    O
chromosomal    O
disorder    O
caused    O
by    O
having    O
three    O
copies    O
(    O
trisomy    O
)    O
of    O
chromosome    B-Body109224911
number    I-Body109224911
9    I-Body109224911
.    O

The    O
gene    O
that    O
encodes    O
for    O
this    O
enzyme    O
,    O
"    O
ASS    O
"    O
,    O
is    O
located    O
on    O
chromosome    B-Body109224911
9    I-Body109224911
.    O

The    O
Lambda    O
baryon    O
was    O
first    O
discovered    O
in    O
October    O
1950    O
,    O
by    O
V.    O
D.    O
Hopper    O
and    O
S.    O
Biswas    O
of    O
the    O
University    O
of    O
Melbourne    O
,    O
as    O
a    O
neutral    O
V    B-Body109224911
particle    I-Body109224911
with    O
a    O
proton    O
as    O
a    O
decay    O
product    O
,    O
thus    O
correctly    O
distinguishing    O
it    O
as    O
a    O
baryon    O
,    O
rather    O
than    O
a    O
meson    O
"    O
i.e.    O
"    O
,    O
different    O
in    O
kind    O
from    O
the    O
K    O
meson    O
discovered    O
in    O
1947    O
by    O
Rochester    O
and    O
Butler    O
;    O
they    O
were    O
produced    O
by    O
cosmic    O
rays    O
and    O
detected    O
in    O
photographic    O
emulsions    O
flown    O
in    O
a    O
balloon    O
at    O
.    O

decay    O
contributes    O
6    O
electron    O
anti    O
-    O
neutrinos    O
per    O
decay    O
(    O
1    O
per    O
beta    O
decay    O
)    O
,    O
resulting    O
in    O
a    O
large    O
detectable    O
geoneutrino    B-Body109224911
signal    O
when    O
decays    O
occur    O
within    O
the    O
Earth    O
.    O

It    O
is    O
an    O
essential    O
process    O
to    O
experiments    O
involving    O
low    O
energy    O
neutrinos    O
(    O
<    O
60    O
MeV    O
)    O
such    O
as    O
those    O
studying    O
neutrino    B-Body109224911
oscillation    I-Body109224911
,    O
reactor    O
neutrinos    O
,    O
sterile    O
neutrinos    O
,    O
and    O
geoneutrinos.    B-Body109224911

To    O
prevent    O
this    O
from    O
happening    O
,    O
there    O
are    O
mechanisms    O
of    O
error    O
detection    O
and    O
correction    O
(    O
as    O
the    O
spindle    B-Body109224911
assembly    I-Body109224911
checkpoint    I-Body109224911
)    O
,    O
whose    O
components    O
reside    O
also    O
on    O
the    O
kinetochores    O
.    O

Dynein    O
is    O
released    O
from    O
kinetochores    O
as    O
they    O
acquire    O
kMTs    O
and    O
,    O
in    O
cultured    O
mammalian    O
cells    O
,    O
it    O
is    O
required    O
for    O
the    O
spindle    B-Body109224911
checkpoint    I-Body109224911
inactivation    O
,    O
but    O
not    O
for    O
chromosome    O
congression    O
in    O
the    O
spindle    O
equator    O
,    O
kMTs    O
acquisition    O
or    O
anaphase    O
A    O
during    O
chromosome    O
segregation    O
.    O

Yet    O
mutants    O
in    O
which    O
kinetochore    O
structure    O
is    O
lost    O
(    O
for    O
instance    O
Ndc10    O
mutants    O
in    O
yeast    O
)    O
are    O
deficient    O
both    O
in    O
the    O
connection    O
to    O
microtubules    O
and    O
in    O
the    O
ability    O
to    O
activate    O
the    O
spindle    B-Body109224911
checkpoint    I-Body109224911
,    O
probably    O
because    O
kinetochores    O
work    O
as    O
a    O
platform    O
in    O
which    O
the    O
components    O
of    O
the    O
response    O
are    O
assembled    O
.    O

monotelic    O
:    O
only    O
one    O
of    O
the    O
chromatids    O
is    O
anchored    O
to    O
MTs    O
,    O
the    O
second    O
kinetochore    O
is    O
not    O
anchored    O
;    O
in    O
this    O
situation    O
,    O
there    O
is    O
no    O
centromeric    O
tension    O
,    O
and    O
the    O
spindle    B-Body109224911
checkpoint    I-Body109224911
is    O
activated    O
,    O
delaying    O
entry    O
in    O
anaphase    O
and    O
allowing    O
time    O
for    O
the    O
cell    O
to    O
correct    O
the    O
error    O
.    O

Orc2    O
(    O
a    O
protein    O
that    O
belongs    O
to    O
the    O
origin    O
recognition    O
complex    O
-ORC-    O
implicated    O
in    O
DNA    O
replication    O
initiation    O
during    O
S    O
phase    O
)    O
is    O
also    O
localized    O
at    O
kinetochores    O
during    O
mitosis    O
in    O
human    O
cells    O
;    O
in    O
agreement    O
with    O
this    O
localization    O
,    O
some    O
studies    O
indicate    O
that    O
Orc2    O
in    O
yeast    O
is    O
implicated    O
in    O
sister    O
chromatids    O
cohesion    O
,    O
and    O
when    O
it    O
is    O
eliminated    O
from    O
the    O
cell    O
,    O
spindle    B-Body109224911
checkpoint    I-Body109224911
activation    O
ensues    O
.    O

methenium    B-Body109224911
cation    O
,    O
(    O
protonated    O
methylene    O
)    O

Chromoplexy    B-Body109224911
refers    O
to    O
a    O
class    O
of    O
complex    O
DNA    O
rearrangement    O
observed    O
in    O
the    O
genomes    O
of    O
cancer    O
cells    O
.    O

Dalantercept    O
,    O
ACE-041    O
(    O
Acceleron    B-Body109224911
)    O

The    O
pGLO    B-Body109224911
plasmid    O
is    O
an    O
engineered    O
plasmid    O
used    O
in    O
biotechnology    O
as    O
a    O
vector    O
for    O
creating    O
genetically    O
modified    O
organisms    O
.    O

See    O
Foldy–Wouthuysen    B-Body109224911
transformation    I-Body109224911
for    O
more    O
theoretical    O
background    O
.    O

The    O
Foldy–Wouthuysen    B-Body109224911
transform    I-Body109224911
is    O
widely    O
used    O
in    O
high    O
energy    O
physics    O
.    O

Current    B-Body109224911
quarks    I-Body109224911
(    O
also    O
called    O
naked    B-Body109224911
quarks    I-Body109224911
or    O
bare    B-Body109224911
quarks    I-Body109224911
)    O
are    O
defined    O
as    O
the    O
constituent    B-Body109224911
quark    I-Body109224911
cores    O
(    O
constituent    O
quarks    O
with    O
no    O
covering    O
)    O
of    O
a    O
valence    B-Body109224911
quark    I-Body109224911
.    O

The    O
current    O
quark    O
masses    O
of    O
the    O
light    O
current    O
quarks    O
are    O
much    O
smaller    O
than    O
the    O
constituent    B-Body109224911
quark    I-Body109224911
mass    I-Body109224911
.    O

The    O
mu    O
problem    O
:    O
The    O
Higgsino    B-Body109224911
mass    O
parameter    O
μ    O
appears    O
as    O
the    O
following    O
term    O
in    O
the    O
superpotential    O
:    O
μHuHd    O
.    O

In    O
the    O
presence    O
of    O
supersymmetry    O
,    O
the    O
triplet    O
Higgsino    B-Body109224911
needs    O
to    O
be    O
more    O
massive    O
than    O
the    O
GUT    O
scale    O
to    O
prevent    O
proton    O
decay    O
because    O
it    O
generates    O
dimension    O
5    O
operators    O
in    O
MSSM    O
;    O
there    O
it    O
is    O
not    O
enough    O
simply    O
to    O
require    O
the    O
triplet    O
to    O
have    O
a    O
GUT    O
scale    O
mass    O
.    O

Derivative    B-Body109224911
chromosome    I-Body109224911
,    O
a    O
structurally    O
rearranged    O
chromosome    O

The    O
neutrino    B-Body109224911
minimal    I-Body109224911
standard    I-Body109224911
model    I-Body109224911
(    O
often    O
abbreviated    O
as    O
νMSM    B-Body109224911
)    O
is    O
an    O
extension    O
of    O
the    O
Standard    O
Model    O
of    O
particle    O
physics    O
,    O
by    O
the    O
addition    O
of    O
three    O
right    O
-    O
handed    O
neutrinos    O
with    O
masses    O
smaller    O
than    O
the    O
electroweak    O
scale    O
.    O

This    O
large    O
effective    O
mass    O
is    O
also    O
reflected    O
in    O
a    O
large    O
contribution    O
to    O
the    O
resistivity    O
from    O
electron    O
-    O
electron    O
scattering    O
via    O
the    O
Kadowaki    B-Body109224911
Woods    I-Body109224911
ratio    I-Body109224911
.    O

He    O
is    O
famous    O
for    O
the    O
Gell-Mann-Okubo    B-Body109224911
mass    I-Body109224911
formula    I-Body109224911
for    O
mesons    O
and    O
baryons    O
in    O
the    O
quark    O
model    O
;    O
this    O
formula    O
correctly    O
predicts    O
the    O
relations    O
of    O
masses    O
of    O
the    O
members    O
of    O
SU(3    O
)    O
multiplets    O
in    O
terms    O
of    O
hypercharge    B-Body109224911
and    O
isotopic    O
spin    O
.    O

The    O
theta    B-Body109224911
meson    I-Body109224911
is    O
a    O
hypothetical    O
form    O
of    O
quarkonium    B-Body109224911
(    O
i.e.    O
a    O
flavourless    O
meson    O
)    O
formed    O
by    O
a    O
top    O
quark    O
and    O
top    O
antiquark    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
penicillin    O
and    O
H2O    O
,    O
whereas    O
its    O
two    O
products    O
are    O
carboxylate    B-Body109224911
and    O
6-aminopenicillanate    O
.    O

:    O
an    O
N    O
-    O
acyl    O
-    O
L    O
-    O
homoserine    O
lactone    O
+    O
H2O    O
L    O
-    O
homoserine    O
lactone    O
+    O
a    O
carboxylate    B-Body109224911

This    O
malyl    O
-    O
CoA    O
intermediate    O
then    O
undergoes    O
hydrolysis    O
at    O
the    O
acyl    O
-    O
CoA    O
portion    O
,    O
replacing    O
it    O
with    O
an    O
carboxylate    B-Body109224911
anion    O
.    O

In    O
the    O
first    O
step    O
,    O
the    O
binding    O
step    O
,    O
the    O
carboxylate    B-Body109224911
group    O
changes    O
from    O
the    O
axial    O
position    O
into    O
the    O
pseudo    O
-    O
equatorial    O
position    O
.    O

The    O
zinc    O
ion    O
,    O
which    O
lies    O
at    O
the    O
bottom    O
of    O
the    O
cleft    O
,    O
exhibits    O
a    O
unique    O
penta    O
-    O
coordinated    O
mode    O
of    O
binding    O
,    O
involving    O
3    O
histidine    O
residues    O
,    O
a    O
tyrosine    O
and    O
a    O
water    O
molecule    O
(    O
which    O
is    O
also    O
bound    O
to    O
the    O
carboxylate    B-Body109224911
side    O
chain    O
of    O
Glu93    O
)    O
.    O

|    O
Carboxylate    B-Body109224911

Acid    O
anhydrides    O
are    O
more    O
reactive    O
than    O
esters    O
because    O
the    O
leaving    O
group    O
is    O
a    O
carboxylate    B-Body109224911
anion    O
—    O
a    O
better    O
leaving    O
group    O
than    O
an    O
alkoxide    O
anion    O
because    O
their    O
negative    O
charge    O
is    O
more    O
delocalised    O
.    O

-    O
amino    O
groups    O
(    O
Active    O
ester    O
,    O
Carboxylate    B-Body109224911
,    O
Isothiocyanate    O
,    O
hydrazine    O
)    O

In    O
addition    O
,    O
magnetic    O
susceptibility    O
studies    O
have    O
shown    O
that    O
chromium    O
does    O
not    O
coordinate    O
to    O
any    O
N    O
-    O
terminal    O
amine    O
groups    O
but    O
rather    O
to    O
carboxylate    B-Body109224911
(    O
although    O
the    O
exact    O
the    O
amino    O
acids    O
involved    O
are    O
still    O
unknown    O
)    O
.    O

Chromium(III    O
)    O
is    O
a    O
hard    O
lewis    O
acid    O
and    O
as    O
such    O
has    O
high    O
affinity    O
to    O
the    O
carboxylate    B-Body109224911
oxygen    O
and    O
medium    O
affinity    O
to    O
the    O
pyridine    O
nitrogen    O
of    O
picolinate    O
.    O

Additionally    O
,    O
the    O
terminal    O
charged    O
primary    O
ammonium    O
on    O
lysine    O
forms    O
salt    O
bridges    O
with    O
carboxylate    B-Body109224911
groups    O
of    O
other    O
amino    O
acids    O
in    O
polypeptides    O
,    O
which    O
is    O
one    O
of    O
the    O
primary    O
influences    O
on    O
the    O
three    O
-    O
dimensional    O
structures    O
of    O
proteins    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
2-lysophosphatidylcholine    O
and    O
H2O    O
,    O
whereas    O
its    O
two    O
products    O
are    O
glycerophosphocholine    O
and    O
carboxylate    B-Body109224911
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
1-phosphatidyl    O
-    O
D    O
-    O
myo    O
-    O
inositol    O
and    O
H2O    O
,    O
whereas    O
its    O
two    O
products    O
are    O
1-acylglycerophosphoinositol    O
and    O
carboxylate    B-Body109224911
.    O

In    O
fatty    O
acid    O
metabolism    O
,    O
fatty    O
acids    O
are    O
changed    O
into    O
fatty    O
acyl    O
-    O
CoA.    O
To    O
do    O
this    O
,    O
the    O
carboxylate    B-Body109224911
which    O
occupies    O
one    O
end    O
of    O
the    O
fatty    O
acid    O
is    O
changed    O
into    O
a    O
thioester    O
by    O
substituting    O
coenzyme    O
A    O
for    O
the    O
hydroxyl    O
group    O
.    O

Calcium    O
stearate    O
is    O
a    O
carboxylate    B-Body109224911
of    O
calcium    O
,    O
classified    O
as    O
a    O
calcium    O
soap    O
.    O

Recent    O
evidence    O
suggests    O
that    O
the    O
glutamic    O
acid    O
residue    O
is    O
involved    O
in    O
the    O
protonating    O
step    O
despite    O
the    O
observation    O
that    O
its    O
carboxylic    O
acid    O
side    O
-    O
chain    O
is    O
stabilized    O
in    O
its    O
carboxylate    B-Body109224911
form    O
.    O

The    O
ester    O
bond    O
is    O
formed    O
between    O
the    O
carboxylate    B-Body109224911
group    O
of    O
a    O
fatty    O
acid    O
and    O
the    O
hydroxyl    O
group    O
of    O
cholesterol    O
.    O

The    O
human    O
"    O
DECR1    O
"    O
gene    O
has    O
11    O
exons    O
and    O
resides    O
on    O
chromosome    B-Body109224911
8    I-Body109224911
at    O
q21.3    O
.    O

This    O
gene    O
is    O
found    O
at    O
8q24    B-Body109224911
.    O

Aldosterone    O
synthase    O
is    O
encoded    O
on    O
chromosome    B-Body109224911
8    I-Body109224911
by    O
the    O
CYP11B2    O
gene    O
.    O

RTS    O
is    O
caused    O
by    O
a    O
mutation    O
of    O
the    O
RECQL4    O
gene    O
,    O
located    O
at    O
chromosome    O
8q24.3    B-Body109224911
.    O

"    O
FAM203B    O
"    O
is    O
located    O
on    O
the    O
positive    O
DNA    O
strand    O
of    O
the    O
long    O
arm    O
of    O
chromosome    B-Body109224911
8    I-Body109224911
at    O
locus    B-Body109224911
24.3    O
(    O
8q24.3    O
)    O
from    O
76,368,898    O
-    O
76,371,411    O
in    O
the    O
human    O
genome    O
.    O

IL-15    O
is    O
14    O
-    O
15    O
kDa    O
glycoprotein    O
encoded    O
by    O
the    O
34    O
kb    O
region    O
of    O
chromosome    O
4q31    O
in    O
humans    O
,    O
and    O
at    O
the    O
central    O
region    O
of    O
chromosome    B-Body109224911
8    I-Body109224911
in    O
mice    O
.    O

Northern    O
epilepsy    O
syndrome    O
is    O
caused    O
by    O
an    O
inherited    O
recessive    O
autosomal    O
mutation    O
in    O
the    O
telomeric    O
region    O
of    O
the    O
short    O
arm    O
of    O
chromosome    B-Body109224911
8    I-Body109224911
.    O

3C    O
syndrome    O
is    O
an    O
autosomal    O
recessive    O
disease    O
,    O
caused    O
by    O
a    O
mutation    O
on    O
the    O
long    O
arm    O
of    O
chromosome    B-Body109224911
8    I-Body109224911
at    O
8q24.13    O
,    O
the    O
locus    B-Body109224911
for    O
KIAA0196    O
,    O
the    O
gene    O
for    O
the    O
protein    O
strumpellin    O
.    O

First    O
,    O
DNA    O
is    O
sheared    O
into    O
larger    O
(    O
50–200    O
kb    O
)    O
pieces    O
,    O
which    O
are    O
cloned    O
into    O
BACs    O
or    O
PACs    B-Body109224911
to    O
form    O
a    O
BAC    O
library    O
.    O

Lyman–Werner    B-Body109224911
photons    I-Body109224911

Thiosulfate    B-Body109224911

Thiosulfate    B-Body109224911

Starkeya    O
novella    O
"    O
has    O
the    O
ability    O
to    O
oxidise    O
thiosulfate    B-Body109224911
.    O

Reduced    O
sulfur    O
compounds    O
,    O
such    O
as    O
hydrogen    O
sulfide    O
,    O
elemental    O
sulfur    O
,    O
sulfite    B-Body109224911
,    O
thiosulfate    B-Body109224911
,    O
and    O
various    O
polythionates    O
(    O
e.g.    O
,    O
tetrathionate    O
)    O
,    O
are    O
used    O
by    O
various    O
lithotrophic    O
bacteria    O
and    O
are    O
all    O
oxidized    O
by    O
"    O
Acidithiobacillus    O
"    O
.    O

In    O
the    O
first    O
step    O
,    O
thiosulfate    B-Body109224911
is    O
reduced    O
by    O
the    O
thiol    O
group    O
on    O
cysteine-247    O
1    O
,    O
to    O
form    O
a    O
persulfide    O
and    O
a    O
sulfite    O
2    O
.    O

This    O
process    O
is    O
used    O
by    O
some    O
bacteria    O
to    O
synthesise    O
carbon    O
compounds    O
,    O
sometimes    O
using    O
hydrogen    O
,    O
sulfide    O
,    O
or    O
thiosulfate    B-Body109224911
as    O
electron    O
donors    O
.    O

Soluble    O
inorganic    O
material    O
such    O
as    O
ammonia    O
,    O
road    O
-    O
salt    O
,    O
sea    O
-    O
salt    O
,    O
cyanide    O
,    O
hydrogen    O
sulfide    O
,    O
thiocyanates    O
,    O
thiosulfate    B-Body109224911
,    O
etc    O
.    O
;    O

Alternatively    O
,    O
a    O
thiosulfate    B-Body109224911
solution    O
may    O
be    O
used    O
as    O
a    O
reducing    O
agent    O
.    O

What    O
separates    O
1pr3    O
T    O
from    O
its    O
sister    O
strains    O
is    O
its    O
ability    O
to    O
reduce    O
sulfite    B-Body109224911
and    O
thiosulfate    B-Body109224911
to    O
hydrogen    O
sulfide    O
(    O
H2S    O
)    O
;    O
reduce    O
nitrate    O
to    O
ammonia    O
;    O
lastly    O
,    O
its    O
presence    O
of    O
cytochrome    O
types    O
b-    O
and    O
c-    O
.    O

As    O
assumed    O
by    O
its    O
name    O
,    O
"    O
Desulfobulbus    O
"    O
"    O
propionicus    O
"    O
reduces    O
sulfate    O
,    O
sulfite    B-Body109224911
,    O
and    O
thiosulfate    B-Body109224911
to    O
hydrogen    O
sulfide    O
(    O
H2S    O
)    O
,    O
but    O
does    O
not    O
reduce    O
elemental    O
sulfur    O
,    O
malate    O
,    O
and    O
fumarate    O
.    O

thiosulfate    B-Body109224911
can    O
not    O
be    O
used    O
for    O
reduction    O
.    O

Concentrated    O
hydrochloric    O
acid    O
decomposes    O
it    O
non    O
-    O
explosively    O
with    O
a    O
hissing    O
noise    O
;    O
thiosulfate    B-Body109224911
also    O
decomposes    O
it    O
non    O
-    O
explosively    O
,    O
and    O
can    O
be    O
used    O
for    O
disposal    O
.    O

It    O
is    O
an    O
inorganic    O
compound    O
with    O
the    O
formula    O
S2O3    B-Body109224911

In    O
the    O
solid    O
state    O
,    O
the    O
thiosulfate    B-Body109224911
anion    B-Body109224911
is    O
tetrahedral    O
in    O
shape    O
and    O
is    O
notionally    O
derived    O
by    O
replacing    O
one    O
of    O
the    O
oxygen    O
atoms    O
by    O
a    O
sulfur    O
atom    O
in    O
a    O
sulfate    O
anion    O
.    O

There    O
are    O
five    O
classes    O
of    O
particle    O
that    O
superpartners    O
of    O
the    O
Standard    O
Model    O
fall    O
into    O
:    O
squark    B-Body109224911
,    O
gluino    B-Body109224911
,    O
charginos    O
,    O
neutralinos    O
,    O
and    O
slepton    B-Body109224911
.    O

Therefore    O
,    O
most    O
experimental    O
signature    O
involve    O
production    O
of    O
squark    B-Body109224911
or    O
gluino    B-Body109224911
.    O

L.    O
David    O
Roper    O
(    O
born    O
1935    O
)    O
,    O
discoverer    O
of    O
the    O
Roper    B-Body109224911
resonance    I-Body109224911
in    O
particle    O
physics    O
and    O
genealogist    O

The    O
human    O
lung    O
and    O
saliva    O
contain    O
a    O
wide    O
range    O
of    O
antimicrobial    O
compound    O
including    O
lactoperoxidase    O
system    O
,    O
producing    O
hypothiocyanite    B-Body109224911
and    O
lactoferrin    O
,    O
with    O
hypothiocyanite    O
missing    O
in    O
cystic    O
fibrosis    O
patients    O
.    O

Triple    O
X    O
syndrome    O
,    O
also    O
known    O
as    O
trisomy    O
X    O
and    O
47,XXX    O
,    O
is    O
characterized    O
by    O
the    O
presence    O
of    O
an    O
extra    O
X    B-Body109224911
chromosome    I-Body109224911
in    O
each    O
cell    O
of    O
a    O
female    O
.    O

Because    O
of    O
the    O
lyonization    B-Body109224911
,    O
inactivation    O
,    O
and    O
formation    O
of    O
Barr    O
bodies    O
in    O
all    O
female    O
cells    O
,    O
only    O
one    O
X    B-Body109224911
chromosome    I-Body109224911
is    O
active    O
at    O
any    O
time    O
.    O

The    O
team    O
identified    O
mutations    O
altering    O
two    O
genes    O
on    O
the    O
X    B-Body109224911
chromosome    I-Body109224911
which    O
seem    O
to    O
be    O
implicated    O
in    O
the    O
formation    O
of    O
synapses    O
(    O
communication    O
spaces    O
between    O
neurons    O
)    O
,    O
in    O
two    O
families    O
where    O
several    O
members    O
are    O
affected    O
.    O

Focal    O
dermal    O
hypoplasia    O
has    O
been    O
associated    O
with    O
PORCN    O
gene    O
mutations    O
on    O
the    O
X    B-Body109224911
chromosome    I-Body109224911
.    O

Female    O
with    O
more    O
than    O
three    O
X    B-Body109224911
chromosomes    I-Body109224911

Mosaicism    O
,    O
lines    O
with    O
various    O
numbers    O
of    O
X    B-Body109224911
chromosomes    I-Body109224911

Klinefelter    O
's    O
syndrome    O
,    O
male    O
with    O
more    O
than    O
two    O
X    B-Body109224911
chromosomes    I-Body109224911

Fragile    O
X    B-Body109224911
chromosome    I-Body109224911

In    O
1997    O
,    O
a    O
patient    O
was    O
identified    O
who    O
carried    O
a    O
rare    O
balanced    O
chromosomal    O
translocation    O
involving    O
chromosome    B-Body109224911
19    I-Body109224911
and    O
the    O
X    B-Body109224911
chromosome    I-Body109224911
.    O

The    O
best    O
characterized    O
form    O
of    O
dyskeratosis    O
congenita    O
is    O
a    O
result    O
of    O
one    O
or    O
more    O
mutations    O
in    O
the    O
long    O
arm    O
of    O
the    O
X    B-Body109224911
chromosome    I-Body109224911
in    O
the    O
gene    O
DKC1    O
.    O

Females    O
have    O
two    O
X    B-Body109224911
chromosome    I-Body109224911
,    O
and    O
males    O
have    O
a    O
Y    O
chromosome    O
and    O
an    O
X    O
chromosome    O
.    O

Identical    O
copies    O
of    O
this    O
gene    O
reside    O
on    O
the    O
pseudoautosomal    O
regions    O
of    O
the    O
X    B-Body109224911
and    O
Y    O
chromosomes    O
.    O

He    O
is    O
best    O
known    O
for    O
a    O
collaboration    O
with    O
Ronald    O
Davidson    O
and    O
Harold    O
Nitowsky    O
,    O
which    O
demonstrated    O
random    O
inactivation    B-Body109224911
of    O
one    O
of    O
the    O
two    O
X-chromosome    B-Body109224911
in    O
mammalian    O
female    O
cells    O
,    O
a    O
mechanism    O
of    O
dosage    O
compensation    O
.    O

Kaveggia    O
syndrome    O
)    O
is    O
a    O
rare    O
genetic    O
syndrome    O
caused    O
by    O
one    O
or    O
more    O
recessive    O
genes    O
located    O
on    O
the    O
X    B-Body109224911
chromosome    I-Body109224911
and    O
causing    O
physical    O
anomalies    O
and    O
developmental    O
delays    O
.    O

The    O
first    O
study    O
of    O
the    O
syndrome    O
,    O
published    O
in    O
1974    O
,    O
established    O
that    O
it    O
was    O
linked    O
to    O
inheritance    O
of    O
the    O
X    B-Body109224911
chromosome    I-Body109224911
.    O

The    O
X    B-Body109224911
chromosome    I-Body109224911
is    O
a    O
large    O
acrocentric    O
while    O
the    O
Y    O
chromosome    O
a    O
minute    O
one    O
.    O

He    O
and    O
his    O
collaborators    O
contributed    O
to    O
the    O
identification    O
of    O
several    O
genes    O
associated    O
with    O
Primary    O
immunodeficiency    O
diseases    O
located    O
on    O
the    O
X    B-Body109224911
chromosome    I-Body109224911
,    O
including    O
CD40L    O
,    O
Wiskott    O
-    O
Aldrich    O
syndrome    O
protein    O
,    O
Bruton    O
's    O
tyrosine    O
kinase    O
,    O
and    O
FOXP3    O
.    O

Both    O
known    O
genes    O
are    O
on    O
the    O
X    B-Body109224911
chromosome    I-Body109224911
.    O

PRC2    O
has    O
a    O
role    O
in    O
X    B-Body109224911
chromosome    I-Body109224911
inactivation    O
,    O
in    O
maintenance    O
of    O
stem    O
cell    O
fate    O
,    O
and    O
in    O
imprinting    O
.    O

It    O
has    O
also    O
been    O
established    O
that    O
X-chromosome    B-Body109224911
inactivation    O
occurs    O
in    O
an    O
imprinted    O
manner    O
in    O
the    O
extra    O
-    O
embryonic    O
tissues    O
of    O
mice    O
and    O
all    O
tissues    O
in    O
marsupials    O
,    O
where    O
it    O
is    O
always    O
the    O
paternal    O
X    O
-    O
chromosome    O
which    O
is    O
silenced    O
.    O

LBR    O
also    O
interacts    O
with    O
long    O
non    O
-    O
coding    O
RNA    O
XIST    O
in    O
mouse    O
cells    O
and    O
potentially    O
assist    O
the    O
spreading    O
XIST    O
across    O
X    B-Body109224911
chromosome    I-Body109224911
.    O

p90    O
Rsk-2    O
is    O
located    O
at    O
Xp22.2    B-Body109224911
and    O
contains    O
22    O
exons    O
.    O

Homozygous    O
females    O
,    O
both    O
of    O
whose    O
X    B-Body109224911
chromosomes    I-Body109224911
have    O
a    O
mutation    O
leading    O
to    O
CAG    O
expansion    O
of    O
the    O
"    O
AR    O
"    O
gene    O
,    O
have    O
been    O
reported    O
to    O
show    O
only    O
mild    O
symptoms    O
of    O
muscle    O
cramps    O
and    O
twitching    O
.    O

The    O
genetics    O
of    O
spinal    O
and    O
bulbar    O
muscular    O
atrophy    O
have    O
to    O
do    O
with    O
the    O
mutated    O
androgen    O
receptor    O
gene    O
located    O
on    O
the    O
X    B-Body109224911
chromosome    I-Body109224911
.    O

All    O
dog    O
chromosomes    O
except    O
X    B-Body109224911
and    O
Y    O
are    O
acrocentric    O
,    O
having    O
a    O
centromere    O
very    O
near    O
to    O
the    O
end    O
of    O
the    O
chromosome    O
,    O
while    O
many    O
of    O
the    O
CTVT    O
chromosomes    O
are    O
metacentric    O
or    O
submetacentric    O
,    O
having    O
a    O
centromere    O
nearer    O
to    O
the    O
middle    O
.    O

In    O
molecular    O
biology    O
,    O
the    O
AMMECR1    O
protein    O
(    O
Alport    O
syndrome    O
,    O
intellectual    O
disability    O
,    O
midface    O
hypoplasia    O
and    O
elliptocytosis    O
chromosomal    O
region    O
gene    O
1    O
protein    O
)    O
is    O
a    O
protein    O
encoded    O
by    O
the    O
AMMECR1    O
gene    O
on    O
human    O
chromosome    B-Body109224911
X    I-Body109224911
.    O

Male    O
pattern    O
hair    O
loss    O
(    O
balding    O
)    O
:    O
autosomal    O
SNPs    O
,    O
0.473(0.013    O
)    O
,    O
X    B-Body109224911
chromosome    I-Body109224911
,    O
0.046(0.03    O
)    O
,    O
0.519    O
total    O

Firre    O
(    O
functional    O
intergenic    O
repeating    O
RNA    O
element    O
)    O
is    O
a    O
long    O
non    O
-    O
coding    O
RNA    O
located    O
on    O
chromosome    B-Body109224911
X    I-Body109224911
It    O
is    O
retained    O
in    O
the    O
nucleus    O
via    O
interaction    O
with    O
the    O
nuclear    O
matrix    O
factor    O
hnRNPU    O
.    O

CXorf26    O
(    O
Chromosome    O
X    O
Open    O
Reading    O
Frame    O
26    O
)    O
,    O
also    O
known    O
as    O
MGC874    O
,    O
is    O
a    O
well    O
conserved    O
human    O
gene    O
found    O
on    O
the    O
plus    O
strand    O
of    O
the    O
short    O
arm    O
of    O
the    O
X    B-Body109224911
chromosome    I-Body109224911
.    O

CXorf26    O
is    O
found    O
on    O
the    O
plus    O
strand    O
of    O
the    O
short    O
arm    O
of    O
the    O
X    B-Body109224911
chromosome    I-Body109224911
,    O
specifically    O
on    O
the    O
gene    O
locus    O
Xq13.3    O
spanning    O
the    O
genomic    O
chromosome    O
region    O
from    O
bases    O
75,393,420    O
-    O
75,397,740    O
.    O

The    O
PBDX    O
gene    O
that    O
encodes    O
the    O
antigen    O
is    O
located    O
on    O
the    O
short    B-Body109224911
arm    I-Body109224911
of    O
the    O
X    B-Body109224911
chromosome    I-Body109224911
.    O

Chromosomal    O
abnormalities    O
include    O
a    O
total    O
of    O
three    O
copies    O
of    O
the    O
X    B-Body109224911
chromosome    I-Body109224911
and    O
four    O
copies    O
of    O
chromosome    B-Body109224911
17    I-Body109224911
and    O
chromosome    B-Body109224911
22    I-Body109224911
.    O

The    O
X    B-Body109224911
chromosome    I-Body109224911
is    O
either    O
acrocentric    O
,    O
with    O
a    O
long    O
and    O
a    O
short    O
arm    O
,    O
or    O
subtelocentric    O
,    O
with    O
a    O
long    O
and    O
a    O
vestigial    O
arm    O
.    O

Xist    O
(    O
X    O
-    O
inactive    O
-    O
specific    O
transcript    O
)    O
is    O
a    O
long    O
ncRNA    O
gene    O
on    O
the    O
X    B-Body109224911
chromosome    I-Body109224911
of    O
the    O
placental    O
mammals    O
that    O
acts    O
as    O
major    O
effector    O
of    O
the    O
X    B-Body109224911
chromosome    I-Body109224911
inactivation    I-Body109224911
process    O
forming    O
Barr    O
bodies    O
.    O

In    O
the    O
fruit    O
fly    O
,    O
"    O
Drosophila    O
"    O
,    O
one    O
X    B-Body109224911
chromosome    I-Body109224911
in    O
the    O
male    O
is    O
almost    O
the    O
same    O
as    O
two    O
X    O
chromosomes    O
in    O
the    O
female    O
in    O
terms    O
of    O
the    O
gene    O
product    O
produced    O
.    O

XMEN    O
follows    O
an    O
X    O
-    O
linked    O
inheritance    O
pattern    O
because    O
the    O
"    O
MAGT1    O
"    O
is    O
located    O
on    O
the    O
X    B-Body109224911
chromosome    I-Body109224911
.    O

The    O
X    B-Body109224911
chromosome    I-Body109224911
is    O
medium    O
-    O
sized    O
and    O
subtelocentric    O
,    O
with    O
a    O
long    O
and    O
a    O
short    O
arm    O
,    O
and    O
the    O
Y    O
chromosome    O
is    O
very    O
small    O
and    O
is    O
acrocentric    O
in    O
Jujuy    O
specimens    O
,    O
but    O
metacentric    O
in    O
those    O
from    O
Tucumán    O
.    O

By    O
contrast    O
,    O
the    O
allosome    O
pair    O
consists    O
of    O
two    O
X    B-Body109224911
chromosome    I-Body109224911
in    O
females    O
or    O
one    O
X    O
and    O
one    O
Y    O
chromosome    O
in    O
males    O
.    O

Generally    O
the    O
X    B-Body109224911
chromosome    I-Body109224911
constitutes    O
5    O
percent    O
of    O
the    O
haploid    B-Body109224911
chromosomal    O
complement    O
;    O
but    O
the    O
X    O
chromosome    O
of    O
the    O
blackbuck    O
this    O
percentage    O
is    O
14.96    O
.    O

The    O
first    O
RFLP    O
that    O
Page    O
found    O
was    O
from    O
a    O
site    O
of    O
homology    O
between    O
the    O
X    B-Body109224911
chromosome    I-Body109224911
and    O
Y    O
chromosome    O
,    O
a    O
coincidence    O
that    O
would    O
set    O
the    O
direction    O
of    O
his    O
subsequent    O
career    O
.    O

This    O
was    O
the    O
first    O
X    O
-    O
linked    O
blood    O
group    O
to    O
be    O
discovered    O
in    O
1962    O
,    O
and    O
led    O
to    O
extensive    O
work    O
over    O
the    O
following    O
decades    O
,    O
usually    O
with    O
collaborators    O
,    O
to    O
map    O
genes    O
on    O
the    O
human    O
X    B-Body109224911
chromosome    I-Body109224911
.    O

The    O
"    O
NR0B1    O
"    O
gene    O
is    O
located    O
on    O
the    O
short    O
(    O
p    O
)    O
arm    O
of    O
the    O
X    B-Body109224911
chromosome    I-Body109224911
between    O
positions    O
21.3    O
and    O
21.2    O
,    O
from    O
base    O
pair    O
30,082,120    O
to    O
base    O
pair    O
30,087,136    O
.    O

The    O
X    O
factor    O
theory    O
proposes    O
that    O
a    O
mutation    O
within    O
a    O
gene    O
located    O
on    O
the    O
x    B-Body109224911
chromosome    I-Body109224911
of    O
horses    O
causes    O
a    O
larger    O
-    O
than    O
-    O
average    O
heart    O
.    O

In    O
supergravity    O
theories    O
combining    O
general    O
relativity    O
and    O
supersymmetry    O
,    O
the    O
gravitino    B-Body109224911
is    O
the    O
gauge    O
fermion    O
supersymmetric    O
partner    O
of    O
the    O
hypothesized    O
graviton    O
.    O

But    O
it    O
has    O
been    O
speculated    O
that    O
dark    O
matter    O
is    O
constitutes    O
gravitino    B-Body109224911
,    O
a    O
spin    O
3/2    O
particle    O
with    O
mass    O
,    O
its    O
supersymmetric    O
partner    O
being    O
the    O
graviton    O
.    O

Through    O
the    O
supersymmetric    O
version    O
of    O
the    O
Higgs    O
mechanism    O
,    O
the    O
gravitino    B-Body109224911
,    O
the    O
supersymmetric    O
version    O
of    O
the    O
graviton    O
,    O
acquires    O
a    O
mass    O
.    O

This    O
kind    O
of    O
chromosome    O
is    O
also    O
known    O
as    O
Holocentric    B-Body109224911
chromosome    I-Body109224911
.    O

Dominant    O
optic    O
atrophy    O
is    O
associated    O
with    O
mutation    O
of    O
the    O
OPA1    O
gene    O
found    O
on    O
chromosome    B-Body109224911
3    I-Body109224911
,    O
region    O
q28-qter    O
.    O

Thrombopoietin    O
(    O
TPO    O
)    O
is    O
a    O
353-amino    O
acid    O
protein    O
encoded    O
on    O
chromosome    B-Body109224911
3    I-Body109224911
.    O

The    O
thrombopoietin    O
gene    O
is    O
located    O
on    O
the    O
long    O
arm    O
of    O
chromosome    B-Body109224911
3    I-Body109224911
(    O
q26.3    O
-    O
27    O
)    O
.    O

Furthermore    O
,    O
cells    O
will    O
show    O
chromosomal    O
aberrations    O
,    O
the    O
most    O
frequent    O
being    O
monosomy    O
7    O
and    O
partial    O
trisomies    O
of    O
chromosome    B-Body109224911
3q    I-Body109224911
15    O
.    O

In    O
two    O
of    O
these    O
families    O
,    O
two    O
family    O
-    O
specific    O
single    O
nucleotide    O
polymorphisms    O
were    O
present    O
while    O
in    O
the    O
other    O
there    O
persisted    O
a    O
large    O
-    O
scale    O
deletion    O
(    O
821    O
base    O
pairs    O
of    O
DNA    O
)    O
on    O
chromosome    B-Body109224911
3    I-Body109224911
which    O
includes    O
74    O
bases    O
coding    O
for    O
a    O
section    O
of    O
the    O
H    O
/    O
ACA    O
domain    O
.    O

In    O
the    O
human    O
genome    O
,    O
part    O
of    O
the    O
collagen    O
VI    O
family    O
is    O
located    O
on    O
chromosome    B-Body109224911
3    I-Body109224911
in    O
order    O
of    O
COL6A4    O
,    O
COL6A5    O
,    O
COL6A6    O
.    O

The    O
gene    O
responsible    O
for    O
the    O
formation    O
of    O
the    O
blue    O
photopigment    O
is    O
in    O
a    O
position    O
far    O
away    O
,    O
on    O
chromosome    B-Body109224911
7    I-Body109224911
and    O
the    O
gene    O
responsible    O
for    O
the    O
formation    O
of    O
rhodopsin    O
(    O
the    O
rod    O
photopigment    O
)    O
is    O
located    O
on    O
chromosome    B-Body109224911
3    I-Body109224911
.    O

The    O
germline    O
mutations    O
of    O
VHL    O
tumor    O
suppressor    O
gene    O
will    O
be    O
found    O
on    O
3p25    O
-    O
26    O
(    O
short    O
arm    O
of    O
chromosome    B-Body109224911
3    I-Body109224911
)    O
,    O
usually    O
between    O
base    O
pair    O
10,158,318    O
to    O
10,168,761    O
.    O

The    O
gene    O
is    O
encoded    O
on    O
Chromosome    B-Body109224911
3    I-Body109224911
(human)    I-Body109224911
at    O
p25.3    O
on    O
the    O
minus    O
strand    O
from    O
10081320    O
-    O
10108339nt    O
.    O

The    O
Cervical    O
Cancer    O
,    O
TERC    O
,    O
Fluorescence    O
in    O
situ    O
hybridization    O
test    O
,    O
detects    O
amplification    O
of    O
the    O
human    O
telomerase    O
RNA    O
component    O
(    O
TERC    O
)    O
gene    O
and/or    O
polysomy    O
of    O
chromosome    B-Body109224911
3    I-Body109224911
.    O

Also    O
present    O
are    O
molecular    O
hydrogen    O
,    O
atomic    O
helium    O
,    O
C18O    O
(    O
CO    O
with    O
oxygen    O
as    O
the    O
18O    O
isotope    O
)    O
,    O
CS    O
,    O
NH3    O
(    O
ammonia    O
)    O
,    O
H2CO    O
(    O
formaldehyde    O
)    O
,    O
c    O
-    O
C3H2    O
(    O
cyclopropenylidene    O
)    O
and    O
a    O
molecular    O
ion    O
N2H+    O
(    O
diazenylium    B-Body109224911
)    O
,    O
all    O
of    O
which    O
are    O
relatively    O
transparent    O
.    O

There    O
are    O
five    O
classes    O
of    O
particle    O
that    O
superpartners    O
of    O
the    O
Standard    O
Model    O
fall    O
into    O
:    O
squark    B-Body109224911
,    O
gluino    B-Body109224911
,    O
charginos    O
,    O
neutralinos    O
,    O
and    O
slepton    B-Body109224911
.    O

Therefore    O
,    O
most    O
experimental    O
signature    O
involve    O
production    O
of    O
squark    B-Body109224911
or    O
gluino    B-Body109224911
.    O

The    O
squark    B-Body109224911
are    O
the    O
scalar    O
superpartners    O
of    O
the    O
quarks    O
and    O
there    O
is    O
one    O
version    O
for    O
each    O
Standard    O
Model    O
quark    O
.    O

where    O
is    O
the    O
top    O
mass    O
and    O
is    O
the    O
mass    O
of    O
the    O
top    O
squark    B-Body109224911
.    O

Cancellation    O
of    O
the    O
Higgs    B-Body109224911
boson    I-Body109224911
quadratic    O
mass    O
renormalization    O
between    O
fermionic    O
top    O
quark    O
loop    O
and    O
scalar    O
top    O
squark    B-Body109224911
Feynman    O
diagrams    O
in    O
a    O
supersymmetric    O
extension    O
of    O
the    O
Standard    O
Model    O
.    O

The    O
discovery    O
was    O
made    O
in    O
1956    O
in    O
the    O
neutrino    B-Body109224911
experiment    I-Body109224911
.    O

They    O
were    O
discovered    O
independently    O
,    O
long    O
before    O
the    O
hunt    O
for    O
dark    O
matter    O
:    O
they    O
were    O
postulated    O
in    O
1930    O
,    O
and    O
detected    B-Body109224911
in    I-Body109224911
1956    I-Body109224911
.    O

:    O
This    O
contains    O
an    O
account    O
of    O
an    O
experiment    B-Body109224911
first    O
suggested    O
by    O
Wang    O
,    O
confirming    O
the    O
existence    O
of    O
a    O
particle    O
(    O
the    O
neutrino    O
,    O
more    O
precisely    O
the    O
electron    O
neutrino    O
)    O
first    O
predicted    O
by    O
Pauli    O
in    O
1940    O
;    O
a    O
result    O
that    O
was    O
rewarded    O
almost    O
forty    O
years    O
later    O
with    O
the    O
1995    O
Nobel    O
Prize    O
for    O
Reines    O
.    O

Exotic    B-Body109224911
hadron    I-Body109224911

Exotic    B-Body109224911
hadron    I-Body109224911

Pentaquark    B-Body109224911
and    O
other    O
exotic    B-Body109224911
hadron    I-Body109224911
:    O
What    O
combinations    O
of    O
quarks    O
are    O
possible    O
?    O

Toxin-antitoxin    B-Body109224911
database    I-Body109224911

The    O
presence    O
of    O
a    O
single    O
transverse    O
palmar    O
crease    O
can    O
be    O
,    O
but    O
is    O
not    O
always    O
,    O
a    O
symptom    O
associated    O
with    O
abnormal    O
medical    O
conditions    O
,    O
such    O
as    O
fetal    O
alcohol    O
syndrome    O
,    O
or    O
with    O
genetic    O
chromosomal    O
abnormalities    O
,    O
including    O
Down    O
Syndrome    O
(    O
chromosome    B-Body109224911
21    I-Body109224911
)    O
,    O
cri    O
du    O
chat    O
syndrome    O
(    O
chromosome    B-Body109224911
5    I-Body109224911
)    O
,    O
Klinefelter    O
syndrome    O
,    O
Wolf    O
-    O
Hirschhorn    O
Syndrome    O
,    O
Noonan    O
syndrome    O
(    O
chromosome    B-Body109224911
12    I-Body109224911
)    O
,    O
Patau    O
syndrome    O
(    O
chromosome    B-Body109224911
13    I-Body109224911
)    O
,    O
Edward    O
's    O
syndrome    O
(    O
chromosome    B-Body109224911
18    I-Body109224911
)    O
,    O
and    O
Aarskog    O
-    O
Scott    O
syndrome    O
(    O
X    O
-    O
linked    O
recessive    O
)    O
,    O
or    O
autosomal    O
recessive    O
disorder    O
,    O
such    O
as    O
Leaukocyte    O
adhesion    O
deficiency-2    O
(    O
LAD2    O
)    O
.    O

Support    O
for    O
this    O
postulate    O
comes    O
from    O
the    O
location    O
of    O
the    O
gene    O
for    O
the    O
amyloid    O
precursor    O
protein    O
(    O
APP    O
)    O
on    O
chromosome    B-Body109224911
21    I-Body109224911
,    O
together    O
with    O
the    O
fact    O
that    O
people    O
with    O
trisomy    O
21    O
(    O
Down    O
Syndrome    O
)    O
who    O
have    O
an    O
extra    O
gene    O
copy    O
almost    O
universally    O
exhibit    O
at    O
least    O
the    O
earliest    O
symptoms    O
of    O
AD    O
by    O
40    O
years    O
of    O
age    O
.    O

In    O
humans    O
,    O
Down    O
syndrome    O
appears    O
in    O
children    O
carrying    O
in    O
their    O
cells    O
one    O
extra    O
copy    O
of    O
chromosome    B-Body109224911
21    I-Body109224911
,    O
as    O
a    O
result    O
of    O
a    O
defect    O
in    O
chromosome    B-Body109224911
segregation    I-Body109224911
during    O
meiosis    O
in    O
one    O
of    O
the    O
progenitors    O
.    O

Polysomy    O
is    O
found    O
in    O
many    O
diseases    O
,    O
including    O
Down    O
syndrome    O
in    O
humans    O
where    O
affected    O
individuals    O
possess    O
three    O
copies    O
(    O
trisomy    O
)    O
of    O
chromosome    B-Body109224911
21    I-Body109224911
.    O

survive    O
to    O
term    O
,    O
and    O
fetuses    O
with    O
aneuploidy    O
of    O
gene    O
-    O
poor    O
chromosomes    O
—    O
such    O
as    O
chromosome    B-Body109224911
21    I-Body109224911
are    O
still    O
miscarried    O
over    O
23%    O
of    O
the    O
time    O
.    O
Possessing    O
a    O
single    O
copy    O
of    O
an    O
autosome    O
(    O
known    O
as    O
a    O
monosomy    O
)    O

A    O
common    O
example    O
is    O
Down    O
syndrome    O
,    O
which    O
is    O
caused    O
by    O
possessing    O
three    O
copies    O
of    O
chromosome    B-Body109224911
21    I-Body109224911
instead    O
of    O
the    O
usual    O
two    O
.    O

In    O
humans    O
,    O
Robertsonian    O
translocations    O
generally    O
occurs    O
in    O
the    O
five    O
acrocentric    O
chromosome    O
pairs    O
,    O
namely    O
13    B-Body109224911
,    O
14    B-Body109224911
,    O
15    B-Body109224911
,    O
21    B-Body109224911
and    O
22    B-Body109224911
.    O

#    O
Ion    B-Body109224911
Gun    I-Body109224911
,    O
used    O
to    O
direct    O
a    O
beam    O
of    O
ions    B-Body109224911
at    O
a    O
target    O
sample    O
.    O

Since    O
chromosome    B-Body109224911
segregation    I-Body109224911
is    O
driven    O
by    O
microtubules    O
,    O
colchicine    O
is    O
also    O
used    O
for    O
inducing    O
polyploidy    O
in    O
plant    O
cells    O
during    O
cellular    O
division    O
by    O
inhibiting    O
chromosome    O
segregation    O
during    O
meiosis    O
;    O
half    O
the    O
resulting    O
gametes    O
,    O
therefore    O
,    O
contain    O
no    O
chromosomes    O
,    O
while    O
the    O
other    O
half    O
contains    O
double    O
the    O
usual    O
number    O
of    O
chromosomes    O
(    O
i.e.    O
,    O
diploid    B-Body109224911
instead    O
of    O
haploid    B-Body109224911
,    O
as    O
gametes    O
usually    O
are    O
)    O
,    O
and    O
lead    O
to    O
embryos    O
with    O
double    O
the    O
usual    O
number    O
of    O
chromosomes    O
(    O
i.e.    O
,    O
tetraploid    O
instead    O
of    O
diploid    O
)    O
.    O

Amon    O
's    O
more    O
recent    O
work    O
has    O
investigated    O
the    O
regulation    O
of    O
chromosome    B-Body109224911
segregation    I-Body109224911
and    O
how    O
chromosomes    O
are    O
accurately    O
transmitted    O
to    O
gametes    O
in    O
meiosis    O
by    O
examining    O
gene    O
regulatory    O
networks    O
.    O

Reversine    O
is    O
a    O
potent    O
inhibitor    O
of    O
the    O
mitotic    O
kinase    O
Mps1    O
and    O
it    O
is    O
widely    O
used    O
to    O
study    O
the    O
process    O
of    O
chromosome    B-Body109224911
segregation    I-Body109224911
.    O

In    O
cancer    O
cells    O
,    O
aneuploidy    O
is    O
a    O
frequent    O
event    O
,    O
indicating    O
that    O
these    O
cells    O
present    O
a    O
defect    O
in    O
the    O
machinery    O
involved    O
in    O
chromosome    B-Body109224911
segregation    I-Body109224911
,    O
as    O
well    O
as    O
in    O
the    O
mechanism    O
ensuring    O
that    O
segregation    O
is    O
correctly    O
performed    O
.    O

In    O
humans    O
,    O
Down    O
syndrome    O
appears    O
in    O
children    O
carrying    O
in    O
their    O
cells    O
one    O
extra    O
copy    O
of    O
chromosome    B-Body109224911
21    I-Body109224911
,    O
as    O
a    O
result    O
of    O
a    O
defect    O
in    O
chromosome    B-Body109224911
segregation    I-Body109224911
during    O
meiosis    O
in    O
one    O
of    O
the    O
progenitors    O
.    O

A    O
satellite    B-Body109224911
chromosome    I-Body109224911
or    O
SAT    B-Body109224911
chromosome    I-Body109224911
has    O
a    O
chromosome    O
segment    O
that    O
is    O
separated    O
from    O
the    O
main    O
body    O
of    O
the    O
chromosome    O
by    O
such    O
a    O
secondary    O
constriction    O
.    O

It    O
is    O
probably    O
the    O
salt    O
SCl3+Cl−    O
,    O
since    O
related    O
salts    O
are    O
known    O
with    O
noncoordinating    B-Body109224911
anion    I-Body109224911
.    O

The    O
counterions    O
are    O
bulky    O
tetraarylborate    B-Body109224911
.    O

Similar    O
to    O
silver    O
nitrate    O
,    O
silver    O
perchlorate    O
is    O
an    O
effective    O
reagent    O
for    O
replacing    O
halides    O
ligands    O
with    O
perchlorate    O
,    O
which    O
is    O
a    O
weakly    O
or    O
non-coordinating    B-Body109224911
anion    I-Body109224911
.    O

Tetrafluoroborate    B-Body109224911
salts    O
are    O
commonly    O
employed    O
as    O
non-coordinating    B-Body109224911
anion    I-Body109224911
.    O

The    O
use    O
of    O
a    O
BAr−    B-Body109224911
anions    I-Body109224911
has    O
proven    O
to    O
be    O
the    O
most    O
widely    O
applicable    O
solution    O
to    O
the    O
aggregation    O
problem    O
.    O

Dicentric    B-Body109224911
chromosome    I-Body109224911

In    O
addition    O
to    O
the    O
normal    O
karyotype    O
,    O
wild    O
populations    O
of    O
many    O
animal    O
,    O
plant    O
,    O
and    O
fungi    O
species    O
contain    O
B    B-Body109224911
chromosomes    I-Body109224911
(    O
also    O
known    O
as    O
supernumerary,    B-Body109224911
accessory    B-Body109224911
,    O
(conditionally-)dispensable,    B-Body109224911
or    O
lineage-specific    B-Body109224911
chromosomes    I-Body109224911
)    O
.    O

B    B-Body109224911
chromosome    I-Body109224911

Ionic    B-Body109224911
potential    I-Body109224911


